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Abstract 
The mechanisms that are involved in maintaining a human pregnancy to term, and the 
switches that lead to a normal labour and pregnancy outcome or indeed an adverse 
outcome such as miscarriage, pre-eclampsia (PE), fetal growth restriction (FGR) or 
preterm labour, are complex but the role of the placenta is crucial to them all. Heat shock 
proteins (HSPs) play an important role in regulating signal transduction, inhibition of 
apoptosis and cellular proliferation and differentiation.  Apoptosis has been implicated in 
both PE and labour. In the apoptotic pathway, HSPs act at several stages to prevent cell 
death initiated by stress-induced damage.  Toll-like receptors (TLR) are the principal 
signalling molecules through which mammals sense infection. Since these pathways play a 
role in oxidative stress and inflammation, both features of labour and PE, the hypothesis 
was that placental stress pathways (HSP70, HSP27, HSF1-2, small HSPs family, 
DNAJAB, HSP60, GRP78, HSP90AA, HSP90B1 and HSP105), inflammatory mediates 
(TLRs, MyD88 and NF-κB) and apoptotic markers (caspases (CASP) 3, 7 and 9) pathways 
expression would alter during labour and pregnancies complications such as PE and FGR 
and this would vary in different placental zones perhaps due to the variation in blood 
supply to each zone or link to ischemic-reperfusion (IR) injury and are some zones of 
placenta more susceptible to IR injury. HSPs, TLRs and caspases were examined in 
placentas obtained from women who delivered by caesarean section (non-labour) and were 
not in labour and compared to the equivalent zone of placentas obtained from women who 
delivered vaginally (labour)  following an uncomplicated labour. Samples were obtained 
from 12 sites within each placenta: 4 equally spaced apart pieces were sampled from the 
inner, middle and outer placental regions.  The expression was investigated by Western 
blotting (HSP70, HSF1, HSP27 and P-HSP27) and real time PCR (HSP families, HSF1-2, 
TLRs, MyD88, NF-κB and caspases).  
The first aim of this study was to examine the spatial expression of HSPs, caspases and 
TLR genes in placentas.  Two HSF1 forms were observed in all samples which, according 
to the data sheet represent the phosphorylated (P-HSF1) and non-phosphorylated (NP-
HSF1) forms. HSP70, HSF1 and HSP27 are expressed in a spatial manner in the placenta 
with the highest expression being in the middle zone in the labour group (HSF1, both 
forms) and in both the labour and the non-labour groups (HSP70 and HSP27). HSF1 
mRNA expression was spatially distributed in the non-labour group with highest 
expression being in the outer zone.  No spatial differences were noticed in both P-HSP27 
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protein expression and mRNA expression of other HSPs families, HSF2, TLRs, MyD88, 
NF-κB and caspases3, 7 and 9 genes.  
Human parturition involves interaction of hormonal, neurological, mechanical stretch and 
inflammatory pathways and the placenta plays a crucial role.  The second aim of this study 
was to determine these genes expression in the non-labour group compare to the labour 
group at the inner, middle and outer placental zones.  When non-labour groups were 
compared with the labour group at the three zones the changes found can be summarized 
as follows:  
HSP70 protein expression was increased in the labour group compared to the non-labour 
group and in contrast to that, HSP27 protein and mRNA expression were increased in the 
non-labour group both at the middle zone. 
Phosphorylated-HSP27 (P-HSP27) expression was increased in the non-labour group 
compared to the labour group at the inner (all ser sites) and outer (ser 15 and 78) zones.  
No differences were found at the middle zone. HSF1 protein expressions (both forms) was 
increased in the non-labour, group compared to the non-labour group, paradoxically, HSF1 
mRNA expression was increased in in the labour group at the inner zone. 
HSPB6, HSP32 and DNAJB1 mRNA expression was increased in the non-labour group 
compared to the labour group at the middle zone. HSPB2, HSP90AA and HSP90B1 
mRNA expression was increased in the labour group compared to the non-labour group at 
the outer zone. TLR5 and CASP7 mRNA expression was increased in labour group 
compared to the non-labour group at the middle zone.  TLR9-10 mRNA expression was 
neglectable.  No other changes were found for any other genes. 
PE is associated with maternal and placental oxidative stress. The third aim was to 
determine the expression of genes of the same pathways described above in the placenta in 
pregnancies complicated with PE and FGR compare to the normal pregnancies.  HSPs, 
TLRs and caspases were examined in placentas obtained from non-labouring women who 
delivered by caesarean section (normal pregnancy and PE) and compared to women who 
delivered vaginally (normal pregnancy and PE).  Samples were obtained from 12 sites 
within each placenta: Four equally spaced apart pieces were sampled from the inner, 
middle and outer, however, due to time constraints only the inner and middle zones were 
investigated in PE group (except HSP27 and HSP70).  Samples from FGR placentas were 
obtained from 8 sites within each placenta represent inner and outer zones.  Western 
blotting and qRT-PCR was used for the analysis as required.  
When PE (non-labour and labour) and FGR (labour only) groups were compared with the 
controls (non-labour and labour) at the two zones, the changes found can be summarized as 
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follows: HSP70 was increased in the non-labour-PE group compared to the non-labour 
control group at the inner zone.  No other differences were found. Non- Phosphorylated-
HSF1 (NP-HSF1) protein expression and HSF1 mRNA expression were increased in the 
PE group (non-labour and labour) compared to the control group (non-labour and labour) 
at the inner zone. HSP27 and P-HSP27 protein expression was increased in the PE (labour) 
compared to the control (labour) at the middle zone.  No changes were found in the mRNA 
expression of HSP27. There was a significant increase in P-HSP27 protein expression in 
labour PE compared to the labour control at the inner (ser 78 and 82) and middle (ser 15) 
zones.  
CASP7 and CASP9 mRNA expression was increased in the non-labour control compared 
to the non-labour PE at the inner (CASP7) and middle (CASP9) zones. CASP3 mRNA 
expression was increased in the labour PE compared to labour control at the middle zone. 
There was decreased in mRNA expression of HSPB6, TLR5 and TLR1 in the PE group 
non-labour compared to the controlnon-labour at the inner (HSPB6) and middle (TLR1 and 
TLR5) zones. 
Towards the end of the PhD time preliminary experiments were performed to determine if 
different zones of the placenta were more susceptible to heat shock and IR injury in vitro.  
The markers mentioned above were used and pieces of placenta from each zone were 
exposed to 2% oxygen then 8% oxygen for different time periods to create an IR model.  
The number of experiments were not sufficient to make definitive conclusions but the pilot 
data suggest this should be explored more in future studies include more placenta tissue 
exposed to IR injury and heat shock to understand how placental stress might affect 
placental function. 
Obesity is characterized by a chronic, low-grade inflammation and an impaired 
intracellular stress defence system. Obesity increases the risk for PE.  The last aim was to 
screen for different HSPs and CASPs families in placentas obtained from 4 BMI groups 
(non-labour).  In general, HSPs expression was reduced whereas caspases expression was 
increased in the morbid obesity group (BMI>40) compared to the normal BMI group.  This 
indicates reduced cellular protection and increased cellular damage respectively in 
placentas from obese women. 
In summary this thesis has reiterated the importance of controlled sampling of the placenta 
for studying pregnancy disorders.  The results show that spatial changes in inflammatory 
and stress markers occur in both labour and PE. Trying to make sense of the data is very 
difficult however the preliminary data from the in vitro studies suggests that further studies 
exposing different zones of the placenta to stress may help to understand the process that 
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take place during stress. Clearly the bigger aim would be, one day, to try and decide which 
of the pathways might be targeted for therapy for pre-term labour and PE.  
  
5 
 
Table of Contents 
Abstract ................................................................................................................................. 1 
List of Tables ...................................................................................................................... 16 
List of Figures ..................................................................................................................... 17 
Acknowledgement .............................................................................................................. 44 
Author’s Declaration ......................................................................................................... 46 
Definitions/Abbreviations .................................................................................................. 48 
Chapter I: General introduction....................................................................................... 54 
1 Introduction ................................................................................................................ 54 
1.1 The placenta .......................................................................................................... 54 
1.1.1 The term placenta ........................................................................................... 54 
1.1.2 Placenta shape and cord insertion: ................................................................. 56 
1.1.3 Early development of the human placenta ..................................................... 56 
1.1.3.1 The decidua of the endometrium ................................................................ 56 
1.1.3.2 Early development of the blastocyst .......................................................... 57 
1.1.4 Implantation of the blastocyst ........................................................................ 57 
1.1.4.1 Pre-lacunar stage ........................................................................................ 57 
1.1.4.2 Lacunar stage .............................................................................................. 58 
1.1.5 Development of the placenta and utero-placenta circulation ......................... 59 
1.1.5.1 Villous structure and development ............................................................. 59 
1.1.5.2 Trophoblast invasion .................................................................................. 60 
1.1.6 Mechanism of control of the trophoblast invasion ......................................... 61 
1.1.6.1 Role of integrin and cell adhesion molecules: ............................................ 62 
1.1.6.2 Role of PECAM-1 ...................................................................................... 62 
1.1.6.3 Role of proteases ........................................................................................ 62 
1.1.6.4 Oxygen tension and trophoblast invasion .................................................. 63 
1.1.7 Placenta functions .......................................................................................... 63 
1.1.7.1 Hormone synthesis and secretion ............................................................... 63 
1.1.7.2 Placental transport system .......................................................................... 63 
1.1.1 Placental sampling and mRNA Analyses ...................................................... 64 
1.2 Normal Parturition ................................................................................................. 65 
1.2.1 Definition ....................................................................................................... 65 
1.2.2 Parturition as an inflammatory process .......................................................... 65 
1.2.3 Parturition and link with oxidative stress ....................................................... 68 
1.3 Pre-eclampsia (PE) ................................................................................................ 70 
1.3.1 Definition of PE ............................................................................................. 70 
1.3.2 PE risk ............................................................................................................ 71 
1.3.3 Clinical presentation....................................................................................... 72 
6 
 
1.3.4 PE classification ............................................................................................. 72 
1.3.5 Pathophysiology of PE ................................................................................... 73 
1.3.5.1 Immunological factors in PE ...................................................................... 73 
1.3.5.2 Abnormal placentation ............................................................................... 74 
1.3.5.3 Endothelial dysfunction .............................................................................. 75 
1.3.5.4 Angiogenic factors in PE ............................................................................ 75 
1.3.5.5 Genetics factors in PE ................................................................................ 76 
1.3.6 Prediction of PE ............................................................................................. 76 
1.3.7 PE and link with oxidative stress ................................................................... 77 
1.4 Fetal growth restriction (FGR) .............................................................................. 79 
1.4.1 Definition ....................................................................................................... 79 
1.4.2 Pathophysiology of FGR ................................................................................ 79 
1.4.3 Causes of FGR ............................................................................................... 80 
1.4.4 Diagnosis and Surveillance ............................................................................ 80 
1.4.5 Fetal and maternal health risks ....................................................................... 81 
1.4.6 The placenta in FGR ...................................................................................... 81 
1.5 Maternal obesity .................................................................................................... 83 
1.5.1 Obesity classification ..................................................................................... 83 
1.5.2 Obesity and pregnancy ................................................................................... 84 
1.5.3 The rising trends in maternal obesity ............................................................. 84 
1.5.4 Maternal complications associated with maternal obesity ............................. 85 
1.5.4.1 Maternal mortality ...................................................................................... 85 
1.5.4.2 Gestational diabetes mellitus (GDM) ......................................................... 85 
1.5.4.3 Thromboembolic complications ................................................................. 85 
1.5.4.4 Effects of obesity on labour and delivery ................................................... 85 
1.5.4.5 Hypertensive disease in pregnancy ............................................................ 86 
1.5.5 Obesity and PE ............................................................................................... 86 
1.5.6 Obesity management during pregnancy ......................................................... 88 
1.6 Thesis aims ............................................................................................................ 89 
Placenta tissue experiments study .................................................................................... 90 
BMI study ........................................................................................................................ 91 
2 Chapter II: Materials and methods .......................................................................... 92 
2.1 Patient consenting process ..................................................................................... 92 
2.1.1 Identification .................................................................................................. 92 
2.1.2 Patient recruitment ......................................................................................... 92 
2.1.3 Ethical approval ............................................................................................. 93 
2.2 Subjects ................................................................................................................. 93 
2.2.1 Control groups: .............................................................................................. 93 
7 
 
2.2.2 Obese group: .................................................................................................. 93 
2.2.3 PE group: ........................................................................................................ 94 
2.2.4 FGR group ...................................................................................................... 94 
2.3 Buffers ................................................................................................................. 100 
2.3.1 Phosphate buffered saline (PBS) .................................................................. 100 
2.3.2 Tissue homogenization buffers (1 L) ........................................................... 100 
2.3.3 Bradford Assay buffers ................................................................................ 100 
2.3.4 Western blotting buffers ............................................................................... 100 
2.3.4.1 Sample loading buffer (2x) ....................................................................... 101 
2.3.4.2 Buffer A for the resolving gel (1 L, pH 8.8) ............................................ 101 
2.3.4.3 Buffer B for the stacking gel .................................................................... 101 
2.3.4.4 Composition of resolving and stacking gels (Table 2-3) ......................... 101 
2.3.4.5 10% ammonium per sulphate (APS) solution .......................................... 102 
2.3.4.6 Running buffer (5x) .................................................................................. 102 
2.3.4.7 Running buffer diluted ............................................................................. 102 
2.3.5 Transfer of proteins to nitrocellulose: buffers required ............................... 102 
2.3.6 Immuno-detection of proteins: buffer required ............................................ 102 
2.3.7 TAE buffer for gel electrophoresis .............................................................. 102 
2.3.8 Supplemented media for tissue culture (hypoxia-reperfusion and heat shock 
experiments). .............................................................................................................. 103 
2.4 Placenta sampling methods ................................................................................. 103 
2.4.1 Collection and processing of placental tissue at the delivery suite .............. 104 
2.5 Protein expression analysis: ................................................................................ 104 
2.5.1 Placenta tissue homogenisation ................................................................... 104 
2.5.2 Protein estimation using Bradford assay ...................................................... 105 
2.5.3 Western blotting ........................................................................................... 106 
2.5.3.1 Samples preparation and gel electrophoresis ........................................... 106 
2.5.3.2 Transfer of proteins to Nitrocellulose (semi-dry transfer): ...................... 107 
2.5.3.3 Immuno-detection of proteins (Immune-blotting).................................... 107 
2.5.3.4 Detection .................................................................................................. 111 
2.5.3.5 Loading control ........................................................................................ 111 
2.6 RNA extraction from placenta tissue .................................................................. 112 
2.6.1 RNA extraction ............................................................................................ 112 
2.6.2 Quantification of RNA ................................................................................. 112 
2.6.3 Reverse transcription (converting mRNA into cDNA) ................................ 114 
2.6.4 Testing cDNA quality .................................................................................. 114 
2.6.5 Gel electrophresis using 2% agarose gels .................................................... 115 
2.6.6 Quantitative real time polymerase chain reaction (qRT-PCR) .................... 116 
2.6.7 qRT-PCR data analysis ................................................................................ 123 
8 
 
2.6.8 Evaluation of TaqMan gene expression assay product by performing gel 
electrophoresis............................................................................................................ 123 
2.7 Mammalian tissue culture.................................................................................... 124 
2.7.1 Hypoxia-normoxia (model of IR injury) tissue culture................................ 124 
2.7.2 HSP induction experiment ........................................................................... 129 
2.8 Statistical analysis: .............................................................................................. 133 
2.9 Troubleshooting ................................................................................................... 133 
2.9.1 Optimization of Santa Cruz and Abcam TLR2 and TLR4 antibodies ......... 133 
2.9.2 Different protocols ....................................................................................... 133 
2.9.3 Western blotting of membrane protein ........................................................ 134 
2.9.4 Running the positive control using Santa Cruz TLR4 antibody .................. 134 
2.9.5 Blotting using only secondary antibodies .................................................... 135 
Chapter III: HSP70, HSF1 and HSF2 expression in normal pregnancies and 
pregnancies complicated with PE and FGR (HSP70 only) 
3 Introduction .............................................................................................................. 136 
3.1 Heat shock proteins ............................................................................................. 136 
3.1.1 Discovery ..................................................................................................... 136 
3.1.2 Functions ...................................................................................................... 137 
3.1.2.1 Intra-cellular HSPs ................................................................................... 137 
3.1.2.2 Extra-cellular HSPS ................................................................................. 139 
3.1.3 Synthesis of HSPs ........................................................................................ 140 
3.1.4 HSPs and the immune system ...................................................................... 141 
3.1.5 Families of heat shock protein ..................................................................... 141 
3.2 Heat shock protein 70 (HSP70) ........................................................................... 142 
3.2.1 HSP70 structure ........................................................................................... 142 
3.2.2 HSP70 family members and chaperone function ......................................... 143 
3.2.3 HSP70 chaperone function ........................................................................... 144 
3.2.4 HSP70 and anti-apoptotic function .............................................................. 144 
3.2.5 HSP70 and inflammatory pathways ............................................................. 144 
3.2.6 HSP70 and cardio protection ....................................................................... 145 
3.2.7 HSP70 in cancer ........................................................................................... 146 
3.2.8 HSP70 gene regulation ................................................................................. 146 
3.2.8.1 Heat shock elements (HSEs) .................................................................... 146 
3.2.8.2 Heat shock transcription factors (HSFs) .................................................. 147 
3.3 Results ................................................................................................................. 150 
3.3.1 Patient clinical data analysis ........................................................................ 150 
3.3.1.1 Normotensive, PE and FGR groups: ........................................................ 150 
3.3.2 Analysis of protein and mRNA HSP70 expression in normal pregnancy ... 151 
9 
 
3.3.3 Analysis of protein and mRNA HSP70 expression in pregnancies 
complicated with PE .................................................................................................. 155 
3.3.4 Analysis of protein and mRNA expression of HSP70 in pregnancies 
complicated with FGR. .............................................................................................. 158 
3.3.5 Analysis of protein and mRNA expression of HSF1 in normal pregnancy . 160 
3.3.6 Analysis of protein and mRNA expression of HSF1 in pregnancies 
complicated with PE .................................................................................................. 167 
3.3.7 Analysis of mRNA expression of HSF2 in normal pregnancies and 
pregnancies complicated with PE at the inner and middle zones. ............................. 172 
3.3.8 Results summary .......................................................................................... 176 
3.3.8.6 Summary results for mRNA expression of HSF2 .................................... 179 
3.4 Discussion ........................................................................................................... 180 
3.4.1 HSP70 and present findings ......................................................................... 180 
3.4.2 Key findings HSP70 ..................................................................................... 180 
3.4.3 HSF1 and present findings ........................................................................... 180 
3.4.4 Key findings HSF1 ....................................................................................... 181 
3.4.5 Key findings HSF2 ....................................................................................... 182 
3.4.6 HSP70 expression in labour, PE and FGR ................................................... 183 
3.4.7 HSF1 in labour and PE ................................................................................. 187 
3.4.8 HSF2 in labour and PE ................................................................................. 189 
Chapter IV: HSP27 and P-HSP27 expression in normal pregnancies and pregnancies 
complicated with PE and FGR (HSP27 only). ............................................................... 190 
4 Introduction .............................................................................................................. 190 
4.1 Heat shock protein 27 (HSP27) ........................................................................... 190 
4.1.1 HSP27 gene structure ................................................................................... 190 
4.1.2 Post-translational modifications ................................................................... 191 
4.1.3 Functions of HSP27 ..................................................................................... 192 
4.1.3.1 HSP27 and chaperone function ................................................................ 193 
4.1.3.2 HSP27 and actin filament functions ......................................................... 193 
4.1.3.3 HSP27 and anti-apoptotic function .......................................................... 193 
4.1.4 HSP27 and oxidative stress .......................................................................... 194 
4.1.5 HSP27 and ER stress .................................................................................... 194 
4.1.6 HSP27 and Disease ...................................................................................... 195 
4.1.7 HSP27 as a therapeutic agent ....................................................................... 196 
4.2 Results ................................................................................................................. 196 
4.2.1 Patient clinical data analysis ........................................................................ 196 
4.2.2 Analysis of protein and mRNA HSP27 expression in normal pregnancy ... 197 
4.2.3 Analysis of protein and mRNA expression of HSP27 in pregnancy 
complicated with PE. ................................................................................................. 200 
10 
 
4.2.4 Analysis of protein and mRNA expression of HSP27 in pregnancies 
complicated with FGR. .............................................................................................. 204 
4.2.5 Analysis of protein expression of P-HSP27 at ser 15, 78 and 82 in normal 
pregnancies and pregnancies complicated with PE. .................................................. 206 
4.2.6 Results summary .......................................................................................... 217 
4.2.6.1 Summary results for HSP27 expression in normal pregnancy: ................ 217 
4.2.6.2 Summary results for HSP27 expression in pregnancy complicated with PE
 218 
4.2.6.3 Summary of HSP27 expression in FGR group ........................................ 218 
4.2.6.4 Summary of results for P-HSP27 at ser 15, ser 87 and ser 82 ................. 219 
4.3 Discussion ........................................................................................................... 220 
4.3.1 HSP27 and present findings ......................................................................... 220 
4.3.2 P-HSP27 and present finding ....................................................................... 220 
4.3.2.1 HSP27 expression in labour ..................................................................... 220 
4.3.3 P-HSP27 (ser 15, 78 and 82) in labour and PE ............................................ 223 
4.3.4 HSP27 expression in PE and FGR ............................................................... 225 
Chapter V: Analysis of mRNA expression of small HSP family in human placenta of 
normal pregnancies and pregnancies complicated with PE 
5 Small HSP family (sHSP) ........................................................................................ 228 
5.1 Introduction ......................................................................................................... 228 
5.1.1 Definition ..................................................................................................... 228 
5.1.2 HSPB2 (heat shock 27kDa protein 2) .......................................................... 230 
5.1.3 HSPB3 (HSP17/27) ...................................................................................... 231 
5.1.4 HSPB4 (CRYAA, αA-crystallin) ................................................................. 231 
5.1.5 HSPB5 (CRYAB, αB-crystallin) ................................................................. 232 
5.1.5.1 HSPB5 functions ...................................................................................... 232 
5.1.6 HSPB6 (heat shock protein, alpha-crystallin-related B6, HSP20) ............... 233 
5.1.6.1 HSPB6 functions ...................................................................................... 234 
5.1.6.2 HSPB6 chaperone function ...................................................................... 234 
5.1.6.3 HSPB6 and cardio protective role ............................................................ 234 
5.1.7 HSPB7 (heat shock 27kDa protein family, member 7 (cardiovascular, 
cvHSP) 235 
5.1.8 HSPB8 (heat shock 22kDa protein 8) .......................................................... 235 
5.1.8.1 HSPB8 chaperone function ...................................................................... 235 
5.1.8.2 HSPB8 and inflammation ......................................................................... 236 
5.1.8.3 HSPB8 and cardiac protection ................................................................. 236 
5.2 Results ................................................................................................................. 237 
5.2.1 Patient clinical data analysis ........................................................................ 237 
5.2.2 Undetermined sHSPs ................................................................................... 237 
5.2.3 HSPB2 expression in normal pregnancies and PE ....................................... 237 
11 
 
5.2.4 HSPB5 expression in normal pregnancies and PE ....................................... 240 
5.2.5 HSPB6 expression in normal pregnancies and PE ....................................... 242 
5.2.6 HSPB7 expression in normal pregnancies and PE ....................................... 245 
5.2.7 HSPB8 expression in normal pregnancies and PE ....................................... 248 
5.2.8 Results summary .......................................................................................... 250 
5.3 Discussion ........................................................................................................... 253 
5.3.1 HSPB2 (HSP22) and present findings ......................................................... 253 
5.3.2 HSPB2 in labour and PE .............................................................................. 254 
5.3.3 HSPB5 and present findings ........................................................................ 254 
5.3.4 HSPB5 and labour and PE ........................................................................... 254 
5.3.5 HSPB6 and present finding .......................................................................... 255 
5.3.6 HSPB6 expression in labour and PE ............................................................ 255 
5.3.7 HSPB7 and HSPB8 ...................................................................................... 255 
5.3.8 Linking sHSPs expression to oxidative stress and cell death ...................... 256 
Chapter VI: Analysis of mRNA expression of HO-1 (HSP32), DNAJ (HSP40) and 
HSPD1 (HSP60) families in human placenta of normal pregnancies and pregnancies 
complicated with PE 
6 HO-1, DNAJ and HSPD1 ........................................................................................ 258 
6.1 Introduction ......................................................................................................... 258 
6.1.1 Heme oxygenase (decycling)-1 (HO-1, HSP32) .......................................... 258 
6.1.1.1 HO-1 functions ......................................................................................... 259 
6.1.1.2 HSP32 and anti-apoptotic and anti-inflammatory functions .................... 259 
6.1.1.3 Linking of HSP32 expression to oxidative stress and IR injury .............. 259 
6.1.1.4 HO-1 expression in the placenta............................................................... 260 
6.1.2 DNAJ (HSP40) heat shock protein .............................................................. 261 
6.1.3 HSPD1 (HSP60) .......................................................................................... 262 
6.1.3.1 HSPD1 functions ...................................................................................... 262 
6.1.3.2 HSPD1 immunological roles .................................................................... 263 
6.2 Results ................................................................................................................. 264 
6.2.1 Patient clinical data analysis ........................................................................ 264 
6.2.2 HO-1 expression in normal pregnancies and PE.......................................... 264 
6.2.3 DNAJAB1 expression in normal pregnancies and PE ................................. 266 
6.2.4 HSPD1 expression in normal pregnancies and PE ...................................... 269 
6.2.5 Results summary .......................................................................................... 272 
6.3 Discussion ........................................................................................................... 274 
6.3.1 HO-1 and present findings ........................................................................... 274 
6.3.2 HO-1 in labour and PE ................................................................................. 274 
6.3.3 DNAJB1 and the present findings ............................................................... 277 
6.3.4 HSPD1 and present findings ........................................................................ 278 
12 
 
6.3.5 HSPD1 expression in labour and PE ............................................................ 278 
Chapter VII: Analysis of mRNA expression of HSPA5 (GRP78), HSP90 (HSP90AA 
and HSP90B1) and HSPH1 (HSP105) families in human placenta of normal 
pregnancies and pregnancies complicated with PE 
7 HSPA5, HSP90 and HSPH1 expression ................................................................. 280 
7.1 Introduction ......................................................................................................... 280 
7.1.1 Glucose regulated protein (GRP78, HSPA5) ............................................... 280 
7.1.1.1 GRP78 immunological roles .................................................................... 281 
7.1.2 Heat shock protein 90 (HSP90) ................................................................... 281 
7.1.2.1 Intracellular location ................................................................................. 281 
7.1.2.2 HSP90 isoforms and transcriptional regulation ........................................ 282 
7.1.3 HSPH1 (HSP105/HSP110 family) ............................................................... 283 
7.2 Results ................................................................................................................. 283 
7.2.1 Patient clinical data analysis ........................................................................ 283 
7.2.2 HSPA5 expression in normal pregnancies and PE ...................................... 284 
7.2.3 HSP90AA expression in normal pregnancies and PE.................................. 286 
7.2.4 HSP90B1 expression in normal pregnancies and PE ................................... 289 
7.2.5 HSPH1 expression in normal pregnancies and PE ...................................... 292 
7.2.6 Results summary .......................................................................................... 295 
7.3 Discussion ........................................................................................................... 297 
7.3.1 GRP78 expression in the labour and PE ...................................................... 297 
7.3.2 HSP90AA and HSP90AB1 and the present findings ................................... 299 
7.3.3 HSP90AA and HSP90AB1 expression in the labour and PE ...................... 300 
7.3.4 HSPH1 (HSP105/HSP110) and present finding .......................................... 302 
7.3.5 HSPH1 expression in the placenta ............................................................... 302 
Chapter VIII: Analysis of mRNA expression of Caspases (CASP3, 7 and 9) apoptotic 
markers in human placenta of normal pregnancies and pregnancies complicated with 
PE 
8 Caspases (CASP3, 7 and 9) expression ................................................................... 303 
8.1 Introduction ......................................................................................................... 303 
8.1.1 Apoptosis ..................................................................................................... 303 
8.1.1.1 Intrinsic pathways ..................................................................................... 304 
8.1.1.2 Extrinsic pathway ..................................................................................... 304 
8.1.2 CASPs in inflammation and immunity ........................................................ 306 
8.1.3 Apoptosis and HSPs ..................................................................................... 306 
8.2 Results ................................................................................................................. 308 
8.2.1 Patient clinical data analysis ........................................................................ 308 
8.2.2 CASP3 mRNA expression in the labour and PE ......................................... 308 
8.2.3 CASP7 mRNA expression in the labour and PE ......................................... 310 
13 
 
8.2.4 CASP9 mRNA expression in the labour and PE ......................................... 313 
8.2.5 Results summary .......................................................................................... 316 
8.3 Discussion ........................................................................................................... 318 
8.3.1 CASPs mRNA expression and key findings ................................................ 318 
8.3.2 CASPs mRNA expression in the human placenta during labour and PE .... 318 
Chapter IX: Analysis of mRNA expression of TLRs, MyD88 and NF-κB families in 
human placenta of normal pregnancies and pregnancies complicated with PE 
9 TLR expression in the placenta during labour and PE ........................................ 322 
9.1 Introduction ......................................................................................................... 322 
9.1.1 Toll-like receptors (TLRs) and innate immunity ......................................... 322 
9.1.2 Human immune system ................................................................................ 322 
9.1.2.1 Adaptive immunity ................................................................................... 322 
9.1.2.2 Innate immune system .............................................................................. 323 
9.1.3 TLRs ............................................................................................................. 324 
9.1.4 TLRs and their ligands ................................................................................. 325 
9.1.5 Myeloid differentiation primary response gene (88) ................................... 328 
9.1.6 Nuclear factor kappa light chain enhancer of activated B cells (NF-κβ) ..... 328 
9.1.7 TLRs signalling pathways ............................................................................ 328 
9.1.7.1 MyD88 dependent pathway ...................................................................... 329 
9.1.7.2 The TRIF dependent pathway .................................................................. 329 
9.2 Results: ................................................................................................................ 330 
9.2.1 Patient clinical data analysis ........................................................................ 330 
9.2.2 Analysis of mRNA TLRs 1-8 expression in normal pregnancy .................. 330 
9.2.3 Analysis of mRNA TLRs 1-8 expression in pregnancies complicated with PE
 336 
9.2.4 Analysis of mRNA of MYD88 expression in normal pregnancy ................ 348 
9.2.5 Analysis of mRNA MyD88 expression in pregnancies complicated with PE
 350 
9.2.6 Analysis of mRNA NF-κB expression in normal pregnancy....................... 352 
9.2.7 Analysis of mRNA NF-κB expression in pregnancies complicated with PE
 353 
9.2.8 Results summary .......................................................................................... 355 
9.3 Discussion ........................................................................................................... 357 
9.3.1 TLRs and present findings ........................................................................... 357 
9.3.2 MyD88 and NF-κB and the present findings ............................................... 357 
9.3.3 TLRs expression at the maternal-fetal interface .......................................... 358 
9.3.4 TLR signalling and function at the maternal-fetal interface ........................ 358 
9.3.5 TLRs expression in female reproductive tract ............................................. 358 
9.3.6 TLRs expression in decidua and amnion ..................................................... 359 
14 
 
9.3.7 TLRs expression in placental tissue ............................................................. 359 
9.3.8 TLRs in complicated pregnancies ................................................................ 362 
9.3.9 Immune mechanisms and PE ....................................................................... 364 
9.3.9.1 Infectious microorganisms in PE ............................................................. 364 
9.3.9.2 TLR polymorphisms and susceptibility to PE .......................................... 364 
Chapter X: Investigation of several HSPs and CASPs (tissue culture experiment) .. 365 
10 Hypoxia-reperfusion tissue culture experiment .................................................... 365 
10.1 Introduction ...................................................................................................... 365 
10.1.1 Response of ischemic placenta to reperfusion during peri-partum period ... 365 
10.1.2 Free radicals and oxidative stress in normal pregnancy............................... 366 
10.1.3 Endoplasmic reticulum (ER) stress .............................................................. 366 
10.1.4 IR experiments ............................................................................................. 367 
10.2 Results .............................................................................................................. 368 
10.2.1 Protein and mRNA expression of HSP70 analysis using hypoxia-reperfusion 
tissue culture experiment............................................................................................ 368 
10.2.2 Analysis of protein and mRNA expression of HSP27 in the hypoxia-
reperfusion tissue culture experiment. ....................................................................... 374 
10.2.3 Analysis of mRNA expression of HSF1 in the hypoxia-reperfusion tissue 
culture experiment. ..................................................................................................... 380 
10.2.4 Analysis of mRNA expression of HSP90AA in the hypoxia-reperfusion 
tissue culture experiment............................................................................................ 383 
10.2.5 Analysis of mRNA expression of HSP90B1 in the hypoxia-reperfusion tissue 
culture experiment. ..................................................................................................... 386 
10.3 Discussion ........................................................................................................ 389 
10.3.1 IR experiment and present findings ............................................................. 389 
10.3.2 IR experiment and key findings ................................................................... 390 
10.3.3 Placental oxidative stress in labour and PE.................................................. 391 
10.3.4 Placenta ER and the inflammatory response ................................................ 392 
Chapter XI: Heat shock tissue culture experiment and investigation of HSPs and 
caspases at the inner, middle and outer placental zones. ............................................. 394 
11 Heat shock tissue culture experiment ..................................................................... 394 
11.1 Introduction ...................................................................................................... 394 
11.2 Results .............................................................................................................. 395 
11.2.1 Analysis of protein and mRNA expression of HSP70 in the heat shock tissue 
culture experiment. ..................................................................................................... 395 
11.2.2 Analysis of protein and mRNA expression of HSP27 in the heat shock tissue 
culture experiment. ..................................................................................................... 401 
11.2.3 Several HSPs and caspases mRNA expression after exposure to the heat 
shock ……………………………………………………………………………..407 
11.3 Discussion ........................................................................................................ 409 
11.3.1 HSP70 and HSP27 protein and mRNA expression and present findings .... 409 
15 
 
11.3.2 Different HSPs mRNA expression and present findings ............................. 409 
11.3.3 CASPs mRNA expression and present findings .......................................... 409 
11.3.4 Heat shock experiment ................................................................................. 409 
Chapter XII: Analysis of stress and apoptic pathways in placentas from four different 
BMI groups 
12 BMI study ................................................................................................................. 412 
12.1 Introduction ...................................................................................................... 412 
12.1.1 Obesity and inflammation ............................................................................ 412 
12.1.2 Obesity and endothelial dysfunction ............................................................ 413 
12.1.3 Obesity and insulin resistance ...................................................................... 413 
12.1.4 Obesity and oxidative stress ......................................................................... 414 
12.1.5 The association of obesity with PE .............................................................. 414 
12.2 Results .............................................................................................................. 415 
12.2.1 Patient clinical data analysis ........................................................................ 415 
12.2.1.1 BMI groups: .......................................................................................... 415 
12.2.2 Analysis of protein and mRNA expression of HSP70 between 4 BMI groups.
 ……………………………………………………………………………..415 
12.2.3 Analysis of protein and mRNA expression of HSP27 between 4 BMI groups.
 ……………………………………………………………………………..419 
12.2.4 Analysis of mRNA expression of other HSPs families between 4 BMI 
groups. …………………………………………………………………………….424 
12.2.5 Analysis of mRNA expression of CASP3, 7 and 9 between 4 BMI groups.
 ……………………………………………………………………………..432 
12.2.6 Results summary .......................................................................................... 436 
12.3 Discussion ........................................................................................................ 439 
12.3.1 HSPs family expression in obese pregnant women and the present findings
 ……………………………………………………………………………..439 
12.3.2 Key findings of HSP70 and HSP27 protein and mRNA expression ........... 439 
12.3.3 Key findings of other HSPs families mRNA expression ............................. 439 
12.3.4 Key findings in mRNA expression of CASPs ............................................. 439 
12.3.5 Obesity and HSPs ......................................................................................... 440 
13 Chapter XIII: Difficulties and limitation ............................................................... 442 
14 Chapter XIV: Summary and conclusions .............................................................. 443 
15 List of References ..................................................................................................... 450 
16 Appendices ................................................................................................................ 495 
 
  
16 
 
List of Tables 
Table ‎1-1: Severe PE criteria. .............................................................................................. 71 
Table ‎1-2: Classification of weight status according to BMI (WHO, 2000). ...................... 83 
Table ‎2-1: Patient clinical details. ........................................................................................ 95 
Table ‎2-2: BMI patient details. ............................................................................................ 97 
Table ‎2-3: Resolving and stacking gels compositions. ...................................................... 101 
Table ‎2-4: Standards stock dilution (µg/ml). ..................................................................... 105 
Table ‎2-5: Primary antibodies ............................................................................................ 108 
Table ‎2-6: Cell lysate positive control ............................................................................... 109 
Table ‎2-7: Secondary antibodies ........................................................................................ 110 
Table ‎2-8: TaqMan gene expression assays of stress pathways. ....................................... 118 
Table ‎2-9: TaqMan gene expression assays of inflammatory pathways ............................ 120 
Table ‎2-10: TaqMan gene expression assays of apoptotic pathways ................................ 122 
Table ‎2-11: Different primary and secondary antibodies were run for TLR2 and TLR4 .. 134 
Table ‎3-1: Functions and intra-cellular location of major HSPs ....................................... 138 
Table ‎3-2: Patient’s clinical details; the descriptive analysis showed the mean and standard 
deviation. ............................................................................................................................ 150 
Table ‎3-3: Patients clinical details; statistical analysis of the groups that were statistically 
significant in Table 2-2 above.. .......................................................................................... 151 
Table ‎3-4: Summary of different comparison in protein and mRNA expression of HSP70 
(blue arrow) and HSF1 (red arrow) .................................................................................... 182 
Table ‎5-1: α-Crystallin-related small heat-shock proteins (HSPB1–HSPB10) ................. 230 
Table ‎5-2: Summary of different comparison in mRNA expression of the sHSP family.. 253 
Table ‎9-1: Pattern Recognition Receptors (PRRs), location and functions. ...................... 324 
Table ‎9-2: TLRs ligands..................................................................................................... 327 
Table ‎12-1: Patient’s clinical details; the descriptive analysis showed the mean and 
standard deviation. . ........................................................................................................... 415 
 
  
17 
 
List of Figures 
Figure 1-1: Pictures of the term human placenta. The left panel shows the fetal side of the 
placenta and umbilical cord inserts within the chorionic plate.  The right shows the 
maternal side which is contact with uterus and divided into cotyledons. (C): cotyledons. 
(A): amnion. (UC): umbilical cord....................................................................................... 55 
Figure 1-2: Illustration shows the blastocyst just before implantation (apposition). The 
blastocyst contains a single layer of trophoblast (trophectoderm) which is the outer layer of 
cells comprised of trophoblast cells seen in purple (arrow), inner cell mass and blastocyst 
cavity (arrows). The endometrium is seen in red (arrow). ................................................... 58 
Figure 1-3: Inflammatory pathway in parturition is associated with the influx of leukocytes 
(mainly neutrophils and macrophages) into the myometrium and cervix during labour, 
result in release IL 1, IL6 and IL8. These cytokines up-regulate MMP expression and 
activity in the cervix, causing collagen breakdown and cervical ripening. In the 
myometrium, IL1 activity leading to more calcium entry to cells, also cytokines increase 
COX2 expression, causing increase of prostaglandin production both will stimulate 
myometrium contractions. Modified from (Jabbour et al., 2009). ....................................... 67 
Figure 2-1: Photograph of placenta shown the 12 sites within the three placenta zones 
where samples were obtained in each individual placenta. ................................................ 104 
Figure 2-2: Example of standard curve. ............................................................................. 106 
Figure 2-3: PROTEAN II xi systems by Bio-Rad Laboratories: photograph shows a sample 
being loaded (left) and a gel that is running (right). .......................................................... 107 
Figure 2-4: Example of nitrocellulose membrane illuminated with Ponceau S solution. .. 111 
Figure 2-5: Example of transcript from Nanodrop reading in ng/µl. The ratio of absorbance 
at 260 nm and 280 nm (260/280) is given an indication of RNA purity. .......................... 113 
Figure 2-6: RNA concentration of representative placenta sample: number 1BMI6 in ng/µl 
(366.5). ............................................................................................................................... 113 
Figure 2-7: Gel showing products of the PCR multiplex reaction using the Human 
cDNAOKᴉ® Kit (Microzone, cat.no. 2HCDOK-150). cDNA was made using Quantitect® 
kit and GoScript™ reverse transcriptase. Products were separated on 2% agarose gel using 
100 bp moelcualr ladders. The negative control was run in first lane. The other lanes show 
different samples that showed good quality cDNA . ......................................................... 115 
18 
 
Figure 2-8: 2% gel electrophoresis of PCR products of HSP70 TaqMan gene expression 
assay, band corresponded to amplicon length of the TaqMan 124 base pairs. Negative 
control was loaded in first lane showed no expression. ..................................................... 124 
Figure 2-9: Figure showing the time course of hypoxia-reperfusion experiment. (A) 
Collection of first reference samples from (inner (IZ), middle (MZ) and outer (OZ) 
placental zones). The rest of placenta tissue samples were collected in three flasks (8% O2) 
for each of the three zones. (B) in the lab: the second reference samples were collected 
from the three zones, the remaining placenta tissue samples were cut up and distributed 
into control (8% O2) and experiment (2% O2), then each were put into relevant incubator. 
(C) After one hour all plates were taken out the incubators and were placed in the 
biological safety unit (BSU) and then transferred into a new culture media (8% O2). All 
were returned back to the (8% O2) incubator for different time points. (D) After each time 
point (2, 6, 12 and 22 h) one plate containing control and experiment tissue for inner, 
middle and outer zones was taken out of the incubator, the tissue were snap frozen in liquid 
nitrogen, then stored at -80 °C. .......................................................................................... 128 
Figure 2-10: Figure showing the time course of heat shock induction experiment. (A) 
Collection of first reference samples from (inner (IZ), middle (MZ) and outer (OZ) 
placental zones) and collection of placenta samples in three flasks represent the three 
zones. (B) Placenta samples were cut down and were distributed into controls or 
experiment (heat shock). Controls were placed in 37°C incubator and experiments were 
placed in 43°C oven for 30 min. (C)  After 30 min plates were taken out of the incubator 
and oven, were put in the BSU and then were transferred into a new culture media (37° C). 
All were placed back to the (37 °C) incubator for different time points. (D) after each time 
point (1, 3, 6, 12 and 24 h) one plate contain control and experiment tissue for IZ, MZ and 
OZ was taken out of the incubator and snap frozen in liquid nitrogen, then stored at –80 ᵒC.
 ............................................................................................................................................ 132 
Figure 3-1: HSP70 gene structure and domains: HSP70 contain two domains; nucleotide 
binding domain/ATPase domain and substrate binding domain modified from (Grubišic, 
2005). ................................................................................................................................. 143 
Figure 3-2: HSF1 activation and degradation cycle. In non-stress conditions, HSF1 exists 
as an inactive monomer in the cytoplasm. Upon stress HSF1 form homotrimers linked 
together by disulphide bond and become localized to the nucleus to bind to HSE in the 
promoters of stress-responsive genes. HSF1 becomes dissociated from DNA after HSP70 
and HSP40 re-associate with the HSF1 transactivation domain. Adapted with permission 
from (Neef et al., 2011). ..................................................................................................... 148 
19 
 
Figure 3-3: Representative images of Western blots showing HSP70 protein expressions in 
inner, middle and outer zones of individual placentas of non-labour group (A) and labour 
group (B). Four quadrants were sampled in each zone. Graphs show the median for HSP70 
protein expressions. Comparison between zones was performed using Friedman analysis.
 ............................................................................................................................................ 152 
Figure 3-4: Representative images of Western blots showing HSP70 expressions in the 
inner, middle and outer placental zones in non-labour and labour (n=6 in each group). The 
graphs show the box and whiskers analysis of the blots. Comparison between zones was 
performed using Mann-Whitney analysis. NLG non-labour group, LG labour group. ..... 153 
Figure 3-5: RQ values for HSP70 mRNA measurements in inner (n=4), middle (n=4) and 
outer zones (n=4) of individual placentas (non-labour and labour groups). Four quadrants 
were sampled in each zone. Graphs show the median for HSP70 mRNA expressions. 
Comparison between zones was performed using Friedman analysis. .............................. 154 
Figure 3-6: RQ values for HSP70 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis. ........................................................ 154 
Figure ‎3-7: Representative images of Western blots showing HSP70 expressions in the 
inner, and outer placental zones in non-labour control (n=6) and non-labour PE (n=3). The 
graphs show the box and whiskers analysis of the blots of three placenta zones. In the 
Middle Western blot image empty lane was removed (dotted lines). Comparison between 
zones was performed using Mann-Whitney analysis. NLG-C non-labour control group, 
NLG-PE non-labour PE group. .......................................................................................... 155 
Figure ‎3-8: Representative images of Western blots showing HSP70 expressions in the 
inner and middle placental zones in labour control and labour PE groups (n=6 for each 
group). Western blot image empty lanes were removed (dotted lines). The graphs show the 
box and whiskers analysis of the blots. Comparison between zones was performed using 
Mann-Whitney analysis. LG-C labour control group, LG-PE labour PE group. ............... 156 
Figure ‎3-9: RQ values for HSP70 mRNA measurements in inner, middle and outer 
placental zones for the non-labour control group (n=6) compared with non-labour PE 
groups (n=3). Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 157 
Figure ‎3-10: RQ values for HSP70 mRNA measurements in inner, middle and outer 
placental zones for labour control group (n=6) compared with labour PE groups (n=6). 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 157 
20 
 
Figure ‎3-11: RQ values for HSP70 mRNA measurements in normotensive pregnancies 
group (non-labour and labour were combined) (n=12) compared to the pregnancies 
complicated with PE group (non-labour and labour were combined) (n=12) at the inner, 
middle and outer placental zones. Comparison between zones was performed using Mann-
Whitney analysis. ............................................................................................................... 158 
Figure ‎3-12: Representative images of Western blots showing HSP70 expression at the 
inner zone (upper panel) and the outer zone (lower panel) in labour control (n=6) and 
labour FGR group (n=6). The graphs show the box and whiskers analysis of the blots. 
Comparison between zones was performed using Mann-Whitney analysis. LG-C labour 
group control, LG-FGR labour group FGR. ...................................................................... 159 
Figure ‎3-13: RQ values for HSP70 mRNA measurements in inner and outer placental 
zones for labour control group (n=6) compared with labour FGR-groups (n=6). 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 160 
Figure ‎3-14: Representative images of Western blots showing expression of HSF1 
phosphorylated and non- phosphorylated forms expressions in inner, middle and outer 
zones of individual placentas of non-labour group. Four quadrants were sampled in each 
zone. Graphs show median and interquartile range for HSF1 phosphorylated and non-
phosphorylated forms expressions. Comparison between zones was performed using 
Friedman analysis. P-HSF-1= phosphorylated HSF1, NP-HSF-1= non-phosphorylated 
HSF1. ................................................................................................................................. 161 
Figure ‎3-15: Representative images of Western blots showing HSF1 phosphorylated and 
non-phosphorylated forms expressions in inner, middle and outer zones of individual 
placentas of labour group. Four quadrants were sampled in each zone. Graphs show 
median and interquartile range for HSF1 phosphorylated and non-phosphorylated forms 
expressions. Comparison between zones was performed using Friedman analysis. P-HSF-
1= phosphorylated HSF1, NP-HSF-1= non-phosphorylated HSF1. .................................. 162 
Figure ‎3-16: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the inner 
placental zone in non-labour and labour (n=6 in each group). Both bands of Western blot 
image showed separately. The graphs show the box and whiskers analysis of the blots. 
Comparison between zones was performed using Mann-Whitney analysis. NLG non-
labour group, LG labour group. ......................................................................................... 163 
Figure ‎3-17: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the middle 
placental zone in non-labour and labour (n=6 in each group). First lane is the protein 
21 
 
marker and second lane is the positive control sample. The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. NLG non-labour group, LG labour group. ........................................... 164 
Figure ‎3-18: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the outer 
placental zone in non-labour and labour (n=6 in each group). First lane is the protein 
marker and second lane is the positive control sample. The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. NLG non-labour group, LG labour group. ........................................... 165 
Figure ‎3-19: RQ values for HSF1 mRNA measurements in in inner (n=4), middle (n=4) 
and outer zones (n=4) of individual placentas (non-labour and labour groups). Four 
quadrants were sampled in each zone. Graphs show the median for HSF1 mRNA 
expressions. Comparison between zones was performed using Friedman analysis. ......... 166 
Figure ‎3-20: RQ values for HSF1 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis. ........................................................ 166 
Figure ‎3-21: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the inner 
placental zone in non-labour control (n=6) and non-labour PE (n=3). First lane is the 
protein marker and second lane is the positive control sample. The graphs show the box 
and whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. NLG-C non-labour control group, NLG-PE non-labour PE group. ..... 167 
Figure ‎3-22: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the middle 
placental zone in non-labour control (n=6) and non-labour PE (n=3). First lane is the 
protein marker and second lane is the positive control sample. The graphs show the box 
and whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. NLG-C non-labour control group, NLG-PE non-labour PE group. ..... 168 
Figure ‎3-23: Representative images of Western blots showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the inner 
placental zone in labour control and PE (n=6 for both groups). The graphs show the box 
and whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. LG-C labour control group, LG-PE labour PE group. ......................... 169 
Figure ‎3-24: The graphs presentations show the box and whiskers analyisis of HSF1 
phosphorylated form and HSF1 non-phosphorylated form expressions in the middle 
22 
 
placental zone in labour control and PE (n=6 for both groups). Both bands of Western blot 
image showed separately. As curved gel, areas of splicing of gel image where indicated 
(dotted lines). Comparison between zones was performed using Mann-Whitney analysis. 
LG-C labour control group, LG-PE labour PE group. ....................................................... 170 
Figure 3-25: RQ values for HSF1 mRNA measurements in inner and middle placental 
zones for non-labour control group (n=6) compared with non-labour PE groups (n=3). 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 171 
Figure 3-26: RQ values for HSF1 mRNA measurements in inner and middle placental 
zones for labour control group (n=6) compared with labour PE groups (n=6). Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 171 
Figure 3-27: RQ values for HSF1 mRNA measurements in normotensive pregnancies 
group (n=12) compared to the pregnancies complicated with PE group (n=12) at the inner 
and middle placental zones. Comparison between zones was performed using Mann-
Whitney analysis. ............................................................................................................... 172 
Figure 3-28: RQ values for HSF2 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups). Four 
quadrants were sampled in each zone. Graphs show the median for HSF2 mRNA 
expressions. Comparison between zones was performed using Friedman analysis. ......... 173 
Figure 3-29: RQ values for HSF2 mRNA measurements in non-labour group (n=6) 
compared to the labour group (n=6) at the inner, middle and outer placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 174 
Figure 3-30: RQ values for HSF2 mRNA measurements in non-labour control group (n=6) 
compared to the non-labour PE group (n=3) at the inner and middle placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 174 
Figure 3-31: RQ values for HSF2 mRNA measurements in labour control group (n=6) 
compared to the labour PE group (n=6) at the inner and middle placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 175 
Figure 3-32: RQ values for HSF2 mRNA measurements in normotensive pregnancies 
group (n=12) compared to the pregnancies complicated with PE group (n=12) at the inner 
and middle placental zones. Comparison between zones was performed using Mann-
Whitney analysis. ............................................................................................................... 176 
Figure 4-1: HSP27 gene structure. The N-terminus of HSP27 contains a hydrophobic 
WDPF motif, which is adjacent to a mitogen-activated protein kinases associated protein 
(MAPKAP) kinases (MK2) phosphorylation site at Ser15. The C-terminal 18–20 amino 
23 
 
acids include an α-crystallin motif that is highly conserved among species and a flexible C-
terminal tail modified  from (Salinthone et al., 2008)........................................................ 191 
Figure 4-2: P-HSP27 functions and its possible implication in diseases. HSP27 may be 
present in un-phosphorylated and phosphorylated forms depending on the cellular stress 
conditions. The central part is referred to the normal function of HSP27 and P-HSP27 
(pink). The outer part is referred to the pathogenic conditions (blue) adapted from 
(Henderson and Pockley, 2012). ........................................................................................ 196 
Figure 4-3: Representative images of Western blots showing HSP27 protein expressions in 
inner, middle and outer zones of individual placentas of non-labour group (A) and labour 
group (B). Four quadrants were sampled in each zone. Graphs show the median for HSP27 
protein expressions. Comparison between zones was performed using Friedman analysis.
 ............................................................................................................................................ 197 
Figure 4-4: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in non-labour and labour (n=6 in each group). The 
graphs show the box and whiskers analysis of the blots. Comparison between zones was 
performed using Mann-Whitney analysis. NLG non-labour group, LG labour group. ..... 198 
Figure 4-5: RQ values for HSP27 mRNA measurements in in inner (n=4), middle (n=4) 
and outer zones (n=4) of individual placentas (non-labour and labour groups). Four 
quadrants were sampled in each zone. Graphs show the median for HSP70 mRNA 
expressions. Comparison between zones was performed using Friedman analysis. ......... 199 
Figure 4-6: RQ values for HSP27 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis. ........................................................ 200 
Figure ‎4-7: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in non-labour control (n=6) and non-labour PE 
(n=3). The graphs show the box and whiskers analysis of the blots. Comparison between 
zones was performed using Mann-Whitney analysis. NLG-C non-labour control group, 
NLG-PE non-labour PE group. .......................................................................................... 200 
Figure 4-8: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in labour control and labour PE groups (n=6 for 
each group). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. LG-C labour control group, 
LG-PE labour PE group. .................................................................................................... 201 
Figure 4-9: RQ values for HSP27 mRNA measurements in inner, middle and outer 
placental zones for the non-labour control group (n=6) compared with non-labour PE 
24 
 
groups (n=4). Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 202 
Figure 4-10: RQ values for HSP27 mRNA measurements in inner, middle and outer 
placental zones for labour control group (n=6) compared with labour PE groups (n=6). 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 203 
Figure 4-11: RQ values for HSP27 mRNA measurements in normotensive pregnancies 
group (n=12) compared to the pregnancies complicated with PE group (n=9) at the inner, 
middle and outer placental zones. Comparison between zones was performed using Mann-
Whitney analysis. ............................................................................................................... 204 
Figure 4-12: Representative images of Western blots showing HSP27 expression at the 
inner zone (upper panel) and the outer zone (lower panel) in labour control (n=6) and 
labour FGR group (n=6). The graphs show the box and whiskers analysis of the blots. 
Comparison between zones was performed using Mann-Whitney analysis. LG-C labour 
group control, LG-FGR labour group fetal growth restriction. ......................................... 205 
Figure 4-13: RQ values for HSP27 mRNA measurements in inner and outer placental 
zones for labour control compared with labour FGR groups. Comparison between zones 
was performed using Mann-Whitney analysis. .................................................................. 206 
Figure 4-14: Representative images of Western blots showing P-HSP27 ser 15 expression 
in inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 15 expressions. Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 207 
Figure 4-15: Representative images of Western blots showing P-HSP27 ser 78 expression 
in inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 78 expressions. Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 208 
Figure 4-16: Representative images of Western blots showing P-HSP27 ser 82 expression 
in inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 82 expression. Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 209 
Figure 4-17: Representative images of Western blots showing P-HSP27 ser 15 expression 
in inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
25 
 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 
15 expression. Comparison between zones was performed using Friedman analysis. ...... 210 
Figure 4-18: Representative images of Western blots showing P-HSP27 ser 78 expression 
in inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 
78 expression. Comparison between zones was performed using Friedman analysis. ...... 211 
Figure 4-19: Representative images of Western blots showing P-HSP27 ser 82 expression 
in inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 
82 expression. Comparison between zones was performed using Friedman analysis. ...... 212 
Figure 4-20: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the inner placental 
zone in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group. .......................................................... 213 
Figure 4-21: Representative images of Western blots showing P-HSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the middle placental 
zone in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group. .......................................................... 214 
Figure 4-22: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the outer placental 
zone in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group. .......................................................... 215 
Figure 4-23: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the inner placental 
zone in labour control (n=6) and labour PE group (n=7). The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. LG-C labour group control, LG-PE labour group pre-eclampsia. ........ 216 
Figure 4-24: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the middle placental 
zone in labour control (n=6) and labour PE group (n=7). The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. LG-C labour group control, LG-PE labour group pre-eclampsia. ........ 217 
26 
 
Figure 5-1: RQ values for HSPB2 mRNA measurements in in inner (n=4), middle (n=4) 
and outer zones (n=4) of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone.  Graphs show the median for 
HSPB2 mRNA expressions. Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 237 
Figure 5-2: RQ values for HSPB2 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 238 
Figure 5-3: RQ values for HSPB2 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE groups (n=3) at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 239 
Figure 5-4: RQ values for HSPB2 mRNA measurements in labour control (n=6) compared 
to the labour PE groups (n=6) at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 239 
Figure 5-5: RQ values for CRYAB mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone.  Graphs show median and 
interquartile range for CRYAB mRNA expressions.  Comparison between zones was 
performed using Friedman analysis. .................................................................................. 240 
Figure 5-6: RQ values for CRYAB mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 241 
Figure 5-7: RQ values for CRYAB mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 241 
Figure 5-8: RQ values for CRYAB mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 242 
Figure 5-9: RQ values for HSPB6 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show median and 
interquartile range for HSPB6 mRNA expressions.  Comparison between zones was 
performed using Friedman analysis. .................................................................................. 243 
27 
 
Figure 5-10: RQ values for HSPB6 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 243 
Figure 5-11: RQ values for HSPB6 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 244 
Figure 5-12: RQ values for HSPB6 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 245 
Figure 5-13: RQ values for HSPB7 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show median and 
interquartile range for mRNA expressions of HSPB7.  Comparison between zones was 
performed using Friedman analysis. .................................................................................. 245 
Figure 5-14: RQ values for HSPB7 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 246 
Figure 5-15: RQ values for HSPB7 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 247 
Figure 5-16: RQ values for HSPB7 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 247 
Figure 5-17: RQ values for HSPB8 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions HSPB8.  Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 248 
Figure 5-18: RQ values for HSPB8 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) groups at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 249 
Figure 5-19: RQ values for HSPB8 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 249 
28 
 
Figure 5-20: RQ values for HSPB8 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 250 
Figure 6-1: RQ values for HSP32 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups). Four 
quadrants were sampled in each zone 6 placentas were studied in each group. Graphs show 
the median for mRNA expressions of HSP32.  Comparison between zones was performed 
using Friedman analysis. .................................................................................................... 264 
Figure 6-2: RQ values for HSP32 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 265 
Figure 6-3: RQ values for HSP32 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. ..................... 265 
Figure 6-4: RQ values for HSP32 mRNA measurements in labour control (n=6) compared 
to the labour PE groups (n=6) at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 266 
Figure 6-5: RQ values for DNAJB1 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of DNAJB1.  Comparison between zones was performed using 
Friedman analysis............................................................................................................... 267 
Figure 6-6: RQ values for DNAJB1 mRNA measurements in non-labour (n=6) compared 
to the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 267 
Figure 6-7: RQ values for DNAJB1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 268 
Figure 6-8: RQ values for DNAJB1 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 269 
Figure 6-9: RQ values for HSPD1 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show the median for 
29 
 
mRNA expressions of HSPD1.  Comparison between zones was performed using 
Friedman analysis............................................................................................................... 270 
Figure 6-10: RQ values for HSPD1 mRNA measurements in non-labour (n=6) compared 
to the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 270 
Figure 6-11: RQ values for HSPD1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 271 
Figure 6-12: RQ values for HSPD1 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 272 
Figure 7-1: RQ values for HSPA5 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone.  Graphs show the median and for 
mRNA expressions HSPA5. Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 284 
Figure 7-2: RQ values for HSPA5 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) groups at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 285 
Figure 7-3: RQ values for HSPA5 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 285 
Figure 7-4: RQ values for HSPA5 mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 286 
Figure 7-5: RQ values for HSP90 AA mRNA measurements in in inner (n=4), middle 
(n=4) and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 
placentas in each group).  Four quadrants were sampled in each zone. Graphs show the 
median for mRNA expressions of HSP90AA.  Comparison between zones was performed 
using Friedman analysis. .................................................................................................... 287 
Figure 7-6: RQ values for HSP90AA mRNA measurements in non-labour (n=6) compared 
to the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 288 
30 
 
Figure 7-7: RQ values for HSP90AA mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 288 
Figure 7-8: RQ values for HSP90AA mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 289 
Figure 7-9: RQ values for HSP90B1 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSP90B1.  Comparison between zones was performed using 
Friedman analysis............................................................................................................... 290 
Figure 7-10: RQ values for HSP90B1 mRNA measurements in non-labour (n=6) compared 
to the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 290 
Figure 7-11: RQ values for HSP90B1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 291 
Figure 7-12: RQ values for HSP90B1 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 292 
Figure 7-13: RQ values for HSPH1 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSPH1.  Comparison between zones was performed using 
Friedman analysis............................................................................................................... 292 
Figure 7-14: RQ values for HSPH1 mRNA measurements in non-labour (n=6) compared 
to the labour group (n=6) at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 293 
Figure 7-15: RQ values for HSPH1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 294 
Figure 7-16: RQ values for HSPH1 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 294 
31 
 
Figure 8-1: Apoptotic signaling pathways with overview of two major caspases-dependent 
apoptotic including (1) cytokines/Fas-mediated CASP8 pathways, (2) mitochondrial-
mediated CASP9 pathways.  Modified from (Kwak, 2013). ............................................. 305 
Figure 8-2: RQ values for CASP3 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of CASP3.  Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 308 
Figure 8-3: RQ values for CASP3 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 309 
Figure 8-4: RQ values for CASP3 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 309 
Figure 8-5: RQ values for CASP3 mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 310 
Figure 8-6: RQ values for CASP7 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of CASP7.  Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 311 
Figure 8-7: RQ values for CASP7 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 311 
Figure 8-8: RQ values for CASP7 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 312 
Figure 8-9: RQ values for HSPB2 mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 313 
Figure 8-10: RQ values for CASP9 mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
32 
 
mRNA expressions of CASP9.  Comparison between zones was performed using Friedman 
analysis. .............................................................................................................................. 313 
Figure 8-11: RQ values for CASP9 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 314 
Figure 8-12: RQ values for CASP9 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 315 
Figure 8-13: RQ values for CASP9 mRNA measurements in labour control (n=6) 
compared to the labour PE (n=6) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 315 
Figure 9-1: RQ values for TLR1-4 mRNA measurements in in inner, middle and outer 
zones of individual placentas of non-labour (n=6) and labour groups (n=6).  Four quadrants 
were sampled in each zone. Graphs show the median for TLR1-4 mRNA expressions.  
Comparison between zones was performed using Friedman analysis. .............................. 331 
Figure 9-2: RQ values for TLR5-8 mRNA measurements in in inner, middle and outer 
zones of individual placentas of non-labour (n=6) and labour groups (n=6).  Four quadrants 
were sampled in each zone. Graphs show the median for TLR5-8 mRNA expressions.  
Comparison between zones was performed using Friedman analysis. .............................. 332 
Figure 9-3: RQ values for TLR1 (A) and TLR2 (B) mRNA measurements in non-labour 
(n=6) compared to the labour group (n=6) at the inner, middle and outer placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 333 
Figure 9-4: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 334 
Figure 9-5: RQ values for TLR5 (A) and TLR6 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 335 
Figure 9-6: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis .......................................... 336 
Figure 9-7: RQ values for TLR1 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 337 
33 
 
Figure 9-8: RQ values for TLR2 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 337 
Figure 9-9: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in the non-
labour PE group compared to the non-labour control group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 338 
Figure 9-10: RQ values for TLR5 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 339 
Figure 9-11: RQ values for TLR6 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 339 
Figure 9-12: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in the non-
labour PE group compared to the non-labour control group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 340 
Figure 9-13: RQ values for TLR1 mRNA measurements in the labour PE group compared 
to the labour control group at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. ........................................................ 341 
Figure 9-14: RQ values for TLR2 mRNA measurements in the labour PE group compared 
to the labour control group at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis ......................................................... 341 
Figure 9-15: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in the labour 
PE group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 342 
Figure 9-16: RQ values for TLR5 (A) and TLR6 (B) mRNA measurements in the labour 
PE group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis ...................... 343 
Figure 9-17: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in the labour 
PE group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 344 
Figure 9-18: RQ values for TLR1 mRNA expression in the PE pregnancy group compared 
to the normotensive pregnancy group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 345 
34 
 
Figure 9-19: RQ values for TLR2 mRNA expression in the PE pregnancy group compared 
to the normotensive pregnancy group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 345 
Figure 9-20: RQ values for TLR3 (A) and TLR4 (B) mRNA expression in the PE 
pregnancy group compared to the normotensive pregnancy group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 346 
Figure 9-21: RQ values for TLR5 (A) and TLR6 (B) mRNA expression in the PE 
pregnancy group compared to the normotensive pregnancy group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 347 
Figure 9-22: RQ values for TLR7 (A) and TLR8 (B) mRNA expression in the PE 
pregnancy group compared to the normotensive pregnancy group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 348 
Figure 9-23: RQ values for MYD88 mRNA measurements in in inner, middle and outer 
zones of individual placentas (non-labour and labour groups).  Four quadrants were 
sampled in each zone. Graphs show the median for MYD88 mRNA expressions.  
Comparison between zones was performed using Friedman analysis. .............................. 349 
Figure 9-24: RQ values for MYD88 mRNA measurements in non-labour compared to the 
labour group at the inner, middle and outer placental zones.  Comparison between zones 
was performed using Mann-Whitney analysis. .................................................................. 349 
Figure 9-25: RQ values for MYD88 mRNA measurements in non-labour control compared 
to the non-labour PE groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. ........................................................ 350 
Figure 9-26: RQ values for MYD88 mRNA measurements in labour control compared to 
the labour PE groups at the inner and middle placental zones.  Comparison between zones 
was performed using Mann-Whitney analysis. .................................................................. 351 
Figure 9-27: RQ values for MYD88 mRNA measurements in normotensive pregnancies 
group compared to the pregnancies complicated with PE group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 351 
Figure 9-28: RQ values for NF-κB mRNA measurements in in inner, middle and outer 
zones of individual placentas (non-labour and labour groups).  Four quadrants were 
35 
 
sampled in each zone. Graphs show the median for NF-κB mRNA expressions.  
Comparison between zones was performed using Friedman analysis. .............................. 352 
Figure 9-29: RQ values for NF-κB mRNA measurements in non-labour compared to the 
labour group at the inner, middle and outer placental zones.  Comparison between zones 
was performed using Mann-Whitney analysis. .................................................................. 353 
Figure 9-30: RQ values for NF-κB mRNA measurements in labour control compared to the 
labour PE groups at the inner and middle placental zones.  Comparison between zones was 
performed using Mann-Whitney analysis. ......................................................................... 353 
Figure 9-31: RQ values for NF-κB mRNA measurements in labour control compared to the 
labour PE groups at the inner and middle placental zones.  Comparison between zones was 
performed using Mann-Whitney analysis. ......................................................................... 354 
Figure 9-32: RQ values for NF-κB mRNA measurements in normotensive pregnancies 
group compared to the pregnancies complicated with PE group at the inner and middle 
placental zones. Comparison between zones was performed using Mann-Whitney analysis.
 ............................................................................................................................................ 355 
Figure 10-1: Western blots showing HSP70 expression (upper panel) in the inner placental 
zone. Ref1 is the sample collected in the labour suite. Ref2 is the sample collected after 
arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of reperfusion were 
performed.  The graph shows the interaction plot analysis of the data for HSP70 protein 
expression at the inner zone. Samples exposed to hypoxia-reperfusion are shown as a (red 
dotted line, YES) and compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 369 
Figure 10-2: Western blots showing HSP70 expression (upper panel) in the middle 
placental site. Ref1 is the sample collected in the labour suite. Ref2 is the sample collected 
after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of reperfusion 
were performed.  The graph shows the interaction plot analysis of the data for HSP70 
protein expression at the middle site. Samples exposed to hypoxia-reperfusion are shown 
as a (red dotted line, YES) and compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 370 
Figure 10-3: Western blots showing HSP70 expression (upper panel) in the outer placental 
zone. Ref1 is the sample collected in the labour suite. Ref2 is the sample collected after 
arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of reperfusion were 
performed.  The graph shows the interaction plot analysis of the data for HSP70 protein 
expression at the outer zone. Samples exposed to hypoxia-reperfusion are shown as a (red 
36 
 
dotted line, YES) and compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 371 
Figure 10-4: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 372 
Figure 10-5: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 373 
Figure 10-6: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the outer zone.  The graph shows data of the samples exposing to hypoxia reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. ......................................................................................................................... 374 
Figure 10-7: Western blots showing HSP27 expression (upper panel) in the inner placental 
zone. Ref1 is the sample collected in the labour suite. Ref2 is the sample collected after 
arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of reperfusion were 
performed.  The graph shows the interaction plot analysis of the data for HSP27 protein 
expression at the inner zone. Samples exposed to hypoxia-reperfusion are shown as a (red 
dotted line, YES) and compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 375 
Figure 10-8: Western blots showing HSP27 expression (upper panel) in the middle 
placental zone. Ref 1 is the sample collected in the labour suite. Ref 2 is the sample 
collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP27 protein expression at the middle zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. ...................................................................................... 376 
Figure 10-9: Western blots showing HSP27 expression (upper panel) in the outer placental 
zone. Ref 1 is the sample collected in the labour suite. Ref 2 is the sample collected after 
arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of reperfusion were 
performed.  The graph shows the interaction plot analysis of the data for HSP27 protein 
expression at the outer zone. Samples exposed to hypoxia-reperfusion are shown as a (red 
dotted line, YES) and compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 377 
37 
 
Figure 10-10: The graph shows the interaction plot analysis of the data for HSP27 mRNA 
at the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 378 
Figure 10-11: The graph shows the interaction plot analysis of the data for HSP27 mRNA 
at the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 379 
Figure 10-12: The graph shows the interaction plot analysis of the data for HSP27 mRNA 
at the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 380 
Figure 10-13: The graph shows the interaction plot analysis of the data for HSF1 mRNA at 
the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 381 
Figure 10-14: The graph shows the interaction plot analysis of the data for HSF1 mRNA at 
the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 382 
Figure 10-15: The graphs show the interaction plot analysis of the data for HSF1 mRNA at 
the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. .......................................................................................................... 383 
Figure 10-16: The graph shows the interaction plot analysis of the data for HSP90AA 
mRNA at the inner zone.  The graph shows data of the samples exposing to hypoxia-
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 384 
Figure 10-17: The graph shows the interaction plot analysis of the data for HSP90AA 
mRNA at the middle zone.  The graph shows data of the samples exposing to hypoxia-
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 385 
Figure 10-18: The graph shows the interaction plot analysis of the data for HSP90AA 
mRNA at the outer zone.  The graph shows data of the samples exposing to hypoxia-
38 
 
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 386 
Figure 10-19: The graph shows the interaction plot analysis of the data for HSP90B1 
mRNA at the inner zone.  The graph shows data of the samples exposing to hypoxia-
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 387 
Figure 10-20: The graph shows the interaction plot analysis of the data for HSP90B1 
mRNA at the middle zone.  The graph shows data of the samples exposing to hypoxia-
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 388 
Figure 10-21: The graph shows the interaction plot analysis of the data for HSP90B1 
mRNA at the outer zone.  The graph shows data of the samples exposing to hypoxia-
reperfusion (Red dotted line, YES) compared to the control samples (Blue continuous line, 
NO) at different time points. .............................................................................................. 389 
Figure 11-1: Western blots showing HSP70 expression (upper panel) in the inner placental 
zone. Ref is the sample collected in the labour suite.  Different time points (1, 3, 6, 12 and 
24 h) of recovery at 37 C were studied. Graphs show the interaction plots analysis of the 
data for HSP70 protein expression at the inner zone.  Samples exposed to heat shock are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. ...................................................................................... 396 
Figure 11-2: Western blots showing HSP70 expression (upper panel) in the middle 
placental zone. Ref is the sample collected in the labour suite.  Different time points (1, 3, 
6, 12 and 24 h) of recovery at 37 C were performed.  Graphs show the interaction plots 
analysis of the data for HSP70 protein expression at the middle zone.  Samples exposed to 
heat shock are shown as a (red dotted line, YES) and compared to the control samples 
(Blue continuous line, NO) at different time points. .......................................................... 397 
Figure 11-3: Western blots showing HSP70 expression (upper panel) in the outer placental 
zone. Ref is the sample collected in the labour suite.  Different time points (1, 3, 6, 12 and 
24 h) of recovery at 37 C were studied.  Graphs show the interaction plots analysis of the 
data for HSP70 protein expression at the outer zone.  Samples exposed to heat shock are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. ...................................................................................... 398 
Figure 11-4: The graphs show the interaction plots analysis of the data for HSP70 mRNA 
at the inner zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
39 
 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. ................................................................................................................................. 399 
Figure 11-5: The graphs show the interaction plots analysis of the data for HSP70 mRNA 
at the outer zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. ................................................................................................................................. 400 
Figure 11-6: The graphs show the interaction plots analysis of the data for HSP70 mRNA 
at the outer zone. The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. ................................................................................................................................. 401 
Figure 11-7: Western blots showing HSP27 expression (upper panel) in the inner placental 
zone. Ref is the sample collected in the labour suite.  Different time point (1, 3, 6, 12 and 
24 h) of recovery at 37 ᵒC was performed.  Graphs show the interaction plots analysis of 
the data for HSP27 protein expression at the inner zone.  Samples exposed to heat shock 
are shown as a (red dotted line, YES) and compared to the control samples (Blue 
continuous line, NO) at different time points. ................................................................... 402 
Figure 11-8: Western blots showing HSP27 expression (upper panel) in the middle 
placental zone. Ref is the sample collected in the labour suite.  Different time points (1, 3, 
6, 12 and 24 h) of recovery at 37  C were performed.  Graphs show the interaction plots 
analysis of the data for HSP27 protein expression at the middle zone.  Samples exposed to 
heat shock are shown as a (red dotted line, YES) and compared to the control samples 
(Blue continuous line, NO) at different time points. .......................................................... 403 
Figure 11-9: Western blots showing HSP27 expression (upper panel) in the outer placental 
zone. Ref is the sample collected in the labour suite.  Different time points (1, 3, 6, 12 and 
22 hours) of recovery at 37 ᵒC were performed.  Graphs show the interaction plots of the 
data for HSP27 protein expression at the outer zone.  Samples exposed to heat shock are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. ...................................................................................... 404 
Figure 11-10: The graphs show the interaction plots analysis of the data for HSP27 mRNA 
at the inner zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. ................................................................................................................................. 405 
Figure 11-11: The graphs show the interaction plots analysis of the data for HSP27 mRNA 
at the middle zone.  The graph shows data of the samples exposing to heat shock (Red 
40 
 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. ......................................................................................................................... 406 
Figure 11-12: The graphs show the interaction plots analysis of the data for HSP27 mRNA 
at the outer zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. ................................................................................................................................. 407 
Figure 12-1: Western blots showing HSP70 expressions in the inner placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP70 protein expressions.  
Comparison between zones was performed using Kruskal Wallis analysis. ............... Error! 
Bookmark not defined. 
Figure 12-2: Western blots showing HSP70 expressions in the middle placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP27 protein expressions. 
Comparison between zones was performed using Kruskal-Wallis analysis. ..................... 417 
Figure 12-3: Western blots showing HSP70 expressions in the outer placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP27 protein expressions.  
Comparison between zones was performed using Kruskal-Wallis analysis. ..................... 418 
Figure 12-4: Graph showing mRNA expressions of HSP70 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP27.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 419 
Figure 12-5: Western blots showing HSP27 expressions in the inner placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP27 protein expressions.  
Comparison between zones was performed using Kruskal-Wallis analysis. ..................... 420 
Figure 12-6: Graph showing the sub-analysis of 4 BMI groups HSP27 expression at the 
inner zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 in 
each group). The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 420 
Figure 12-7: Western blots showing HSP27 expressions in the middle placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP27 protein expressions. 
Comparison between zones was performed using Kruskal-Wallis analysis. ..................... 421 
Figure 12-8: Graph showing the sub-analysis of 4 BMI groups for HSP27 expression at the 
middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 
in each group). The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 422 
41 
 
Figure 12-9: Western blots showing HSP27 expressions in the middle placental zone in 4 
BMI groups (n=6 in each group).  Graphs show the median for HSP27 protein expressions.  
Comparison between zones was performed using Kruskal-Wallis analysis. ..................... 423 
Figure 12-10: Graph showing the sub-analysis of 4 BMI groups HSP27 expression at the 
middle zone.  Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 
in each group). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 423 
Figure 12-11: Graph showing mRNA expressions of HSP27 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP27.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 424 
Figure 12-12: Graph showing mRNA expressions of HSPB6 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSPB6.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 425 
Figure 12-13: Graph showing the sub-analysis of 4 BMI groups HSPB6 expression at the 
middle zone.  Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 
in each group).The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. ......................................... 425 
Figure 12-14: Graph showing mRNA expressions of HSPB2 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSPB2. Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 426 
Figure 12-15: Graph showing mRNA expressions of HSP32 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP32.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 427 
Figure 12-16: Graph showing mRNA expressions of DNAJB1 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of DNAJB1.  Comparison between zones was performed using 
Kruskal-Wallis analysis. .................................................................................................... 428 
Figure 12-17: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
HSPD1 at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 
BMI group (n=6 in each group). The graphs show the box and whiskers analysis of the 
blots.  Comparison between zones was performed using Mann-Whitney analysis. .......... 429 
42 
 
Figure 12-18: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
HSPA5 at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 
BMI group (n=6 in each group).The graphs show the box and whiskers analysis of the 
blots. Comparison between zones was performed using Mann-Whitney analysis. ........... 430 
Figure 12-19: Graph showing mRNA expressions of HSP90AA in the in 4 BMI groups 
(n=6 in each group) at the inner, middle and outer placental zones.  Graphs show the 
median for mRNA expressions of HSP90AA.  Comparison between zones was performed 
using Kruskal-Wallis analysis. ........................................................................................... 430 
Figure 12-20: Graph showing mRNA expressions of HSP90B1 in the in 4 BMI groups 
(n=6 in each group) at the inner, middle and outer placental zones.  Graphs show the 
median for mRNA expressions of HSP90B1.  Comparison between zones was performed 
using Kruskal-Wallis analysis. ........................................................................................... 431 
Figure 12-21: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
HSPH1 at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 
BMI group (n=6 in each group). The graphs show the box and whiskers analysis of the 
blots.  Comparison between zones was performed using Mann-Whitney analysis. .......... 432 
Figure 12-22: Graph showing mRNA expressions of CASP3 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of CASP3.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 433 
Figure 12-23: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
CASP3 at the inner zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI 
group (n=6 in each group). The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 433 
Figure 12-24: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
CASP3 at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI 
group (n=6 in each group).  The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 434 
Figure 12-25: Graph showing mRNA expressions of CASP7 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of CASP7.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 435 
Figure 12-26: Graph showing mRNA expressions of CASP9 in the in 4 BMI groups (n=6 
in each group) at the inner, middle and outer placental zones.  Graphs show the median for 
43 
 
mRNA expressions of CASP9.  Comparison between zones was performed using Kruskal-
Wallis analysis. .................................................................................................................. 436 
Figure 12-27: Graph showing the sub-analysis of 4 BMI groups mRNA expression of 
CASP3 at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI 
group (n=6 in each group). The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. ..................... 436 
 
  
44 
 
Acknowledgement 
First of all, I owe it all to Almighty God for granting me the strength to undertake this 
research task and enabling its completion. Thanks God for all the blessings that make the 
impossible possible  
The completion of this work was possible with the support of several people to whom I 
would like to express my sincere gratitude.  
I would like to thank my co-supervisor Dr Kevin Hanretty for the support and help in the 
sample collection process. I would also thankful to all staff at the delivery suite at the 
Southern General Hospital for all their help with placenta sample collection, which was 
crucial for this project.  
I would like to thank Libyan embassy for providing the funding for my project without 
which this research would not have been possible. 
I would like to thank Mr David Young for the advice given on statistical analysis 
I would also like to thank my colleague at the department, Mrs Anne Theriaul for her help 
and unlimited support. 
I am very much indebted to my family and friends in Libya and here in Glasgow, who 
encouraged and helped me at every stage of my personal and academic life. They were the 
joy of my life and they will be forever.  
I would to thank my husband for his love, support and constant patience that inspired me to 
complete this work as you made our future look brighter.   
  
45 
 
Dedication  
A special feeling of gratitude to my loving parents, whose endless love, care, 
encouragement filled me with joy, strength and tenacity each day of my life.   
For my loving mother and my deceased father, I would like to dedicate this work to you 
both.  
46 
 
Author’s Declaration 
I declare that, except where explicit reference is made to the contribution of others, that the 
composition of this thesis and the work described within it was carried out entirely by 
myself and has not submitted for any other degree at the University of Glasgow or any 
other institution. 
 
 
 
 
Signed ………………………………………… 
Akrem Abdulsid 
May 2018 
 
 
47 
 
Publication  
1. Alwarfaly, S., Abdulsid, A., Hanretty, K., and Lyall, F. (2014)Paraoxonase 2 protein 
is spatially expressed in the human placenta and selectively reduced in labour. PLoS 
ONE, 9 (5). e96754. ISSN 1932-6203 (doi:10.1371/journal.pone.0096754) 
Poster and oral presentations  
Abdulsid A., Walker S., Hanretty K., Lyall F. (2011).Heat shock protein 70 is expressed 
in a temporal manner in the placenta and up-regulated during labour. Tensvo Research 
Day, Glasgow, UK. 
Abdulsid A. and Lyall F (2012). Heat Shock Protein 70 Expression Is Spatially 
Distributed in Human Placenta and Selectively Up-regulated during Labour and Pre-
eclampsia. Women Research day, Glasgow, UK. 
Abdulsid A. and Lyall F (2013). Heat shock protein 27 expression is spatially 
distributed in human placenta and selectively regulated during pre-eclampsia. ISSHP, 
Tromso, Norway. 
Abdulsid A.
,
 Hanretty K., Lyall F.
 
(2014). Stress, inflammatory and apoptotic pathways 
expression in human placenta of normotensive pregnancy and pregnancy complicated 
by FGR or pre-eclampsia. 3 minutes competition at University of Glasgow, Glasgow, 
UK. 
Abdulsid A.
,
 Hanretty K., Lyall F (2014). HSP 27 and 70 expressions in the placenta of 
labour FGR cases versus control labour cases. ISGE meeting, Florence, Italy. 
Abdulsid A.
,
 Hanretty K., Lyall F (2014). TLR Expression in the Placenta during 
Labour and Pre-eclampsia. ISGE meeting, Florence, Italy. 
Abdulsid A.
,
 Alwarfaly S., Hanretty K., Lyall F.
 
(2014). PON 2 Expression in Labour 
and Pre-Eclampsia. SGI 61st Annual Scientific Meeting, Florence, Italy. 
Abdulsid A.
,
 Hanretty K., Lyall F (2014). HSP 27 and 70 expressions in the placenta of 
labour FGR cases versus control labour cases. ISGE meeting, Florence, Italy. Young 
research winner. 
Abdulsid A.
,
 Hanretty K., Lyall F (2014). Heat shock transcription factor 1 expression is 
spatially distributed and selectively down-regulated in the human placenta during 
labour. IFPA meeting, Paris, France.  
Abdulsid A.
,
 Hanretty K., Lyall F (2014). Placental expression of heat shock 
transcription factor 1 in healthy pregnancy and pre-eclampsia. ISSHP, New Orleans, 
USA. 
48 
 
Definitions/Abbreviations 
Ab/Am   Antibiotic antimycotic solution  
AIF   Apoptosis-inducing factor 
ANOVA  Analysis Of Variance  
Apaf1   Apoptotic protease activation factor-1  
APC   Antigen presentation cells  
APS   Ammonium per sulphate  
ASK1   Apoptosis signal-regulating kinase 1  
ATF6   Activating transcription factor 6 
ATP   Adenosine triphosphate 
BAD   Bcl-2-associated death promoter  
Bcl-2   B cell lymphocytic-leukaemia proto-oncogene released proteins 
BiP   Binding immunoglobulin protein  
BMI   Body mass index 
Bp   Base pair  
BSA   Bovine serum albumin  
C pneumonia  Chlamydia pneumonia  
cAMP   Cyclic adenosine momophosphate 
CASP3  Caspase-3  
CASP7  Caspase-7  
CASP9  Caspase-9  
CD14   Cluster of differentiation 14  
cDNA   Complementary Deoxy-Ribonucleic Acid  
CEMACH  Confidential Enquiries into Maternal Deaths  
CHD   Coronary heart disease  
CMV   Cytomegalovirus  
CO   Carbon monoxide  
COX2   Cyclooxygenase 2  
CRH   Corticotrophin-releasing hormone  
CRP   C-reactive protein  
CS   Caesarean section  
CT value  Threshold cycle value  
Cᴛ   Threshold cycle  
49 
 
CTB   Cytotrophoblasts  
CVD   Cardiovascular diseases  
CXCL   Chemokine CXC motif ligand  
CXCL8  Chemokine CXC motif ligand 8 
DAMPs  Damage-associated molecular patterns 
DBP   Diastolic blood pressure  
DD   N-terminal death domain 
DIC   Disseminated intravascular coagulation  
DISC   Death-inducing signalling complex  
DNA   Deoxyribonucleic acid 
DTT   Dithiothreitol  
EDTA   Ethylenediaminetetraacetic acid  
EFW   Estimated fetal weight  
EGF   Epidermal growth factor 
eIF2α   Eukaryotic Initiation Factor 2 (eIF2) 
 ELC/S   Elective caesarean section 
ELISA   Enzyme-linked immunosorbent assay  
EMC/S  Emergency caesarean section 
EndoG   Endonuclease G   
ER   Endoplasmic reticulum  
ERAD   ER associated degradation  
ETB   Endovascular trophoblasts 
EVT   Extra villous trophoblast  
 FADD  Fas receptor with Fas associated-death-domain  
FBS   Fetal bovine serum  
FEEL-1  Fasciclin, EGF-like, laminin-type EGF-like, and link domain-
containing scavenger receptor-1  
FFA   Free fatty acid  
FGR   Fetal growth restriction  
GDM   Gestational diabetic mellitus  
GRP78  Glucose regulated protein 78  
GRP94  Heat shock protein 90kDa beta member 1  
H   Hour 
HCG   Human chorionic gonadotropin  
HCL   Hydrochloric acid  
50 
 
HNE   4-hydroxy-2-nonenal adducts  
HO-1   Hemoxygenase-1  
hPGH   Human placental growth hormone  
hPL   Human placental lactogen 
HRP   Horseradish peroxidise  
HSBP1   Heat shock protein binding factor 1  
HSEs   Heat shock elements  
HSF1   Heat shock transcription factor 1 
HSP70   70 kilo Dalton heat shock proteins 
HSP90AA  Heat shock protein 90kDa alpha (cytosolic), class A member 1  
HSP90B1  Heat shock protein 90kDa alpha (cytosolic), class B member 1) 
HSPA5  Heat shock 70 kDa protein 5  
HSPH1  Heat shock 105kDa/110kDa protein 1 
HSPs   Heat shock proteins 
HSR   Heat shock response  
IFN-B   Inducing interferon-B  
IFN-γ   Interferon-γ  
IgG   Immunoglobulin G  
IHC   Immunohistochemistry  
 IL   Interleukin  
IL1   Interleukin 1  
iNOS   Inducible nitric oxide synthase  
IQR   Interquartile range  
IRAKs   Interleukin-1 receptor-associated kinases  
Ire1   Inositol-requiring 1  
IRF   Interferon regulation factor  
IUGR   Intrauterine growth restriction  
JNK    c-Jun N-terminal kinase  
KDa    kilo Dalton 
LDL   Low-density lipoprotein  
LG   Labour group 
 LG-FGR  Labour-FGR 
LG-PE   Labour-PE 
LH   Luteinizing hormone 
LIF   Leukemia inhibitory factor  
51 
 
LOX-1   Lectin-like oxidized LDL receptor-1  
MAP   Mitogen-activated protein  
MAPKAP  MAP kinase activated protein  
MAPKAPKs  MAP kinase-activated protein kinase  
MAPKs  Mitogen-activated protein kinases  
Mcl-1   Myeloid leukemia cell differentiation protein  
MCP-1  Monocyte chemotactic protein 1 
MDPK   Myotonic dystrophy protein kinase  
Mg   Milligram 
mg/L   Milligrams per litre 
MHC   Major histocompatibility complex  
MKBP   Myotonic dystrophy protein kinase-binding protein 
mL    Millilitre  
mM   Mili-molar 
mmHg   Millimeter of mercury 
MMP   Matrix metalloproteinase  
mRNA   Messenger ribonucleic acid  
MyD88   Myeloid differentiation factor 88  
NaOH   Sodium hydroxide solution  
NBD   N-terminal ATPase domain  
NCBI   National center for biotechnology information  
NDRG1  N-myc downstream-regulated gene 1  
NF-κB   Nuclear factor kappa-light-chain-enhancer of activated B cells  
Ng   Nanogram 
NK   Natural killer  
NLG   Non-labour group  
NLG-PE  Non-labour-PE 
NO   Nitric oxide 
PAMPs  Pathogen-associated molecular patterns  
Par-4   Prostate apoptosis response 4 
PBS   Phosphate buffered saline  
PCOS   Polycystic ovarian syndrome  
PE   Pre-eclampsia  
PECAM-1  Platelet endothelial cell adhesion molecule-1 
PERK   PKR-like endoplasmic reticulum kinase  
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 PG   Primigravida 
PGH   Placental growth hormone 
PIC   Protease Inhibitor Cocktail  
PIH   Pregnancy induced hypertension  
PlGF   Placental growth factor  
PlGF   Placental growth factor 
PRRs   Pattern-recognition receptors  
qRT-PCR  Quantitative real time polymerase chain reaction  
 RNA    Ribonucleic acid 
ROS   Reactive oxygen species  
Rpm   Revolutions per minute  
RQ   Relative quantification of gene expression.  
RT   Room temperature  
RT-PCR  Reverse transcriptase polymerase chain  
SARM   Sterile-alpha and armadillo motif containing protein  
SBD   Substrate binding domain  
SBP   Systolic blood pressure  
SDS   Sodium dodecyl sulphate  
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide  
sEng   Soluble endoglin  
sFlt-1   Soluble fms-like tyrosine kinase receptor-1 
SGA   Small for gestational age  
sHSP   Small HSPs  
SREC-1  Scavenger receptor expressed by endothelial cell-I  
ssRNA   Single stranded RNA  
STAT1  Signal transducers and activators of transcription  
STB   Syncytiotrophoblast 
STD   Stock standard solution 
SVD   Spontaneous vaginal delivery 
TEMED  N,N,N,N tetramethylethylenediamine 
TGF   Transforming growth factor  
TGF-β   Transforming the growth factor beta  
TIR   Toll/IL-1 receptor domain 
TLR   Toll like receptors  
TNF   Tumour necrosis factor  
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TNFα   Tumour necrosis factor α  
TRAIL  TNF-related apoptosis-inducing ligand  
TRAM   TRIF-related adapter molecule  
TRIF   Toll/IL-1 receptor domain-containing adaptor inducing interferon-β  
UPR   Unfolded protein response  
USS   Ultrasound scan  
UV   Ultraviolet  
vCTB   villous cytotrophoblast 
VEGF   Vascular endothelial growth factor  
VEGF-A  Vascular endothelial growth factor-A  
VTE   Venous thromboembolic  
WHO   World Health Organization   
Wks   Weeks  
XD/XO  xanthine dehydrogenase to xanthine oxidase  
β-ME   Beta-Mercaptoethanol  
μg   Microgram 
 μL    Microliter  
2D   Two-dimensional  
8-isoPGF α  8-iso prostaglandin F2α (oxidative stress marker) 
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Chapter I: General introduction 
1 Introduction  
1.1 The placenta 
The human placenta is a unique organ that connects the growing fetus to the uterine wall 
via the umbilical cord.  According to the Oxford English dictionary a placenta is a flattened 
circular shape organ formed in the uterus of pregnant mammals, that provides nourishment, 
maintaining, waste elimination and gas exchange of the fetus through the umbilical cord 
(Dictionary, online) (Benirschke et al., 2012c).  It also produces hormones that support 
pregnancy and fights against infection.  In early pregnancy the placenta is formed from the 
union of the chorion and the allantois. 
1.1.1 The term placenta  
The full term human placenta is a disc like and round to oval organ  in about 90 % of cases 
(Benirschke et al., 2012c).  In approximately 10% of the cases, however, it has an 
abnormal shape, such as placenta duplex, placenta succenturiate, zonary placenta and 
placenta membranacea (Torpin, 1969).  At term, the placenta is on average 22 cm in 
diameter, 2.5 cm central thickness and an average weight about 470 gram (Benirschke et 
al., 2012a).  Those measurements show considerable individual variation depending on 
several factors such as mode of delivery, time of cord clamping and time between delivery 
and examination.  As the placenta is a highly vascular organ, the time of cord clamping is 
important because fetal and maternal blood loss can have an impact on the measurement 
(Bouw et al., 1976). 
The fetal surface named as the chrorionic or amniotic plate has a glossy appearance and 
facing the amniotic cavity, it is a vascular membrane that contains the chorionic vessels 
(Figure 1-1).  Chorionic vessels branch out over the placenta and form a star like pattern 
network, where the arteries cross superficial to the veins.  The chorionic vessel network is 
covered by a single epithelium layer.  The chorionic plate has an opaque appearance 
because of a huge number of collagen fibers accompany the vessels.  There are transparent 
areas in between, which are black and shine because of maternal blood in the intervillous 
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space (Benirschke et al., 2012c).  The transparency of the chorionic plate decreases near 
the placental margin. 
The maternal surface of the placenta is an opaque surface originating from the separation 
of the organ from the uterine wall (Figure 1-1).  This process of separation subdivides the 
junctional zone between the placenta and uterine wall into the basal plate and placental 
bed.  The basal plate is the attachment site of the placenta to the uterus and it is composed 
of decidual cells and trophoblastic embedded in an extracellular fibrinoid, debris and blood 
clots (Benirschke et al., 2012c).  The placental bed remains in the uterus after delivery. The 
placenta is subdivided by grooves into about 10-40 irregular shaped lobules named 
cotyledons.  Major branches of the umbilical circulation supply each cotyledon. 
Cotyledons consist of villous trees structure bathed in maternal blood.   
 
 
Figure 1-1: Pictures of the term human placenta. The left panel shows the fetal side of the 
placenta and umbilical cord inserts within the chorionic plate.  The right shows the maternal 
side which is contact with uterus and divided into cotyledons. (C): cotyledons. (A): amnion. 
(UC): umbilical cord. 
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1.1.2 Placenta shape and cord insertion:  
The umbilical cord contains two arteries and one vein, it is approximately 55-60 cm in 
length and inserts eccentrically in most placentas into the chrorionic plate (Rampersad et 
al., 2011).  The cord insertion point and the placenta shape are important structurally 
parameters but not functionally and algorithms can be used to obtain the shape index into 
either round  (Salafia et al., 2007) or oval shapes (Pathak et al., 2010).  It has been 
suggested (Salafia et al., 2010) that increased variability in the pattern of placenta growth 
associated with different placenta function dimensions, as assessed by the ratio of birth and 
placenta weights that may indicate utero-placental pathology.  The umbilical cord is 
usually inserted near the center of the placenta as a result of a blastocyst orientation during 
the implantation.  It has been shown (Pathak et al., 2010) that eccentric is the common site 
of cord insertion.  The ratio of fetal to placenta weight is lower in a off-center cord 
insertion, suggesting placenta function dimension (Yampolsky et al., 2009).  High blood 
vessels resistance of the umbilical circulation is associated with eccentric insertion of the 
umbilical cord (Nordenvall et al., 1991). 
1.1.3 Early development of the human placenta 
1.1.3.1 The decidua of the endometrium 
Preparation of the endometrium for implantation depends on hormonal stimulation as well 
as the interaction between the blastocyst and the endometrium (Loke et al., 1995, Gellersen 
et al., 2007, Ramathal et al., 2010).  This interaction is mediated by several factors such as 
growth factors, cytokines and adhesion molecules, which are secreted by the endometrium 
and the blastocyst (Cross et al., 1994, Lindhard et al., 2002).  Preparation of the 
endometrial stroma (decidualization) is the changes that occur in the endometrium 
structure in anticipation of pregnancy.  The decidua is a specialized, modified 
endometrium of pregnancy and is a function of hemochorial placentation that has a 
common process of trophoblast invasion.  The decidualization is started in the mid-
secretory phase of each menstrual cycle, in pregnancy and due to high level of 
progesterone continues throughout the pregnancy.  Decidualization is mainly dependent on 
oestrogen, progesterone and regulatory molecules that include cytokines, chemokines and 
proteases (Dimitriadis et al., 2010).  Cytokines include leukaemia inhibitory factor (LIF) 
(Laird et al., 1997) and interleukin (IL) 11 (Dimitriadis et al., 2003) both are important 
factors in the implantation process.  The decidua is composed of three parts, decidua 
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basalis that lies beneath the site of blastocyst implantation, decidua capsularis which 
overlies the blastocyst and decidua parietalis which line the rest of the uterus. 
1.1.3.2 Early development of the blastocyst  
Following fertilization, the fertilized egg called the zygote, moves down the fallopian tube 
to the uterine cavity.  In the fallopian tube the zygote undergoes mitotic division to form a 
ball of cells (morula), which are surrounded by the zona pellucida that helps to hold them 
together.  On day 4-5 post conception the morula subsequently develops into a blastocyst 
soon after entering the uterine cavity.  The blastocyst is formed of a fluid filled cavity 
surrounded by differentiated trophoblast forming a single outer layer of multinucleated 
syncytiotrophoblast (STB) that later forms the extraembryonic membrane and placenta 
(Luckett, 1978).  At one end of the blastocyst the inner cell mass is formed by an 
asymmetric group of cells that give rise to the embryo (Boyd and Hamilton, 1970, Selwood 
and Johnson, 2006, Benirschke et al., 2012a). 
1.1.4 Implantation of the blastocyst 
1.1.4.1 Pre-lacunar stage 
Blastocyst implantation is the important key step for pregnancy to occur.  Apposition of 
the blastocyst is the first step in implantation then followed by an adhesion step (Schlafke 
and Enders, 1975).  The ability of the blastocyst to adhere to the epithelium (apposition) is 
dependent on the interaction between cell surface receptors at the site of implantation and 
receptor on the blastocyst (Lessey and Castelbaum, 2002, Lindhard et al., 2002).  Epithelia 
receptive development depends mainly on estrogen and progesterone production by the 
corpus luteum after ovulation, if blastocyst approaches the endometrium after day 24 of the 
cycle the potential for adhesion is decreased as a result of the synthesis of anti-adhesive 
glycoproteins that prevent receptor interaction (Navot et al., 1991).  The pre-lacunar stage 
begins on day 6-7 post conception, microvillus emanating from the trophectoderm make 
the initial contact with the uterus epithelium (Figure 1-2).  Attachment of the blastocyst 
follows soon through a complex interplay between both decidua and trophoblast cells.  The 
blastocyst begins interstitial implantation close to the maternal blood vessels which will 
provide the placenta with blood flow.  The blastocyst adhesion involves modification in to 
the expression of cellular adhesion molecules such as integrin.  The area of the uterus 
underlying the placenta (placenta bed), contains spiral arteries that play a role in supporting 
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placenta.  By day 7 post conception the embryo is embedded in the uterus and epithelial 
cells grow over the site of implantation (Hertig et al., 1956).  The inner cell mass also 
differentiates into bilaminar disk of embryoblast and amnioblast (Rampersad et al., 2011). 
 
Figure 1-2: Illustration shows the blastocyst just before implantation (apposition). The 
blastocyst contains a single layer of trophoblast (trophectoderm) which is the outer layer of 
cells comprised of trophoblast cells seen in purple (arrow), inner cell mass and blastocyst 
cavity (arrows). The endometrium is seen in red (arrow).  
1.1.4.2 Lacunar stage  
Around 8 days post conception; multiple vacuoles filled with fluid begin to develop within 
the STB mass. These vacuoles coalesce and become confluent, forming the lacunae.  The 
separating lamellae of STB are called the trabeculae and their appearances indicate the 
beginning of placenta trabecular stage.  After formation of the lacunae the trophoblasts 
subdivides into three layers the first one is facing the blastocyst and is called the primary 
chorionic plate, the second layer is the lacunar together with the trabeculae system together 
and the third layer is facing the endometrium and called the cytotrophoblastic shell  
(Benirschke et al., 2012a).  After implantation is completed the trophoblast undergo further 
differentiation into inner villous cytotrophoblast (vCTB) and extra villous trophoblast 
(EVT), each one has distinct functions when it makes contacts with the maternal tissue 
(Loke et al., 1995).  The vCTB villous are the precursor cells that differentiate into STB. 
The EVT because of their location migrate into decidua and myometrium (attaching to the 
extracellular matrix, degrading and then migrating), and then penetrating the maternal 
vasculature this is the beginning of the process of trophoblast invasion (Meekins et al., 
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1994, Pijnenborg et al., 2006, Pijnenborg et al., 1981).  The EVT then follow two pathways 
either interstitially or follow an endovascular route.  The interstitial trophoblasts invade the 
maternal decidua and myometrium in the placenta bed and surround the spiral arteries.  
The endovascular trophoblasts (ETB) enter the lumen of spiral arteries.  This process is 
regulated by several factors including decidua, trophoblast cells and other diffusible factors 
(Lyall, 2006).  The cells invading the uterus reach up to an inner third of the myometrium, 
where some undergo fusion forming giant cells (Al-Lamki et al., 1999).  In the early stages 
of implantation, endometrium superficial venules undergo dilation to form sinusoids, 
which are subsequently eroded into by the STB (Hertig et al., 1956) forming the venous 
circulation and maternal arteries circulation will be established by the end of the first 
trimester (Burton et al., 1999).  Subsequently, the early inter-villous space is formed to 
allow the intercommunication network in particular oxygen and nutrient transport between 
mother and fetus (Burton et al., 1999).  In the first 10 weeks of pregnancy there is no 
maternal blood flow going to the intervillous space due to trophoblast plugs, this will result 
in low oxygen levels until losing the trophoblast plugs (Lyall and Belfort, 2007).  During 
the organogenesis stage the low oxygen environment protects the fetus from reactive 
oxygen species (ROS) (Burton et al., 1999).  Plasma filtrate and uterine glandular 
secretions in the intervillous space provide the nutrients necessary for embryo 
development.  At the end of the first trimester the oxygen concentration rises three fold, 
and may precipitate in a pregnancy complication by inducing the oxidative stress (Burton 
et al., 1999).  However, the placenta expresses anti-oxidants in normal pregnancy which 
help protect from the onset of oxidative stress (Burton et al., 1999).  Fetal-maternal 
exchange of oxygen and nutrients starts at the end of the first trimester after the spiral 
arterioles begin to perfuse the intervillous space (Hustin et al., 1988). 
1.1.5 Development of the placenta and utero-placenta 
circulation 
1.1.5.1 Villous structure and development  
The villi are complex tree-like projections of the chorionic plate into the inter-villous 
space.  These projections represent primary villi, which are composed of core of 
mononucleated cytotrophoblasts (CTB) and are covered by an outer layer of 
multinucleated STB. Their presence marks the beginning of the villous stages of 
placentation.  Trophoblasts form the villi cover which is bathed initially by the clear fluid 
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and later by the maternal blood.  The secondary villi is formed from the primary villi 
around week five of gestation after invading the extraembryonic mesenchyme, which then 
initiates the development of primitive villous trees and the feto-placenta circulation.  When 
primitive villous trees contact the trophoblastic shell, they are called anchoring villi. 
Mesenchymal villi give rise to the mature intermediate villi, from which terminal villi will 
sprout.  Non-branching angiogenesis gives rise to terminal villi and because they are in 
contact with the trophoblast, they are the last to form vessels that allow the exchange of 
oxygen and nutrients.  Fetal vessels are present inside the villi that connect to the fetal 
circulatory system via the umbilical cord.  However, the fetal and placental circulations 
develop independently with a little communication up to the sixth week (Corner, 1929). 
With subsequent villi development, the villous tree is established throughout the feto-
placenta circulation forming a complex network which supports the growing fetus by the 
maternal. 
1.1.5.2 Trophoblast invasion 
Trophoblasts are the first cell lineage to differentiate during development.  Trophoblasts 
play a critical role at the fetal-maternal interface.  Trophoblasts are derived from the 
trophoectoderm of a developing blastocyst, after eight days of fertilization and initial 
blastocyst implantation the trophoblast has differentiated into an outer multinucleated 
syncytium (primitive STB) and inner mononuclear CTB.  After implantation is complete 
the trophoblast undergo further differentiation into villous and EVT.  The villous gives rise 
to the chorionic villi of the placenta with functions in the transport of oxygen and nutrient 
between the mother and fetus, as well as placental hormone and growth factor production. 
The invading extra villous trophoblast cells follow two routes, endothial trophoblast (ETB) 
cells which penetrates the lumen of maternal spiral arteries, and the interstitial trophoblast 
cells which migrate into decidua and myometrium, then penetrate the maternal vasculature 
forming the placenta bed and surrounding the spiral arteries (Pijnenborg, 1994).  This is a 
controlled process regulated by several factors including decidua, trophoblast cells and 
other diffusible factors (Lyall, 2006).  The perivascular trophoblasts at eight weeks form 
around 20% of myometrium spiral arteries and 60% at 16-18 weeks (Pijnenborg et al., 
1983). 
After 11 weeks of gestation the number of CTB is reduced probably due to the formation 
of a multinuclear giant cells after the fusion of the CTB cells (Pijnenborg, 1996).  The ETB 
invasion occurs in two different waves.  Firstly, a decidual phase completed within 10 
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weeks and the second myometrium phase starting 4-5 weeks later (Pijnenborg et al., 1983). 
The morphological basis of this theory is still unclear (Lyall, 2005).  However, (Robson et 
al., 2001) reported that endovascular migration into myometrium arteries is a continuous 
progressive process rather than two different waves.  The interstitial trophoblast migrates 
and invades the uterine tissue and anchors the placenta to the uterus.  Uterine spiral arteries 
undergo physiological modification as a result of the interaction of the invasive ETB and 
the arterial vessel wall.  As a result the spiral arteries are converted into distended, inelastic 
flaccid vessels without maternal vasomotor control.  This process is termed a conversion 
which forms a vessel of low resistance and high capacitance in order to meet fetal 
requirements.  The remodelling can be classified into three phases; trophoblast invasion 
without vascular changes, vascular remodelling by perivascular interstitial trophoblast and 
trophoblast infiltration of arterial wall (Kaufmann et al., 2003). 
During the invasion process the trophoblast becomes embedded in a wall of spiral arteries, 
replacing the endothelial cell lining, and destroying the elastic and muscular coat which is 
replaced by an amorphous fibrinoid material.  The conversion of the spiral arteries occurs 
by end of the first trimester (Lyall and Belfort, 2007).  This process involves mainly the 
spiral arteries in the centre of the placental bed, the density of invasion of spiral arteries 
decreases towards the placenta margin (Brosens, 1988). 
The source of ETB cells and route of invasion is still controversial between the 
intravasation, and extravasation models.  In the intravasation model the spiral arteries are 
infiltrated by interstitial and perivascular trophoblast.  In the extravasation model the 
endovascular trophoblasts enters the spiral arteries from the intervillous space and migrate 
along the arterial lumen retrograde to blood flow to replace the endothelium and infiltrate 
the wall and centrifugally invade media and adventitia.  One group (Kam et al., 1999) 
suggested a combination of two hypotheses, infiltration and replacement by interstitial 
trophoblast followed by replacement of endothelium by a different population of 
trophoblast. 
1.1.6 Mechanism of control of the trophoblast invasion  
Invasion of the decidua and myometrium by trophoblast occurs in a controlled manner. 
The villous trophoblast changes their differentiation into anchoring trophoblast due to 
decidua contact either through a paracrine pathway or by a direct contact with the 
extracellular matrix (Kam et al., 1999).  Signals from the decidual extracellular matrix play 
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a role in this differentiation (Vićovac et al., 1995).  However, (cytokines) paracrine factors 
effect the trophoblast express specific antigens such as the integrin cell-extracellular matrix 
antigens, metalloproteinases, adhesion kinase, transforming growth factor-β 1, insulin like-
growth factor-2, vascular endothelial factor and its receptor (Myatt, 2002). 
1.1.6.1 Role of integrin and cell adhesion molecules:  
The extra villous trophoblast expresses extracellular molecules such as integrin, selectins 
and immunoglobulin on the trophoblast surface to enable their adhesion to the extracellular 
matrix in decidua which control their invasion include (Kreis and Vale, 1993).  The 
integrin is acting as a receptor for the extracellular matrix which plays an important role in 
the trophoblast invasion.  Proliferating and invasive trophoblast secrete different kinds of 
integrin (Damsky et al., 1994).  In addition, proliferating cells secrete cell adhesion 
molecules for example E-cadherin which response for cell to cell contact (Kreis and Vale, 
1993). 
1.1.6.2 Role of PECAM-1  
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a transmembrane glycoprotein 
present in a wide range of cell including endothelial.  Few studies suggested that the CTB 
that invades spiral arteries and replace the endothelial cells express PECAM-1.  However, 
it has been shown that that PECAM-1 does not play a role in trophoblast (Blankenship and 
Enders, 1997, Holthe et al., 2004, Lyall et al., 2001) . 
1.1.6.3 Role of proteases 
Trophoblast invade the decidua and myometrium after degrading the extracellular matrix 
by releasing enzymes known as proteases matrix metalloproteinase (MMPs) (Grahamm 
and Lala, 1992).  Proteases matrix metalloproteinase include MMP-1 (interstitial 
collagenase) degrade fibrillar collagens, MMP-2 ( 72-kDa type VI collagenase, gelatinase 
A), MMPs 9 (92-kDa type IV collagenase, gelatinases B) degrade denatured collagens, 
MMP-3 (stromelysin), MMP-7 (matrilysin) have several substrate include fibronectin, 
laminin, elastin, and collagens III, V, and IX (Myatt, 2002).  MMP-14, MMP-15, MMP-
16, and MMP-17 present on the cell surfaces and activates progelatinase-A (Lyall, 2006). 
Trophoblast invasion also involves a balance between the release of MMPs and their tissue 
inhibitors (Lyall, 2006). 
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1.1.6.4 Oxygen tension and trophoblast invasion  
Before twelve weeks of pregnancy the villous tissue is separated from the maternal 
circulation by a trophoblast layer indicating that during the early stages of gestation the 
placenta develops in a physiological low oxygen environment (Burton et al., 2001).  It was 
reported that at 10-12 weeks of gestation maternal blood flow comes into the intervillous 
space with an increase in oxygen tension (Jauniaux et al., 2003a).  This alteration in 
oxygen tension affects the trophoblast invasion as low tension prevents invasion by EVT. 
Other factors include apoptosis, carbon monoxide (CO) and hemeoxygenase (HO), nitric 
oxide synthase and trophoblast invasion, oxygen tension, trophoblast invasion and human 
leukocyte antigen-G and natural killer cells. 
1.1.7 Placenta functions  
Placenta is a remarkable organ with diverse functions.  These unique functions include 
materno-fetal transport, hormone synthesis and production, metabolism of several 
compounds, barrier to vertical transmission of pathogens and an immunological interface. 
1.1.7.1 Hormone synthesis and secretion 
Placenta plays an important role as a secretory organ by synthesizes of important hormones 
that support pregnancy.  Most of the placenta hormones are produced and secreted from 
CTB, STB, or both. Most of these placenta hormones are proteins hormones; however 
progesterone and oestrogen are steroid hormones.  Placenta hormones include estrogen, 
progesterone, human chorionic gonadotropin (hCG), human placental lactogen (hPL), 
human placental growth hormone (hPGH) (Lacroix et al., 2002).  It also produces many 
growth factors that promote uterine blood flow and placental development such as 
placental growth factor (PlGF), epidermal growth factor (EGF), vascular endothelial 
growth factor (VEGF), and transforming growth factor (TGF).  Furthermore it also secretes 
others peptide hormones such as oxytocin, inhibits, corticotrophin-releasing hormone 
(CRH) and prolactin (Kay et al., 2011). 
1.1.7.2 Placental transport system  
Nutrients, ions, gases and water are transported to the fetus and waste products are 
transferred via the placenta.  Several materno-fetal exchange systems are involved include 
passive diffusion, active transport, facilitated diffusion, ion diffusion systems and receptor 
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transport; these are reviewed in (Sibley and Boyd, 1988, Kay et al., 2011).  Excretion of 
waste products such as uric acid, urea and creatinine are transferred to the maternal 
circulation by the placenta through diffusion. 
1.1.1 Placental sampling and mRNA Analyses 
Studies of gene expression have been used to investigate the pathophysiology of several 
placental diseases.  Special collection procedures are required in order to obtain accurate 
representative sample, these procedures firstly start with mode of delivery.  A placenta 
delivered after vaginal delivery either spontaneous or induced is associated with  
metabolic, endocrine and cytokine changes, generation of oxidative and other stresses, 
activation of signalling pathways and gene transcription compared to the placenta 
delivered after caesarean section (Burton et al., 2014, Yung et al., 2014a).  Many of the 
changes in normal placenta after labour are also observed in the placenta from a pre-
eclampsia (PE) patient (Cindrova-Davies et al., 2007b).  Therefore, the placenta delivered 
by a caesarean section (CS) should be subject to analysis to separate from the effects of 
labour.  Second variations in the time interval between delivery and sample collection will 
be important. Inevitably, the placenta is exposed to a period of ischaemia following 
separation from the uterine wall and as mRNA degrades rapidly following delivery, 
freezing of tissue samples should be done rapidly, preferably within 10 min. several studies 
reported that after 10 min oxidative and metabolic changes are detectable (Serkova et al., 
2003, Yung et al., 2014a).  One group recommended that the placenta sample should be 
taken in a systemic uniform random sampling in which the first sample is chosen randomly 
and then a pre-determined pattern decides the sites of the other samples (Mayhew, 2008).  
In addition, others, recommended that samples should be taken from at least ten placentas 
because of the intra and inter placenta variability in gene expression (Avila et al., 2010). 
Our own publications (which make up part of this thesis) found a clear zonal variation in 
gene expression across individual placenta (Abdulsid et al., 2013a, Abdulsid et al., 2013b, 
Abdulsid and Lyall, 2014, Alwarfaly, 2015) and this varied from gene to gene.  Placenta 
samples should be washed thoroughly in buffered saline to remove maternal contaminants, 
frozen rapidly in liquid nitrogen, and then stored in a -80°C freezer until processing.  A 
housekeeping gene should be used to increase the accuracy of normalization (Benirschke et 
al., 2012b). 
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1.2 Normal Parturition  
Pregnancy is characterized by a complex interplay of inflammatory events regulated by 
both the innate and acquired immune systems.  In humans parturition involves interaction 
of hormonal, neurological, mechanical stretch and inflammatory pathways and the placenta 
plays a crucial role (Challis et al., 2000, Keelan et al., 2003, Petraglia et al., 2010, 
MacIntyre et al., 2012). 
1.2.1  Definition  
Labour (parturition) is a physiological process during which the fetus, membranes, 
umbilical cord, and placenta are expelled from the uterus.  Labour is initiated by hormones 
which cause the muscular walls of the uterus to contract and the process is achieved with 
changes in the biochemical connective tissue and with gradual effacement and dilatation of 
the uterine cervix as a result of rhythmic uterine contractions of sufficient frequency, 
intensity, and duration  (Norwitz, 2003).  Obstetricians have divided labour into three 
stages which occurs in a continuous manner.  The first stage begins with regular uterine 
contractions and ends when the cervix fully dilated at 10 cm. The second stage begins with 
full cervical dilation and ends with delivery of the fetus.  The third stage is the period 
between delivery of the fetus and the delivery of the placenta. 
1.2.2 Parturition as an inflammatory process 
It is known that normal pregnancy is a pro-inflammatory state (Redman et al., 1999), 
which increases in normal pregnancy as the pregnancy advances (Duckitt and Harrington, 
2005). 
Inflammatory mediators such as cytokines and prostaglandins in the cervix, myometrium, 
placenta and fetal membranes play a crucial role in parturition. (Kelly, 1996, Thomson et 
al., 1999, Jabbour et al., 2009, MacIntyre et al., 2012, Osman et al., 2003, Gomez‐Lopez et 
al., 2013).  Leukocytes, predominantly neutrophils and macrophages, infiltrate the 
myometrium especially lower uterine segment during labour at term adaptive immune 
cells, and specifically T cells, play a role in the onset of spontaneous labour at term 
pregnancy (Thomson et al., 1999, Gomez‐Lopez et al., 2013).  Leukocyte infiltration has 
been demonstrated in all these tissue (Gomez-Lopez et al., 2011).  In addition, neutrophil 
chemokines and other inflammatory mediators are over-expressed in the chorio-amniotic 
membranes, even in the absence of leukocyte infiltration (histologic chorioamnionitis) 
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(Haddad et al., 2006, Gomez‐Lopez et al., 2013). 
The inflammatory cell infiltration may be attracted by an increase in cell adhesion 
molecule and E-selectin expression on the vascular endothelium of myometrium, placenta, 
cervix, and fetal membranes at or immediately after the onset of labour (Winkler et al., 
1998, Thomson et al., 1999, Ledingham et al., 2001, Gomez‐Lopez et al., 2013). 
Coincident with infiltration of leucocytes is the production of pro-inflammatory cytokines 
(IL-1β, IL-6, IL-8) and tumour necrosis factorα (TNFα) (Osman et al., 2003, Gomez‐
Lopez et al., 2013) (Figure 1-3).  In addition, it has been shown that two T-cell subsets of 
memory-like T cells; cluster of differentiation (CD) (CD3+ CD4+ CD45RO+ and CD3+ 
CD4CD8CD45RO+ cells) were identified in the chorio-decidua of women who had 
spontaneous labour (Gomez‐Lopez et al., 2013).  Leukocytes particularly neutrophils 
contribute to cervical remodelling by releasing proteolytic enzymes such as collagenase 
and elastase that effect on collagen fibre molecule, which provides the rigidity for cervix 
that will result in cervical ripening (Jabbour et al., 2009). 
The initiation of this process could involve neutrophil chemotactic agents such as IL-8. 
Stimulation of IL-8 occur either in the cervical fibroblast or monocytes which are potent 
sources of IL-8, prostaglandin-E and nitric oxide (NO) (Kelly, 2002).  It has been proposal 
that labour would result by release of two activating and effector molecules waves, which 
together create local responses leading to induction of myometrium contractions and 
extracellular degradation in cervical canal and promote spontaneous labour (Gomez‐Lopez 
et al., 2013).  Activating molecules include prof-inflammatory cytokine (IL1β, TNFα) and 
chemokines (chemokine CXC motif ligand 8 or IL8 (CXCL8), CXCL10) (Gomez-Lopez et 
al., 2011).  Effector molecules include MMPs and prostaglandins (Maymon et al., 2000, 
Xu et al., 2002, Gomez‐Lopez et al., 2013). 
The biochemical events associated with labour involve increased IL-1β (Allport et al., 
2001). IL-1β and TNFα increase the production of proteinases including MMP-1, MMP-3, 
MMP-9 and cathepsin S that can digest the collagen and elastin fibres in the extra-cellular 
matrix of the cervix (Ledingham et al., 2000a, Kelly, 2002).  It has been reported that IL-
1α and IL-1β have been shown to induce proMMP-9, cyclooxygenase 2 (COX2) and 
Prostaglandin-E2 production, all of which play essential roles in myometrium contraction 
and cervical ripening and dilution (Imada et al., 1997, Gomez‐Lopez et al., 2013)  (Figure 
1-3). 
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Figure 1-3: Inflammatory pathway in parturition is associated with the influx of leukocytes 
(mainly neutrophils and macrophages) into the myometrium and cervix during labour, result 
in release IL 1, IL6 and IL8. These cytokines up-regulate MMP expression and activity in the 
cervix, causing collagen breakdown and cervical ripening. In the myometrium, IL1 activity 
leading to more calcium entry to cells, also cytokines increase COX2 expression, causing 
increase of prostaglandin production both will stimulate myometrium contractions. Modified 
from (Jabbour et al., 2009). 
NO is an inflammatory mediator that is increased at term and along with prostaglandin-E2 
increases blood vessel permeability for leukocyte trafficking (Ledingham et al., 2000b).  
Cytokines release leads to up-regulation of several inducible enzymes including COX2 and 
inducible nitric oxide synthase (iNOS). COX2 is induced rapidly during labour and play a 
role in conversion of free arachidonic acid into prostaglandin precursors (Slater et al., 
1999).  In vitro studies also suggest that hypoxia-reoxygenation increases COX2 which 
may in turn play a role in augmentation or even initiation of labour (Burdon et al., 2007). 
Prostaglandin is a potential stimulator for uterine contractions.  Clinically, iNOS has an 
important role in cervical ripening (Ledingham et al., 2000a).  In addition, human placental 
trophoblast shows activation of the nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB), COX2 and iNOS during labour (Allport et al., 2001).  Furthermore, 
corticotrophin releasing hormone and oxytocin secreted from placenta are crucial 
mediators involved in human parturition (MacIntyre et al., 2012).  Increase in levels of 
cleaved caspase-3 (CASP3) and cleaved caspase-9 (CASP9) confirm evidence of placental 
apoptosis during labour (Cindrova-Davies et al., 2007b). 
Several studies showed that inflammatory gene expression is profoundly altered during 
parturition (Bollopragada et al., 2009).  The initiating signal that drives these inflammatory 
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events is still unknown; however, some studies showed that Toll like receptors (TLRs) that 
are responsible for receiving these signals increased toward end of pregnancy and during 
labour (Cindrova-Davies et al., 2007b).  In addition, chemotactic ability of leukocytes 
increases in those taken from blood samples of labouring women compared to the non-
labouring women (Yuan et al., 2009). 
Prostaglandins are well established agent in having a primary action in cervical ripening 
and have considerable clinical use where labour is associated with poor progression of 
cervical ripening (Kelly, 1996).  Prostaglandins formation is known to be stimulated by 
pro-inflammatory cytokines that are secreted locally by intrauterine tissues. Just before 
labour, the myometrium switch from prostacyclin synthesis (uterine contraction 
suppressor) to Prostaglandins-E1 and Prostaglandins-F2 synthesis (uterotonic). 
Prostaglandins arise by action of COX enzymes, primarily via transcriptional up-regulation 
of the inducible isoform COX2 (Kniss, 1999). 
Studies showed that anti-inflammatory pathways are also involved in the mechanism of   
parturition, for example, during labour IL10 levels increase in amniotic fluid (Gotsch et al., 
2008).  In addition, it has been reported (Maldonado-Perez et al., 2009) that anti-
inflammatory lipid mediators such as lipoxins increase in both synthetic capacity and 
receptor density of these molecules in the myometrium during labour.  Moreover, other 
research group has been shown  that mechanical stretch could promote a wave of entry of 
amniotic fluid components into the uterine blood vessel and this would be followed by the 
second big wave of subsequent myometrium contraction (Kobayashi, 2012). 
1.2.3 Parturition and link with oxidative stress  
The contractions that occur during labour are associated with intermittent utero-placental 
perfusion and could lead to an ischemia-reperfusion (IR) type injury to the placenta 
(Fleischer et al., 1987, Brar et al., 1988).  This intermittent perfusion can be expected to 
provide the basis for IR type injury of the placenta.  Indeed Doppler ultrasound studies 
have demonstrated a linear inverse relationship between uterine artery resistance and the 
intensity of the uterine contractions during labour (Brar et al., 1988). 
Labour is also associated with placental alterations in several pathways linked to oxidative 
stress (Many and Roberts, 1997, Cindrova-Davies et al., 2007b, Sitras et al., 2008, Lim et 
al., 2012, Díaz-Castro et al., 2015).  Oxidative stress is related with conversion of xanthine 
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dehydrogenase to xanthine oxidase (XD/XO) a marker of IR injury, and the latter increases 
in labouring placentas compared to the non-labour controls (Many and Roberts, 1997).  In 
addition, during labour there is a reduction in tissue concentrations of ATP, depletion of 
vitamin C in maternal blood and high glutathione levels in umbilical venous blood 
compared to the non-labour controls (Bloxam and Bobinski, 1984, Woods et al., 2002, 
Raijmakers et al., 2003). 
During oxytocin-induced contractions, a 50% reduction in flow into the intervillous space 
was found compared to when no contractions occurred.  This suggests that intermittent 
perfusion of the intervillous space would lead to an IR injury of the placenta. Reactive 
oxygen species (ROS) and the oxidant/antioxidant balance can be affected as a result 
(Mccord, 1993).  Other studies looking at heat shock proteins (HSPs), Superoxide 
dismutase (SOD) is an enzyme that alternately catalyzes the dismutation (or partitioning) 
of thesuperoxide (O2
−
) radical into either ordinary molecular oxygen (O2) or hydrogen 
peroxide (H2O2). Mn-SOD, Cu/Zn-SOD  We conclude that oxidative stress is a potent 
inducer of placental synthesis and release of proinflammatory factors. Most of 
these effects are mediated through the p38 MAPK and nuclear factor-
kappaB pathways and can be effectively blocked by vitamins C and E in vitro.  
Peroxidation of lipids and oxidative damage mediators also show an association between 
labour and placental oxidative stress (Cindrova-Davies et al., 2007b, Abdulsid et al., 
2013b, Abdulsid et al., 2013a, Díaz-Castro et al., 2015). 
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1.3 Pre-eclampsia (PE) 
PE is a disorder of widespread vascular endothelial dysfunction and vasoconstriction 
which occurs after the 20
th
 weeks of pregnancy and can present as late as 4-6 weeks after 
delivery.  PE remains to be one of the leading causes of maternal morbidity and mortality 
worldwide.  PE affects about 2-3% of all pregnancy but this can be much higher in 
underdeveloped countries. About 50 thousand women die in developing countries each 
year from PE disorder (Duley, 1992).  Maternal mortality is far less in developed nations 
due to proper perinatal observation; nevertheless morbidity still remains the leading cause 
of admissions to intensive unit care (Tang et al., 1997).  PE is an important cause of fetal 
growth restriction and iatrogenic prematurity (Redman and Sargent, 2005).  Of all preterm 
births 8% are due to delivery of women who develop severe PE early in gestation (Ananth 
and Vintzileos, 2006).  PE is a common cause of still birth and early neonatal death (Ngoc 
et al., 2006).  PE is also associated with several pregnancy complications such as placenta 
abruption and caesarean section decision.  Women who develop PE are at an increased risk 
of cardiovascular disease later in life (Myatt et al., 2014b). 
1.3.1 Definition of PE 
A number of classifications for hypertensive disorders in pregnancy have been proposed 
(Davey and MacGillivray, 1988, Chung et al., 2001).  According to the International 
Society for the Study of Hypertension in Pregnancy (ISSHP) (Myatt et al., 2014b), PE is 
currently defined as a blood pressure of >140/90 mm Hg on two occasions at least six 
hours apart occurring in women who was normotensive before 20
th
 weeks gestation and 
accompanied by proteinuria (>300 mg/L in a 24 hour urine collection) but without 
evidence of end-organ damage.  However, since this system does not take into account the 
multisystem nature of PE, patients with other characteristics such as thrombocytopenia, 
abnormal liver function or fetal growth restriction (FGR) may be overlooked (Chung et al., 
2001).  PE is also defined as a cardiovascular and renal dysfunction identified by blood 
pressure and proteinuria measurements.  In women with pre-existing essential 
hypertension, PE is diagnosed if systolic blood pressure (SBP) has increased by 30 mm Hg 
or if diastolic blood pressure (DBP) has increased by 15 mm Hg. Sever PE is defined as the 
presence of PE with presence one of the following symptoms and signs being present 
(Table 1-1) (Paruk and Moodley, 2000).  Eclampsia is defined as a pregnancy-specific 
seizure disorder that cannot be attributable to other causes in a woman with PE (Chesley, 
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1984).  Eclampsia is estimated to occur in 1 of 200 cases of PE when magnesium 
prophylaxis is not administered (Livingston et al., 2003).  Delivery of the fetus and 
placenta are the only way to relieve PE symptoms. 
Table 1-1: Severe PE criteria. 
 
1) SBP of 160 mm Hg or higher or DBP of 110 mm Hg or higher on 
2 occasions at least 6 hours apart.  
2) Proteinuria of more than 5 g in a 24-hour collection or more than 
3+ on 2 random urine samples collected at least 4 hours apart.  
3) Oliguria (< 400 mL in 24 hours).  
4) Epigastric pain. 
5) Impaired liver function.  
6) Pulmonary oedema. 
7) Thrombocytopenia.  
8) HELLP syndrome. 
9) Placental abruption 
Neurological symptoms or signs:  
 Persistent headaches.  
 Visual blurring. 
 Altered consciousness . 
 
1.3.2 PE risk 
The incidence of PE is higher in women with a history of PE, multiple gestations, and 
chronic hypertension or underlying renal disease.  Gestational hypertension and proteinuria 
predict an increased risk for developing PE.  However, there is an increased risk associated 
with hypertension when accompanied by other systemic involvement even without 
proteinuria (Myatt et al., 2014b).  There are several risk factors for PE include maternal: 
old age> 40, nulliparity, black race, high BMI, diabetes mellitus, chronic renal disease and 
chronic hypertension (Knight et al., 2010, Practice, 2002, Ziadeh and Yahaya, 2001, 
Sohlberg et al., 2012, O’Brien et al., 2003, Staff et al., 2014).  Fetal factors include 
multiple pregnancy and environmental factors (Long and Oats, 1987, Neela and Raman, 
1993).  There is also a correlation between PE and maternal genes (Roberts and Cooper, 
2001). 
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1.3.3 Clinical presentation 
Maternal organ systems that are susceptible to excessive inflammation and endothelial 
damage are the CNS, kidneys, lungs, liver, systemic vasculature, coagulation, and the 
heart.  Patients frequently have epigastric or right upper quadrant pain, along with 
headache, visual changes, and nausea or vomiting, seem to be more predictive than are 
laboratory parameters for adverse maternal outcomes (Sibai, 2004, Cavkaytar et al., 2007).  
The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, 
elevated liver enzymes and low platelet count occurring in 0.5 to 0.9% of all pregnancies 
and in 10–20% of cases with severe PE.  Complications of HELLP syndrome are abruption 
placentae, disseminated intravascular coagulation (DIC), pulmonary oedema, acute renal 
failure, eclampsia  and sub-capsular liver haematoma (Haram et al., 2009). 
1.3.4 PE classification 
Several schemes have been proposed for PE classification, and the most common is to 
divide cases clinically into early and late-onset PE (term and pre-term PE), according to 
the gestational age at diagnosis or when delivery is necessitated.  The majority of cases are 
late-onset, usually defined as PE that occurs after 34 weeks of the gestational age.  Early-
onset is often considered more severe, as it is associated with a higher rate of 
complications such as FGR and risk of maternal cardiovascular complications after 
delivery (Paruk and Moodley, 2000).  It has been proposed that PE can be classified on the 
basis of pathophysiology into ‘placental’ and ‘maternal’ causation or mix of them (Redman 
and Sargent, 2005).  In the placental class, it is postulated that malperfusion leads to 
placental stress and hence the release of cytokines and angiogenic regulators, which will 
then cause maternal endothelial cell activation.  Recently (Redman et al., 2014) suggested 
that there may be two placental causes for PE, the first is an extrinsic placental mechanism 
is the dysfunctional remodelling of the uteroplacental spiral arteries that feeding blood into 
the intervillous space, the second is intrinsic placental mechanism which due to an 
increasing placental size leads to a restricted intervillous perfusion.  In the maternal class, 
it is believed that the same final stage is reached due to a predisposing exaggerated 
maternal endothelial sensitivity to factors emanating from a relatively normal or 
excessively large placenta.  The maternal classification is based on normal pregnancy 
being a pro-inflammatory state, with an activation of circulating immune cells (Redman 
and Sargent, 2003) and elevated systemic oxidative stress as gestation advances (Belo et 
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al., 2004).  Therefore, maternal PE has been suggested to be an excessive maternal 
response towards an existing inflammation (Redman et al., 1999).  Several studies showed 
that women with chronic systemic inflammation, due to conditions such as renal disease, 
autoimmune diseases or metabolic syndromes, have an increased risk of developing PE 
near to term (Duckitt and Harrington, 2005). 
1.3.5 Pathophysiology of PE 
PE is a condition of imbalance between factors produced by the placenta and the maternal 
reaction to them.  Although the cause of PE remains largely unknown, but a 3-stage model 
is suggested for the (placental type) of PE (Redman and Sargent, 2010).  The 1
st
 stage is 
dysregulated immunological factors; the 2
nd
 stage is an abnormal placentation with reduced 
trophoblast invasion and failure to fully remodel maternal spiral arteries and the 3
rd
 stage is 
the clinical signs of PE hypertension and proteinuria due to an excessive maternal 
inflammatory response and endothelial dysfunction as a result of placenta oxidative and 
endoplasmic reticulum (ER) stresses (Redman and Sargent, 2005).  Abnormal placentation, 
immunologic intolerance, cardiovascular and inflammatory changes, genetic and 
environmental factors are important factors in PE development (Cunningham et al., 2014). 
1.3.5.1 Immunological factors in PE 
Immunological factors have long been considered to be a key factor in PE.  One important 
component is a poorly understood dysregulation of maternal tolerance to paternally derived 
placental and fetal antigens.  One important theory was based on a model of immune-
regulation in pregnancy that is based on shifting of the maternal immune response away 
from Th1 (T-helper1 cell-mediated graft rejection responses) to Th2 (T-helper2  antibody-
mediated responses) that result in protecting the conceptus from the maternal cell mediated 
immune attack (Wegmann et al., 1993).  In PE, the pregnancy shift to Th2 either does not 
occur or is reversed early in the disorder.  Thus, Th1 responses are not suppressed and 
production of cytokine interferon-γ (IFN-γ) is normal.  There is a possibility that fetal 
antigen play a role in this regulation (Sargent et al., 2006).  In addition, the endothelial cell 
dysfunction may be partially due to an extreme activation of leukocytes in the maternal 
blood circulation, as evidenced by an up-regulation of Th1.  Immune responses may play 
an important role in PE by restricting trophoblast invasion through the interaction of 
trophoblast major histocompatibility complex (MHC) and decidual natural killer (NK) 
cells in early pregnancy and through the interaction of STB debris and circulating NK cells 
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to stimulate the intense systemic inflammatory response in late pregnancy (Sargent et al., 
2006). 
1.3.5.2 Abnormal placentation  
The mechanisms that are involved in maintaining a human pregnancy to term, and the 
switches that lead to a normal labour and pregnancy outcome or indeed an adverse 
outcome such as miscarriage, PE, FGR or preterm labour, are complex but the role of the 
placenta is crucial to them all (Petraglia et al., 2010, Challis et al., 2000, Roberts and 
Escudero, 2012, Burton and Jauniaux, 2011).  Abnormal placentation and trophoblastic 
invasion of uterine spiral arteries is a major cause of hypertension associated with PE 
syndrome (Redman and Sargent, 2005, Zhou et al., 1997).  During a healthy pregnancy 
maternal spiral arteries are dramatically remodelled.  They become widely dilated and lose 
their responsiveness to vasoconstrictive stimuli.  Thus blood enters the inter-villous space 
in a non-pulsatile manner and under low pressure (Lyall, 2006).  PE is characterized by 
defective in spiral arteries remodelling, high resistance of utero-placental circulation, and 
inadequate placenta perfusion.  The frequent findings in the PE are low number of 
trophoblast invasion of the maternal spiral arteries and muscular media persists these 
changes involve myometrial arteries primarily (Pijnenborg et al., 1991).  Incomplete 
trophoblastic invasion of the spiral arteries is directly correlated with the severity of 
subsequent maternal hypertension.  In PE spiral artery remodelling is partial or 
incomplete (Lyall, 2006).  The ensuing high pressure flow results in a hydrostatic damage 
to the placental villi.  Acute atherosis is also a characteristic of decidual changes (Lyall, 
2003, Staff et al., 2014).  Furthermore perfusion by intermittent pulses of fully oxygenated 
arterial blood is thought to lead to fluctuations in oxygen delivery resulting in oxidative 
stress and release of systemic vasoactive compounds (Burton and Jauniaux, 2011, Roberts 
and Hubel, 2009).  These compounds cause vasoconstriction, endothelial damage, 
inflammation hypercoagulability and platelet dysfunction, which all contribute to organ 
dysfunction and clinical feature of PE.  The maternal syndrome is, at least in part, due to 
the maternal response to this damaged placenta. This is known as the two -stage model of 
PE (Roberts and Hubel, 2009). 
Placental pathology is generally worse in an early-onset PE however there is no 
histological evidence that spiral artery remodelling is restricted to early-onset disease only 
(Lyall et al., 2013a).  There appears to be a spectrum of changes both within all the spiral 
arteries of individual cases and across gestational ages (Lyall et al., 2013a). 
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1.3.5.3 Endothelial dysfunction 
In PE, new hypertension and proteinuria arise secondarily to diffuse maternal endothelial 
and inflammatory dysfunction.  Imbalance of proangiogenic and antiangiogenic factors 
produced by the placenta may play a major role in mediating endothelial dysfunction.  
Markers of endothelial cell injury can be demonstrated in women who develop PE before 
they became symptomatic.  These markers include endothelin, cellular fibronectin, 
plasminogen activator inhibitor-1 and von Willebrand factor (Taylor et al., 1997, Friedman 
et al., 1995).  A poorly perfused placenta resulting from insufficient trophoblast invasion 
and placental bed vascular remodelling, may cause the placenta to secrete placental factors 
into the maternal circulation and this will altered the endothelial cell activity.  This 
activation will lead to change in the vascular sensitivity to activate coagulation, and reduce 
vascular integrity resulting in the pathophysiological changes of PE.  Oxidative stress, 
inflammation and circulatory maladaptation also contribute to the endothelial dysfunction 
and PE pathogenesis (Staff et al., 2010). 
1.3.5.4 Angiogenic factors in PE 
Angiogenesis is important for successful placentation and the normal interaction between 
trophoblasts and uterus endothelium.  The circulating proangiogenic factors secreted by the 
placenta include a vascular endothelial growth factor (VEGF), soluble vascular endothelial 
growth receptor-1 (sVEGFR-1), sVEGFR-1 also known as soluble fms-like tyrosine kinase 
receptor-1 (sFlt-1), placental growth factor (PlGF) and soluble endoglin (sEng). The 
receptor sFlt-1 is a soluble isoform of Flt-1, which is a transmembrane receptor for VEGF.  
Although sFlt-1 lacks the transmembrane domain, it contains the ligand-binding region and 
is capable of binding circulating VEGF and PlGF, hence preventing these growth factors 
from binding to the transmembrane receptors. Thus, sFlt-1 has an antiangiogenic effect. 
VEGF and PlGF are growth factors produced by the placenta and the serum level of PlGF 
rises much more during pregnancy. In women who later developed PE there is an increased 
level of sFlt1 (antagonist of VEGF and PIGF) (Maynard et al., 2003, Thadhani et al., 2004, 
Vatten et al., 2007) and decrease levels of both VEGF and PIGF (Taylor et al., 2003, 
Maynard et al., 2003, Levine et al., 2004, Thadhani et al., 2004).  In early onset PE, there 
are elevated levels of sFlt-1, sEng with reduced PlGF (Maynard et al., 2003, Staff et al., 
2013) and the serum level of sFlt-1 was higher in women who developed severe early PE 
(< 34 wk) than it was in women who developed mild PE at term (Levine et al., 2004) .  
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However, late onset PE is not characterized by low circulating levels of PlGF (biomarker 
for poor placental function) and elevated sFlt1 but the angiogenic imbalance is therefore 
not likely to explain all features of the heterogeneous PE syndrome (Staff et al., 2013).  
The vascular endothelial growth factor A (VEGF-A) levels in PE are biologically active 
and one study suggested that the cause of an increased vascular permeability of PE is due 
to loss of  the repression of VEGFR1 signalling by PlGF-1, and VEGF₁₆₅b (Bills et al., 
2011).  The sEng is a soluble isoform of co-receptor for transforming the growth factor 
beta (TGF-β).  As sEng contains the TGF-β binding domain, it can bind to circulating 
TGF-β and decrease circulating levels.  TGF-β is a proangiogenic molecule, so the net 
effect of high levels of sEng is anti-angiogenic. sEng is found in the blood of a women 
with PE and its level in maternal circulation correlates with the syndrome severity (Levine 
et al., 2006, Venkatesha et al., 2006).  sEng inhibits TGF-β in endothelial cells and also 
inhibits TGF-β -1 activation of NO mediated vasodilatation (Venkatesha et al., 2006).  
There is also evidence that sEng  may act in concert with sFlt1 to induce severe PE 
(Venkatesha et al., 2006). 
1.3.5.5 Genetics factors in PE 
PE has been shown to involve multiple genes.  Several genes (maternal and paternal) have 
been studied for their association with PE, including genes known to play a role in 
cardiovascular disease (Williams and Morgan, 2012).  There is a family risk of PE between 
close relative.  However, as the PE is a genetically and phenotypically complex disease, it 
is unlikely that any single gene will be shown to play a dominant role in its development 
(Liu et al., 2015). 
1.3.6 Prediction of PE 
In the past two decades, our understanding of PE has increased greatly.  In vivo and in 
vitro studies have increased our knowledge of the mechanisms involved in failed 
conversion of the maternal spiral arteries (Lyall et al., 2013b) and this can lead to an IR 
injury of the placenta (Burton et al., 2009a).  PE is a multisystem disorder with an 
inflammation role involve in their pathogenesis (Roberts et al., 1989).  The organs 
involvements include liver, kidney, CNS, cardiovascular system and placenta.  However, 
although this has helped to direct research efforts to better understand the PE etiology, it 
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has not had a significant effect on the clinical management for PE patients or indeed how 
the condition is predicted reliably. 
There are several promising attempts for prediction and the most successful one was to 
measure factors for example placental derived factors, implicated in the pathophysiology 
of PE to try predicting the PE.  None have as yet been adopted for use in a routine clinical 
practice due to problems such as adequate sensitivity and specificity (Conde-Agudelo et 
al., 2009, Redman et al., 2014).  Measurement of urinary kallikrein was shown to have a 
high predictive value, but it was not reproducible (Kyle et al., 1996).  Although work on 
sFlt-1, PlGF, and VEGF has been promising, their positive predictive value in predicting 
PE have yet to be evaluated in a prospective fashion. In addition, (Meads et al., 2008) 
reviewed 27 predict tests for PE, only a few reached specificities above 90%. Tests that 
reached specificities above 90% were body mass index greater than 34, alpha-fetoprotein 
and uterine artery Doppler (bilateral notching).  Sensitivity of higher than 60% was 
achieved only by uterine artery Doppler resistance index and combinations of indices. 
Kallikreinuria (sensitivity >80% and specificity >90%), cellular and total fibronectin 
(specificity >90%) seem worthy of further investigation (Meads et al., 2008).  
Prediction and treatment of PE has been more successful in small studies than larger 
powered multi-centre studies.  This has been put down to smaller studies having a more 
homogenous population and conversely larger multi-centre trials having a more 
heterogenous population (Myatt et al., 2014a).  Add to this the factors being measured are 
not present in all women with PE (Myatt et al., 2014a).  All of this supports the idea that 
sub-groups of PE exist which all end up presented as high blood pressure and proteinuria. 
1.3.7 PE and link with oxidative stress  
Oxidative stress occurs when the production of ROS overwhelms the intrinsic anti-oxidant 
defences.  It may induce a range of cellular responses depending upon the severity of the 
insult and the compartment in which reactive oxidative species are generated (Burton and 
Jauniaux, 2011, Roberts and Hubel, 2009).  There is an irrefutable evidence of placental 
oxidative stress in PE, including increased concentrations of protein carbonyls, lipid 
peroxides, nitrotryosine residues, glutathione and DNA oxidation (Burton and Jauniaux, 
2011, Myatt and Cui, 2004, Serdar et al., 2003, Orhan et al., 2003).  In PE, there are 
increased levels of placental N-myc downstream-regulated gene 1 (NDRG1) (response for 
78 
 
hypxia) expression (Choi et al., 2007), hypoxia-activated genes (Vaiman et al., 2005), STB 
apoptosis (Leung et al., 2001, Allaire et al., 2000), maternal serum cell-free fetal DNA 
(Sekizawa et al., 2003), maternal serum TNF-α, IL-6, IL-8 (Johnson et al., 2002) and 
maternal serum leptin (Laivuori et al., 2006).  PE, and the deleterious effect of ROS may 
be counteract by an antioxidant therapy, and there is the need to investigate the optimum 
dosing and timing of antioxidants administration, since an inappropriate 
antioxidant treatment in pregnant women may have deleterious consequences, 
reducing placental cells proliferation until to cell death  (Fiore and Capasso, 2008).  The 
superoxide dismutase  gene SOD3 Ala40Thr single nucleotide polymorphism in a 
Caucasian population from Hungary also increased in blood with the oxidative stress in 
severe FGR complicated PE (Rosta et al., 2009).  Due to the deficiency of the superoxide 
dismutase activity, the concentration of superoxide anion concentration is increased, which 
in conjunction with increased concentration of iron would result in a greater oxidative 
stress (Zhang et al., 2005).  In addition, NO reacts with a superoxide during the deficiency 
of superoxide dismutase activity forming a strong oxidizing agent (peroxynitrite (ONOO)) 
that initiates lipid peroxidation. 
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1.4 Fetal growth restriction (FGR)  
1.4.1 Definition  
FGR is the failure of the fetus to achieve its genetically pre-determined potential size due 
to adverse genetic or environmental factors.  FGR is a serious complication of pregnancy; 
it affects 3-10% of pregnancies, and is generally defined as an estimated fetal weight 
(EFW) at or below the 10
th
 percentile for his or her gestation age in weeks by using the 
Standardized Scottish (or other) Birth Weight Table (Resnik, 2002, Alberry and Soothill, 
2007).  Perinatal morbidity and mortality increases markedly as birth weight falls from the 
10
th
 to the first percentile (Resnik, 2002).  Severe FGR is defined when the fetal weight 
estimation is less than the 3
th
 percentile and most consistently associated with adverse 
perinatal outcome (Unterscheider et al., 2013).  This definition excludes fetuses that are 
small for gestational age (SGA), in which the estimated weight is less than a cut off weight 
for a given population, often because of constitutional factors.  There are numerous 
standard curves for fetal growth that has been published and it is well recognized that 
growth may be influenced by factors such as race, gender and socioeconomic environment. 
Customized growth curves for ethnicity, parental height and weight and fetus gender are in 
development in order to improve the sensitivity and specificity of a diagnosis (Gardosi, 
2006, Groom et al., 2007), in addition, using a customized rather than population based 
growth curve is more accurate (Figueras et al., 2007).  Furthermore, it would thus seem 
good to use a single customized standard chart for all racial groups within a specific 
geographic area (Greene et al., 2008).  Perinatal morbidity is more predicted with 
asymmetric fetal estimated weight less than 3
th
 percentile. FGR can be classified along 
with the Doppler measurement of umbilical/uterine artery blood flow; abnormal 
measurement is associated with poor prognosis (Albaiges et al., 2000).  It contributes to a 
third of antepartum death, 10 fold rises in perinatal mortality and also increases health 
complications later on in an adult life. 
1.4.2 Pathophysiology of FGR 
FGR is not a specific disease, but rather a manifestation of many possible fetal and 
maternal disorders. However, although the aetiology is multifactorial; placenta 
insufficiency is the most common cause and is usually due to poor utero-placental blood 
flow and placental infarcts (Alberry and Soothill, 2007).  FGR with PE and abruption 
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placenta are pregnancy disorders associated with placental ischemia and share many 
similar pathological and pathophysiological features and are usually associated with failure 
to delivery oxygen and nutrients to the placenta (Roberts, 2014).  Early onset PE and 
chronic hypertension with superimposed PE usually have the most profound effect on fetal 
growth (Ødegård et al., 2000).  There is a strong association between FGR and  
chromosomal disorders such as  trisomy 13, 18, and 21, those are frequently growth 
restricted (Snijders et al., 1993, Resnik, 2002).  In addition, there are several factors that 
seems to be associated with FGR such as prothrombin gene mutation, antiphospholipid 
syndrome, maternal nutritional abnormalities, cytomegalovirus infection, or fetal alcohol 
syndrome (Kupferminc et al., 2000, Resnik, 2002).  FGR fetuses placentas will frequently 
have abnormal size and function, FGR placentas are usually much smaller than normal 
placentas (Heinonen et al., 2001).  Krebs et al. (Krebs et al., 1996) found severe 
abnormalities at the terminal villous, which explains vascular impedance observed 
clinically using Doppler velocimetry. 
1.4.3 Causes of FGR 
There are numerous causes leading to FGR without a direct link to the placenta, and these 
including genetic abnormalities such as imbalances of chromosome number, mosaicism 
and single gene mutations.  Environmental causes like maternal infection 
(cytomegalovirus), drugs (opiates, cocaine, and some anti-hypertensive drugs) and severe 
alcohol consumption may influence the fetal growth.  Also, smoking-mediated through 
nicotine that mediates secretion of vasoconstrictive catecholamine to which the placenta 
adapts by increasing angiogenesis and excessive apoptosis.  FGR occurs when gas 
exchange and nutrient delivery to the fetus are not sufficient (Roberts, 2014); this process 
can occur because of a maternal disease such as chronic hypertension, diabetic, 
autoimmune disease, protein-calorie malnutrition and uterine malformations. Placental 
causes include multiple gestations, chronic abruption, cord and placental abnormalities and 
placenta previa (Severi et al., 1999). 
1.4.4 Diagnosis and Surveillance 
FGR screening is based on clinical examination and identification of risk factors such as 
previous history of pregnancy with FGR, PE and a low pre-pregnancy weight.  Screening 
includes abdominal palpation, symphysis to fundal (S-F) height measurement, and 
Ultrasound scan (USS) examination.  For most cases, an estimation fetal weight (EFW) at 
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or below the 10
th
 percentile is used to identify fetuses at risk.  However, it is important to 
understand that this is not a definitive cut off for utero-placental insufficiency.  USS 
evaluation of the fetus is considered the standard for the diagnosis of FGR as it gives a 
reasonably precise estimates of fetal weight, as well as the ability to follow interval growth 
and the pattern of growth abnormality (symmetric or asymmetric).  However, although a 
diagnosis of placenta insufficiency can be based on USS parameters, FGR is often a 
diagnosis of exclusion.  When a small fetus is detected, diagnostic signs also include 
abnormal umbilical artery Doppler impedance indexes, reduced amniotic fluid volume, 
decreased fetal growth rate, and fetal karyotype abnormality. 
1.4.5 Fetal and maternal health risks  
The growth restricted fetus can experience several complications in the neonatal period due 
to growth insults as well as antepartum and intrapartum factors which include neonatal 
asphyxia, meconium aspiration and hypoglycaemia.  The FGR infant is at an increased risk 
of mortality, necrotizing enterocolities and a need for respiratory support (Garite et al., 
2004).  The FGR infant also associated with spastic cerebral palsy (Blair and Stanley, 
1990).  Later on in the adult life of the FGR is a significant risk factor diabetes, chronic 
hypertension, ischemic heart disease and obstructive lung disease (Barker, 2001).  The 
underlying placental dysfunction suggests that there would be a similar increase in future 
maternal morbidity and mortality among women whose pregnancies are complicated by 
FGR, especially when it is early-onset and severe, resulting in a preterm birth.  Few studies 
found that there is an inverse relationship between infant birthweight and cardiovascular 
mortality in the mother (Smith et al., 2000a, Smith et al., 2005).  This may be related to the 
adverse effects of an increased total cholesterol, higher triglycerides, increased BMI, 
increased insulin resistance, genetic pathway and socioeconomic status found among 
women with a history of FGR.  
1.4.6 The placenta in FGR 
At the same time, there are direct placenta dependent causes that result in FGR.  A 
decrease in placental weight and a reduction in functional placental units are generally 
related to FGR (Heinonen et al., 2001, Pardi et al., 2002).  Failure of remodeling of 
maternal spiral arteries is another cause of FGR, villus injury and thrombotic lesions 
(Parham, 2004, Burton et al., 2009a, Roberts, 2014).  These lesions can be diagnosis by 
82 
 
sonographic examination which may reveal placenta lakes in severe cases of FGR.  These 
lakes are described by an area of hypo-echogenicity and defined as ischemic thrombotic 
lesions.  The placenta has a significant reserve capacity, and due to the accumulation of 
utero-placenta lesions and villus injury, this leads to the clinical apparent placental 
dysfunction.  
 Apoptotic pathways is associated with FGR placentas, there is increased level of placental 
NDRG1 expression (response for hypoxia) (Choi et al., 2007), there is no changes in the 
Hypoxia-activated genes in FGR (Vaiman et al., 2005), STB apoptosis (Leung et al., 2001, 
Allaire et al., 2000) and DNA damage (Takagi et al., 2004).  There is also no change in 
maternal serum cell-free fetal DNA (Sekizawa et al., 2003), maternal serum TNF-α, IL-6, 
IL-8 (Johnson et al., 2002) and  maternal serum leptin (Laivuori et al., 2006). ER stress 
also plays a role in the pathophysiology of unexplained FGR, with speculation that this 
arises secondary to mal-perfusion (Burton et al., 2009b).  
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1.5 Maternal obesity  
Obesity is a condition characterised by excess of body fat, frequently resulting in a 
significant impairment of health and longevity (WHO, 2000).  Body mass index (BMI) is 
used to classify obesity. Obesity is a chronic multifactorial disease caused by genetic, 
behavioural and environmental factors that leads to serious health consequences.  Obese 
adults are at significantly higher risk for cancer, cardiovascular and metabolic morbidity 
and mental disease, as well as overall mortality (Calle and Kaaks, 2004, Kenchaiah et al., 
2002, Friedman and Brownell, 1995, Allison et al., 1999).  In addition, the health resources 
of a population are increase as the number of obese individuals in that population increases 
(Popkin et al., 2001, 2013). 
1.5.1 Obesity classification 
BMI is the body weight of an individual in kilograms divided by their height in metres 
squared [weight (kg)/height (m2)].  A BMI below 18.5 is categorised at underweight, a 
BMI of 18.5-24.9 is normal/healthy weight, a BMI of 25.0-29.9 is overweight and a BMI 
of 30 and above is obese (Table 1-2). 
Table 1-2: Classification of weight status according to BMI (WHO, 2000). 
BMI (kg/m2 Classification 
<18.5                                                                                               Underweight  
18.5-24.9                                                                                           Normal weight  
25-29.9                                                                                              Overweight 
30-34.9                                                                                              Obese I
35-39.9  Obese II 
>40                                                                                                Obese III
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1.5.2 Obesity and pregnancy  
Obesity in pregnancy is increasing worldwide and is associated with increased risk of 
adverse outcomes for both mother and child (Ng et al., 2014, Lutsiv et al., 2015).  Obesity 
complicates around 20% of pregnancies in a typical antenatal clinic in the UK and leads to 
short- and long-term complications affecting the fetus, mother and the pregnancy (Huda et 
al., 2010, Jarvie and Ramsay, 2010, Kerrigan and Kingdon, 2010, McGuire et al., 2010). 
Pre-pregnant obesity is associated with increased risk of PE, gestational diabetic mellitus 
(GDM), venous thromboembolism (VTE) and CS (Jarvie and Ramsay, 2010, Flick et al., 
2010, Faucher and Barger, 2015, Sween et al., 2015). 
Obese pregnant women are more likely to give birth to an infant with congenital anomalies 
(Stothard et al., 2009) and obesity also lowers detection rates of fetal anomalies during 
prenatal USS (Dashe et al., 2009). 
Multiple studies have been shown that maternal obesity and excessive weight gain during 
pregnancy are associated with large for gestational age infants (Faucher and Barger, 2015).  
Offspring of obese mothers have a higher perinatal morbidity and mortality, higher birth 
weight and long-term health problems such as coronary heart disease (Haeri et al., 2009, 
Ferraro et al., 2012).  The odds ratios for these outcomes directly increase with pre-
pregnant BMI (Schrauwers and Dekker, 2009, Flick et al., 2010). 
1.5.3 The rising trends in maternal obesity 
Obesity in the pregnant population has increased by more than 70% over a decade and 1 in 
5 pregnant women in the United Kingdom is obese (Heslehurst et al., 2010).  This lead to 
increased risk for several clinical and obstetric complications such preterm delivery, 
instrumental delivery, operative and anaesthetic issues and birth injury (Sebire et al., 2001, 
Torloni et al., 2009a, Torloni et al., 2009b, Lutsiv et al., 2015).  Maternal obesity has also 
been linked to the development of obesity in offspring via a fetal over-supply of glucose 
and/or lipids in utero (Faucher and Barger, 2015). 
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1.5.4 Maternal complications associated with maternal obesity 
1.5.4.1 Maternal mortality  
Maternal obesity is overrepresented in maternal deaths in developed countries.  The 
Confidential Enquiries into Maternal Deaths (CEMACH) report on maternal death in the 
2003-2005 triennium showed that 28% of mothers who died overweight or obese (Lewis, 
2007), although in the published report 2008-2011 maternal obesity prevalence rate was 
running at 16% and so it has been chosen as CEMACH’s principal project with focus on 
maternal health (Lewis, 2011).  This finding reflect the fact that obesity is a leading cause 
of mortality by either direct or indirect causes include PE, cardiovascular diseases (CVD) 
and thromboembolism. 
1.5.4.2 Gestational diabetes mellitus (GDM) 
Diabetes mellitus is a metabolic disorder characterized by persistent hyperglycemia, with 
disturbance of carbohydrate metabolism resulting from a defect in insulin secretion 
(Consultation, 1999).  There is a strong correlation between obesity and GDM (Sebire et 
al., 2001, Torloni et al., 2009a).  Torloni et al (Torloni et al., 2009a) reported that morbid 
obesity BMI >40 kg/m
2  
is associated with five times the increased risk of GDM.  Other 
risk factors related to the development of GDM are age, parity, family history and ethnicity 
(Group, 2008). 
1.5.4.3 Thromboembolic complications 
Venous thromboembolic (VTE) complications are a leading direct cause of maternal 
mortality in the UK and other developed countries (Bourjeily et al., 2010).  There is two 
and half times more risk for obese women to develop VTE compared to lean pregnant 
women (Knight, 2008).  The possible mechanisms for VTE may related to several factors 
include inflammatory damage to the venous endotheium, sedentary lifestyle and high 
maternal coagulation factors (Lippi and Franchini, 2008). 
1.5.4.4 Effects of obesity on labour and delivery 
Obese pregnant women have an increased incidence of labour induction, CS, infection and 
postpartum haemorrhage (Zhang et al., 2007, Sebire et al., 2001, Poobalan et al., 2009, 
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Heslehurst et al., 2008).  In addition, obese women have prolonged labour and reduction in 
uterine contraction (Kominiarek et al., 2011). 
1.5.4.5 Hypertensive disease in pregnancy 
Several studies show that maternal obesity is associated with increased risk of gestational 
hypertension (O’Brien et al., 2003).  Two large population-based studies also showed 
strong positive associations between pre-pregnancy BMI and the risk of PE (Sebire et al., 
2001, O’Brien et al., 2003).  In addition, (Bellamy et al., 2007) showed that women who 
develop PE are more likely to develop CVD later in life.  The association between the PE 
prevalence and high BMI may be explained by inflammation, oxidative stress and insulin 
resistance (Oteng-Ntim and Doyle, 2012). 
1.5.5 Obesity and PE 
PE risk is linked with greater BMI; the mechanisms for this relationship remain unclear. 
Several of the postulated causal pathways are studied but most of them from observational 
studies and inevitably suffer from potential limitations (Sattar and Freeman, 2012).  These 
pathways include obesity association with metabolic syndrome include hypertension and 
proteinuria, dyslipidaemia, insulin resistance, inflammation and altered vascular function. 
There is much evidence that obesity is a major risk factor for essential hypertension and 
risk of proteinuria in non-pregnant subjects (Whaley‐Connell et al., 2006).  Obesity is 
associated with the mild form of PE rather than the severe form (Bodnar et al., 2007).  
Furthermore, there is a clear association between PE and subsequent CVD risk especially 
in early onset PE (Sattar and Freeman, 2012). 
PE is characterized by dyslipidaemia, predominantly hypertriglyceridemia, linked to this, 
the plasma levels of free fatty acid (FFA) and low-density lipoprotein (LDL) molecules 
concentrations are also increased (Sattar and Greer, 2002).  There are several mechanisms 
that show the associations between lipid profile and PE, these include LDL molecules, 
which are more prone to oxidation and the rise in FFA may facilitate lipid accumulation in 
some organs such as liver and kidney, placenta (Sattar et al., 1996).  The relative 
endothelial dysfunction in obese pregnancy is in part explained by altered levels of plasma 
cytokines IL6 and IL10 with obesity (Stewart et al., 2007).  In addition, high maternal BMI 
is associated with increased levels of circulating leptin secreted by placentas in PE patients 
(Chappell et al., 2002). 
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However, raise lipids levels in PE could also serve as a protective mechanism (improve 
transfer of placental nutrient), thereby counteracting deficiencies arising from 
compromised placental blood flow (Sattar and Freeman, 2012).  
Several researchers suggested that PE arises from an inflammatory state.  In mothers with 
PE there are high circulating levels of pro-inflammatory cytokine level (Lyall et al., 1997, 
Freeman et al., 2004), as well as changes of inflammatory profile in the placenta of obese 
women (Walsh, 2007).  Obesity is linked to a low-grade inflammatory response in 
pregnancy and some postulated that obesity increase PE risk through inflammatory 
pathway, however, this  relationship does not approved (Ramsay et al., 2002) 
(Walsh,2007).  There are no studies of anti-inflammatory interventions that have addressed 
the prevention or treatment of PE, trials of low does aspirin have been approached but 
remains to approved, however aspirin has less effect on this pathways (Sattar and Freeman, 
2012).  In addition, it has been shown (Poston et al., 2006) that concomitant 
supplementation with vitamin C and vitamin E does not prevent PE in women at risk, but 
does increase the rate of low birthweight.  Furthermore, it has been reported that no 
evidence support the use of antioxidants during pregnancy for the prevention of PE and 
other outcomes (Salles et al., 2012). 
Lipid peroxides are increased in healthy pregnancy (Little and Gladen, 1999), however few 
findings are available on oxidative stress in obese pregnancy.  In addition, obesity puts 
overload on the ER due to an accumulation of misfolded proteins, lipid over-supply and 
increased demand on the synthetic machinery (Özcan et al., 2004).  Increased glucose 
metabolism can also cause an increase in ROS in the mitochondria.  It has been shown  
(Houstis et al., 2006) by using gene expression analysis, a role for ROS in both TNFα and 
glucocorticoid models of insulin resistance.  As both ER and oxidative stress are known to 
induce inflammatory signalling cascades (Özcan et al., 2004, Kamata et al., 2005), these 
may provide another explanation by which obesity disrupts insulin signalling. 
PE is characterized by maternal vascular dysfunction.  Maternal obesity is associated with 
an atherogenic LDL sub-fraction phenotype (Meyer et al., 2013).  In addition, elevation in 
plasma levels of asymmetric dimethylarginine (ADMA) (NO synthesis inhibitor) has been 
shown to predict coronary heart disease (CHD) and PE (Roberts et al., 2011).  ADMA 
levels are effected by many factors such as obesity and dietary factors, few studies 
postulated their role as link between  obesity and PE (Roberts et al., 2011). 
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Insulin resistance could be a major link between PE and obesity as it is involved in several 
abnormal pathways such as dyslipidemia, vascular dysfunction, inflammation and PE.  
Reducing insulin resistance via either lifestyle changes or pharmacotherapy might 
therefore lead to decrease PE risk.  In addition, it has been shown (De Leo et al., 2011) that 
continuing metformin therapy throughout pregnancy resulted in significant reduction in 
pregnancy complications for example PE in women with polycystic ovarian syndrome 
(PCOS) and hyperinsulinemia.  However, conflicted results came from another study 
(Vanky et al., 2010). 
Successful placentation is essential for healthy pregnancy outcome, and in PE partial 
failure of trophoblast invasion is likely to play a major role in the disease process (Lyall et 
al., 2013b).  There is no clear causal link between obesity and PE but few speculatives 
have been carried out including how obesity can  influence placentation and placental 
function and thereby contribute to the primary pathology in PE (Sattar and Freeman, 
2012).  Plasma adiponectin concentrations are elevated in women with PE, perhaps as a 
salvage mechanism (Ramsay et al., 2003). 
Physical activity and lifestyle interventions seems to be associated with lower PE risk 
(Sorensen et al., 2003).  Weight loss via bariatric surgery can considerably decrease PE 
risk (Bennett et al., 2010).  In addition, the current evidence does not favour use of 
antioxidant supplements to prevent PE (Rumbold et al., 2008).  Thus, while obesity 
appears causally related to risk of PE, there appears to be no single mechanism that is able 
to explain this link (Sattar and Freeman, 2012). 
1.5.6 Obesity management during pregnancy 
There are currently no universal guidelines for management of the obese woman during 
pregnancy and recent review of evidence relating to interventions targeting weight loss 
showed a lack in appropriate interventions (Birdsall et al., 2009).  Diet and exercise have a 
role in the management of obesity in pregnancy and the ideal weight gain for various 
degrees of maternal obesity is still unknown. Ideally, women would try to achieve a lower 
BMI prior to pregnancy and attend for pre-conceptual counselling clinic according to the 
ACOG Committee opinion no. 549 (2013). 
It is recommended that obese women should give birth in consultant-led units in view of 
the increased risk of induction of labour and emergency caesarean section.  It is also 
recommended that the psychological, social and emotional needs of each obese pregnant 
89 
 
woman should be recognised, despite their care being largely consultant-led.  The support 
of a named midwife should be available to all women throughout the childbearing 
experience. 
 
1.6 Thesis aims  
Uterine contractions during labour are associated with intermittent utero-placental 
perfusion providing the basis for ischemia-reperfusion type injury to the placenta. Doppler 
ultrasound studies have demonstrated a linear inverse relationship between uterine artery 
resistance and the intensity of the uterine contractions during labour.  Labour is associated 
with placental alterations in several pathways linked to oxidative stress. 
 PE is an important cause of maternal death worldwide and a leading cause of iatrogenic 
prematurity and FGR. In PE spiral artery remodeling is partial or incomplete in many 
cases.  The ensuing high pressure flow results in hydrostatic damage to the placental villi. 
Furthermore perfusion by intermittent pulses of fully oxygenated arterial blood is thought 
to lead to fluctuations in oxygen delivery resulting in oxidative stress.  
HSPs play an important role in regulating signal transduction, inhibition of apoptosis and 
cellular proliferation and differentiation.  Apoptosis has been implicated in both PE and 
labour. In the apoptotic pathway, HSPs act at several stages to prevent cell death initiated 
by stress-induced damage.  TLRs are the principal signalling molecules through which 
mammals sense infection.  Since these pathways play a role in oxidative stress and 
inflammation, both features of labour and PE.  The hypothesis was that placental stress 
pathways, inflammatory mediators and apoptotic markers would alter during labour and 
pregnancies complications such as PE and FGR.  Furthermore changes in expression vary 
in different placental zones perhaps due to the variation in blood supply to each zone or 
due to the fact that some zones of the placenta are more susceptible to IR injury. 
Clearly the bigger aim would be, one day, to try and decide which of the pathways might 
be targeted for therapy for pre-term labour and PE.  
 
 
90 
 
1.6.1 Placenta tissue experiments study 
The first aim of this project was to investigate the spatial expression of both protein and 
mRNA of stress proteins HSP70, HSF1, HSP27 and P-HSP27and mRNA expression of  
(i) Stress genes (HSF2, HSPB2-8, HSP32, HSP40, HSP60, GRP78, HSP90AA, 
HSP90B1 and HSP105). 
(ii) Inflammatory mediators (TLRs). 
(iii) Apoptotic pathway markers (CASP3, 7 and 9) 
For the above, placentas were obtained from non-labour and labour groups and the spatial 
distribution was assessed by comparing the inner, middle and outer placenta zones within 
individual placentas. 
The second aim of this project was to compare expression of both the protein and mRNA 
of stress proteins HSP70, HSF1, HSP27 and P-HSP27 and mRNA expression of  
(i) Stress genes (HSF2, HSPB2-8, HSP32, HSP40, HSP60, GRP78, HSP90AA, 
HSP90B1 and HSP105) 
(ii)  Inflammatory mediators (TLRs) 
(iii) Apoptotic pathway markers (CASP3, 7 and 9)  
For the above, placentas were obtained from non-labour and labour groups and the 
difference in expression was assessed by comparing the inner, middle and outer placenta 
zones of the non-labour group with the respective zone of the labour group. 
The third aim of this project was to compare both the protein and mRNA expression of 
stress proteins HSP70, HSF1, HSP27 and P-HSP27 and mRNA expression of  
(i) Stress genes (HSF2, HSPB2-8, HSP32, HSP40, HSP60, GRP78, HSP90AA, 
HSP90B1 and HSP105)  
(ii) Inflammatory mediators (TLRs)  
(iii) Apoptotic pathway markers (CASP3, 7 and 9)  
For the above, placentas were obtained from non-labour PE, labour PE, non-labour 
control and labour control groups.  Due to time constraints only the inner and middle 
zones were examined for the mRNA work. Protein analysis of HSP70 and HSP27 was 
performed on all placenta zones.  The aim was to determine if there was a difference, at 
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each zone, for labour PE versus control labour and non--labour PE versus non-labour 
control. 
 
1.6.2 Tissue culture experiments study  
The aim of the first study was to develop an in vitro model of the hypoxia-reperfusion that 
the placenta is exposed to during labour contractions and also in PE as a result of failed 
spiral artery physiological conversion.  The ain was to measure expression of pre-defined 
proteins or mRNA at placental samples taken from different zones and then exposed to this 
stress. This might help explain why protein expression varied between zones in labour and 
PE in the initial experiments performed in this thesis.  Specifically, at the protein level 
HSP70 and HSP27 were studied and at the mRNA level HSP70, HSP27, HSF1, HSP90AA 
and HSP90B1 were studied. 
The aim of second study was to determine how heat shock (classical way of inducing stress 
proteins) affected the expression of pre-defined proteins or mRNA.  The aim was also to 
determine if any zones of the placenta were more susceptible to heat shock which might 
help explain why protein expression varied between zones in labour and PE.  Specifically 
at the protein level HSP70 and HSP27 were studied and at the mRNA level HSP70, 
HSP27, HSPB6, HSPB2, HSP32, DNAJAB1, HSP90AA, HSP90B1, HSPD1, HSF1, 
HSF2, CASP3, CASP7 and CASP9 were studied. 
1.6.3 BMI study  
Nothing is known about HSPs expression in the placenta of obese women.  However since 
obesity is associated with oxidative stress and inflammation, the aim was to screen for 
different HSPs and CASPs families in the human placenta and then compare their 
expression in placentas from 4 different BMI groups at the inner, middle and outer 
placental zones.  Specifically at the protein levels of HSP70 and HSP27 were studied and 
at the mRNA level HSP70, HSP27, HSPB6, HSPB2, HSP32, DNAJAB1, HSPD1, HSPA5, 
HSP90AA, HSP90B1, HSPH1, CASP3, CASP7 and CASP9 were studied. 
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Chapter II: Materials and methods 
2 Materials and methods  
2.1 Patient consenting process  
2.1.1 Identification  
Women who underwent elective caesarean section surgery for obstetric reasons were 
identified as a potential participant.  The participants in the control groups of non-labour 
and obese group were identified by reviewing the surgical list of the obstetrics operation 
theatre.  The participant control labour group were identified by review the antenatal ward 
list or labour room notice board showing those who were in  in first stage of their labour. 
The participants in the PE and fetal growth restriction group were identified by reviewing 
the maternity department notes. 
2.1.2 Patient recruitment  
Women were approached when they were admitted to the maternity department.  During 
this routine meeting with them, I would introduce my study to them and request invites 
them to consider participating in it; they would also be given an information sheet.  The 
period between approach (i.e the first introduction of the project to prospective 
participants) and obtaining consent varied from a few hours to 2 days. Written consent was 
always obtained through a signed consent form, and the women were given time making 
their decision between their admission into a labour or a recovery room and a few hours 
prior to the delivery.  This is the time period that the women will have in order to decide 
whether they want to take part in the study and to sign the consent form.  It was made clear 
to the women that they would always have the right to withdraw from participating at any 
time, irrespective of the fact that they had signed a consent form.  If a woman was 
interested in participating in the study once they were approached at the maternity 
department, I would discuss the study further and answer any questions she might have. 
All consent forms were filed along with the clinical notes pertaining to the patient.  A copy 
was kept in the study file at the Medical Genetics Department. 
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2.1.3 Ethical approval 
Human term placentae were collected from pregnant women at the Southern General 
Hospital, Glasgow.  The ethical approval for this project was approved by the West of 
Scotland Research Ethics service and was in compliance to the terms in the Declaration of 
Helsinki (REC reference number 13/WS/0149, IRAS ID 130896), consent forms and 
information sheets. Signed patient consent was obtained prior to delivery.  The information 
and consent sheets were also approved by the ethics committee.  All signed consent sheets 
were stored in case of the need for an audit arose (appendix 1).   
2.2 Subjects  
The participants were pregnant women at the Southern General Hospital, Glasgow.  The 
patient’s details are shown in (Table 2-1) and (Table 2-2).  Placentas were collected from:  
2.2.1 Control groups:  
Women who had uncomplicated pregnancies and either had spontaneous vaginal delivery 
at term (labour group (LG), n= 6) or deliveries by elective caesarean section (non-labour 
group (NLG), n= 6).  All those in the labour group had spontaneous labour; this was a tight 
group in term of length of delivery (the minimum time taken for labour was 3 hours and 
the maximum was 8 hours).  CS was performed for obstetric reasons such as breach 
presentation, previous caesarean section or because of maternal request.  All chosen 
placentas were confirmed free of infection by pathology report.  The control groups studied 
had no underlying maternal conditions such as hypertension, PE, diabetes or gestational 
diabetes or other medical disorders.  There was no fetal pathology such as fetal anomalies 
or FGR. 
2.2.2 Obese group: 
Obesity is a condition characterized by excess of body fat and consequently resulting in a 
significant impairment of health. BMI (kg/m²) is defined as persons’s weight (kg) divide 
by the height (m²).  It is a simple index that is commonly used to classify overweight as 
BMI >25 and obesity BMI >30 in adults.  Obese women who had uncomplicated 
pregnancies delivered by elective CS were classified into three groups according to their 
BMI (Table 2-2). 
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Obesity group 1: BMI between 30 and 35 (n=6), group 2: BMI between 35 and 40 (n=6), 
group 3: BMI equal or greater than 40 (n=6).  The control placental samples were collected 
from women with normal BMI i.e BMI between 19 and 25(n=6). 
2.2.3 PE group: 
This group includes women who had pregnancies complicated by PE. Non-labour PE 
(n=5) and labour PE (n=7) were compared to non-labour and labour normotensive 
pregnancies.  Late onset PE is defined as blood pressure of >140/90 mm Hg on at least 2 
occasions at least 6 hours apart occurring in women were normotensive before pregnancy 
after 20 weeks’ gestation and accompanied by proteinuria (>300 mg/L in a 24 hour urine 
collection) with no other underlying clinical problems or maternal disease such as renal 
impairment (Brown et al., 2001). 
2.2.4 FGR group 
This group includes women who had pregnancies complicated by FGR.  FGR is a concept 
signifying that the fetus has not achieved its optimal growth and it generally defined as 
EFW at or below the 10
th
 weight percentile for his or her gestation age in weeks.  Severe 
FGR when EFW is at or below 3
th
 weight percentile and is probably a more reliable cut off 
for associated perinatal morbidity (Resnik, 2002).  However, some of the FGR definitions 
used in the published literature vary, or can be used inappropriate.  About 50-70% of the 
babies in research publications are actually constitutionally small, with fetal growth 
appropriate for maternal size and ethnicity (Alberry and Soothill, 2007).  The Royal 
College of Obstetricians and Gynaecologists in Green–top Guideline No. 31 have of 
defined FGR as “Growth restriction implies a pathological restriction of the genetic growth 
potential.  As a result, growth restricted fetuses may manifest evidence of fetal 
compromise (abnormal Doppler studies, reduced liquor volume)”.  All the samples used in 
this study (n=8) were obtained from a sever group with EFW< 5
th
 weight percentile. 
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Table 2-1: Patient clinical details. NLG (non-labour group); LG (labour group); NLG-PE (non-labour-PE); LG-PE (labour-PE); EMC/S (emergency caesarean 
section); ELC/S (elective caesarean section); SVD (spontaneous vaginal delivery); BMI (body mass index); LG-FGR (labour-FGR); PG (primigravida); G 
refers to the number of pregnancies the woman has had and P refers to the number of live children from these pregnancies. PO+2=2 miscarriages. 
Sample Age (years) Parity  Smoker Gestation 
(weeks/ days) 
Birth weight (g) Placenta 
weight (g) 
Mode of 
delivery 
BMI 
NLG  22 G3P2 NO 38 +4  3840 680 ELC/S 37 
NLG 34 G2P1 NO 41+3 3100 450 ELC/S 30.6 
NLG 26 G2P1 YES 39  2860 683 ELC/S 23 
NLG 22 PG YES 39+2 3050 465 ELC/S 21 
NLG 34 G3P2 NO 39+1 3555 685 ELC/S 32.4 
NLG 32 G2P1 NO 39  4255 605 ELC/S 27 
LG 27 PG NO 40+2 4192 585 SVD 24 
LG 28 PG NO 40+4 3646 595 SVD 28 
LG 22 PG NO 41+3 3940 700 EMC/S 34 
LG 25 PG NO 41+3 3310 486 SVD 24 
LG 28 G3P2 NO 37+6 3354 636 SVD 26 
LG 25 G4P3 NO 41+1 3870 535 SV 33.9 
NLG-PE 34 G3P2 NO 39 3490 592 ELC/S 27 
NLG-PE 33 PG NO 36+6 2800 450 ELC/S 39 
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NLG-PE 28 G2P0 YES 36+3 4525 1309 ELC/S 57.3 
NLG-PE 38 G2P1 NO 39  3736 695 E/CLS 47.2 
NLG-PE 29 G2P1 NO 37 +3 3210 675 ELC/S 32.2 
LG-PE 42 G6P4 NO 36+6 2248 449 EMC/S 29 
LG-PE 32 PG NO 38+1 2812 521 SVD 23 
LG-PE 30 PG NO 28+5 1230 265 EMC/S 29.7 
LG-PE 32 PG NO 38+3 2990 420 EMC/S 21.9 
LG-PE 28 PG NO 40+6 3530 692 SVD 26.7 
LG-PE 17 PG NO 29+2 1260 317 EMC/S 23 
LG-PE 35 PO+2 YES 35+6 2210 780 SVD 29.2 
LG-FGR 27 G4P2 NO 37 1880 310 SVD 29 
LG-FGR 33 G2P1 NO 35+2 1850 370 EMC/S 34.5 
LG-FGR 30 G2P1 YES 34+4 1056 350 EMC/S 18.1 
LG-FGR 32 G8P0 NO 37+4 1990 265 EMC/S 39 
LG-FGR 22 PG NO 37+6 2368 470 EMC/S 21.3 
LG-FGR 28 G3P2 NO 37+2 2075 324 EMC/S 20.1 
LG-FGR 23 PG NO 38+4 
2880 
427 SVD 22.4 
LG-FGR 42 PG YES 36.6 2180 442 EMC/S 18.1 
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Table 2-2: BMI patient details.  
Sample Age years Parity  Smoker Gestation 
(weeks/ days) 
Birth weight (g) Placenta 
weight (g) 
Mode of delivery BMI 
BMI 1-1 26 G2P1 YES 39  2860 683 ELC/S 23 
BMI 1-2 22 PG YES 39+2 3050 465 ELC/S 21 
BMI 1-3 32 G2P1 NO 39  4255 605 ELC/S 27 
BMI 1-4 25 G2P1 NO 40 5250 980 ELC/S 24.1 
BMI 1-5 32 G2P1 NO 39 3510 716 ELC/S 24.4 
BMI 1-6 36 G2P1 NO 39+1 4220 630 ELC/S 23 
BMI 2-1 34 G2P1 NO 41+3 3100 450 ELC/S 30.6 
BMI 2-2 34 G3P2 NO 39+1 3555 685 ELC/S 32.4 
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BMI 2-3 33 G2P1 YES 38+6 3450 625 ELC/S 33.2 
BMI 2-4 29 G2P1 NO 37+3 3210 675 ELC/S 32.2 
BMI 2-5 43 G4P3 NO 37 3515 750 ELC/S 32.8 
BMI 2-6 37 PG NO 38+3 3460 595 ELC/S 33.1 
BMI 3-1 25 G2P1 NO 39+5 3770 690 ELC/S 36.7 
BMI 3-2 40 G3P2 NA 38+4 4850 940 ELC/S 36.6 
BMI 3-3 32 PG NA 38+5 2740 430 ELC/S 37.9 
BMI 3-4 36 G2P1 NA 39+3 4035 790 ELC/S 35.9 
BMI 3-5 33 G3P2 YES 40+1 3725 722 ELC/S 37.4 
99 
 
BMI 3-6 22 G3P2 NO 38+4 3840 680 ELC/S 37 
BMI 4-1 29 G3P2 NO 39+3 4015 995 ELC/S 40.3 
BMI 4-2 46 G3P1+1 NO 38 2845 590 ELC/S 42.3 
BMI 4-3 42 G3P2 NO 39+3 3550 685 ELC/S 44.7 
BMI 4-4 25 G3P1+1 NO 38+4 3575 645 ELC/S 49 
BMI 4-5 38 G2P1 NO 39 3736 695 ELC/S 47.2 
BMI 4-6 33 G2P1 NO 39+2 2940 494 ELC/S 52 
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2.3 Buffers 
Water (dH2O) used in buffer preparation was Milli-Q RG Ultrapure. 
2.3.1  Phosphate buffered saline (PBS) 
 PBS (Sigma-Aldrich, cat.no. P4417-50 TAB) 
Phosphate buffered saline: A solution of one PBS tablet per 100 ml dH2O 
2.3.2 Tissue homogenization buffers (1 L) 
 Tris (Sigma-Aldrich, cat.no. 93352) 
 EDTA (Sigma-Aldrich, cat.no. E6758) 
 Sucrose (Sigma-Aldrich, cat.no. S9378) 
 Protease Inhibitor Cocktail (PIC) (Sigma Aldrich cat. no. P8340-5ml) 
1L of dH2O, 25mM Tris (3.02g), 1mM ethylenediaminetetraacetic acid (EDTA) (0.4g), 
250mM sucrose (85.6g).  The pH adjusted to 7.6. The buffer was stored at 4°C. On the 
experiment day 12.5µl/ml of PIC designed for use with mammalian cells (250µl in 20ml of 
the buffer) was added. 
2.3.3 Bradford Assay buffers 
 Bovine Serum Albumin (BSA) (Sigma-Aldrich, cat.no. A7906-50G) 
 Bradford reagent (Sigma-Aldrich, cat.no. B6916-500ML) 
Stock standard solution for Bradford assay contained 10mg of BSA in 10ml dH2O 
2.3.4 Western blotting buffers 
 10% sodium dodecyl sulphate (SDS) (Sigma-Aldrich, cat.no. 35000)  
 Bromophenol blue (solid) (Sigma-Aldrich, cat.no. B0126-25G) 
 Glycerol (Sigma-Aldrich, cat.no.G2025) 
  Tris (Sigma-Aldrich, cat.no. 93352) 
 Acrylamide (Sigma-Aldrich, cat.no.A3699-100ML) 
101 
 
 Ammonium persulfate (Sigma-Aldrich, cat. No. A3678-100G)  
 TEMED: N,N,N,N tetramethylethylenediamine (Sigma-Aldrich, cat.no.T9281-
100ML). 
2.3.4.1 Sample loading buffer (2x) 
1.2ml of 1M Tris, PH 6.8, 2ml Glycerol, 4ml of 10% SDS, 0.8ml of dH2O, 2ml of 1M 
dithiolthreitol (DTT) and a few bromophenol blue crystals. 
2.3.4.2 Buffer A for the resolving gel (1 L, pH 8.8) 
One L of dH2O contained 1.5M Tris (181.65 g) and 0.4% SDS (40 ml of 10% SDS). 
The pH was adjusted to 8.8. 
2.3.4.3 Buffer B for the stacking gel 
One L of dH2O contained 1M of Tris (60.55g) and 0.4 % SDS (40 ml of 10% SDS). The 
pH was adjusted to 6.8. 
2.3.4.4 Composition of resolving and stacking gels (Table 2-3) 
Table 2-3: Resolving and stacking gels compositions.  
Reagent  Resolving gel (2 gels) 
        (10%) 
Stacking gel (2 gels) 
      (4%) 
 Volume Volume 
30% acrylamide/bis-
acrylamide 
24 ml  2.7 ml  
50% glycerol 4.8 ml N/A 
Buffer A 18 ml N/A 
Buffer B N/A 5 ml 
Distilled water  24.8 ml 12.2 ml 
10% AMPS 360 µl  100 µl 
TEMED 36 µl 20 µl 
Total  36x2 ml for 2 gels 20 ml for 2 gels 
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2.3.4.5 10% ammonium per sulphate (APS) solution  
To 1ml of dH2O, 0.1 g of APS was added and allowed to dissolve 
2.3.4.6 Running buffer (5x) 
Four L of dH2O contained 25mM Tris (60.4 g), 190mM glycine (288 g), 0.4% SDS (200ml 
of 10% SDS) was added. The pH was adjusted to 8.3. 
2.3.4.7 Running buffer diluted 
Diluted 1:5 on the day of experiment: 0.5L running buffer (5x) added to 2 L of dH2O. 
2.3.5 Transfer of proteins to nitrocellulose: buffers required 
 Tris (Sigma-Aldrich, cat.no. 93352) 
 NaOH (Sigma-Aldrich, cat.no. 655104) 
 Glycine (Sigma-Aldrich, cat.no. G8898-500G) 
Transfer buffer in 1L: 800ml of dH2O, 25mM of Tris (3 g), 190mM glycine (14.4 g), 20% 
methanol (200 ml). 
Sodium hydroxide solution (NaOH): 0.1 g NaOH in 100ml dH2O. 
2.3.6 Immuno-detection of proteins: buffer required 
2.3.6.1 TBSTB (in 1 Litre, PH 7.5) 
 Tris (Sigma-Aldrich, cat.no. 93352) 
 NaCl (Sigma-Aldrich, cat.no.S7653) 
 Tween-20 (Sigma-Aldrich, cat.no.P1379) 
 Bovine serum albumin (BSA) (Sigma-Aldrich, cat.no. A7906) 
700 ml of dH2O contained 20 mM Tris (2.4g), 5M HCL (3ml, pH 7.5), 0.5M NaCL 
(29.2g), 0.4% Tween-20 (4 ml) and 0.25% BSA (2.5g) was mixed and final volume of 1 L 
was made and stored at 4°C. 
2.3.7 TAE buffer for gel electrophoresis  
 Tris (Sigma-Aldrich, cat.no. 93352) 
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 EDTA (Sigma-Aldrich, cat.no. E6758) 
 Glacial acetic Acid (Sigma-Aldrich, cat.no. 1005706-3X1.5ML) 
1L of dH2O contained 242 g, 0.5M EDTA (100 ml, pH 8.3) and 57.1 ml of glacial 
acetic acid.  This was stored at room temperature. 
2.3.8 Supplemented media for tissue culture (hypoxia-reperfusion 
and heat shock experiments). 
 Medium199 (M199) (with Earle’s salts, L-glutamine and sodium bicarbonate. The 
liquid was supplied sterile-filtered, cell culture tested) (Sigma-Aldrich, cat. no. 
M4530-100ML). 
 5% fetal bovine serum (heat inactivated) (FBS) (Sigma-Aldrich, cat. no. F9665) 
  1% antibiotic antimycotic solution (Ab/Am) (Sigma-Aldrich, cat. no. A5955) 
Every 20 ml aliquot of M199 media was supplemented with 5% of FBS (1ml) and 1% 
Ab/Am (0.2ml). 
2.4  Placenta sampling methods 
Placentas were obtained after delivery and washed with tap water to remove blood.  The 
amnion was cut off and then the whole placenta was weighed.  The placenta was divided 
into three zones (inner, middle and outer) by three imaginary concentric circles and was 
labelled with 12 numbers before a photograph was taken (Figure 2-1).  Each circle was 
divided into quadrants.  A full thickness piece of placenta, approximately ~1 cm
3
 was 
obtained from each of the three zones by taking measurements from the umbilical cord 
insertion point: inner zone being the inner third closest to cord insertion point, the middle 
zone being the third located roughly in the middle of the distance between the umbilical 
cord insertion point and the periphery, and the outer zone being the third closes to the 
periphery of the placenta.  This was all performed as previously described and is shown in 
(Abdulsid et al., 2013b, Abdulsid et al., 2013a, Abdulsid and Lyall, 2014, Alwarfaly, 
2015). In the FGR placentas, as placenta were smaller, samples were obtained from two 
zones (inner and outer).  Within each zone four separate samples were obtained 
representing the four quadrants.  Placentas had a central cord insertion.  Samples were 
immediately flash frozen in liquid nitrogen.  The remaining part of the placenta was 
transported to the pathology department and sections were examined by a pathologist.  
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Figure 2-1: Photograph of placenta shown the 12 sites within the three placenta zones 
where samples were obtained in each individual placenta. 
2.4.1 Collection and processing of placental tissue at the delivery 
suite  
Tissue samples were collected according to systemic sampling methods.  They were 
washed three times in PBS (phosphate buffered saline) until any remaining traces of blood 
was washed away then, flash frozen in liquid nitrogen.  The liquid nitrogen has been 
collected in sterile containers and all equipment used for the tissue collection was sterile. 
Cryostat containers were cooled on dry ice and each was labelled and used to store a 
sample of tissue.  Snap frozen tissue was then brought to the laboratory on dry ice and 
stored in -80 °C until required. 
2.5 Protein expression analysis: 
2.5.1 Placenta tissue homogenisation 
An appropriate volume of tissue homogenising buffer (section 2.3.2) supplemented with 
protease inhibitor cocktail was aliquot into a universal container and kept on wet ice.  
Relevant tissue samples were removed from –80 °C storage and ground down to a fine 
powder in liquid nitrogen using a mortar and pestle.  Homogenising buffer was added to 
the fine powder at a final ratio of 3:1 (v:w).  The sample was then homogenised using 5 
bursts of 10 second at a speed 20 with 1 minute (min) of cooling interval on ice between 
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bursts using a rotor-stator homogeniser (polytron® PT 1600E, Lucerne, Kinematica) was 
used. Placenta homogenates were then spun at 5000g for 10 min at 4°C to remove debris. 
The supernatant containing the total protein (both particular and cytosolic fractions) was 
extracted and divided into aliquots and stored at -70°C.  The amount of protein in each 
sample was quantified by the method of Bradford. 
2.5.2 Protein estimation using Bradford assay 
The protein concentration was determined according to the Bradford dye-binding method 
(Bradford, 1976).  Bradford assay: is a spectroscopic analytical procedure used to measure 
the concentration of protein in a solution. It is subjective, i.e., dependent on the amino acid 
composition of the measured protein.  The quantification is based on the colour change of 
Coomassie Blue G-250 in response to various concentrations of protein.  is based on 
an absorbance shift of the dye Coomassie Brilliant Blue G-250 in which under acidic 
conditions the red form of the dye is converted into its bluer form to bind to the protein 
being assayed.  The stock standard solution (STD) of bovine serum albumin (BSA) (1 mg 
per ml) (section 2.3.3) was used to create the standard curve.  A series of standard solution 
(STD) using the dilutions below were prepared as shown in (Table 2-4). 
Table 2-4: Standards stock dilution (µg/ml). 
STD concentration 
(µg/ml) 
Vol. stock std (µl) Vol. of d H2O (µl) 
0 n/a 50 
200 10 40 
400 20 30 
600 30 20 
800  40 10 
1000 50 n/a 
 
Samples were diluted 1:40 (39 µl of dH2O and 1 µl of protein homogenate).  Measurement 
of protein samples was performed in duplicate and samples were read in a 
BioPhotometer® (Eppendorf).  A standard curve was created of absorbance against 
different BSA concentrations and this was used to find the concentration of protein 
samples concentration (Figure 2-2).  For a Western blot, 50 mg of protein loaded into each 
well.  The calculation to convert µg to mg = reading value divided by 1000.  The value 
obtained was then multiplied by 40 (dilution factor).  
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Figure 2-2: Example of standard curve.  
2.5.3 Western blotting 
Sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gel electrophoresis separates 
proteins according to their molecular weight.  Proteins migration is determined by the 
negative charge to mass ratio.  Proteins separation is determined by the size of the proteins 
as well as the size of the pores of the gel.  The protocol in this study used a 10% resolving 
gel and 4% stacking gel. 
2.5.3.1 Samples preparation and gel electrophoresis  
Equal concentration of protein samples (including control) were denatured and reduced in 
the presence of mercatoethanol and sodium deodecyl sulphate (SDS) (2.4.4.1) by boiling 
for 5 min in heat block at 95 °C before loading.  After brief centrifugation, each well was 
loaded with 50 µl of protein samples (50 mg of protein). 20 µl of pre-stained SDS-PAGE 
protein molecular weight standards (Low range, BIO-RAD, cat.no. 161-0305) was loaded 
to the first well. 50 µl of positive control (same normal placenta used for all gels) was 
loaded to the second well and used as a reference sample for subsequent densitometry. 
Samples were resolved on polyacrylamide gels (4-10%) (section: 2.4.4.2 to 2.4.4.5). 
Samples were separated using the Protean II® xi Cell System (Bio-Rad Laboratories, 
Hemelhempstead, UK) immersed in running buffer (section 2.4.4.6) at 300 V, 27 mA for 
the first hour (h) then the current was turned up to 30 mA, for a total time period of about 5 
hours (h) until the dye front was close to the bottom of the gel (Figure 2-3). 
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Figure 2-3: PROTEAN II xi systems by Bio-Rad Laboratories: photograph shows a sample 
being loaded (left) and a gel that is running (right). 
2.5.3.2 Transfer of proteins to Nitrocellulose (semi-dry transfer): 
Resolved proteins were electro-transferred onto Whatman Protran® nitrocellulose transfer 
membranes (Sigma-Aldrich, cat.no. Z61360).  Two blotting papers and nitrocellulose 
paper were kept in transfer buffer (section 2.4.5) for 20 min.  The transfer was performed 
using a Trans-Blot SD Semi-Dry® Electrophoretic Transfer Cell (Bio-Rad, cat.no. 170-
3940) at 22 Volts (V) and a constant current (membrane area x 2.5) for 30 min.  Successful 
transfer was indicated by full transfer of the prestained molecular weight markers onto the 
nitrocellulose membrane.  Complete transfer of protein was demonstrated using Ponceau S 
solution staining and then de-staining of the nitrocellulose was carried out in 0.1% NaOH 
solution (Figure 2-4). 
2.5.3.3 Immuno-detection of proteins (Immune-blotting) 
Membranes were blocked in 5% normal donkey serum (Serotec, cat.no CO6SBZ) or 5% 
normal goat serum (Sigma-Aldrech, cat.no. cat.G9023) in TBSTB (section 2.3.6) for 1h at 
room temperature (RT) with gentle agitation.  Primary antibodies were pre-absorbed for 30 
min in 5% normal human serum (Sera Laboratories International, cat.no. S-123-H) in 
TBSTB at room temperature during the blocking stage.  Membranes were then exposed to 
specific primary antibodies and incubated for 1h at RT (Table 2-5).  Different positive 
control protein samples were run when appropriate (Table 2-6).  The membranes were 
washed three times for 5 min each in TBSTB (section 2.3.6.1) before adding appropriate 
horseradish peroxidise (HRP) conjugated anti-immunoglobulin G (IgG) secondary 
antibody at the appropriate different dilution in TBSTB buffer for 1h at RT (Table 2-7). 
After secondary antibody incubation membranes were washed twice in TBSTB for 5 min 
each and then in water for 5 min. 
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Table 2-5: Primary antibodies  
Antibody Supplier Catalogue No  Host Dilution 
HSP27 Cell Signalling Technology 2402 Mouse mono-clonal 1:1000 
P-HSP27 (Ser15) Cell Signalling Technology 2404S Rabbit polyclonal 1:1000 
P-HSP27 (Ser78) Cell Signalling Technology 2405S Rabbit polyclonal 1:1000 
P-HSP27 (Ser82) Cell Signalling Technology 2401S Rabbit polyclonal 1:1000 
HSF1 Enzo ADI-SPA-901 Rabbit polyclonal 1:1000 
HSP70 Enzo ADI-SPA-812 Rabbit polyclonal 1:1000 
Actin-β Abcam Ab8227 Rabbit polyclonal 1:2000 
Caspase-3 Enzo ADI-AAP-113 Rabbit polyclonal 1:1000 
TLR4 Abcam ab47839 Rabbit polyclonal 1:500 
TLR4 Abcam ab22048 Mouse monoclonal  1:1000 
TLR2 Santa Cruz Sc8690 Goat polyclonal 1:200 
TLR4 Santa Cruz  Sc-8694(C18) Goat polyclonal 1:200 
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Table 2-6: Cell lysate positive control 
Cells  Supplier Catalogue number  Cell type Source Function  
HL-60 Santa Cruz Sc-2209 Whole cell lysate Ready made Positive control 
HEL92.1.7 Santa Cruz Sc-2270 Cell lysate Ready made Positive control 
Caco-2 Santa Cruz Sc-2262 Cell lysate Ready made Positive control 
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Table 2-7: Secondary antibodies  
Antibody Supplier Catalogue   Host Dilution  
 
Donkey anti-mouse IgG-HRP Abcam ab6820 Donkey polyclonal antibody to 
mouse  
1:1000 
Donkey anti-Rabbit IgG-HRP Abcam ab7083 Donkey polyclonal antibody to rabbit  1:3000 
gout anti-Mouse IgG-HRP Abcam ab6789 
 
Goat polyclonal antibody to Mouse 1:2000 
Rabbit-anti-Mouse IgG-HRP 
 
Abcam ab6728 Rabbit polyclonal antibody to Mouse 1:2000 
Donkey anti-Goat IgG-HRP Santa Cruz Sc-2033 Donkey polyclonal antibody to Goat 1:200 
Rabbit anti-Goat IgG-HRP 
  
Santa Cruz Sc-2768 Rabbit polyclonal antibody to Goat 1:1000 
 
goat anti-Rabbit IgG-HRP 
 
Cell-Signalling  
Technology 
 
7074 
 
Goat polyclonal antibody to rabbit  
 
1:1000 
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2.5.3.4 Detection  
Immunologically reactive protein were visualised using the enhance Amersham ECL® 
Western Blotting Substrate (Amersham Pharmacia Biotech, GE healthcare, cat. No 
RPN2106).  Chemiluminescent images of immune-detected bands were obtained on 
sensitive autoradiography X-ray films (Kodak film. Sigma- Aldrich, cat.no. Z373508-
50EA) after exposed for different times periods (e.g. 1 min, 30 seconds then 10 seconds) 
until bands were clearly not saturated).  The films were developed using an Ecomax x-ray 
film processor (Protec Medical Systems, cat.no. 1186-3-0000).  Intensities of bands on 
exposed films were quantitatively analysed using a multi-Analysis® software Bio-Rad GS-
700® imaging densitometer.  The density of the placental reference sample (added to every 
gel) was used as internal control and other bands density were expressed relative to it. 
2.5.3.5 Loading control 
Ponceau S solution also was used to ensure the transfer and equality of sample loading 
(Figure 2-4). 
 
 
Figure 2-4: Example of nitrocellulose membrane illuminated with Ponceau S solution. 
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2.6 RNA extraction from placenta tissue 
2.6.1 RNA extraction  
 Total RNA was extracted using the RNeasy Midi Kit (Qiagen .cat.no. 75142) from snap 
frozen placenta samples. RNA extraction after overnight incubation in RNALater® 
(Sigma-Aldrich, cat.no R0901) was also attempted at the beginning of the thesis but 
because of poor yields of RNA obtained compared to the freshly frozen samples all 
subsequent samples were snap frozen immediately after collection. 
When required placenta samples were removed from -80° C storage and placed in a pre-
weighed plate to determine the correct weight of starting material (maximum 250 mg of 
tissue was used at any one time).  The sample was disrupted in 4 ml RLT buffer (provided 
with the kit) supplemented with Beta-Mercaptoethanol (β-ME) (10 µl β-ME per 1ml of 
RLT Buffer).  Homogenisation of tissue was carried out using a Rotor-stator homogeniser 
(Polytron PT1600E, Lucerne, Kinematica) at full speed setting for 45 seconds. 
Homogenised lysate from each sample was then spun at 4000g, 25°C for 10 min.  The 
supernatant was then removed carefully to a new 15ml Falcon tube (Sigma-Aldrich, 
cat.no.Z617849) and then 4 ml of ethanol (70%) was added to the supernatant and mixed 
by shaking vigorously until the solution was clear. 
RNasey® Midi kit spin columns already contained within the 15 ml collection tubes were 
retrieved and 4 ml of mixed supernatant (ethanol and supernatant) was added to the column 
which was then spun at 4000g, 25°C for 5 min. The flow-through was discarded.  Next the 
column was washed three times in 4.0 ml of RW1 buffer (provided with the kit) then 2.5 
ml of RPE (twice).  After each wash the column was spun at 4000g, 25°C, for 5, 5 and 2 
min respectively.  For RNA elution, the RNeasy column was transferred to a new 15 ml 
collection tube. 250 µl of RNase-free water was added into the RNeasy silica-gel 
membrane and allowed to stand for 1 min.  After that the columns were spun at 4000g, 
25°C for 3 min.  This step was then repeated twice.  Then RNA was aliquoted and stored at 
-80°C. 
2.6.2 Quantification of RNA  
Total RNA concentration (ng/µl) was calculated using a Nanodrop 1000™ 
spectrophotometer (Thermo Scientific).  The ratio of absorbance at 260/280 nm indicates 
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the RNA purity; a value ratio close to 2 indicates optimal purity.  The final measurements 
were in ng/µl (Figure 2-5) (Figure 2-6). 
 
 
Figure 2-5: Example of transcript from Nanodrop reading in ng/µl. The ratio of absorbance at 
260 nm and 280 nm (260/280) is given an indication of RNA purity. 
 
Figure 2-6: RNA concentration of representative placenta sample: number 1BMI6 in ng/µl 
(366.5). 
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2.6.3 Reverse transcription (converting mRNA into cDNA) 
RNA was reverse-transcribed to first strand complementary DNA (cDNA) using an 
adapted protocol that used the QuantiTech Kit (Qiagen, cat.no 205310) and GoScript™ 
(Promega, cat.no. A5003).  As a result of an initial optimization process, the quality of 
cDNA obtained using GoScript™ reverse transcriptase was better quality than reverse 
transcriptase of the Qiagen kit. 
Reverse transcription reaction included two steps as follows:  
 Genomic DNA elimination reaction: 
Based on their original concentration the amount of RNA required for 100 ng was 
calculated according to following equation: 
 
 
For each DNA elimination reaction (in each PCR tube) the mixture was: 12 µl of RNA 
(100 ng) from the previous calculation, 2 μl of wipe-out buffer (Qiagen kit) was added to 
mixture and tubes were put through gOUT program, using a thermal cycler (DNA 
Engine®, Bio-Rad) for 3 min at 42 °C. 
 Reverse transcript (RT) reaction  
Once the gDNA wipeout reaction was completed, to each tube 1 μl of GoScript Reverse 
transcriptase ((Promega), 1 μl RT primer Mix (Qiagen kit) and 4 μl RT Buffer (Qiagen kit) 
were added and PCR tubes were again placed in the thermal cycler and the RT4 program 
was used as follows; 30 min at 42°C and 5 min at 95°C.  Once the reaction was completed, 
the cDNA was stored at -20 °C. 
2.6.4 Testing cDNA quality 
The cDNA quality was tested using the human cDNAOK!® kit (Microzone, cat.no. 
2HCDOK-150).  The human cDNAOK mix and megaMix-Gold are supplied from 
Microzone and the primers sequence was held by company.  Interpretation of the results as 
following: expected fragment size: 125 bp, 250, 375, 500 and 650 bp.  If all 5 fragments 
are observed the cDNA intergrate is okay.  The 500 bp (arrow) fragment is derived from an 
115 
 
internal control and should always be present (even in negative control), if not, PCR has 
failed and needs repeating.  However, if less than 5 fragments are observed then the cDNA 
is likely to not be okay.  The PCR reaction was as following; 7.5 µl of human cDNAOK!® 
Kit mix,  12.5µ master mix Gold, 4µl  RNase-free water and 1µl cDNA (RNase-free water 
was added to the negative control). PCR tubes were put into the thermal cycler program 
(cDNAOK) 
o 95°C for 30 seconds 
o For 35 cycles:  
 95°C for 30 seconds 
 59°C for 20 seconds 
 72°C for 45 seconds 
Once completed, the PCR products were separated on a 2% agarose gel at a constant 
voltage of 50 V (Figure 2-7). 
 
Figure 2-7: Gel showing products of the PCR multiplex reaction using the Human 
cDNAOKᴉ® Kit (Microzone, cat.no. 2HCDOK-150). cDNA was made using Quantitect® kit and 
GoScript™ reverse transcriptase. Products were separated on 2% agarose gel using 100 bp 
moelcualr ladders. The negative control was run in first lane. The other lanes show different 
samples that showed good quality cDNA . 
2.6.5 Gel electrophresis using 2% agarose gels  
1g of agarose (Sigma-Aldrich, cat.no. 05066-50G) was added to 50 ml of TAE (section 
2.4.7) buffer then dissolved in a microwave for 30, 20 and 10 seconds with a short interval 
between each time.  7µL of Sybr safe DNA gel stain (Invitrogen, cat.no. S33102) was 
added. Gel electrophoresis was performed using RunOne™ Electrophoresis cell (EmbTec, 
cat.no. E15659).  The loading was as following; DNA ladder (Sigma-Aldrich, 
cat.no.P1473) was loaded in the first well, dH2O as negative control in the second well, 
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then samples were then added in order and finally the positive control.  The run was at 
constant 50 V. the gel was then viewed on a UV transilluminator and a photograph was 
taken. 
2.6.6 Quantitative real time polymerase chain reaction (qRT-PCR) 
Gene-specific real-time PCR TaqMan gene expression assays were predesigned by 
Applied Biosystems.  All gene expression assays have FAM™ reporter dye at the 5ꞌ end of 
the probe, TaqMan® MGB probe and a non-fluorescent quencher at the 3ꞌ end of the 
probe.  Both the TaqMan® MGB probes and primers have been premixed to a 
concentration of 18 uM for each primer and 5 uM for the probe.  All gene expression 
assays amplicon length were less than 150 bp (endogenous control amplicon Length was 
171 bp) and all were linked to FAM-MGB dye.  These assays were readymade and 
supplied by Applied Biosystems (cat.no 4331182).  If possible, the primers were selected 
span exons in order to exclude the amplification of genomic DNA. 
Real-time PCR was performed from reverse transcribed cDNA samples using the 
Quantitative PCR StepOnePlus® machine (applied Biosystems), following the 
manufacturer’s instructions.  Briefly, 100 ng of cDNA (including the reference sample) 
were diluted 1:5 in RNase-free water and then added to a 96-well MicroAmp® Fast 
Optical Reaction Plate (Applied Biosystems, cat.no. 4346906) with 10 µl of TaqMan 
Master mix (Applied Biosystems, cat.no. 4369514), 4 µl RNase-free water and 1 µl 
TaqMan Gene Expression Assay (either gene-specific inventoried assays or endogenous 
reference assays).  β-actin (Applied Biosystems, cat.no. Hs99999903_ml) was used as an 
internal control for normalising relative expression levels in the different RNA samples. 
The choice of endogenous control is important and for this work the endogenous control 
was β-actin, which has previously been demonstrated as a suitable endogenous control in 
this laboratory.  Placenta cDNA (primer design) was used as a positive reference sample.  
Thermal cycling and fluorescent monitoring were performed using the StepOnePlus® 
machine (Applied Biosystems). 
PCR amplification was performed using the following conditions: initial holding stage at 
50 °C for 2 min and then 95 °C for 10 min, followed by a total of 50 cycles (15 seconds at 
95 °C for denaturation and 1 min at 60 °C for anneal/extend).  During the extension step of 
each cycle the fluorescence data were collected.  Negative controls using RNase-free water 
as template were included to test for the presence of any genomic DNA contamination. 
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TaqMan gene expression assays of different genes which were used in my studies are 
shown in (Table 2.8), (Table 2-9) and (Table 2-10).  All assays were inventoried assays 
(prepared by Applied Biosystems) and have a unique catalogue number (4331182).  This 
means that primer sequences and details are withheld by the company. 
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Table 2-8: TaqMan gene expression assays of stress pathways. Hs means Homo sapiens, m means an assay whose probe spans an exon junction, s an 
assay whose primers and probes are designed within a single exon. Such assays, by definition, detect genomic DNA. g an assay that may detect genomic 
DNA. The assay primers and probe may also be within a single exon.  
Human assay ID Gene name/Gene aliases  Gene 
Symbol 
Assay Design                     
Amplicon length  
Hs00328933_m1 heat shock protein, alpha-crystallin-related, B6/  (HSP20) HSPB6  probe spans exons 96 
Hs00166138_m1 crystallin, alpha A / (HSPB4, HSP20) CRYAA probe spans exons 123 
Hs00157107_m1 crystallin, alpha B / (HSPB5, HSP20) CRYAB  probe spans exons 66 
Hs00205056_m1 heat shock 22kDa protein 8 /HSP22 HSPB8 probe spans exons 66 
Hs03044127_g1 heat shock 27kDa protein 1 HSPB1 probe spans exons 145 
Hs00155436_m1 heat shock 27kDa protein 2 /(HSPB2-C110, MKBP) HSPB2 probe spans exons 116 
Hs00272204_s1 heat shock 27kDa protein 3 HSPB3  both primers and probe 
map within a single exon 
77 
Hs00205296_m1 heat shock 27kDa protein family, member 7 (cardiovascular)/ 
(ccV HSP) 
HSPB7  probe spans exons 79 
Hs01110250_m1 heme oxygenase (decycling) 1/ HSP32 HMOX1 probe spans exons 82 
Hs00428680_m1 DnaJ (Hsp40) homolog, subfamily B, member 1/(HSP40) DNAJB1  probe spans exons 130 
Hs01036753_g1 heat shock 60kDa protein 1 (chaperonin) HSPD1 probe spans exons 81 
Hs00359163_s1 heat shock 70kDa protein 1A HSPA1A both primers and probe 
map within a single exon 
124 
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Hs00607129_gH heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) HSPA5 probe spans exons 146 
Hs00743767_sH Heat shock protein 90α HSP90AA1  both primers and probe 
map within a single exon 
133 
Hs00427665_g1 heat shock protein 90kDa beta (Grp94), member 1 HSP90B1  probe spans exons 135 
Hs00971475_m1 heat shock 105kDa/110kDa protein 1 HSPH1 probe spans exons 114 
Hs00232134_m1 heat shock transcription factor 1 HSF1 probe spans exons 102 
Hs00988308_g1 heat shock transcription factor 2 HSF2 probe spans exons 68 
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Table 2-9: TaqMan gene expression assays of inflammatory pathways: TLRs, MYD88 and NFKB1. SA: single exons 
Human assay ID Gene name/Gene aliases  Gene 
 
Assay Design Amplicon length  
Hs00413978_m1 toll-like receptor 1 TLR1 probe spans exons 72 
Hs00610101_m1 toll-like receptor 2 TLR2 probe spans exons 80 
Hs01551078_m1 toll-like receptor 3 TLR3 probe spans exons 132 
Hs00152939_m1 toll-like receptor 4 TLR4 probe spans exons 89 
Hs00152825_m1 toll-like receptor 5 TLR5 probe spans exons 78 
Hs00271977_s1 toll-like receptor 6 TLR6 both primers and probe map within SA 122 
Hs00152971_m1 toll-like receptor 7 TLR7 probe spans exons 125 
Hs00152972_m1 toll-like receptor 8 TLR8 probe spans exons 89 
Hs00152973_m1 toll-like receptor 9 TLR9 probe spans exons 139 
Hs01675179_m1 toll-like receptor 10 TLR10 probe spans exons 121 
121 
 
Hs00182082_m1 myeloid differentiation primary 
response 88 
MYD88 Probe spans exons 104 
Hs00765730_m1 nuclear factor of kappa light 
polypeptide gene enhancer in B-
cells  
NFKB1 probe spans exons 66 
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Table 2-10: TaqMan gene expression assays of apoptotic pathways: CASP3, CASP7, CASP9 and ACTB. Β-Actin TaqMan® gene expression assay ID 
beginning with “Hs999999…” and ending in “_m1” identifies that amplifies a region spanning an exon junction. 
Human assay ID Gene name/Gene aliases  Gene 
Symbol 
Assay Design Amplicon length  
Hs00234387_m1 caspase 3, apoptosis-related cysteine peptidase CASP3 probe spans exons 100 
Hs00154261-m1 caspase 9, apoptosis-related cysteine peptidase CASP9 probe spans exons 65 
Hs00169152-m1 caspase 7, apoptosis-related cysteine peptidase CASP7 probe spans exons 76 
Hs99999903-m1 Β-actin ACTB amplicon spans exons and 
probe does not span exons 
171 
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2.6.7 qRT-PCR data analysis 
Gene expression in different samples was quantified using the comparative Cᴛ method 
(∆∆Cᴛ) as described by Livak and Schmittgen (Livak and Schmittgen, 2001) and 
according to Applied Biosystem guides (part number. 4376785).  There are two different 
methods of analysing data from real-time, quantitative PCR experiments: absolute 
quantification and relative quantification.  The absolute quantification determines the 
transcript copy number usually comparing to a standard curve while the relative 
quantification related the PCR signal (or fold change in gene expression level) of a target 
gene in a one group to the positive control after normalising to an endogenous reference 
gene.  We followed the relative quantification method based on Cᴛ values.  Briefly, 
threshold cycle (Cᴛ) is the fractional cycle at which the amount of PCR amplified gene 
reaches a fixed threshold in exponential phase, Cᴛ is determined from a log-linear curve 
where PCR signal is plotted against the cycle number, and was obtained from the PCR 
machine.  The Cᴛ values of each sample were then imported into Microsoft Excel at end of 
PCR reaction. 
The amount of transcript gene detected at a certain cycle number is directly related to the 
initial amount of target in the sample.  In order to determine the amount of specific 
transcripts present in cDNA, firstly, Cᴛ values for each sample should be normalised to 
obtain ∆ Cᴛ.  For each group; subtracting the mean Cᴛ value of endogenous reference gene 
β-actin from the corresponding mean Cᴛ value of specific gene (SG) (∆Cᴛ = Cᴛ SG - Cᴛ β-
actin).  Then concentration of a specific gene in the samples relative to the positive control 
was normalised by subtraction to obtain ∆∆Cᴛ values (∆∆Cᴛ = ∆Cᴛ sample - ∆Cᴛ of 
positive control).  Finally, the relative expression which is often named as RQ value was 
determined by raising 2 to the power of the negative value of ∆∆Cᴛ (2-∆∆Cᴛ) for each 
sample (Amount of target = 
-∆∆ Cᴛ2). 
2.6.8 Evaluation of TaqMan gene expression assay product by 
performing gel electrophoresis  
This step was done in order to ensure that TaqMan gene expression assays were working 
properly.  Amplified PCR products were then run on a 2% agarose gel to detect the right 
Amplicon length for the specific gene.  For example, HSP70 gene expression Amplicon 
length was 124 base pairs; the band was exactly at 125 base pair confirming that it was the 
specific gene (Figure 2-8). 
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Figure 2-8: 2% gel electrophoresis of PCR products of HSP70 TaqMan gene expression 
assay, band corresponded to amplicon length of the TaqMan 124 base pairs. Negative 
control was loaded in first lane showed no expression. 
2.7 Mammalian tissue culture 
All cell culture procedures were carried out in in a Biological Safety Unit (BSU) Class II 
hoods using standard aseptic techniques and sterile instruments.  The tissue culture flasks, 
dishes and pipettes were obtained from Corning (UK). Culture reagents were purchased 
from Sigma-Aldrich. 
2.7.1 Hypoxia-normoxia (model of IR injury) tissue culture 
This experiment was undertaken to investigate the effect of exposing placenta tissue to 2% 
O2 (hypoxia) for one hour followed by exposing the same placental samples to 8% O2 
(normoxia) (normal O2 concentration in placenta) for four time points (2, 6, 12 and 22 h).  
Control samples were exposed to 8% O2 for the entire duration.  This tissue experiment 
was done to recreate the type of ischemic reperfusion of placenta that occurs in labour and 
PE and to examine this effect on expression of selected genes.  During labour, due to 
uterine muscle contractions the blood vessels contract and relax giving an IR kind of 
injury.  In PE, uterine spiral artery remodelling is incomplete and blood flow may occur in 
pulsatile manner which is also an IR kind of injury.  The aim was to determine whether 
pilot data from this group of experiments revealed any data suggesting that more 
experiments were needed.  It was known at the start of this group of experiments that there 
was only enough time to perform pilot experiments. 
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The experiment was carried out as follows: 
2.7.1.1 Experiment preparation  
One day before experiment (in the lab): Two NuAir® incubators were set to 2% (hypoxia) 
and 8% (normoxia) O2 concentration.  Three T5 culture flasks (labelled inner, middle and 
outer zones) with 10 ml of supplemented media (section 2.3.8) were placed in the 8% O2 
incubator (normal placenta oxygen concentration) for 24 h before tissue collection.  These 
sets of culture flask were transported to the maternity unit on the day of tissue collection 
with the lids sealed. 
Twelve culture Plates (24 well culture plates) containing two ml of supplemented media 
(section 2.3.8) were placed in the 8% O2 incubator (normal placenta oxygen concentration) 
for 24 h prior to tissue collection.  These sets of twelve plates remained in the laboratory. 
2.7.1.2 In the hospital collection room 
Step 1: Three pieces of placenta tissue representing the inner, middle and outer zones 
(2cm
3
) were taken and each was cut into four parts.  The first piece was used as baseline 
reference hence it was immediately snap frozen in liquid nitrogen.  The other three pieces 
were collected and then transported to the laboratory in the T5 culture flasks (Figure 2-9 
A). 
2.7.1.3 On the day of experiment (in the lab): 
Step 2: The placental tissue was transported to the Yorkhill Hospital laboratory in three 8% 
O2 T5 culture flasks; each flask contained inner, middle or outer zones placenta tissue. 
Each flask contained three pieces; the first piece was used as a second reference point after 
sample transportation to the lab in order to investigate transport time effect on stress genes 
expression.  The other two pieces were cut down into four equal sized pieces. Eight culture 
plates were removed from the 8% O2 incubator (four plates for the experiment group and 
four plates for the control group; each plate was used for each time point i.e 2, 6, 12 and 22 
h. Four pieces (in the first row) were added to the experimental cultural plates and four 
pieces (in the first row) were added to the control cultural plates.  In each well one piece 
from each zone was added.  The four experimental plates were put in the 2% O2 incubator 
and the four control plates were put back into 8% O2 incubator (Figure 2-9 B). 
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2.7.1.4 The experiment (in the lab):  
Step 3: The hypoxia exposure time for all experimental placental pieces (inner, middle and 
outer) was 1 h at 2% O2.  After that the tissue plates were removed from the incubator, 
samples were transferred to pre-equilibrated 8% O2 medium (the other four plates) and 
transferred back to the 8% O2 incubator.  The recovery time in 8% O2 for the experiment 
plates were 2, 6, 12 and 22 h respectively.  The control samples were incubated for 1h in 
8% O2 incubator rather than 2% O2.  They then underwent the same second step and were 
placed back in the 8% O2 incubator (Figure 2-9 C).  Thus the control samples did not get 
exposed to the low oxygen environment. 
2.7.1.5 Experiment recovery time (in the lab):  
Step 4: At the end of each time point (2, 6, 12, 22 h) the relevant tissue plate was taken 
from the 8% O2 incubator and the three pieces of placenta tissue of the inner, middle and 
outer zones from both experiment (2% O2 -8% O2) and control wells (8%O2 -8% O2) were 
collected, snap frozen in liquid nitrogen and stored at -80 °C.  One ml of tissue culture 
media was taken in each point and stored for cytokine analysis should time allow for this in 
the future (Figure 2-9 D). 
When required tissues were taken from -80 °C storage, RNA and protein was then 
extracted from the frozen tissue and processed according to the protein or molecular 
analysis protocol. 
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Figure 2-9: Figure showing the time course of hypoxia-reperfusion experiment. (A) Collection of first reference samples from (inner (IZ), middle (MZ) and 
outer (OZ) placental zones). The rest of placenta tissue samples were collected in three flasks (8% O2) for each of the three zones. (B) in the lab: the second 
reference samples were collected from the three zones, the remaining placenta tissue samples were cut up and distributed into control (8% O2) and 
experiment (2% O2), then each were put into relevant incubator. (C) After one hour all plates were taken out the incubators and were placed in the biological 
safety unit (BSU) and then transferred into a new culture media (8% O2). All were returned back to the (8% O2) incubator for different time points. (D) After 
each time point (2, 6, 12 and 22 h) one plate containing control and experiment tissue for inner, middle and outer zones was taken out of the incubator, the 
tissue were snap frozen in liquid nitrogen, then stored at -80 °C.
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2.7.2 HSP induction experiment  
The heat shock protein induction experiment was undertaken to investigate the effect of 
exposing placenta tissue from three different placental zones to heat shock (43 °C) for 30 
min followed by a recovery period compared to the control group which did not receive 
heat shock and remained at 37 ᵒC throughout.  This experiment was undertaken to 
investigate whether a classical “shock” would differentially induce heat shock proteins in 
different placental zones.  The aim was to determine whether pilot data from this group of 
experiments revealed any data suggesting that more experiments were warranted in the 
future.  Heat shock is the classical way to induce heat shock proteins therefore a decision 
was made to try and determine the effects of heat shock exposure on the different placental 
zones.  If there was a response the next step would be determine if different placental 
zones were differentially sensitive to heat shock and this might give some clues to help 
understand why the protein expression of HSPs proteins can vary at different zones of the 
placenta. 
The experiment was carried out as follows: 
2.7.2.1 Experiment preparation (in the lab): 
All media preparation was done on the day of the experiment.  An oven incubator (Philip 
Harris ltd, Shenstone) was adjusted to 43 °C and NuAir® incubators were set to 20% O2, 
90% humidity and 37 °C. 
Three T5 culture flasks (labelled inner, middle and outer zones) containing 10 ml of 
supplemented media (section 2.3.8), ten culture plates (24 well culture plates) containing 
two ml of supplemented media in each well and 15 bijous containing four ml of 
supplemented media were placed in the 20% O2 at 37 °C incubator for four hours before 
tissue collection.  These culture flasks were transported to the maternity unit on the same 
day for tissue collection with the lids sealed while the plates and bijous remained in the 
laboratory. 
2.7.2.2 In the hospital collection room:  
Step 1: Tissue collection:  The T5 culture flasks were retrieved from the incubator and 
transported to the theatre.  One piece of tissue was collected for each placenta zone IZ, MZ 
and OZ.  Each piece was cut into three and one section was used as a baseline reference 
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hence was immediately snap frozen in liquid nitrogen.  The two remaining pieces of tissue 
collected (2X3= 6) were put three T5 culture flasks (Figure 2-10 A). 
2.7.2.3 On experiment day (in the lab):  
Step 2: The tissue was transported to Yorkhill Hospital.  The placenta tissue was removed 
quickly from the cultural flasks.  Each piece from each zone (2) was cut up into five equal 
sized pieces, five pieces were used as controls and five were experimental (Figure 2-10 B). 
2.7.2.4 The experiment (in the lab) 
Step 3: Experimental placenta pieces were placed into pre incubated bijous to then be 
placed in an oven adjusted at 43 °C for 30 min.  Control samples were placed into pre 
incubated plates and were incubated for 30 min at 37 °C. 
After heat shock in the oven experimental tissue was placed into pre incubated plates in 
order to be incubated at 37 °C.  Tissues were allowed to recover from that point on for 
periods of 1, 3, 6, 12 or 24 h (Figure 2-10 C). 
2.7.2.5 Experiment recovery period (in the lab) 
Step 4: At each time point  (1, 3, 6, 12, 24 h) the relevant tissue plate containing pieces of 
inner, middle and outer zones of both heat shocked and control samples were collected and 
snap frozen in liquid nitrogen.  1 ml of tissue culture media was taken in each point and 
stored for cytokine analysis should time allows in the future (Figure 2-10 D). 
RNA and protein were then extracted from the frozen tissue and process according to 
protein or molecular analysis protocol. 
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Figure 2-10: Figure showing the time course of heat shock induction experiment. (A) Collection of first reference samples from (inner (IZ), middle (MZ) and 
outer (OZ) placental zones) and collection of placenta samples in three flasks represent the three zones. (B) Placenta samples were cut down and were 
distributed into controls or experiment (heat shock). Controls were placed in 37°C incubator and experiments were placed in 43°C oven for 30 min. (C)  
After 30 min plates were taken out of the incubator and oven, were put in the BSU and then were transferred into a new culture media (37° C). All were 
placed back to the (37 °C) incubator for different time points. (D) after each time point (1, 3, 6, 12 and 24 h) one plate contain control and experiment tissue 
for IZ, MZ and OZ was taken out of the incubator and snap frozen in liquid nitrogen, then stored at –80 ᵒC. 
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2.8 Statistical analysis: 
Statistical analysis was performed using GraphPad prism 5.  Results are expressed as 
median unless otherwise stated.  Repeated measures one way ANOVA (Friedman test) 
followed by Dunn’s post hoc test were used to compare the difference in the three groups 
of parametric data for the samples from same placenta.  A Kruskal-Wallis test was used to 
compare difference within three or four groups of non-parametric data for the samples 
from different placenta.  Comparison between the two groups was performed using Mann 
Whitney test (two tailed) and using whiskers: min to max.  Statistical significance was 
considered with p values of <0.05. Graphs show box and whiskers plots.  The statistical 
analysis of hypoxia-reperfusion and heat shock experiments was performed using 
Minitab17 software.  General linear model two-way ANOVA was using with Turkey pair-
wise comparison post hoc test.  Two factors (hypoxia and time) or (heat shock and time) 
were measured.  Graphs show interaction plots were demonstrated.  
2.9 Troubleshooting  
2.9.1 Optimization of Santa Cruz and Abcam TLR2 and TLR4 
antibodies  
I started looking at TLR2 and TLR4 protein expression using commercially available 
antibodies used in published papers.  However, it soon become clear that these antibodies 
either do not work or produce many non-specific bands, I have detailed the procedure 
followed in troubleshooting.  In the end we were refunded by the companies for the cost of 
the antibodies. Summary of several experiments that were carried out is shown below 
2.9.2 Different protocols 
Different western blotting protocols were attempted but the correct molecular weight bands 
were not detected.  These protcols include using different reagents (TSBA, PBS and 
TSHB), using milk as blocker and overnight incubation of primary antibody. Primary 
antibodies that had been used are shown in (Table 2-11). 
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2.9.3 Western blotting of membrane protein 
Membrane proteins were separated and run according to the Western blot protocol but also 
multiple non-specific bands were detected. 
 
Table 2-11: Different primary and secondary antibodies were run for TLR2 and TLR4  
Antibody  Company/ 
catalogue 
number  
Secondary 
antibody  
Observation  Action 
TLR4 Santa Cruz (C-
18): Sc-8694. 
1:200 
donkey anti-
goat IgG-
HRP: Sc-
2033, 1:100 
multiple bands secondary was 
diluted and  
different  blocker 
protocols were 
tried 
TLR4  Abcam mouse 
monoclonal 
ab22048. 
 1:200 
gout anti-
mouse IgG-
HRP 
ab6789 
1:2000 
no band  positive control run 
TLR2  Santa Cruz (C-
19): Sc-8690. 
1:200 
donkey anti-
goat IgG-
HRP: Sc-
2033  
1:100 
no bands different primary 
antibody 
concentrations 
were tried 
TLR4 Abcam Rabbit 
polyclonal, 
ab47839.  
1:500 
donkey anti-
Rabbit IgG-
HRP 
ab7083. 
1:3000 
no bands positive control 
was run 
 
2.9.4 Running the positive control using Santa Cruz TLR4 
antibody 
Positive controls were purchased from Santa Cruz; the company literature stated that they 
are detected by the TLR4 antibody.  It became clear that these positive controls do not 
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detect the antibody.  These are two positive controls that I tried from Santa Cruz. 1) 
Positive control caco-2 cell lysate: Sc-2262. 2)  Positive control Hl-60 whole cell lysate: 
Sc-2209. Next a different control supplied by a collaborator was used.  No bands were 
detected by both protocols. 
2.9.5 Blotting using only secondary antibodies 
Several Western blots were run in standard way but without primary antibodies in order to 
detect if there is any nonspecific bands.  Multiple non-specific bands were detected. 
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Chapter III: HSP70, HSF1 and HSF2 expression in 
normal pregnancies and pregnancies complicated 
with PE and FGR (HSP70 only). 
3 Introduction  
3.1 Heat shock proteins 
Heat-shock proteins (HSPs) are a family of protein that are expressed by all cells and 
organisms.  They have many important physiological functions as well as helping cells to 
cope with stressful situations.  Some HSPs are expressed constitutively while others are 
induced by a range of damaging insults including heat shock, ischemia, hypoxia, oxidative 
stress and physical injury (Lanneau et al., 2010).  HSPs perform chaperone function by 
stabilizing new protein to ensure correct folding. HSPs are required for proper folding and 
activity of protein in the cell (Saibil, 2013).  HSPs are classified according to their 
molecular weight into two groups: the small HSPs family and the high molecular weight 
HSPs.  The small HSPs are ATP independent and their functions controlled by their 
phosphorylation status. The high molecular weights HSPs include HSP60, HSP70, HSP90 
and HSP110 families.  They are ATP dependent chaperones.  HSPs have become an area 
of intensive research due to their remarkable properties, their role in disease and the 
potential to modulate their expression for therapeutic benefit. 
3.1.1 Discovery 
In 1962, it was observed that exposing salivary gland of the fruit fly (Drosophila busckii) 
to heat induced a characteristic pattern of puffing on the polytene chromosomes (Ritossa, 
1962).  This indicated heat shock induced gene expression and rapidly induced the 
synthesis of a new set of proteins, which eventually became known as HSPs (Tissiéres et 
al., 1974).  HSPs are highly conserved and are found in virtually all living organisms, from 
prokaryotes to eukaryotes (Feder and Hofmann, 1999).  HSPs are expressed in distinct 
compartments of the cell including cytoplasm, nucleus, mitochondria and ER. They are 
associated with various structural proteins such as actin and collagens (de Jong et al., 
2009). 
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3.1.2 Functions 
3.1.2.1 Intra-cellular HSPs 
HSPs are chaperones being important in proper folding of nascent proteins, refolding, 
assembly and degradation of proteins, in fact, not all, but most of the HSP function is as  
chaperones (Horváth et al., 2008).  Their expressions allow cells to survive sub-lethal 
conditions by binding to partially denatured proteins, dissociating protein aggregates and 
regulating correct folding (Jolly and Morimoto, 2000, Young et al., 2004, Sarto et al., 
2000, de Jong et al., 2009, Horváth et al., 2008).  HSPs have been shown to be involved in 
cell differentiation, tissue development, apoptosis and hormonal stimulation (Sarto et al., 
2000).  The ER is a major site for production of proteins and controls this process: if it 
overburdened by misfolded proteins this will triggers cell death by apoptosis (Young et al., 
2004).  All HSP families contain of members expressed either constitutively or regulated 
inductively and are targeted to several cellular compartments (Schmitt et al., 2007). For 
example, in contrast to the HSP90, which is expressed constitutively, HSP27 and HSP70 
are highly inducible proteins (Schmitt et al., 2007).  HSPs also have an important role 
under normal physiological conditions with the constitutively expressed protein making up 
to 5-10% of total cellular protein.  Under stressful conditions the concentration can be 
increased two to three fold (Pockley, 2003).  HSPs function under non-stress conditions by 
carrying denatured proteins to the proteasome and helping newly synthesised protein fold 
properly. When cells exposed to stress, the expression of HSPs are increased and became 
upmost important to the cells to ensure protein confirmation in the correct form. In 
addition to their role as molecular chaperones they also influence transport, aggregation, 
and folding of other proteins.  HSPs play a critical role in modulating the execution of the 
apoptotic signalling pathways to maintain cell survival and to ensure that stress induced 
damage does not trigger cell death inappropriately (Schmitt et al., 2007, Latchman, 2001).  
They are two apoptotic pathways, intrinsic and extrinsic pathways, HSPs play an important 
role in regulation of these pathways.  The intrinsic pathways (mitochondria) can be 
induced by HSP10 and HSP60 (Samali et al., 1999) and inhibited by HSP70, HSP27 and 
HSP90 (Bruey et al., 2000a, Beere et al., 2000, Pandey et al., 2000).  The extrinsic 
pathways (receptor mediated) are inhibited by HSP27, HSP90 and HSP70 (Charette et al., 
2000, Sato et al., 2000, Garrido et al., 2003). (Table 3-1) shows major HSPs families and 
their intra-cellular location and roles. 
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Table 3-1: functions and intra-cellular location of major HSPs Adapted from (Pockley, 2003, 
Calderwood et al., 2007a, Noble et al., 2008, Grubišic, 2005)  
HSP families names                               Intracellular location                                Functions 
Small HSPs α,β crystalline 
 
Cytoplasm   Cytoskeletal stabilisation 
HSP25/HSP27 Cytoplasm and  nucleus Molecular chaperone and 
anti-apoptotic  
HSP32 Cytoplasm   Anti-oxidant (heam 
catabolism) 
 
HSP40 
HSP47 
Cytoplasm  and  nucleus 
ER 
Co-factor of HSP70 
Processing of pro-collagen 
HSP60 (chaperonins) Cytoplasm   and 
mitochondria  
 
Assist correct folding,  
assembly of multimeric 
complexes and anti-
inflammatory 
 
HSP70 
Inducible:HSP70/HSP72 
Constitutive: HSC70/HSP75 
GRP78 
  
 
Cytoplasm  and  nucleus 
Cytoplasm  and  nucleus 
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3.1.2.2 Extra-cellular HSPS  
HSPs were initially believed to be solely intracellular, where they have their cytoprotective 
functions (molecular chaperones).  However, it is now well established that HSPs can be 
also be present extracellularly where they display a different function (Mambula et al., 
2007, De Maio and Vazquez, 2013, Binder, 2014).  HSPs outside the cell act as cellular 
communicators in response to stress by alerting other cells especially immune system cells 
to avoid the propagation of the insult (De Maio, 2014, De Maio, 2011, Binder, 2014, De 
Maio and Vazquez, 2013).  It has been reported (Gastpar et al., 2004) that HSP70 was 
expressed in human tumour plasma membranes. HSP70 expression has also been shown in 
several tissues such as vascular smooth muscle, blood mononuclear cells and neuronal 
cells (Robinson et al., 2005, Liao et al., 2000, Hunter-Lavin et al., 2004).  Recombinant 
HSP70 can modulate the immune system by activation of macrophages; this activation can 
measured by increases in calcium levels and cytokine release (Asea et al., 2000). HSP70 
bound with high affinity to the plasma membrane, elicited a rapid intracellular calcium 
flux, activated nuclear factor (NF)-kappaB and upregulated the expression of pro-
inflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-6 
in human monocytes.  In addition, several studies have demonstrated that HSP70 is 
capable of activating cells of the immune system (Vega et al., 2008, Henderson and 
Pockley, 2010).  HSP 60 and HSP70 have been detected in blood serum samples (Pockley 
et al., 2008).  HSP60 was detected in the plasma membrane of mitochondria and cardiac 
myocytes (Gupta and Knowlton, 2002, Lin et al., 2007).  Furthermore, HSP60 has been 
found in plasma in some disease conditions (Pockley et al., 2000). GRP78 (HSPA5), which 
is ER resident, has also been detected in the extracellular compartment human peripheral 
circulation (Delpino and Castelli, 2002).  In addition, a homologous form of cytosolic 
HSP90 (GRP94) was also detected outside the baby hamster kidney cells secreted into a 
serum-free medium (Evdokimovskaya et al., 2012).  The small heat shock protein families 
(sHSPs) are also secreted by cells and modulate the immune system (van Noort et al., 
2012).  HSP27 has been detected in blood during pathological diseases such as chronic 
pancreatitis and pancreatic carcinoma (Liao et al., 2009). 
The mechanism of export of HSPs to the extracellular compartment has been also subject 
of controversy among researchers (De Maio, 2014, Henderson and Pockley, 2012, De 
Maio, 2011).  Different mechanisms have been proposed including translocation across the 
plasma membrane, endolysosomal pathways and the passive release after cell death by 
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necrosis (De Maio, 2014, Mambula and Calderwood, 2006b, Vega et al., 2008, Mambula 
and Calderwood, 2006a). 
HSP70 secretion does not follow a leader classical signal pathways (Calderwood et al., 
2007a).  It was suggested (Nickel and Seedorf, 2008) that HSP70 may be exported via an 
alternative mechanism, which has been named the non-classical or unconventional 
secretory pathway but the mechanism for this pathways has not yet emerged.  Another way 
of HSP extra-cellular secretion is via secretory vesicles in a similar to interlukin-1β 
(leaderless protein) secretion from macrophage (MacKenzie et al., 2001, De Maio, 2011). 
HSP27, HSC70, HSP70 and HSP90 have been shown to be released extra-celluarly from 
heat shocked B-cells via exosomes (Clayton et al., 2005).  HSP70 is also released via 
lysosomal endosomes especially from tumour cells that transfer intracellular proteins to the 
plasma membrane then release them to the extra-cellular space (Mambula and Calderwood, 
2006b).  In addition, HSP90 has been proposed as being exported via exosomes or by 
direct translocation across the plasma membrane (McCready et al., 2010, Li et al., 2012b) 
3.1.3 Synthesis of HSPs 
HSP production is a key part of the heat shock response.  HSPs expression can be induced 
by several insults other than heat shock; these insults include steroid hormones, 
hyperthermia, ROS, hypoxia, ischemia, bacterial infection and inflammation (Patel et al., 
1995, Horváth et al., 2008, Kukreja et al., 1994, Norton and Latchman, 1989, Richard et 
al., 1996, SLAKEY et al., 1993, Zheng et al., 2004).  Heat shock transcription factor 1 
(HSF1) is the stress responsive transcriptional activator responsible for the inducible 
transcription of genes encoding HSPs. It binds to regulatory heat shock elements present in 
the promoter region of all heat shock genes (Yao et al., 2006).  In non-stress conditions 
HSF1 is present as a monomer in the cytosol.  After stress, damaged protein induced 
phosphorylation of HSF1 and then HSF1 is translocated into the nuclear compartment.  In 
the nucleus, HSF1 forms homotrimers and bind to HSP gene promoter regions, leading to 
induction of HSP gene transcription.  Upon cell recovery, HSF is dephosphorylated, 
however, little is known about the fate of HSF1 after its dissociation from DNA and many 
controversies in this area.  It has been suggested (Yang et al., 2008) that HSF1 may be a 
substrate for chaperone mediated autophagy.  In addition, the fate of the disulphide linked 
HSF1 monomers is also not known, if they reduced and allowing the HSF1 to retain to an 
inactive state in the cytoplasm or just degraded after its dissociation from DNA (Neef et 
al., 2011). 
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3.1.4 HSPs and the immune system 
The extracellular HSPs functions have been investigated intensively for example their 
interaction with the immune system (Calderwood et al., 2007b, Srivastava, 2000, 
Calderwood et al., 2005, Binder, 2014).  HSPs plays important roles include pro-
inflammation and lead to cytokine release (Asea et al., 2002), anti-inflammation (Van 
Eden et al., 2005, Hauet-Broere et al., 2006) and antigen presentation (Noessner et al., 
2002).  Extra-cellular HSPs which function as anti-inflammatory agent include HSP20 
(Wang et al., 2009), HSP27 (Calderwood et al., 2007a) and HSP32 (Yeh et al., 2009).  
Other immune functions of extra-cellular HSPs include HSP60 as pro-inflammation (Lin et 
al., 2007) and HSP70 as pro-inflammation and antigen presentation (Lin et al., 2007, 
Gastpar et al., 2004, Liao et al., 2000, Noessner et al., 2002). HSP90 functions as pro-
immune (Calderwood et al., 2007a).  Secreted HSPs, including HSP70, can take part in 
immune surveillance.  They can capture antigens and interact with receptors on antigen 
presenting cells.  HSP70 complexes are able to deliver antigens to major histocompatibility 
complex (MHC) class I and II molecules on the antigen presenting cell (APC) cell surface 
and lead to the presentation of tumor antigens to T lymphocytes.  HSP70 also has anti-
inflammatory properties.  For example it can bind to, and activate, human monocytes, 
inhibiting the secretion of inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 and 
increasing secretion of the anti-inflammatory IL-10 (Asea et al., 2000). 
3.1.5 Families of heat shock protein  
HSPs are classified into six major families: HSP110, HSP90, HSP70, HSP60, HSP40, 
HSP32 (heme oxygenase-1), small HSPs (sHSPs) where the monomer size typically ranges 
between 12- to 30-kDa (e.g HSP20, HSP27 and αβ-crystalline) and ubiquitin (Latchman, 
2001, Pockley, 2003, Kappe et al., 2003).  The sHSP subfamily consists of 10 members 
(HSPB1-HSPB10).  It was proposed by one group (Taylor and Benjamin, 2005) to classify 
the sHSPs into major categories (class I and II) according to their subcellular location, 
gene expression patterns and transcriptional regulation.  Different HSPs families will be 
discussed in more detail in the following chapters. HSP70 will be discussed in this chapter. 
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3.2 Heat shock protein 70 (HSP70) 
HSP70 is the most abundant chaperone and exist in different cellular compartments.  The 
HSP70 family comprises at least 13 members, which are different from each other by 
amino acid sequence, expression level and cellular location, this family also contains 50 J 
proteins (DNAJ or HSP40 proteins) (Kampinga et al., 2009, Tavaria et al., 1996).  The 
diversity of the HSP40 co-chaperones allow recruitment of different members of the 
HSP70 family to multiple cellular location and activities other than chaperone roles 
(Kampinga and Craig, 2010).  HSP70 is the most conserved protein in evolution (Lindquist 
and Craig, 1988, Daugaard et al., 2007).  Immunoglobulin heavy-chain binding protein 
(BiP) is the ER orthologue of the HSP70 family.  BIP is intricately involved in most 
functions of this organelle through its interactions with a variety of substrates and 
regulatory proteins (Behnke et al., 2015). 
3.2.1 HSP70 structure  
The HSP70 family function depends on their ability to bind and release target proteins 
coupled with conformational changes in HSP70, driven by hydrolysis and release of ATP. 
HSP70 has two major functional domains.  The N-terminal ATPase domain (NBD) binds 
ATP and hydrolyses it to ADP lead to conformational changes in other domains (Mayer 
and Bukau, 2005).  The second domain is the substrate binding domain (SBD) that can be 
further divided into substrate binding subdomain and C-terminal subdomain.  The substrate 
binding subdomain contains a groove that recognizes exposed hydrophobic segments of 
target protein.  The C-terminal subdomain is rich in alpha helical structure and acts as a 
'lid' for the substrate binding groove (Lund, 2001).  These domains are connected by an 
inter-domain linker (Figure 3-1).  SBD and NBD interact when HSP70 is ADP bound 
(Swain et al., 2007).  When HSP70 is ATP bound, the lid is open with low affinity for 
peptide and rapid kinetics of binding and release.  When HSP70 is ADP the lid is closed 
and affinity for peptides is increased while kinetics of binding and release is reduced. 
When peptides bind the SBD it stimulates the ATPase activity helping to promote target 
protein loading of HSP70.  The HSP70 intrinsic ATPase activity is low and for his 
chaperone activity HSP70 needs a co-chaperone HSP40 (Henderson and Pockley, 2012). 
HSP70 activity depends on the interaction between these domains and their interaction 
with the co-chaperone for example HSP40 and nucleotide exchange factors (Zuiderweg et 
al., 2013).  The binding of an extended segment of a polypeptide chain to HSP70 can 
prevent mis-folding, aggregation and help to maintain the unfolded state for translocation 
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to another cellular compartment. HSP40 has a diverse function and targets specific sites of 
HSP70. HSP40 is  thought to act as a primary substrate for HSP70 that stimulates the 
HSP70 ATPase (Kampinga and Craig, 2010, Saibil, 2013). 
 
 
Figure 3-1: HSP70 gene structure and domains: HSP70 contain two domains; nucleotide 
binding domain/ATPase domain and substrate binding domain modified from (Grubišic, 
2005). 
3.2.2 HSP70 family members and chaperone function  
The HSP70 family contain several slightly different HSP70 proteins, they all share a 
common domain structure but with different function and cellular locations. HSC70 
(HSPA8/HSP73) is a constitutively expressed chaperone protein.  HSP70 (HSPA1A) is a 
stress inducible one.  HSP70 is one of the best studied HSPs (Nollen and Morimoto, 2002, 
Clerico et al., 2015).  Both forms are localised in the cytoplasm and the nucleus (Brown et 
al., 1993, Noble et al., 2008).  The HSP70 family also include HSP78 (ER) and HSP75 
(mitochondria), both function as chaperones (Noble et al., 2008).  HSP70 has been 
localised in the extra-cellular space (Schmitt et al., 2007).  
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3.2.3 HSP70 chaperone function  
In non-stress conditions HSP70 and HSC70 act as molecular chaperones and their 
functions include assisting protein folding and refolding, degradation of unstable protein 
and misfolded proteins and transport of proteins between different cellular compartments.  
HSP70 is induced under stress conditions to maintain cellular stability and protect cells 
against damage (Schmitt et al., 2007, Clerico et al., 2015).  HSP70 also binds to all newly 
forming polypeptides on ribosomes in cells to keep them from folding inappropriately 
while they are being synthesized. HSP70 protein with ATP, HSP40 and HSP90 binds the 
misfolded proteins.  However, If refolding does not occur, then Bag-1 and E3-ubiquitin 
ligase CHIP binds to HSP70, then this complex targets the misfolded protein to the 
proteasome where it is ubiquinated and degraded (Lanneau et al., 2010). 
3.2.4 HSP70 and anti-apoptotic function 
HSP70 can block apoptosis regulator BAX translocation and prevent mitochondrial outer 
membrane permeability.  HSP70 can bind the apoptotic protease activating factor 1 (Apaf-
1) and prevent formation of the apoptosome (Apaf-1, cytochrome C, CASP 9) and 
activation of CASP3 (Joly et al., 2009).  HSP70 can also stabilize the induced myeloid 
leukemia cell differentiation protein (Mcl-1) which prevents BAX activation and 
mitochondrial mediated CASP3 mediated apoptosis (Sharp et al., 2013).  Co-chaperone 
HSP40 with HSP70 can inhibit several apoptotic signalling molecules include tumour 
necrosis factor (TNF) induced apoptosis, assembly of the death inducing signalling 
complex (DISC), inhibiting transmembrane protein-Fas and TNF-related apoptosis-
inducing ligand (TRAIL) (Joly et al., 2009, Sharp et al., 2013).  HSP70 can block c-Jun N-
terminal kinases (JNK) induced release of Bcl-2-associated death promoter (BAD) from 
mitochondria leading to block of CASP8 activation, and binding apoptosis signal-
regulating kinase 1 (ASK1) and block mitogen-activated protein (MAP) kinase induced 
apoptosis (Joly et al., 2009). 
3.2.5 HSP70 and inflammatory pathways 
HSP70 has a profound effect on immune pathways and generally shown to have anti-
inflammatory effects by reducing the activation of the pro-inflammatory gene transcription 
include NF-ĸB in myocyte cells (Shimizu et al., 2002).  HSP70 form a complex with NF-
ĸB that may be cell and stimulus specific.  HSP70/ NF-ĸB interaction can decrease levels 
of TNF, IL-1, MMP9 and other pro-inflammatory mediators that are regulated by NF-ĸB 
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(Sharp et al., 2013).  HSP70 decrease MMP processing from inactive to active forms 
(Sharp et al., 2013).  In addition, HSP70 decreases MMP9 activity through NF-ĸB. HSP70 
can also down regulate MMP2 possibly through interactions of HSP70 with signal 
transducers and activators of transcription (STAT1) (Kim et al., 2012). 
HSP70 can affect both the innate and adaptive immune systems, and generally appear to be 
pro-inflammatory.  HSP70 can stimulate Toll like receptor 2 (TLR2), TLR4 and cluster of 
differentiation 14 (CD14) pathways on monocytes-macrophages and dendritic cells and 
activate intracellular NF-ĸB, interferon regulatory factor (IRF) and STAT3 signalling (Joly 
et al., 2009).  HSP70-peptide complexes can activate CD8+ and CD4+ T cell responses. 
(Joly et al., 2009, Sharp et al., 2013).  HSP70 protein appears to be released into blood 
after acute disorders like myocardial infarction (Giffard et al., 2008). 
3.2.6 HSP70 and cardio protection 
HSP70 is expressed in myocardial tissue under assault and provides cardiac protection 
against myocardial injuries and stress, including IR injury (Latchman, 2001, Lepore et al., 
2001, Liu et al., 2012).  A study (Liu et al., 2007) was performed using liposome-mediated 
gene transfer of HSP70 into rat myometrium showed that overexpression of HSP70 
provided protection against IR injury.  In addition, up-regulation of HSP70 plays a role in 
myocardial adaptation to acute ischemia stress (Kingma, 1999).  Heat shock induced 
expression of HSC70 was shown to restrict the degree of myocardial damage caused by 
ischemia in rat heart myogenic cells (Mestril et al., 1994).  
HSP70 is important in regulating the myocardial innate immune response and cardiac 
function after IR injury (Liu et al., 2012).  HSP70 promotes cardiomyocyte survival by the 
conservation of antioxidants and inhibition of pro-apoptotic pathways including caspase 
and Fas mediated death cascades (Suzuki et al., 2002, Zhao et al., 2007, de Jong et al., 
2009).  HSP70 induces pro-inflammatory cytokines via activation of TLR4 in macrophages 
and myocardium (Liu et al., 2012).  In addition, overexpression of HSP70 in myocardium 
tissue improved post-ischemic cardiac contractility, which inversely correlated with infarct 
size (Plumier et al., 1995, de Jong et al., 2009).  In a rabbit model of IR injury intra-
myocardial injection of recombinant adenovirus–human–HSP70 constructs resulted in a 
twofold reduction in infarct size (Okubo et al., 2001).  Increased levels of HSP70 
expression was associated with improvement of ventricular function after cardiopulmonary 
bypass-associated myocardial IR injury (Yan et al., 2013). 
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Besides its function as a molecular chaperone in cardiac tissues, HSP70 is also involved in 
inflammatory responses after cardiac surgery (de Jong et al., 2009).  High levels of pre-
operative myocardial HSP70 showed reduced levels of biochemical markers of myocardial 
injury postoperatively, whereas patients with low levels of myocardial HSP70 pre-
operative showed an almost twofold increase of biomarkers of myocardial injury after 
surgery (Demidov et al., 1999, Giannessi et al., 2003). 
HSP70 induces cardiac activity tolerance to endotoxin by reducing TNF-α response to 
endotoxin in macrophages and also inhibiting NF-κB activity, TNF- α and ICAM-1 levels 
in cardiac tissues (Ao et al., 2009, Su et al., 2010b, Liu et al., 2012) 
The level of HSP70 is significantly decreased in diabetic myocardium because of insulin 
deficiency (Liu et al., 2012).  HSP70 is commonly found in atherosclerotic plaques in 
atherogenesis and it appears to be a protective factor against cellular stress (Dupont et al., 
2008).  HSP70 expression was decreased significantly in the hypertrophied myocardium 
from peripheral vascular disease (Kawada and Ishii, 2009). 
3.2.7 HSP70 in cancer  
HSP70 is expressed in malignant tumours of different origins (Mosser and Morimoto, 
2004) and its expression correlates with lymph node metastases, increased cell 
proliferation and therapeutic drug resistance in breast cancer (Ciocca et al., 1993, Vargas-
Roig et al., 1998).  HSP70 and HSP90 are very interesting HSPs from drug discovery 
perspective as both have been shown to be highly expressed in cancer (Santarosa et al., 
1997, Nanbu et al., 1997, Trieb et al., 1998, Ricaniadis et al., 2001). 
3.2.8 HSP70 gene regulation 
3.2.8.1 Heat shock elements (HSEs) 
Genomic studies on the HSP70 promoter showed that heat shock induce a rapid binding of 
HSFs to a region of the 5 nGGAn sequence named HSEs.  Regulation of HSPs genes is 
mediated by the interaction of HSF with HSEs in the heat shock promoter regions 
(Voellmy, 1993). 
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3.2.8.2 Heat shock transcription factors (HSFs) 
Heat shock factors are a family of 4 transcription factors (HSF1-4) (Åkerfelt et al., 2010, 
Nakai et al., 1997).  HSF1 is the stress responsive transcriptional activator responsible for 
the inducible transcription of genes encoding HSPs.  It binds to regulatory heat shock 
elements present in the promoter region of all heat shock genes (Yao et al., 2006, Sarge et 
al., 1993).  HSF2 has the characteristics of a temperature sensitive protein and it is 
inactivated when exposed to heat.  HSF2 is more selective in function and also induced 
during differentiation and early development (Pirkkala et al., 2001).  It has been shown that 
HSF2 associated with the expression of chaperone protein-encoding genes via 
heteromultimerization with HSF1 (Sandqvist et al., 2009).  In addition, HSF2 in concert 
with HSF1, promotes the expression of a αB-crystallin (Shinkawa et al., 2011). 
HSF1 also regulates the expression of genes involved in other cell survival aspects such as 
protein degradation, signal transduction, energy generation, carbohydrate metabolism and 
cytoskeleton formation (Trinklein et al., 2004, Gonsalves et al., 2011).  HSF1 promotes 
survival and proliferation of highly malignant cells (Mendillo et al., 2012, Santagata et al., 
2013, Vihervaara and Sistonen, 2014). 
HSF1 is usually present in the cytoplasm as a latent monomer that has no ability for DNA 
binding. In non-stress conditions HSF1 is phosphorylated on ser303 and ser307 residues 
and its activity is repressed through the interaction of the chaperone proteins HSP70, 
HSP90 and HSP40 (Shi et al., 1998, Zou et al., 1998, Guo et al., 2001).  Upon stress, HSF1 
is phosphorylated from a monomer (inactive) to a trimer (activated) translocate from the 
cytosol to the nucleus in order to bind DNA (Sarge et al., 1993, Pockley, 2003, Neef et al., 
2011) (Figure 3-2).  Disulphide bonds stabilize trimer formation, HSP trimers bind to HSP 
gene promoter regions, leading to induction of HSP gene transcription.  This results in 
increased transcription of HSP70 and eventually increased translation of more HSP70 
protein.  HSP70 is needed for the activation of heat shock factor1 in mammalian cells (Ahn 
et al., 2005).  HSF1 is hyper phosphorylated during HSF1-dependent transactivation; this 
process is repressed through a negative feedback inhibition. Induction of HSPs has to be 
tightly controlled as inappropriate growth control may lead to cell death. One mechanism 
that regulates HSP expression is the binding of HSP70 to the HSF1 activation domain (Shi 
et al., 1998, Neef et al., 2011).  The second mechanism is the interaction between heat 
shock protein binding factor 1 (HSBP1) and HSP70, which lead to inhibition of the 
capacity of HSF1 to bind to DNA (Satyal et al., 1998).  For example, HSP70 gene 
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transcription is down-regulated by interaction of HSP70 or HSBP1 with the HSF trimers 
(Pockley, 2003).  Upon cell recovery, HSF1 fate is still unclear and two mechanisms have 
been suggested either HSF1 is dephosphorylated and retained in the cytoplasm or HSF1 is 
degraded (Neef et al., 2011). HSFs also play other important functions spanning from heat 
shock response to metabolism, development, lifespan and disease in particular cancer and 
neurodegenerative disorders. 
HSF1 is involved in balancing cellular processes during stress and then enables their rapid 
re-establishment once suitable conditions for proliferation have been restored.  HSF1 also 
controls target genes in cell stress, development and cancer progression (Mendillo et al., 
2012, Le Masson et al., 2011, Vihervaara et al., 2013). 
 
Figure 3-2: HSF1 activation and degradation cycle. In non-stress conditions, HSF1 exists as 
an inactive monomer in the cytoplasm. Upon stress HSF1 form homotrimers linked together 
by disulphide bond and become localized to the nucleus to bind to HSE in the promoters of 
stress-responsive genes. HSF1 becomes dissociated from DNA after HSP70 and HSP40 re-
associate with the HSF1 transactivation domain. Adapted with permission from (Neef et al., 
2011). 
HSF2 is not activated in response to classical stress stimuli, but under developmentally 
related conditions.  Animal studies showed that HSF2 is not able to functionally substitute 
for HSF1 or to rescue the heat shock response in HSF1 knockout mice (McMillan et al., 
1998, Xiao et al., 1999).  Human HSF2 and HSF4 are capable of complementing the 
viability defect and conferring thermotolerance in S. cerevisiae cells carrying a lethal HSF 
deletion (Liu et al., 1997, Tanabe et al., 1999).  However, different members of the HSF 
149 
 
family could also cooperate in order to regulate expression of their target gene, for 
example, HSF3 has a dominant role in the regulation of the heat shock response and 
directly influences HSF1 activity (Tanabe et al., 1998). 
HSF2 is a non-stress-responsive member of the HSF family.  However, HSF2 plays an 
important role in controlling development and differentiation (Åkerfelt et al., 2010), for 
example, several studies showed that HSP70 transcription induced by hemin in K562 cells 
is mediated by HSF2 (Morimoto, 1998, Theodorakis et al., 1989, Schuetz et al., 1991). 
Furthermore, in K562 cells undergoing hemin-mediated erythroid differentiation, the high 
level of HSF2 protein levels is preceded by transcriptional induction of the HSF2 gene, 
accompanied by increased HSF2 mRNA. In contrast HSF2 is down-regulation during 
TPA-mediated megakaryocytic differentiation (PIRKKALA et al., 1999). 
HSF2 binds to the promoters of HSPs and modulates the activity of HSF1 through 
formation of HSF1-HSF2 heterotrimers (Sandqvist et al., 2009).  HSF2 deficiency has 
been shown to reduce the temperature at which HSF1 is activated (Shinkawa et al., 2011). 
HSF2 is a short-lived protein with a tissue and developmental stage specific expression 
pattern (Björk et al., 2010).  HSF2 activity is regulated by its levels within the cells  
(Sandqvist et al., 2009, Björk and Sistonen, 2010).  HSF2 expression decrease during 
mitosis in human cell lines which corresponds to the HSP70 induction and protection 
against stress induced mitotic abnormalities and apoptosis (Elsing et al., 2014). 
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3.3 Results  
3.3.1 Patient clinical data analysis  
3.3.1.1 Normotensive, PE and FGR groups: 
NLG normotensive compared to LG normotensive groups. NLG and LG normotensive 
groups then compared to the NLG and LG PE groups. LG normotensive groups compared 
to the FGR group (Table 3-2).  The comparisons between groups carried out by using one 
way ANOVA.  Significant p values were sub-analysed individually (Table 3-3).  
 
Table 3-2: Patient’s clinical details; the descriptive analysis showed the mean and standard 
deviation. Analyses between the five groups were performed using one way ANOVA, P 
value < 0.05 was considered statistically significant. Non-labour controls (NLG-C), labour 
controls (LG-C), non-labour PE (NLG-PE), labour PE (LG-PE) and labour FGR (LG-FGR). 
 
 
Category NLG-C 
(n=6) 
LG-C 
(n=6) 
NLG-PE 
(n=5) 
LG-PE 
(n=7) 
LG-FGR 
(n=8) 
p-value 
Maternal 
age (years) 
28.33±5.
7 
26±2.28 32.4±4.03 30.57±6.88 28.88±37 p=0.9 
Placenta 
weight (g) 
594.7±1
10.5 
589.5±75 662.2±164.
12 
591.7±161.
4 
369.8±71.2 
 
p=0.001 
 
 
Birth weight 
(g) 
3443±53
7 
3719±347 3552±645.5
4 
2959±567 2035±516.3 
 
p=0.0007 
No prier 
gravida  
1 4 1 6 3  
Gestation 
age at 
delivery 
(weeks) 
39.3±1.0 40.31±1.4 37.64±1.29 38.55±2.02
4 
36.7±1.3 
 
P=0.001 
 
 
 
No. Smokers 2 0 1 1 2  
BMI 28.50±6.
01 
28.33±4.6 38.56±11.3
5 
25.46±2.93 25.3±7.9 P=0.02 
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Table 3-3: Patients clinical details; statistical analysis of the groups that were statistically 
significant in Table 2-2 above. The analysis between two groups was performed using the 
Mann Whitney test, p<0.05 was statistically significant. 
 
3.3.2 Analysis of protein and mRNA HSP70 expression in normal 
pregnancy  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
protein expressions of HSP70 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
First the non-labour group was compared.  Examples of Western blots showing HSP70 
protein expressions for the non-labour are shown in (Figure 3-3).  The graphs and 
statistical analysis are shown below the blots.  Comparison between zones was performed 
using Friedman test analysis.  There was a significant difference in protein expression of 
HSP70 between the three zones of the non-labour group and the labour group (p=0.04 for 
both).  The sub-analysis showed that there was a significant decrease in HSP70 expression 
Category p values group comparison 
p value analysis for placenta 
weight  
NLG-C v LG-C       (p=0.9) 
NLG-C v NLG-PE  (p=0.7) 
LG-C v LG-PE        (p=0.7) 
LG-C v LG-FGR    (p=0.0007) 
p value analysis for birth  weight 
 
NLG-C  v LG-C       (p=0.2) 
NLG-C v NLG-PE   (p=0.9) 
LG-C v LG-PE         (p=0.03) 
LG-C v LG-FGR     (p=0.0007) 
p value analysis for gestation age NLG-C  v LG-C       (p=0.2) 
NLG-C v NLG-PE   (p=0.05) 
LG-C v LG-PE         (p=0.1) 
LG-C v LG-FGR     (p=0.004) 
p value analysis for BMI NLG-C  v LG-C       (p=0.9) 
NLG-C v NLG-PE   (p=0.09) 
LG-C v LG-PE         (p=0.3) 
LG-C v LG-FGR     (p=0.3) 
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in outer zones compared to the middle zones for both non-labour and labour groups 
(p=0.03, p=0.02 respectively). 
 
 
Figure 3-3: Representative images of Western blots showing HSP70 protein expressions in 
inner, middle and outer zones of individual placentas of non-labour group (A) and labour 
group (B). Four quadrants were sampled in each zone. Graphs show the median for HSP70 
protein expressions. Comparison between zones was performed using Friedman analysis.  
Experiment 2: This experiment was designed to test if there was any difference in HSP70 
protein expression between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Western blots showing placental protein expression of HSP70 in the 
non-labour and the labour at the inner, middle and outer zones are shown in (Figure 3-4). 
The graphs and statistical analysis are shown below the blots.  There was a significant 
decrease in HSP70 expression in the non-labour group when compared to the labour group 
at the middle zone (p=0.008).  There was no significant difference in HSP70 expression in 
the non-labour group when compared to the labour group at the inner and outer zones 
(p=0.2, p=0.06 respectively). 
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Figure 3-4: Representative images of Western blots showing HSP70 expressions in the 
inner, middle and outer placental zones in non-labour and labour (n=6 in each group). The 
graphs show the box and whiskers analysis of the blots. Comparison between zones was 
performed using Mann-Whitney analysis. NLG non-labour group, LG labour group. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HSP70 within individual placentas at different zones (inner, middle and 
outer) in either labour or non-labour.  No spatial differences were found within placentas at 
the mRNA level in non-labour group and labour group (p=0.95, p=0.74). (Figure 3-5) 
shows the HSP70 RQ values in the inner, middle and outer zones for non-labour (A) and 
labour (B). 
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Figure 3-5: RQ values for HSP70 mRNA measurements in inner (n=4), middle (n=4) and outer 
zones (n=4) of individual placentas (non-labour and labour groups). Four quadrants were 
sampled in each zone. Graphs show the median for HSP70 mRNA expressions. Comparison 
between zones was performed using Friedman analysis. 
 
Experiment 4: This experiment was designed to test if there were any differences in mRNA 
expression of HSP70 in the non-labour compared to the labour group at the inner, middle 
and outer zones.  Figure 4 shows the HSP70 RQ values in the non-labour compared to the 
labour group at the inner (A), middle (B) and outer zones (C).  There was no significant 
difference in mRNA expression of HSP70 in the non-labour group compared to the labour 
group at the inner, middle and outer zones (p=0.69, p=0.39, p=0.93 respectively) (Figure 3-
6). 
 
Figure 3-6: RQ values for HSP70 mRNA measurements in non-labour (n=6) compared to the 
labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis.  
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3.3.3 Analysis of protein and mRNA HSP70 expression in 
pregnancies complicated with PE 
Experiment 1: This experiment was designed to test if there was any difference in protein 
expression of HSP70 between non-labour control and non-labour PE groups at the inner, 
middle and outer zones of placentas.  Western blots showing placental HSP70 protein 
expression in the non-labour control and the non-labour PE at the inner, middle and outer 
zones are shown in (Figure 3-7).  The graphs and statistical analysis are shown below the 
blots.  There was a significant decrease in HSP70 expression in the non-labour control 
group when compared to the non-labour PE group at the inner zone (p=0.02).  There was 
no significant difference in HSP70 expression in the non-labour control group when 
compared to the non-labour PE group at the middle and outer zones (p=0.16, p=0.71 
respectively). 
 
Figure 3-7: Representative images of Western blots showing HSP70 expressions in the inner, and 
outer placental zones in non-labour control (n=6) and non-labour PE (n=3). The graphs show the box 
and whiskers analysis of the blots of three placenta zones. Middle Western blot image empty lane was 
removed (dotted lines). Comparison between zones was performed using Mann-Whitney analysis. 
NLG-C non-labour control group, NLG-PE non-labour PE group. 
 
Experiment 2: This experiment was designed to test if there was any difference in HSP70 
expression between labour control and labour PE groups at the inner, middle and outer 
zones of placentas.  Western blots showing placental HSP70 protein expression in the 
labour control and the labour PE at the inner, middle and outer zones are shown in (Figure 
3-9).  The graphs and statistical analysis are shown below the blots.  There was no 
156 
 
significant difference in HSP70 expression in the labour control group compared to the 
non-labour PE group at the inner, middle and outer zones (p=0.6, p=0.9, p=0.1 
respectively). 
 
 
Figure 3-8: Representative images of Western blots showing HSP70 expressions in the inner and 
middle placental zones in labour control and labour PE groups (n=6 for each group). Western blot 
image empty lanes were removed (dotted lines). The graphs show the box and whiskers analysis of 
the blots. Comparison between zones was performed using Mann-Whitney analysis. LG-C labour 
control group, LG-PE labour PE group. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HSP70 in the non-labour control compared to the non-labour PE group at the 
inner, middle and outer placental zones.  (Figure 3-10) shows the HSP70 RQ values in the 
non-labour control compared to the non-labour PE group at the inner (A), middle (B) and 
outer (C) zones.  There was no significant difference in HSP70 mRNA in the non-labour 
control group compared to the non-labour PE at the inner, middle and outer zones (p=0.9, 
p=0.09, p=0.71 respectively). 
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Figure 3-9: RQ values for HSP70 mRNA measurements in inner, middle and outer placental 
zones for the non-labour control group (n=6) compared with non-labour PE groups (n=3). 
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expression of HSP70 between labour control and labour PE groups at the inner, middle and 
outer zones of placentas. Figure 8 shows the HSP70 RQ values in the labour control 
compared to the labour PE group at the inner (A), middle (B) and outer (C) zones. 
Comparison between zones was performed using Mann Whitney test analysis. There was 
no significant difference in mRNA expression of HSP70 in the labour control group 
compared to the labour PE group in the inner, middle and outer placental zones (p=0.48, 
p=0.06,p=0.48 respectively) (Figure 3-11). 
 
Figure 3-10: RQ values for HSP70 mRNA measurements in inner, middle and outer placental 
zones for labour control group (n=6) compared with labour PE groups (n=6). Comparison 
between zones was performed using Mann-Whitney analysis. 
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Experiment 5: This experiment was designed to test if there was any difference in mRNA 
expressions of HSP70 between normotensive pregnancies and pregnancies complicated 
with PE (both labour and non-labour cases were combined) at the inner, middle and outer 
zones of placentas.  (Figure 3-12) shows the HSP70 RQ values in the normotensive 
pregnancies group compared to the PE pregnancies group.  Comparison between zones 
was performed using Mann Whitney test analysis.  There was a highly significant decrease 
in mRNA expression of HSP70 in the normotensive pregnancies group compared to the 
pregnancies complicated with PE group in the middle (p=0.009).  No difference was found 
in the inner and outer placental zones (p=0.54, p=0.12).  
 
Figure 3-11: RQ values for HSP70 mRNA measurements in normotensive pregnancies group 
(non-labour and labour were combined) (n=12) compared to the pregnancies complicated 
with PE group (non-labour and labour were combined) (n=12) at the inner, middle and outer 
placental zones. Comparison between zones was performed using Mann-Whitney analysis.  
 
3.3.4 Analysis of protein and mRNA expression of HSP70 in 
pregnancies complicated with FGR. 
Experiment 1: This experiment was designed to test if there was any difference in HSP70 
protein and mRNA expressions between labour control and labour FGR groups at the inner 
or outer zones of placentas.  Due to time constraints only one set of experiments was 
performed for labour groups and in the inner and outer zones only.  The aim was to 
determine whether pilot data from this group of experiments revealed any data suggesting 
that more experiments were warranted.  Western blots showing placental HSP70 
expression at the inner zone (upper panel) and placental HSP70 expression at the outer 
zone (lower panel) of the labour control group and the labour-FGR group are shown in 
(Figure 3-13).  The graphs and statistical analysis are shown below the blots.  There was a 
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significant decrease in HSP70 expression in the labour-FGR group compared to the control 
labour group in the outer zone (p=0.01).  There was no significant difference in the HSP70 
expression between the labour control and labour FGR groups at the inner zone (p=0.17). 
 
 
Figure 3-12: Representative images of Western blots showing HSP70 expression at the 
inner zone (upper panel) and the outer zone (lower panel) in labour control (n=6) and labour 
FGR group (n=6). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. LG-C labour group control, 
LG-FGR labour group FGR.  
 
Experiment 2: tested whether there was any difference between labour control and labour 
FGR at the inner or outer zones at the HSP70 mRNA level.  The results are shown in 
(Figure 3-14).  No differences were found in the inner or outer zones in the HSP70 mRNA 
expression. 
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Figure 3-13: RQ values for HSP70 mRNA measurements in inner and outer placental zones 
for labour control group (n=6) compared with labour FGR-groups (n=6). Comparison 
between zones was performed using Mann-Whitney analysis. 
 
3.3.5 Analysis of protein and mRNA expression of HSF1 in normal 
pregnancy  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
protein expression of HSF1 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
First the non-labour groups were compared.  Two main bands were detected in all placenta 
samples, which, according to the data sheet represent the phosphorylated 80 kDa and non-
phosphorylated 65 kDa forms.  Examples of Western blots showing HSF1 (phosphorylated 
80 kDa) and (non-phosphorylated 65 kDa) expressions for non-labour are shown in (Figure 
3-15).  The graphs and statistical analysis are shown below the blots.  Comparison between 
zones was performed using Friedman test analysis.  There was no significant difference in 
protein expression of either form between the three zones of the non-labour group (p=0.65, 
p=0.12 respectively). 
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Figure 3-14: Representative image of Western blot showing expression of HSF1 
phosphorylated and non- phosphorylated forms expressions in inner, middle and outer 
zones of individual placentas of non-labour group. Four quadrants were sampled in each 
zone. Graphs show median and interquartile range for HSF1 phosphorylated and non-
phosphorylated forms expressions. Comparison between zones was performed using 
Friedman analysis. P-HSF-1= phosphorylated HSF1, NP-HSF-1= non-phosphorylated HSF1. 
 
Experiment 2: This experiment was designed to test if there was a spatial difference in 
expression of HSF1 within individual placentas obtained from women who were in labour.  
Two main bands were detected in all placenta samples, which, according to the data sheet 
represent the phosphorylated 80 kDa and non-phosphorylated 65 kDa forms.  Examples of 
Western blots showing HSF1 (phosphorylated 80 kDa) and (non-phosphorylated 65 kDa) 
expressions for labour group are shown in (Figure 3-16).  There was a significant decrease 
in both phosphorylated and non-phosphorylated forms at the outer zones compared to the 
inner and middle zones of the labour group (p=0.04 for both).  The sub-analysis showed 
that there was a significant decrease in both phosphorylated and non-phosphorylated forms 
of HSF1 expression in outer zones compared to the inner zone for labour group (p=0.02 for 
both). 
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Figure 3-15: Representative image of Western blot showing HSF1 phosphorylated and non-
phosphorylated forms expressions in inner, middle and outer zones of individual placentas 
of labour group. Four quadrants were sampled in each zone. Graphs show median and 
interquartile range for HSF1 phosphorylated and non-phosphorylated forms expressions. 
Comparison between zones was performed using Friedman analysis. P-HSF-1= 
phosphorylated HSF1, NP-HSF-1= non-phosphorylated HSF1. 
 
Experiment 3: This experiment was designed to test if there was any difference in HSF1 
phosphorylated and and non-phosphorylated forms expression between labour and non-
labour groups at the inner, middle or outer zones of placentas.  Western blots showing 
placental protein expression of HSF1 in the non-labour and the labour at the inner zone are 
shown in (Figure 3-17) phosphorylated 80 kDa (upper panel) and non-phosphorylated 65 
kDa (lower panel).  The graphs and statistical analysis are shown below the blots.  There 
was a significant decrease in HSF1 expression in the labour group when compared to the 
non-labour group for both the phosphorylated form and the non-phosphorylated forms at 
the inner zone (p=0.02, p=0.04). 
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Figure 3-16: Representative images of Western blot showing HSF1 phosphorylated form (upper panel) 
and HSF1 non-phosphorylated form (lower panel) expressions in the inner placental zone in non-
labour and labour (n=6 in each group). Both bands of Western blot image showed separately. The 
graphs show the box and whiskers analysis of the blots. Comparison between zones was performed 
using Mann-Whitney analysis. NLG non-labour group, LG labour group. 
 
Western blots showing placental HSF1 phosphorylated form (upper panel) and HSF1 non-
phosphorylated form (lower panel) expressions in non-labour and labour at the middle 
zone are shown in (Figure 3-18).  The graphs and statistical analysis are shown below the 
blots.  There was a highly significant decrease in HSF1 expression in the labour group 
when compared to the non-labour group for both the phosphorylated and non-
phosphorylated forms at the middle zone (p=0.01, p=0.008 respectively). 
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Figure 3-17: Representative image of Western blot showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the middle 
placental zone in non-labour and labour (n=6 in each group). First lane is the protein marker 
and second lane is the positive control sample. The graphs show the box and whiskers analysis 
of the blots. Comparison between zones was performed using Mann-Whitney analysis. NLG 
non-labour group, LG labour group. 
 
Western blots showing placental HSF1 phosphorylated form (upper panel) and HSF1 non-
phosphorylated form (lower panel) expressions in the non-labour and the labour at the 
outer zone are shown in (Figure 3-19).  The graphs and statistical analysis are shown below 
the blots.  There was no significant difference in HSF1 expression at the outer zone for 
both forms (p=0.30, p=0.48 respectively).  
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Figure 3-18: Representative image of Western blot showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the outer 
placental zone in non-labour and labour (n=6 in each group). First lane is the protein marker 
and second lane is the positive control sample. The graphs show the box and whiskers analysis 
of the blots. Comparison between zones was performed using Mann-Whitney analysis. NLG 
non-labour group, LG labour group. 
 
 
Experiment 4 this experiment was designed to test if there were any differences in mRNA 
expression of HSF1 within individual placentas at different zones (inner, middle and outer) 
in either labour or non-labour.  In the non-labour group there was a significant increased at 
the outer zone (p=0.0001).  No spatial differences were found within placentas at the 
mRNA level in labour group (p=0.4).  (Figure 3-20) shows the HSF1 RQ values in the 
inner, middle and outer zones for non-labour (A) and labour (B). 
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Figure 3-19: RQ values for HSF1 mRNA measurements in in inner (n=4), middle (n=4) and 
outer zones (n=4) of individual placentas (non-labour and labour groups). Four quadrants 
were sampled in each zone. Graphs show the median for HSF1 mRNA expressions. 
Comparison between zones was performed using Friedman analysis. 
 
Experiment 5 this experiment was designed to test if there were any differences in mRNA 
expression of HSF1 in the non-labour compared to the labour group at the inner, middle 
and outer zones.  (Figure 3-21) shows the HSF1 RQ values in the non-labour compared to 
the labour group at the inner (A), middle (B) and outer zones (C).  There was, 
paradoxically, an increase in HSF1 mRNA in the labour group at the inner zone (p=0.01). 
No differences were found in HSF1 mRNA expression at the middle and outer zones (p=1, 
p=0.8). 
 
Figure 3-20: RQ values for HSF1 mRNA measurements in non-labour (n=6) compared to the 
labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis. 
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3.3.6 Analysis of protein and mRNA expression of HSF1 in 
pregnancies complicated with PE 
Experiment 1: This experiment was designed to test if there was any difference in HSF1 
phosphorylated and non-phosphorylated forms expression between non-labour control and 
non-labour PE groups at the inner and the middle zones of placentas.  Due to time 
constraints only two placental zones experiments were analysed.  Western blots showing 
placental HSF1 protein expression in the non-labour control and the non-labour PE at the 
inner zone are shown in (Figure 3-22) phosphorylated 80 kDa (upper panel) and non-
phosphorylated 65 kDa (lower panel).  The graphs and statistical analysis are shown below 
the blots.  There was a significant decrease in HSF1 expression in the non-labour control 
group when compared to the non-labour PE group for the non-phosphorylated forms 
(p=0.04).  There was no significant difference in the phosphorylated form at the inner zone 
(p=0.24).  
 
 
Figure 3-21: Representative image of Western blot showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the inner 
placental zone in non-labour control (n=6) and non-labour PE (n=3). First lane is the protein 
marker and second lane is the positive control sample. The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG-C non-labour control group, NLG-PE non-labour PE group. 
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Western blots showing placental HSF1 phosphorylated form (upper panel) and HSF1 non-
phosphorylated form (lower panel) expressions in the non-labour control and the non-
labour PE at the middle zone are shown in (Figure 3-23).  The graphs and statistical 
analysis are shown below the blots.  There was no significant difference in HSF1 
expression in the non-labour group when compared to the non-labour PE group for both 
the phosphorylated and non-phosphorylated forms at the middle zone (p=0.54, p=0.89 
respectively). 
 
 
Figure 3-22: Representative image of Western blot showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the middle 
placental zone in non-labour control (n=6) and non-labour PE (n=3). First lane is the protein 
marker and second lane is the positive control sample. The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG-C non-labour control group, NLG-PE non-labour PE group. 
 
Experiment 2: This experiment was designed to test if there was any difference in HSF1 
phosphorylated and non-phosphorylated forms expression between the labour control and 
the labour PE groups at the inner and the middle zones of placentas.  Western blots 
showing placental HSF1 expression in labour control and PE at the inner zone is shown in 
(Figure 3-24) phosphorylated 80 kDa (upper panel) and non-phosphorylated 65 kDa (lower 
panel).  The graphs and statistical analysis are shown below the blots.  There was a highly 
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significant decrease in HSF1 expression in the labour control group when compared to the 
labour PE group for the non-phosphorylated form (p=0.002).  There was no significant 
difference in the phosphorylated form at the inner zone (p=0.39).  
 
 
Figure 3-23: Representative image of Western blot showing HSF1 phosphorylated form 
(upper panel) and HSF1 non-phosphorylated form (lower panel) expressions in the inner 
placental zone in labour control and PE (n=6 for both groups). The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. LG-C labour control group, LG-PE labour PE group. 
 
Western blots showing placental HSF1 phosphorylated form (upper panel) and HSF1 non-
phosphorylated form (lower panel) expressions in the labour control and the labour PE at 
the middle zone are shown in (Figure 3-25).  The graphs and statistical analysis are shown 
below the blots.  There was a significant decrease in HSF1 expression in the labour PE 
group when compared to the labour control group for the non-phosphorylated form at the 
middle zone (p=0.004).  There was no significant difference in phosphorylated form at the 
middle zone (p=0.17). 
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Figure 3-24: The graphs presentations show the box and whiskers analyisis of HSF1 phosphorylated 
form and HSF1 non-phosphorylated form expressions in the middle placental zone in labour control 
and PE (n=6 for both groups). Both bands of Western blot image showed separately. As curved gel, 
areas of splicing of gel image where indicated (dotted lines). Comparison between zones was 
performed using Mann-Whitney analysis. LG-C labour control group, LG-PE labour PE group. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HSF1 in the non-labour control compared to the non-labour PE group at the 
inner and middle placental zones.  (Figure 3-26) shows the HSF1 RQ values in the non-
labour control compared to the non-labour PE group at the inner (A) and middle (B) zones.  
There was a significant decrease in mRNA expression of HSF1 in the non-labour control 
group compared to the non-labour PE at the inner zone (p=0.02). No differences were 
found in HSF1 mRNA expression at the middle zone (p=0.1). 
 
 
171 
 
 
Figure 3-25: RQ values for HSF1 mRNA measurements in inner and middle placental zones 
for non-labour control group (n=6) compared with non-labour PE groups (n=3). Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSF1 between the labour control and the labour PE groups at the inner or 
middle zones of placentas.  (Figure 3-27) shows the HSF1 RQ values in the labour control 
compared to the labour PE group at the inner (A) and middle (B) zones.  Comparison 
between zones was performed using Mann Whitney test analysis.  There was no significant 
difference in mRNA expression of HSF1 in the labour control group compared to the 
labour PE group in the inner or middle placental zones (p=0.1, p=0.06 respectively). 
 
 
Figure 3-26: RQ values for HSF1 mRNA measurements in inner and middle placental zones 
for labour control group (n=6) compared with labour PE groups (n=6). Comparison between 
zones was performed using Mann-Whitney analysis. 
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Experiment 5: This experiment was designed to test if there was any difference in mRNA 
expressions of HSF1 between normotensive pregnancies and pregnancies complicated with 
PE regardless the labour factor at the inner or middle zones of placentas.  (Figure 3-28) 
shows the HSF1 RQ values in the labour control compared to the labour PE group at the 
inner (A) and middle (B) zones.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was a highly significant decrease in mRNA expression of 
HSF1 in the normotensive pregnancies group compared to the pregnancies complicated 
with PE group in the inner and middle placental zones (p=0.007, p=0.01).  
 
 
Figure 3-27: RQ values for HSF1 mRNA measurements in normotensive pregnancies group 
(n=12) compared to the pregnancies complicated with PE group (n=12) at the inner and 
middle placental zones. Comparison between zones was performed using Mann-Whitney 
analysis. 
 
3.3.7 Analysis of mRNA expression of HSF2 in normal 
pregnancies and pregnancies complicated with PE at the 
inner and middle zones.  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSF2 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
(Figure 3-29) shows the HSF2 RQ values within individual placenta in the non-labour and 
labour group at the inner (A) and middle (B) zones.  Comparison between zones was 
173 
 
performed using Friedman test analysis.  There was no significant difference in mRNA 
expression of HSF2 between the three zones of the non-labour and labour groups (p=0.9 
for both). 
 
 
Figure 3-28: RQ values for HSF2 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups). Four quadrants 
were sampled in each zone. Graphs show the median for HSF2 mRNA expressions. 
Comparison between zones was performed using Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of HSF2 between the labour and the non-labour groups at the inner, middle or 
outer zones of placentas. (Figure 3-30) shows the HSF1 RQ values in the non-labour group 
compared to the labour group at the inner (A), middle (B) and outer (C) placental zones. 
Comparison between zones was performed using Mann Whitney test analysis.  There was 
no significant difference in mRNA expression of HSF2 in the non-labour group when 
compared to the labour group at the inner, middle and outer zones (p=0.69, p=0.58, p=0.24 
respectively).  
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Figure 3-29: RQ values for HSF2 mRNA measurements in non-labour group (n=6) compared 
to the labour group (n=6) at the inner, middle and outer placental zones. Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSF2 between the non-labour control and the non-labour PE groups at the 
inner or middle placental zones. (Figure 3-31) shows the HSF1 RQ values in the non-
labour control group compared to the non-labour PE group at the inner (A) and middle (B) 
placental zones.  Comparison between zones was performed using Mann Whitney.  There 
was no significant difference in the mRNA expression of HSF2 was found at the inner and 
middle zones (p=0.90 for both). 
 
 
Figure 3-30: RQ values for HSF2 mRNA measurements in non-labour control group (n=6) 
compared to the non-labour PE group (n=3) at the inner and middle placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. 
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Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSF2 between labour control and labour PE groups at the inner or middle 
placental zones. (Figure 3-32) shows the HSF1 RQ values in the labour control group 
compared to the labour PE group at the inner (A) and middle (B) placental zones.  
Comparison between zones was performed using Mann Whitney.  There was no significant 
difference in the HSF2 mRNA was found at the inner and middle zones (p=0.32, p=0.95). 
 
Figure 3-31: RQ values for HSF2 mRNA measurements in labour control group (n=6) 
compared to the labour PE group (n=6) at the inner and middle placental zones. Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Experiment 5: This experiment was designed to test if there was any difference in mRNA 
expressions of HSF2 between normotensive pregnancies and pregnancies complicated with 
PE regardless the labour factor at the inner or middle zones of placentas. (Figure 3-33) 
shows the HSF2 RQ values in the labour control compared to the labour PE group at the 
inner (A) and middle (B) zones.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant decrease in mRNA expression of HSF2 in 
the normotensive pregnancies group compared to the pregnancies complicated with PE 
group in the inner and middle placental zones (p=0.14, p=0.93). 
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Figure 3-32: RQ values for HSF2 mRNA measurements in normotensive pregnancies group 
(n=12) compared to the pregnancies complicated with PE group (n=12) at the inner and 
middle placental zones. Comparison between zones was performed using Mann-Whitney 
analysis. 
 
3.3.8 Results summary  
3.3.8.1 Summary results for HSP70 expression in normal pregnancy: 
Experiment 1: Within individual placentas there was a significant difference in protein 
expression of HSP70 between the three zones of the non-labour group and the labour group 
(p=0.04 for both).  The sub-analysis showed that there was a significant decrease in HSP70 
expression in outer zones compared to the middle zones for both non-labour and labour 
groups (p=0.03, p=0.02 respectively 
Experiment 2: There was a significant decrease in HSP70 expression in the non-labour 
group when compared to the labour group at the middle zone (p=0.008).  No other 
differences were found when comparing labour with non-labour. 
Experiment 3: Within individual placentas no differences in mRNA expression for HSP70 
were found either in the labour or non-labour groups. 
Experiment 4: There was no significant difference in mRNA expression for HSP70 in the 
non-labour group when compared to the labour group at the inner, middle and outer zones 
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3.3.8.2 Summary results for HSP70 expression in pregnancies complicated 
with PE 
Experiment 1: When the PE groups (non-labour) were compared with the control groups 
(non-labour) for protein expression of HSP70 at the inner, middle and outer zones the 
changes found can be summarized as follows: There was a significant decrease in protein 
expression of HSP70 in the non-labour control group compared to the non-labour PE group 
at the inner zone (p=0.02).  No other differences were found when comparing non-labour 
control with non-labour PE. 
Experiment 2: When the PE groups (labour) were compared with the control groups 
(labour) for protein expression of HSP70 at the inner, middle and outer zones the changes 
found can be summarized as follows: There was no significant difference in HSP70 
expression in the labour control group compared to the non-labour PE group at the inner, 
middle and outer zones. 
Experiment 3: There was no significant difference in HSP70 mRNA in the non-labour 
control group when compared to the non-labour PE at the inner, middle and outer zones.  
Experiment 4: There was no significant difference in HSP70 mRNA in the labour control 
group when compared to the labour PE at the inner, middle and outer zones.  
Experiment 5: When non labour and labour was combined, there was a highly significant 
decrease in mRNA expression of HSP70 in the normotensive pregnancies group compared 
to the pregnancies complicated with PE group in the middle (p=0.009).  No difference was 
found in the inner and outer placental zones. 
3.3.8.3 Summary results for HSP70 expression in pregnancy complicated 
with FGR 
Experiment 1: When the FGR groups (labour) were compared with the control groups 
(labour) for protein expression of HSP70 at the inner and outer zones the changes found 
can be summarized as follows: there was a significant decrease in protein expression of 
HSP70 in the FGR labour group compared to the labour control group at the outer zone 
(p=0.01).  No other differences were found when comparing FGR labour with labour 
control at the inner zone. 
Experiment 2: There was no significant differences were found when labour control and 
labour FGR groups were compared at the inner or outer zones. 
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3.3.8.4 Summary results for HSF1 expression in normal pregnancy: 
Experiment 1: Within individual placentas there was no significant spatial difference in 
protein expression of either form of HSF1 between inner, middle and outer placenta zones 
of the non-labour group  
Experiment 2: Within individual placentas there was a significant decrease in both 
phosphorylated and non-phosphorylated forms in outer zone compared to the inner and 
middle zones of the labour group (p=0.04 for both).  The sub-analysis showed that there 
was a significant decrease in HSF1 expression in outer zones compared to the inner zone 
for both forms (p=0.02 for both). 
Experiment 3: There was a significant decrease in HSF1 expression in the labour group 
when compared to the non-labour group for both forms at the inner zone (p=0.02, p=0.04 
respectively) and at the middle zone (p=0.01, p=0.008 respectively).  No other changes 
were found at the outer zone. 
Experiment 4:  Within individual placentas there was a significant spatial difference in the 
mRNA HSF1 in the non-labour group with high expression at the outer zone (p=0.0001).  
No spatial differences were found within placentas of the labour group. 
Experiment 5: There was, paradoxically, an increase in HSF1 mRNA in the labour group at 
the inner zone (p=0.01).  No differences were found in HSF1 mRNA expression at the 
middle and outer zones. 
3.3.8.5 Summary results for HSF1 expression in pregnancies complicated 
with PE 
Experiment 1: When the PE groups (non-labour) were compared with the control groups 
(non-labour) for protein expression of HSF1 at the inner, middle and outer zones the 
changes found can be summarized as follows: there was a significant decrease in protein 
expression of HSF1 in the non-labour control group compared to the non-labour PE group 
for the non-phosphorylated forms (p=0.04) at the inner zone.  There was no significant 
difference in the phosphorylated form at the inner zone.  There was no significant 
difference in HSF1 expression was found at the middle zone. 
Experiment 2: When the PE groups (labour) were compared with the control groups 
(labour) for protein expression of HSF1 for both forms at the inner and middle zones the 
changes found can be summarized as follows:  There was a significant decrease in HSF1 
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expression in the labour control group when compared to the labour PE group for the non-
phosphorylated form at the inner zone (p=0.002).  There was a significant decrease in 
HSF1 expression in the labour PE group when compared to the labour control group for 
the non-phosphorylated form at the middle zone (p=0.004).  There was no significant 
difference in the phosphorylated form at the inner and middle zone (p=0.39).  
Experiment 3: There was a significant decrease in mRNA expression of HSF1 in the non-
labour control group compared to the non-labour PE at the inner zone (p=0.02).  No 
differences were found in HSF1 mRNA expression at the middle zone. 
Experiment 4: There was no significant difference in mRNA expression of HSF1 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
3.3.8.6 Summary results for mRNA expression of HSF2  
Experiment 1: No spatial differences were found in mRNA expression of HSF2 within 
placentas in labour or non-labour groups. 
Experiment 2: No differences were found in mRNA expression of HSF2 between labour 
and non-labour groups at the inner, middle and outer zones. 
Experiment 3: No difference in mRNA expression of HSF2 was found between non-labour 
control and non-labour PE at the inner and middle zones 
Experiment 4: No difference in mRNA expression of HSF2 was found between labour 
control and labour PE at the inner and middle zones 
Experiment 5: When non labour and labour was combined, there was no significant 
difference in mRNA expression of HSF1 in the normotensive pregnancies group compared 
to the pregnancies complicated with PE group in the inner and middle placental zones. 
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3.4  Discussion  
3.4.1  HSP70 and present findings 
This study shows for the first time that HSP70 is expressed in a spatial manner in the 
placenta with the highest expression being in the middle zone in both labour and non-
labour groups.  The study also shows the importance of using a systematic method to 
sample the placenta.  Previous reports of HSP70 expression, and indeed most studies of 
expression of other proteins, do not take this into account.  Therefore by taking a single 
sample or averaging protein expression of several samples may well mask possible 
changes in expression.  The increase in HSP70 in labour, PE and FGR at precise zones 
suggests that there is a controlled spatial change in HSP70 expression.  The physiological 
and pathological significance of these remains to be elucidated but oxidative stress is the 
common link. 
3.4.2 Key findings HSP70  
The main findings of this study were that HSP70 is expressed in a spatial manner in the 
placenta with the highest expression being in the middle zone in both labour and non-
labour groups (p=0.04).  There was a significant increase in protein expression of HSP70 
in labour group compared to the non-labour group at the middle zone (p=0.008).  There 
was no significant difference in mRNA expression of HSP70 between the labour and the 
non-labour groups.  There was a significant increase in protein expression of HSP70 in 
non-labour PE compared to non-labour control group (p=0.02) at the inner zone.  There 
was no change in protein expression of HSP70 in labour PE compared to the labour control 
group.  No changes were found on mRNA level.  However, when non-labour and labour 
groups combined there was a significant increase in mRNA expression of HSP70 in PE 
compared to the normotensive group at the middle zone (p=0.009).  In the FGR study there 
was a significant increase in protein expression of HSP70 in labour control compared to 
the labour FGR group at the outer zone (p=0.04). 
3.4.3 HSF1 and present findings 
Heat shock proteins (HSPs) are induced in cells as a protective mechanism to cope with 
cellular stress.  The activation of the heat shock response is mediated by heat shock 
transcription factor 1 (HSF1). HSFs (HSF1-4) bind to the promoter regions of target genes. 
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HSF1 exists in a complex with HSP40, HSP70 and HSP90 as inactive monomers; after 
stress HSF1 is and trimerizes. Two HSF1 bands were observed which; according to the 
data sheet represent the phosphorylated 80 kDa (active form) and non-phosphorylated 65 
kDa (inactive form). 
3.4.4 Key findings HSF1 
This study shows for the first time that protein expression of HSF1 is spatial distributed in 
the placenta with the highest expression being in the middle zone in the labour group 
(p=0.04).  There was no significant difference in non-labour group.  There was a 
significant increase in non-labour group compared to the labour group for both forms 
phosphorylated and non-phosphorylated at the inner zone (p=0.02, p=0.04 respectively) 
and middle zone (p=0.01, p=0.008 respectively).  No change was found at the outer zone. 
There was a spatial distribution in mRNA expression of HSF1 in the non-labour group 
(p=0.001).  No change was found in the labour group.  There was a paradoxical increase in 
mRNA expression of HSF1 in the labour group compared to the non-labour at the inner 
zone (p=0.01).  No difference was found at the middle zone.  There was a significant 
increase in the non-phosphorylated form of labour PE compared to the labour control in the 
inner and middle zones (p=0.04, p=0.004 respectively).  There was a significant increase in 
mRNA expression of HSF1 in non-labour PE compared to the non-labour control at the 
inner zone (p=0.02).  No other changes were found.  When all labour and non-labour 
groups were combined, there was a significant increase in mRNA expression of HSF1 in 
PE compared to the normotensive group at the inner and middle zones (p=0.007, p=0.01 
respectively). (Table 3-4) showed comparison in protein and mRNA expression of both 
HSP70 and HSF1. 
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Table 3-4: Summary of different comparison in protein and mRNA expression of HSP70 
(blue arrow) and HSF1 (red arrow) in non-labour group (NLG), labour group (LG), non-
labour-PE (NLG-PE) and labour group-PE at the inner, middle and outer zones of placentas. 
Both HSF1 forms; phosphorylated (P) and non-phosphorylated (NP) were included. Spatial 
distribution also was included. Comparison was pointed by arrows to either increase, 
decrease or no change.  
Protein expression                                 Inner                        Middle                           Outer 
  
Spatial distribution   Yes for HSP70  both NLG and LG groups, highest in the  middle zone         
                                   Yes for HSF1 (both forms) only LG, highest in the middle zone. 
 
 
NLG versus LG                                                 (both forms)            (both forms)          
 
NLG-PE versus NLG-C                                    (NP)                              
 
LG-PE versus LG-control                                 (NP)                       (NP)                                                   
mRNA 
 
Spatial distribution              No for HSP70 
                                           Yes for HSF1 only NLG, highest in outer zone. 
 
NLG versus LG               
 
NLG-PE versus NLG-C 
 
LG-PE versus LG-C 
 
 
 
3.4.5 Key findings HSF2 
There was no spatial difference in mRNA expression of HSF2.  There was no difference 
when non-labour and labour groups compared at the inner, middle and outer placental 
zones.  There was no difference comparing both non-labour and labour PE group with both 
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labour and non-labour control.  When labour and non-labour groups were combined there 
was no difference in mRNA expression of HSF2. 
 
3.4.6 HSP70 expression in labour, PE and FGR 
The main components of the HSP70 family are HSP72 (HSP 70i) (induced during cell 
stress) and HSP73 (HSC70) which is constitutively expressed in all cells. Both have very 
similar amino acid sequences.  Both are involved in translocation of proteins from the 
cytosol into the ER and mitochondria and in protein folding during and after synthesis.  
Other family members include GRP75 and GRP78. HSP70 can rescue cells from death by 
inhibiting activation effector caspases (Jäättelä, 1999).  There has been some confusion 
over the use of names for HSPs including HSP70 (Kampinga et al., 2009).  The HSP70 
used in this study is part of the HSPA family. HSPA1A (also called HSP70-1; HSP72; 
HSPA1) and HSPA1B (also called HSP70-2) differ by only two amino acids and are 
believed to be fully interchangeable proteins.  Together with HPA6 (Heat shock 70kD 
protein 6 (HSP70B)) they are the most inducible HSPs. HSPA8 was designated previously 
as (HSC70; HSC71; HSP71; HSP73) and is an essential “house-keeping” HSPA member 
and is involved in co-translational folding and protein translocation across intracellular 
membranes (Kampinga et al., 2009). 
Under non-stressful conditions constitutively expressed members of each HSP family are 
found in almost all organelles including the nucleus, cytoplasm, ER and mitochondria. By 
interacting with proteins and peptides they play an important role in cell and organ 
survival.  HSPs are induced in response to cell stresses including heat shock, oxidative 
stress, ultraviolet radiation, IR injury, viral infections, nutrient deprivation, hypoxia, 
physical damage, ischemia and chemicals.  The perils of subsequent protein misfolding are 
controlled by two mechanisms: (i) the molecular chaperones (including HSPs) that 
facilitate assembly, folding and translocation of proteins as well as the refolding of 
denatured proteins and (ii) the ubiquitin-proteasome system which regulates the 
degradation of misfolded proteins which cannot be renatured (Borges et al., 2012). 
Although originally thought to bind directly to the signalling receptors TLR2, TLR4, 
cluster of differentiation (CD) 40, or CD91 it is now known that HSP70 binds to 
scavenging receptors including lectin-like oxidized LDL receptor-1 (LOX-1), scavenger 
receptor expressed by endothelial cell-I (SREC-1), and fasciclin, EGF-like, laminin-type 
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EGF-like, and link domain-containing scavenger receptor-1 (FEEL-1).  On binding to the 
receptor it is thought that HSP70 then signals to the TLR2 receptor which in turn signals 
MyD88 activation leading to the phosphorylation of ERK which can trigger the activation 
of an undetermined transcription factor that will bind the IL-10 gene promoter leading to 
IL-10 production (Borges et al., 2012).  Interestingly IL-10 can be pro-inflammatory at the 
end of labour and it has been proposed that this inflammatory action of a usually anti-
inflammatory cytokine might be an evolutionary adaptation to accelerate parturition and 
delivery and allow the fetus rapidly to exit a hostile environment (Gibb WL, 2006).  
Labour is a normal physiological process but PE is a disorder.  It is possible in PE that IL-
10 production could be a protective response and future in vitro studies could determine if 
this is mediated by HSP70. 
Apoptosis has been implicated in both PE and labour. In the apoptotic pathway, HSPs act 
at several stages to prevent cell death initiated by stress-induced damage.  For example 
HSP70 inhibits CASP 3 and 9.  Thus it is possible HSP70 acts to keep the rate of apoptosis 
in check (Borges et al., 2012). 
HSP70 also has anti-inflammatory properties.  For example it can bind to, and activate, 
human monocytes, inhibiting the secretion of inflammatory cytokines, such as TNF-α, IL-
1β, and IL-6  (Asea et al., 2000) and increasing secretion of the anti-inflammatory IL-10. 
Since labour and PE are pro-inflammatory states, HSP70 could again be a protective 
mechanism to counter-balance this. 
There are some publications in which HSP70 expression in the placenta and changes 
during adverse pregnancy have been reported.  The major point to highlight is that 
controlled sampling and the confounding effects of labour have not been considered.  
These studies can be summarized as follows. 
Divers et al (Divers et al., 1995) also performed an immunohistochemical (IHC) study of 
HSP70 expression in pre-term labour, term labour, term non-labour and pre-term cesarean 
section for PE or FGR.  No changes in HSP70 were reported however different tissues 
were studied namely amniochorion and basal plate.  The placenta itself was not examined 
and controlled sampling was not performed. 
Li et al reported increased expression of HSP70 in placenta of what they termed “placental 
vascular disease” (PE, IUGR and PE plus IUGR all combined in one group) compared 
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with term non-diseased placentae (Li et al., 1996).  All were delivered by caesarean 
section.  No systematic sampling was performed and labour was not studied. 
Shah et al used IHC to assess HSP70 expression in paraffin sections of placentae from 
normal term pregnancies and reported immunostaining on cell types, both in cytoplasm 
and nucleus (Shah et al., 1998).  Site of sampling or labour was not assessed. 
Ziegert et al (Ziegert et al., 1999) reported that HSP70 was expressed in placenta and 
reported no difference between labour and non-labour however no data or p values were 
shown to support this statement and no systematic sampling was performed.  Similarly (Li 
et al., 1996) found no difference between labour and non-labour but similar issues applied. 
Several years ago we examined HSP70 expression in placentas from normal and PE with 
or without IUGR.  At that time no clear difference in expression was found but we too did 
not control for labour or sampling area (Hnat et al., 2005). 
Barut et al preformed immunofluorescence on paraffin sections and examined HSP70 
expression.  HSP70 expression was reported to be increased on STB, CTB and extravillous 
trophoblast in PE and on endothelial cells in intrauterine growth restriction (Barut et al., 
2010).  This study did not control for placental site or labour. 
Kim et al reported that the presence of a uterine artery notch in a mixed group of normal 
pregnant, PE and PE plus IUGR was associated with increased eNOS and HSP70 in basal 
plate samples taken from patients who underwent caesarean section (Kim et al., 2010).  
Placental villous tissue was not studied. 
Padmini and Lavanya  using western blotting and immunofluorescence found that protein 
expression of HSP70 was increased in PE endothelial cells when compared to 
normotensive subjects (Padmini and Lavanya, 2011a). 
In addition, the same research group (Padmini and Lavanya, 2011a, Padmini et al., 2012a) 
using ELISA found that expression of HSP70 was increased by 30.2% in PE endothelial 
cells when compared to normotensive subjects. 
Some studies have examined HSP70 expression in early pregnancy. (Jauniaux et al., 2000) 
demonstrated a sharp increase in HSP70 during 8-9 weeks of gestation when blood flow to 
the placenta is initiated.  They proposed that the placenta up regulates protective proteins 
to protect it at this time as the initiation of blood flow represents an oxidative stress insult. 
(Hempstock et al., 2003) found increased syncytial HSP70 immunostaining in early 
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pregnancy miscarriage placentae compared with placentae match for gestation from 
pregnancies terminated for psychosocial reasons. Onset of the maternal circulation is 
associated with a three-fold rise in the oxygen concentration within the placenta resulting 
in increased generation of reactive oxygen species. (Jauniaux et al., 2003b) examined 
HSP70 and nitrotyrosine expression in placentae obtained from surgically terminated 
pregnancies between 8-13 weeks of gestation.  They sampled the inner and outer third. 
Immunoreactivity for HSP70 and nitrotyrosine residues was greater in samples from 
peripheral than from central regions of normal placentas and from missed miscarriages 
compared to controls.  They proposed that oxidative damage to the trophoblast, induced by 
premature onset of the maternal placental circulation is a key factor in early pregnancy 
loss. 
Johnstone et al measured HSP70 in purified CTB cells obtained from normal and PE 
pregnancies (Johnstone et al., 2011).  HSP70 was reported to be reduced in the cells from 
PE cases however labour and site of sampling was not studied.  Changes due to the shock 
of enzyme digestion and cell purification are also confounding factors. 
A mechanism which was proposed for increased HSP70 and the link to labour was as 
follows.  Intracellular HSP70 binds to the progesterone receptor, thus functions as a co-
repressor of this receptor and suppresses progesterone binding to the nuclear response 
element (Chaiworapongsa et al., 2008). 
Hung et al exposed term placenta explants from non-labour cases to IR in vitro and 
showed this led to increased HSP72 expression and this could be reduced in the presence 
of reactive oxygen species scavengers (Hung et al., 2001). 
Malyshev et al  showed that oxidative stress increases NF-κB which in turn activates nitric 
oxide synthase, nitric oxide release and subsequently HSP70 induction in several organs 
(Malyshev et al., 1995).  Blocking nitric oxide synthase activity inhibited HSP70 
induction.  Our lab group have previously shown that villous endothelial eNOS (Myatt et 
al., 1997), nitrotyrosine (a marker of peroxynitrite produced by superoxide and nitric oxide 
interaction (Myatt et al., 1996) and 4-hydroxy-2-nonenal adducts (HNE) a marker for lipid 
peroxidation (Hnat et al., 2005) are both increased in PE as is serum placental nitric oxide 
accumulation (Lyall et al., 1995).  Hence future studies that will investigate the role of 
nitric oxide synthase in increasing HSP70 in the placenta would be recommended.  A study 
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by  (Kakui et al., 2003) reported that protein expression of nitric oxide synthase isoforms 
were not altered in labour however nitric oxide synthase activity was not investigated. 
HSPs can be detected in the circulation.  The few reported studies of HSP70 serum 
concentrations in PE and labour are conflicting (Fukushima et al., 2005, Chaiworapongsa 
et al., 2008). 
3.4.7 HSF1 in labour and PE 
HSF1 is a prime coordinator of transcription in stressed cells and involved in a multitude 
of physiological processes (Vihervaara and Sistonen, 2014).  Upon stress HSF1 controls 
the composition of the entire chaperone machinery and adjusts the expression of ubiquitin 
through the proteasomal pathway (Vihervaara et al., 2013).  HSF1 is the stress responsive 
transcriptional activator responsible for the inducible transcription of genes encoding 
HSPs. It binds to regulatory heat shock elements present in the promoter region of all heat 
shock genes (Yao et al., 2006).  It has been shown that active HSF is stably bound to DNA 
and any turnover of transcription activator is not required for rounds of HSP70 
transcription (Yao et al., 2006). 
The expression of HSF1 was investigated.  Similar to HSP70 there was a spatial 
distribution in protein expression of HSF1 in the labour group for both isoforms with the 
highest being in the middle zone.  There was no change in HSF1 protein expression in the 
non-labour placentas.  However, at the mRNA level there was spatial differences only in 
non-labour group.  The complexity of these changes makes it difficult to make clear 
conclusions however the middle site appears to be the site that, for reasons to be explained, 
shows more changes.  Also differences in labour and non-labour may also relate to the fact 
that labour is a large stress compared to non-labour.  Further difficulties in explaining the 
findings relate to what causes the initial labour contractions to start versus the 
consequences of labour.  The fact that mRNA did not always parallel the protein changes 
may also be linked to the same explanation as well as possible differences in 
mRNA/protein stability/turnover in different zones and in labour versus non-labour.  
Overall it can be seen that changes in mRNA and protein are complex and the most 
important conclusion of all is the need for researcher to be consistent in sampling methods 
within their own studies and if comparisons are to be made with other studies then it is 
important that everyone agrees on a sampling methods.  To date despite much discussion 
on this, this has not been achieved.  
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There are several post translational modifications sites on HSF1 including 
phosphorylation, acetylation and sumoylation sites on different serine and threonine sites 
that can be activated by stress active kinases resulting in either activation or inhibition (Xu 
et al., 2012).  HSF1 is strongly induced during stress condition and the phosphorylation 
level of HSF1 correlates well with its transcriptional activity (Seo et al., 2006).  Our 
findings show that both isoforms of HSF1 were increased in the non-labour groups 
compared to the labour at the inner and middle zones, this may be explain that in labour it 
is possible that HSF1has increased and then retained to normal level some time before 
placenta was delivered.  This is correlated with our results that have been shown increased 
in HSP70, which induced by HSF1 in labour group compared to the non-labour (Abdulsid 
et al., 2013b).  
The non-phosphorylated form of HSF1 was increased in the non-labour and labour PE 
groups compared to the non-labour and labour control groups.  Diminished or poor 
placental function in PE increases the chances of apoptosis (Allaire et al., 2000).  HSP70 is 
an anti-apoptotic protein that can influence the apoptotic cascade at multiple sites. Over 
expression of HSF1 and HSP70 are suggesting their protective role in relation to the 
oxidative stress generated in PE. 
Disruption of HSF1 results in reduced constitutive expression of several HSPs, which is 
intimately associated with impaired redox homeostasis and mitochondrial damage (Yan et 
al., 2002).  There are few studies on HSF1 expression in placentas and PE most of them are 
from one research group (Padmini and Lavanya, 2011a, Padmini and Lavanya, 2011b, 
Padmini et al., 2012a, Padmini et al., 2012b). 
Padmini et al (Padmini and Lavanya, 2011b) showed that non-phosphorylate HSF1 (NP-
HSF1) in normotensive women was detected mainly in cytoplasm, whereas phosphorylate 
HSF1 (P-HSF1) in PE women was detected at high level in the nuclear fraction.  
Systematic sampling and labour were not included. 
Padmini et al (Padmini and Lavanya, 2011a, Padmini and Lavanya, 2011b) reported 
increased nuclear fraction of phosphorylated HSF1 protein expression in placentae from 
PE cases compare with uncomplicated pregnancies.  As shown from this study not 
controlling for labour or sampling zone might alter the findings. 
Oddly the same group (Ramayya et al., 1997) reported that there was no mRNA expression 
of HSF1 in placenta.  However, in our study mRNA expression was found.  
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3.4.8 HSF2 in labour and PE 
HSF2 is not activated in response to classical stress stimuli, but under developmentally 
related conditions.  There was no spatial distribution on protein or mRNA expression of 
HSF2 in non-labour and labour groups, also there was no significant differences when 
comparing different groups at different placental zones.  As HSF2 appears to have a role in 
development and differentiation but not stress it would be of interest to follow the 
expression of HSF2 in placental zones throughout gestation.  In addition, it clear that HSF1 
and HSF2 function in response to stress are not linked to each other. 
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Chapter IV: HSP27 and P-HSP27 expression in 
normal pregnancies and pregnancies 
complicated with PE and FGR (HSP27 only). 
 
4 Introduction  
Heat-shock proteins (HSPs) are a family of proteins expressed by all cells.  HSPs are 
chaperones important in the folding, assembly and degradation of proteins.  Their 
expressions allow cells to survive to sub-lethal conditions by binding to partially denatured 
proteins, dissociating protein aggregates and regulating correct folding (Sarto et al., 2000).  
Heat shock proteins are expressed in response to a wide variety of physiological and 
environmental insult such as heat, inflammation, reactive oxygen species, ischemia and 
some anticancer drugs (Sarto et al., 2000, Macario and Conway, 2006, Lanneau et al., 
2010).  HSPs also play an important role in regulating signal transduction, inhibition of 
apoptosis and cellular proliferation and differentiation.  HSP27 is a molecular chaperone 
and several different mechanisms involve in their cytoprotective activity. 
4.1 Heat shock protein 27 (HSP27) 
HSP27 (also known HSPB1) belongs to the family of small heat shock proteins (sHSPs) 
(15-30 kDa) which include ubiquitin; α-crystallin and HSP20 (Schmitt et al., 2007).  
HSP27 is ATP-independent and protects against stress-induced aggregation of proteins. 
HSP27 present in many cell types especially all types of muscle cells.  It is over expressed 
during different stages of cell differentiation and development and becomes 
phosphorylated in response to various stimuli through interaction with different kinases 
(Sarto et al., 2000).  In response to stress, changes in expression of HSP27 occurs and, like 
many proteins, HSP27 function can also be regulated by at the post-translational level 
(Ghayour-Mobarhan et al., 2012). 
4.1.1 HSP27 gene structure  
One of the best studied small HSPs is HSP27 (Kampinga et al., 2009).  HSP27 contains 
two terminals (Figure 4-1).  The first one is less conserved and referred to as the N-
terminus and contains a WDPF motif necessary for multimer formation and protein 
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oligomerization. Multimers are reduced to dimers by phosphorylation of consensus MK2 
phosphorylation sites at serine residues (ser) 15, 78 and 82 (Ghayour-Mobarhan et al., 
2012).  The second terminal is the C-terminus which includes α-crystallin motif that is 
highly conserved among species.  The crystallin domain is necessary for dimer formation, 
while the flexible region has been suggested to participate in the interaction with target 
proteins, to be involved in oligomerization, and to be important for solubility (Salinthone 
et al., 2008, Gusev et al., 2002).  The sHSPs are often found in oligomeric complexes 
involving one or more family members.(Lelj-Garolla and Mauk, 2005) HSP27 activation is 
stimulus dependent. 
 
 
Figure 4-1: HSP27 gene structure. The N-terminus of HSP27 contains a hydrophobic WDPF 
motif, which is adjacent to a mitogen-activated protein kinases associated protein 
(MAPKAP) kinases (MK2) phosphorylation site at Ser15. The C-terminal 18–20 amino acids 
include an α-crystallin motif that is highly conserved among species and a flexible C-
terminal tail modified  from (Salinthone et al., 2008). 
 
4.1.2 Post-translational modifications  
HSP27 undergoes different types of post-translation modification. HSP27 is the main 
methylglyoxal modified protein in different cancer cells that are characterized by high 
level of glycolysis (Sakamoto et al., 2002).  Under conditions of oxidative stress and 
during ischemia and reperfusion, HSP27 undergoes S-thiolation (Eaton et al., 2002). 
HSP27 undergoes multisite phosphorylation at three serine sites (ser 15, 78 and 82), which 
is named as phosphorylated-HSP27 (P-HSP27).  HSP27 can oligomerize into large 
aggregates up to 800 kDa, but it can also form hetero-oligomers with other sHSP family 
members (e.g. HSP20 and αA-crystallin).  This phosphorylation causes a decrease in 
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HSP27 oligomers size (Rogalla et al., 1999).  Large oligomers are the structural 
organization of HSP27 required for its anti-apoptotic activity, chaperone activity and 
protection against oxidative stress (Rogalla et al., 1999, Bruey et al., 2000b, Mehlen et al., 
1997, Kato et al., 1994b).  Regulation of these modification control by cellular signalling 
pathways of HSP27 and involve archetypal phosphorylation cascades, such as MAPKAP 
and PRAK. (Ghayour-Mobarhan et al., 2012) that can be induced by a variety of stress 
including differentiating agents, mitogens, inflammatory cytokines such as TNF (Döppler 
et al., 2005, Garrido, 2002).  Phosphorylation of HSP27 has been shown to result in 
complex dissociation and the subsequent loss of chaperoning activity (Welsh and Gaestel, 
1998).  Activation of phosphatases and inhibition of upstream signalling pathways are 
involoving in inhibition of HSP27 phosphorylation (Cairns et al., 1994).  Phosphorylation 
of ser-15 seems to induce only a small effect on oligomerization (Kostenko and Moens, 
2009).  The residues corresponding to ser-15 and ser-82 in human HSP27 are conserved 
throughout the animal kingdom. It was reported (Stokoe et al., 1992, Paul et al., 2010) that 
ser-82 is phosphorylated much faster than either ser-15 or ser-78.  Oligomerization of 
HSP27 is affected by the phosphorylation pattern but how phosphorylation governs the 
oligomerization process is not known (Henderson and Pockley, 2012). 
It was reported, (Bruey et al., 2000b, Garrido, 2002) that in tumour cells growing in vivo or 
grown at confluence in vitro, cell-cell contacts induce the formation of large oligomers, 
whatever the phosphorylation status of the protein.  These post-translational modifications 
are observed within minutes after cellular stress. This rapidity of modification implicates 
HSP27 in the early response even before HSP27 gene transcriptional activation 
(Jozefowicz-Okonkwo et al., 2009).  One study (Henderson and Pockley, 2012) revealed 
that stimulus-induced HSP27 phosphorylation is often transient, so that HSP27 
phosphatases are also implicated in controlling the phosphorylation status of HSP27. 
4.1.3 Functions of HSP27 
There are several intracellular function of HSP27 such as chaperone activity, control of 
apoptotic signalling, regulation of cell glutathione levels, inhibition of actin 
polymerization, stabilization of actin filament arrays as well as protection against heat 
shock, oxidative stress and mechanical stress (Brown et al., 2007, Ghayour-Mobarhan et 
al., 2012).  HSP27 is expressed during both skeletal and cardiac muscle development and 
has been shown to be involved in a diverse array of cellular processes (Brown et al., 2007). 
HSP27 can bind to proteins and affect their function, and there is evidence that HSP27 
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inhibits enzymes in the apoptotic pathway (Ghayour-Mobarhan et al., 2012).  HSP27 also 
plays a role in atherosclerosis (Martin-Ventura et al., 2004), in regulation of cytokine 
production from monocytes as well as expression of toll-like receptors (De et al., 2000), 
and may play a role in protecting the immature human myocardium in response to stress 
during open heart surgery (Walker et al., 2013). 
4.1.3.1 HSP27 and chaperone function 
HSP27 act as a protein chaperone by binding to unfolded proteins and preventing their 
aggregation (Knauf et al., 1994).  Un-phosphorylated HSP27 forms large multimers, which 
are responsible for protection against cellular stress, while phosphorylation results in 
conformational changes and formation of smaller di- and tetrameric units (Kato et al., 
1994b) and in cooperation of other chaperones allow the target proteins to regain their 
native structure (Ehrnsperger et al., 1997). 
4.1.3.2 HSP27 and actin filament functions 
In addition to its chaperone function, HSP27 also play an important role as a regulator of 
structural integrity and membrane stability, cytoskeleton formation, cell cycle progression, 
pro-inflammatory gene expression, muscle contraction, signal transduction pathways and 
apoptosis (Welsh and Gaestel, 1998, Charette et al., 2000, Gerthoffer, 2005, Garrido et al., 
2006, Stetler et al., 2008).  Under stress, phosphorylation of HSP27 has been shown to 
improve cytoskeleton stability in cells that are known to express constitutively wild type 
HSP27 (Lavoie et al., 1995).  One of important functions of P-HSP27 is the regulatory role 
of P-HSP27 in actin filament functions and their associated processes such as muscle 
contraction, cell division, differentiation and migration (Kostenko et al., 2009).  In its un-
phosphorylated form, HSP27 inhibits actin polymerization while in P-HSP27 allow small 
oligomers to bind to actin and stabilizing them (Dominguez and Holmes, 2011).  HSP27 
also protect cytoskeleton of neonatal cardiac cells (van de Klundert et al., 1998a). 
4.1.3.3 HSP27 and anti-apoptotic function 
Un-phosphorylated and phosphorylated HSP27 exhibit anti-apoptotic functions via 
different mechanisms.  P-HSP27 binds to Daxx and inhibits TNFα and Fas-mediated 
apoptosis or stimulates the pro-survival Akt pathway (Benn et al., 2002, Arrigo, 2000, 
Charette et al., 2000, Garrido et al., 2006), activates protein kinase Akt, phosphorylating 
Bax which prevents pore formation in the outer mitochondria membrane and thus prevents 
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liberation of cytochrome c from mitochondria (Havasi et al., 2008).  HSP27 also seems to 
inhibit the Ask1-JNK pathway which through Bax leads to cytochrome c leakage (Stetler 
et al., 2009).  Un-phosphorylated HSP27 can block apoptosis pathways as it inhibit the 
activation of pro-caspase-9 by its interaction with cytochrome c upon its release from the 
mitochondria, thus preventing the correct formation and function of the apoptosome 
complex (Bruey et al., 2000a, Garrido et al., 2006, Paul et al., 2010, Lanneau et al., 2007, 
Concannon et al., 2003).  In the extrinsic apoptotic pathway, HSP27 prevents translocation 
of activated Bid to the mitochondrial membrane and thus inhibits apoptosis (Arya et al., 
2007).  In addition, HSP27 activation of transcriptional activity of NF-κB can be another 
pathway providing for anti-apoptotic activity of HSP27 (Mymrikov et al., 2011).  
However, other studies have also shown increased HSP27 protection via mechanisms other 
than interaction with the apoptotic processes (Paul et al., 2002). 
4.1.4 HSP27 and oxidative stress 
Oxidative stress is accompanied by increased levels of toxic ROS, such as peroxides and 
free radicals.  HSP27 has important anti-oxidant function by maintaining glutathione in its 
reduced form, to decrease ROS (Arrigo, 2007).  Un-phosphorylated HSP27 reduced ROS 
production, enhanced glutathione levels, and provided cellular protection against oxidative 
stress (Mehlen et al., 1997).  HSP27 and αB-crystallin decrease the intracellular level of 
iron, and as a results they interfere with formation of hydroxyl radicals via the Fenton 
reaction (Arrigo, 2007).  Cell culture of hippocampal HiB5 cells expressing high level of 
HSP-2D (where ser-15 is not substituted by asp) displayed better survival rates and actin 
stability against heat shock than cells over-expressing HSP27-2A (Geum et al., 2002). This 
showed that phosphorylation of HSP27 is important for maintenance of the actin fibres and 
thus enhances thermos-resistance (Geum et al., 2002).  Furthermore, demonstrated that 
HSP27 protected cells against oxidative stress (Rogalla et al., 1999).   
HSP27 can also protect against oxidative stress by the nonspecific chaperone-like activity 
that prevents aggregation of partially denatured proteins by their renaturation or 
proteasome-dependent degradation. 
4.1.5 HSP27 and ER stress 
HSP27 was reported to be induced as a result of ER stress (Ito et al., 2005).  There are 
several conditions that lead to disturbance in ER homeostasis for example, protein 
misfolding, changes in calcium intracellular levels and oxidative stress, evolve an ER 
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stress response in order to cope with the protein load in the organelle (Zhang and Kaufman, 
2004).  The ER has evolved highly specific signalling pathways that causes a general 
attenuation of translation, a transcriptional activation of chaperones, and the ER associated 
degradation (ERAD) of misfolded proteins by the proteasome; this response is named 
unfolded protein response (UPR) (Kaufman, 2002).  HSP27 is involved in proteasome-
apoptotic pathway in vitro and in vivo by binding to polyubiquitin chains and to the 26S 
proteasome (Parcellier et al., 2003).  The ubiquitin-proteasome pathway is involved in the 
activation of transcription factor (NF-B) by degrading its inhibitor (I-Bα). 
Overexpression of HSP27 increases NF-B nuclear rearrangement, the degradation of 
phosphorylated I-Bα was dependent on the interaction of HSP27 with the 26S proteasome 
(Parcellier et al., 2003).  It was shown (Kato et al., 2002) that P-HSP27 and αB-crystallin 
are recruited to protein aggresomes in muscle atrophy.  This finding is suggested to be the 
ability of HSP27 to bind to ubiquitin (Parcellier et al., 2005). 
4.1.6 HSP27 and Disease 
HSP27 has a role in human pathogenesis (Figure 4-2) for example; HSP27 expression 
levels are increased in many cancer cells and their expression contributes to the malignant 
properties of cancer cells such as increased tumorigenicity and treatment resistance, and 
inhibition of apoptosis (Calderwood et al., 2006, Wyttenbach et al., 2002, Kostenko and 
Moens, 2009).  HSP27 expression associated with pathogenesis of neurodegenerative 
disorders, inherited peripheral neuropathy and cardiovascular disease (Ferns et al., 2006, 
Welsh and Gaestel, 1998, Houlden et al., 2008).  HSP27 also has been localized to the 
extra-cellular compartment (Calderwood et al., 2007a).  In animal studies enhanced HSP27 
phosphorylation is associated with nephrotic syndrome and diabetic nephropathy (Smoyer 
et al., 1996, Park et al., 2008).  Animal studies showed that HSP27 also play an important 
role in prevention of pulmonary oedema and viral infection (Liu et al., 2009, Singh et al., 
2007). 
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Figure 4-2: P-HSP27 functions and its possible implication in diseases. HSP27 may be 
present in un-phosphorylated and phosphorylated forms depending on the cellular stress 
conditions. The central part is referred to the normal function of HSP27 and P-HSP27 (pink). 
The outer part is referred to the pathogenic conditions (blue) adapted from (Henderson and 
Pockley, 2012). 
4.1.7 HSP27 as a therapeutic agent 
HSP27 regulates multiple processes in cells and therefore, it may be a potentially important 
therapeutic target.  For example, atovastin which modulates HSP27 phosphorylation can be 
potentially useful in the case of ischemic heart disease (Brundel et al., 2008).  Electro-
injection of HSP27 in retinal ganglion cells protects them from apoptosis and can be a 
treatment agent of some neurodegenerative disorders (O’Reilly et al., 2010).  HSP27 
probably can protect hepatocytes against liver IR injury (Ye et al., 2011).  HSP27 affects 
many different processes and uncontrolled increase in HSP27 expression correlates with 
increased resistance to anticancer drugs. 
 
4.2 Results  
4.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
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4.2.2 Analysis of protein and mRNA HSP27 expression in normal 
pregnancy  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
protein expressions of HSP27 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
First the non-labour group was compared.  Examples of Western blots showing HSP27 
protein expressions for the non-labour are shown in (Figure 4-3).  The graphs and 
statistical analysis are shown below the blots. Comparison between zones was performed 
using Friedman test analysis.  There was a significant difference in protein expression of 
HSP27 between the three zones of the non-labour group and the labour group (p=0.04 for 
both).  The sub-analysis showed that there was a significant decrease in HSP27 expression 
in inner zone compared to the middle zone for non-labour group (p=0.02). 
 
 
Figure 4-3: Representative images of Western blots showing HSP27 protein expressions in 
inner, middle and outer zones of individual placentas of non-labour group (A) and labour 
group (B). Four quadrants were sampled in each zone. Graphs show the median for HSP27 
protein expressions. Comparison between zones was performed using Friedman analysis.  
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Experiment 2: This experiment was designed to test if there was any difference in protein 
expression of HSP27 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Western blots showing placental protein expression of HSP27 in the 
non-labour and the labour at the inner, middle and outer zones are shown in (Figure 4-4). 
The graphs and statistical analysis are shown below the blots.  There was a significant 
decrease in HSP27 expression in the labour group when compared to the non-labour group 
at the middle zone (p=0.002).  There was no significant difference in HSP27 expression in 
the non-labour group when compared to the labour group at the inner and outer zones 
(p=0.93, p=0.69 respectively). 
 
 
Figure 4-4: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in non-labour and labour (n=6 in each group). The 
graphs show the box and whiskers analysis of the blots. Comparison between zones was 
performed using Mann-Whitney analysis. NLG non-labour group, LG labour group. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HSP27 within individual placentas at different zones (inner, middle and 
outer) in either labour or non-labour.  No spatial differences were found within placentas at 
the mRNA level in non-labour group and labour group (p=0.74, p=0.95).  (Figure 4-5) 
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shows the HSP27 RQ values in the inner, middle and outer zones for non-labour (A) and 
labour (B). 
 
 
Figure 4-5: RQ values for HSP27 mRNA measurements in in inner (n=4), middle (n=4) and 
outer zones (n=4) of individual placentas (non-labour and labour groups). Four quadrants 
were sampled in each zone. Graphs show the median for HSP70 mRNA expressions. 
Comparison between zones was performed using Friedman analysis. 
 
Experiment 4: This experiment was designed to test if there were any differences in mRNA 
expression of HSP27 in the non-labour compared to the labour group at the inner, middle 
and outer zones.  (Figure 4-6) shows the HSP27 RQ values in the non-labour compared to 
the labour group at the inner (A), middle (B) and outer zones (C).  There was a significant 
decrease in mRNA expression of HSP27 in the labour group compared to the non-labour 
group at the inner and middle zones (p=0.02, p=0.008 respectively).  No difference was 
found at the outer zone (p=0.1). 
 
200 
 
Figure 4-6: RQ values for HSP27 mRNA measurements in non-labour (n=6) compared to the 
labour group (n=6) at the inner, middle and outer placental zones. Comparison between 
zones was performed using Mann-Whitney analysis. 
4.2.3 Analysis of protein and mRNA expression of HSP27 in 
pregnancy complicated with PE. 
Experiment 1: This experiment was designed to test if there was any difference in protein 
expression of HSP27 between non-labour control and non-labour PE groups at the inner, 
middle and outer zones of placentas.  Western blots showing placental HSP27 protein 
expression in the non-labour control and the non-labour PE at the inner, middle and outer 
zones are shown in (Figure 4-7).  The graphs and statistical analysis are shown below the 
blots.  There was no significant difference in HSP27 expression in the non-labour control 
group when compared to the non-labour PE group at the inner, middle and outer zones 
(p=0.16, p=0.60, p=0.43 respectively). 
 
Figure 4-7: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in non-labour control (n=6) and non-labour PE 
(n=3). The graphs show the box and whiskers analysis of the blots. Comparison between 
zones was performed using Mann-Whitney analysis. NLG-C non-labour control group, NLG-
PE non-labour PE group. 
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Experiment 2: This experiment was designed to test if there was any difference in HSP27 
expression between labour control and labour PE groups at the inner, middle and outer 
zones of placentas.  Western blots showing placental HSP27 protein expression in the 
labour control and the labour PE at the inner, middle and outer zones are shown in (Figure 
4-8).  The graphs and statistical analysis are shown below the blots.  There was a 
significant decrease in HSP27 expression in labour control compared to the labour PE at 
the middle and outer zones (p=0.01, p=0.04 respectively).  No difference was found in 
HSP27 expression at the inner zone (p=0.9). 
 
 
Figure 4-8: Representative images of Western blots showing HSP27 expressions in the 
inner, middle and outer placental zones in labour control and labour PE groups (n=6 for 
each group). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. LG-C labour control group, 
LG-PE labour PE group. 
 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HSP27 in the non-labour control compared to the non-labour PE group at the 
inner, middle and outer placental zones.  (Figure 4-10) shows the HSP27 RQ values in the 
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non-labour control compared to the non-labour PE group at the inner (A), middle (B) and 
outer (C) zones.  There was no significant difference in HSP27 mRNA in the non-labour 
control group compared to the non-labour PE at the inner, middle and outer zones (p=0.9, 
p=0.4, p=0.71 respectively). 
 
 
Figure 4-9: RQ values for HSP27 mRNA measurements in inner, middle and outer placental 
zones for the non-labour control group (n=6) compared with non-labour PE groups (n=4). 
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSP27 between labour control and labour PE groups at the inner, middle 
and outer zones of placentas.  (Figure 4-11) shows the HSP27 RQ values in the labour 
control compared to the labour PE group at the inner (A), middle (B) and outer (C) zones. 
Comparison between zones was performed using Mann Whitney test analysis.  There was 
no significant difference in mRNA expression of HSP27 in the labour control group 
compared to the labour PE group in the inner, middle and outer placental zones (p=0.5, 
p=0.3,p=0.30 respectively). 
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Figure 4-10: RQ values for HSP27 mRNA measurements in inner, middle and outer placental 
zones for labour control group (n=6) compared with labour PE groups (n=6). Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Experiment 5: This experiment was designed to test if there was any difference in mRNA 
expressions of HSP27 between normotensive pregnancies and pregnancies complicated 
with PE regardless the labour factor at the inner, middle and outer zones of placentas.  
(Figure 4-12) shows the HSP27 RQ values in the labour control compared to the labour PE 
group at the inner (A), middle (B) and outer (C) zones.  Comparison between zones was 
performed using Mann Whitney test analysis.  There was no significant difference in 
mRNA expression of HSP27 when the normotensive pregnancies group compared to the 
pregnancies complicated with PE group in the inner, middle and outer (p=0.9, p=0.72, 
p=0.72 respectively).  
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Figure 4-11: RQ values for HSP27 mRNA measurements in normotensive pregnancies group 
(n=12) compared to the pregnancies complicated with PE group (n=9) at the inner, middle 
and outer placental zones. Comparison between zones was performed using Mann-Whitney 
analysis. 
 
4.2.4 Analysis of protein and mRNA expression of HSP27 in 
pregnancies complicated with FGR. 
Experiment 1: This experiment was designed to test if there was any difference in HSP27 
expressions between labour control and labour FGR groups at the inner or outer zones of 
placentas.  Due to time constraints only one set of experiments was performed for labour 
groups and in the inner and outer zones only.  The aim was to determine whether pilot data 
from this group of experiments revealed any data suggesting that more experiments were 
warranted.  Western blots showing placental HSP27 expression at the inner zone (upper 
panel) and placental HSP27 expression at the outer zone (lower panel) in labour control 
and labour FGR are shown in (Figure 4-13).  The graphs and statistical analysis are shown 
below the blots.  There was no significant difference in the HSP27 protein expression 
between the labour control and labour FGR groups at the inner or outer zones (p=0.09, 
p=0.81 respectively). 
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Figure 4-12: Representative images of Western blots showing HSP27 expression at the 
inner zone (upper panel) and the outer zone (lower panel) in labour control (n=6) and labour 
FGR group (n=6). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. LG-C labour group control, 
LG-FGR labour group fetal growth restriction.  
 
Experiment 2: This experiment was tested whether there was any difference between 
labour control and labour FGR of mRNA expression of HSP27 at the inner or outer zones. 
The results are shown in (Figure 4-14).  There was a significant decrease in HSP27 mRNA 
expression in the labour control compared to the labour FGR groups at the inner and the 
outer zones (p=0.008, p=0.02 respectively). 
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Figure 4-13: RQ values for HSP27 mRNA measurements in inner and outer placental zones 
for labour control compared with labour FGR groups. Comparison between zones was 
performed using Mann-Whitney analysis. 
 
4.2.5 Analysis of protein expression of P-HSP27 at ser 15, 78 and 
82 in normal pregnancies and pregnancies complicated with 
PE. 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
expression of P-HSP27 at ser 15, 78 and 82 within individual placentas obtained from 
women who were not in labour.  Examples of Western blots showing P-HSP27 at ser (15, 
87 and 82) expression for 2 different placentas (all non-labour) are shown in (Figures 4-15) 
(Figures 4-16) (Figures 4-17).  The graphs and statistical analysis are shown below the 
blots. Friedman test analysis showed there was no significant difference in expression of P-
HSP27 at ser 15 (p=0.4, p=0.06), ser 78 (p=0.65, p=0.27) and ser 82 (p=0.65, p=0.27) 
between the three zones (inner, middle, outer) within individual placentas for the non-
labour group. 
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Figure 4-14: Representative images of Western blots showing P-HSP27 ser 15 expression in 
inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 15 expressions. Comparison between zones was performed using Friedman 
analysis. 
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Figure 4-15: Representative images of Western blots showing P-HSP27 ser 78 expression in 
inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 78 expressions. Comparison between zones was performed using Friedman 
analysis. 
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Figure 4-16: Representative images of Western blots showing P-HSP27 ser 82 expression in 
inner, middle and outer zones of two individual placentas (non-labour group). Four 
quadrants were sampled in each zone. Graphs show median and interquartile range for P-
HSP27 ser 82 expression. Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2: This experiment was designed to test if there was a spatial difference in 
expression of P-HSP27 at ser 15, ser 78 and ser 82 within individual placentas obtained 
from women who were in labour.  Examples of Western blots showing P-HSP27 at ser (15, 
87 and 82) expression for 2 different placentas (all labour) are shown in (Figure 4-18) 
(Figure 4-19) (Figure 4-20).  The graphs and statistical analysis are shown below the blots. 
Friedman test analysis showed there was no significant difference in expression of P-
HSP27 at ser 15 (p=0.43, p=0.39), ser 78 (p=0.27) and ser 82 (p=0.65) between the three 
zones (inner, middle, outer) within individual placentas for the labour group. 
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Figure 4-17: Representative images of Western blots showing P-HSP27 ser 15 expression in 
inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 15 
expression. Comparison between zones was performed using Friedman analysis. 
  
211 
 
 
Figure 4-18: Representative images of Western blots showing P-HSP27 ser 78 expression in 
inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 78 
expression. Comparison between zones was performed using Friedman analysis. 
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Figure 4-19: Representative images of Western blots showing P-HSP27 ser 82 expression in 
inner, middle and outer zones of two individual placentas (labour group). Four quadrants 
were sampled in each zone. Graphs show median and interquartile range for P-HSP27 ser 82 
expression. Comparison between zones was performed using Friedman analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in P-
HSP27 at ser 15, ser 78 and ser 82 expressions between non-labour and labour groups at 
the inner, middle and outer zones of placentas.  Western blots showing placental P-HSP27 
at ser 15 (upper panel), ser 78 (middle panel) and ser 82 (lower panel) expression in non-
labour and labour at the inner site are shown in (Figure 4-21).  The graphs and statistical 
analysis are shown below the blots.  There was a significant decrease in P-HSP27 
expression in the labour group when compared to the non-labour group at the inner zone 
for all P-HSP27 at ser 15, ser 78 and ser 82 (p=0.008, p=0.01, p=0.05 respectively). 
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Figure 4-20: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the inner placental zone 
in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group. 
  
Western blots showing placental P-HSP27 at ser 15 (upper panel), ser 78 (middle panel) 
and ser 82 (lower panel) expression in non-labour and labour at the middle zone are shown 
in (Figure 4-22).  The graphs and statistical analysis are shown below the blots.  There was 
no significant difference in P-HSP27 expression at the middle zone for all P-HSP27 at ser 
15, 78 and 82 (p=0.13, p=0.30, p=0.69 respectively). 
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Figure 4-21: Representative images of Western blots showing P-HSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the middle placental 
zone in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group. 
Western blots showing placental P-HSP27 at ser 15 (upper panel), ser 78 (middle panel) 
and ser 82 (lower panel) expression in non-labour and labour at the outer zone are shown 
in (Figure 4-23).  The graphs and statistical analysis are shown below the blots.  There was 
a highly significant decrease in P-HSP27 expression in the labour group when compared to 
the non-labour group at the outer zone for P-HSP27 at ser 15 and ser 78 (p=0.004, 
p=0.002respectively).  There was no significant difference in P-HSP27 at ser 82 at the 
outer zone (p=0.09). 
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Figure 4-22: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the outer placental zone 
in non-labour and labour (n=6 in each group). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. NLG non-labour group, LG labour group.  
Experiment 4: This experiment was designed to test if there was any difference in P-
HSP27 at ser 15, 78 and 82 expressions between labour control and labour PE groups at 
the inner or middle zones of placentas.  Due to time constraint only labour group was 
compared.  Western blots showing placental P-HSP27 at ser 15 (upper panel), ser 78 
(middle panel) and ser 82 (lower panel) expression in the labour control and the labour PE 
at the inner zone are shown in (Figure 4-24).  The graphs and statistical analysis are shown 
below the blots.  There was a highly significant decrease in P-HSP 27 at ser 78 and ser 82 
expression in the labour control group compared to the labour PE group at the inner zone 
(p=0.03, p=0.002 respectively).  There was no significant difference in the P-HSP27 at ser 
15 expression between the labour control group and the labour PE group at the inner zone 
(p=0.13). 
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Figure 4-23: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the inner placental zone 
in labour control (n=6) and labour PE group (n=7). The graphs show the box and whiskers 
analysis of the blots. Comparison between zones was performed using Mann-Whitney 
analysis. LG-C labour group control, LG-PE labour group pre-eclampsia.  
  
Western blots showing placental P-HSP27 at ser 15 (upper panel), ser 78 (middle panel) 
and ser 82 (lower panel) expression in the labour control and the labour PE at the middle 
zone are shown in (Figure 4-25).  The graphs and statistical analysis are shown below the 
blots.  There was a significant decrease in P-HSP 27 at ser 15 in the labour control group 
compared to the labour PE group at the middle zone (p=0.04).  There was no significant 
difference in the P-HSP27 at ser 78 and ser 82 expression between the labour control and 
the labour PE groups at the middle zone (p=0.83, p=0.13 respectively). 
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Figure 4-24: Representative images of Western blots showing PHSP27 at ser 15 (upper 
panel), ser 78 (middle panel) and ser 82 (lower panel) expression in the middle placental 
zone in labour control (n=6) and labour PE group (n=7). The graphs show the box and 
whiskers analysis of the blots. Comparison between zones was performed using Mann-
Whitney analysis. LG-C labour group control, LG-PE labour group pre-eclampsia.  
 
4.2.6 Results summary  
4.2.6.1 Summary results for HSP27 expression in normal pregnancy: 
Experiment 1: Within individual placentas there was a significant difference in protein 
expression of HSP27 between the three zones of the non-labour group and the labour group 
(p=0.04 for both).  The sub-analysis showed that there was a significant decrease in HSP27 
expression in inner zones compared to the middle zone for the non-labour (p=0.02). 
Experiment 2: There was a significant decrease in HSP27 expression in the labour group 
when compared to the non-labour group at the middle zone (p=0.002).  No other 
differences were found when comparing labour with non-labour groups at the inner and 
outer zones. 
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Experiment 3: Within individual placentas no differences in mRNA expression for HSP27 
were found either in the labour or non-labour groups. 
Experiment 4: There was a significant decrease in mRNA expression of HSP27 in the 
labour group compared to the non-labour group at the inner and middle zones (p=0.02, 
p=0.008 respectively). No difference was found at the outer zone. 
4.2.6.2 Summary results for HSP27 expression in pregnancy complicated 
with PE 
Experiment 1: When the PE groups (non-labour) were compared with the control groups 
(non-labour) for protein expression of HSP27 at the inner, middle and outer zones the 
changes found can be summarized as follows: There was no significant difference in 
HSP27 expression in the non-labour control group when compared to the non-labour PE 
group at the inner, middle and outer zones. 
Experiment 2: When the PE groups (labour) were compared with the control groups 
(labour) for protein expression of HSP27 at the inner, middle and outer zones the changes 
found can be summarized as follows: There was a significant decrease in HSP27 
expression in labour control compared to the labour PE at the middle and outer zones 
(p=0.01, p=0.04 respectively).  No difference was found in HSP27 expression at the inner 
zone. 
Experiment 3: There was no significant difference in HSP27 mRNA in the non-labour 
control group compared to the non-labour PE at the inner, middle and outer zones.  
Experiment 4: There was no significant difference in mRNA expression of HSP27 in the 
labour control group compared to the labour PE group in the inner, middle and outer 
placental zones.  
Experiment 5: When non-labour and labour was combined, there was no significant 
difference in mRNA expression of HSP27 when the normotensive pregnancies group 
compared to the pregnancies complicated with PE group in the inner, middle and outer 
zones. 
4.2.6.3 Summary of HSP27 expression in FGR group 
Experiment 1: There was no significant difference in the HSP27 protein expression 
between the labour control and labour FGR groups at the inner or outer zones. 
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Experiment 2: There was a significant decrease in mRNA expression of HSP27 in the 
labour control compared to the labour FGR groups at the inner and the outer zones 
(p=0.008, p=0.02 respectively).  
4.2.6.4 Summary of results for P-HSP27 at ser 15, ser 87 and ser 82 
Experiment 1: There was no significant difference in expression of P-HSP27 at ser 15, ser 
78 and ser 82 between the three zones within individual placentas in the non-labour group.  
Experiment 2: There was no significant difference in expression of P-HSP27 at ser 15, ser 
78 and ser 82 between the three zones within individual placentas in the labour group.  
Experiment 3: There was a significant decrease in P-HSP27 expression in the labour group 
when compared to the non-labour group at the inner zone for all P-HSP27 at ser 15, 78 and 
82 (p=0.008, p=0.01, p=0.05 respectively).  There was no significant difference in P-
HSP27 expression at the middle zone. There was a highly significant decrease in P-HSP27 
expression in the labour group when compared to the non-labour group at the outer zone 
for P-HSP27 at serine 15 and ser 78 (p=0.004, p=0.002 respectively).  There was no 
significant difference in P-HSP27 at serine 82 at the outer zone (p=0.09). 
Experiment 4: There was a highly significant decrease in P-HSP 27 at ser 78 and ser 82 
expression in the labour control group compared to the labour PE group at the inner zone 
(p=0.03, p=0.002 respectively).  There was no significant difference in the P-HSP27 at ser 
15 expression between the labour control group and the labour PE group at the inner zone 
(p=0.13).  There was a significant decrease in P-HSP 27 at ser 15 in the labour control 
group compared to the labour PE group at the middle zone (p=0.04).  There was no 
significant difference in the P-HSP27 at ser 78 and ser 82 expressions between the labour 
control and the labour PE groups at the middle zone. 
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4.3 Discussion  
4.3.1 HSP27 and present findings 
This study shows for the first time that HSP27 is expressed in a spatial manner in the 
placenta with the highest expression being in the middle zone in both labour and non-
labour groups.  It therefore shows the importance of using a systematic method to sample 
the placenta.  Most previous reports of placental protein expression do not take this into 
account.  Taking a single or a few samples or averaging protein expression of several 
samples may well mask possible changes in expression.  The study also shows that HSP27 
protein and mRNA are reduced in the labour group compared to non-labour group at 
defined zones (inner for mRNA and middle for protein expression).  In PE patients there 
was a significant decrease in HSP27 expression in labour control compared to the labour 
PE at the middle and outer zones.  In addition, there was a significant decrease in mRNA 
expression of HSP27 in the labour control compared to the labour FGR groups at the inner 
and the outer zones.  Apart from the reported changes and their link to placental pathology 
the results have important implications for how results in placental disease (and perhaps 
other organs) can be influenced by sampling methods. 
4.3.2 P-HSP27 and present finding 
HSP27 can be phosphorylated at ser 15, 78 and 82 by MAPKAPK-2 and 3 (Garrido et al., 
2012).  
 
Phosphorylation favours small oligomers to form whereas de-phosphorylation 
favours formation of large oligomer (Garrido et al., 2012).
 
 Small and large forms may 
have different functions for example, larger forms are important in chaperone and anti-
oxidant roles whereas smaller forms are important in actin regulation (Garrido et al., 2012). 
The HSP 27 gene contains two functional HSE binding sites, a cAMP response element as 
well as HSF-1 and 2 binding sites (Garrido et al., 2012).  This study aims to understand 
whether any changes in of P-HSP27 occurs at defined zones during labour or PE. 
4.3.2.1 HSP27 expression in labour 
The key finding of this study was the fall in both HSP27 mRNA and protein at the inner 
and middle zones of the placenta during labour and which was particularly striking in the 
middle zone.  Many HSPs are increased to protect against stress in disease states (Garrido 
et al., 2012) however in the present study HSP27 was reduced.  One reason for this may be 
that a fall in HSP27 may be necessary to facilitate the inflammatory steps of labour which 
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is, after all, a normal physiological process, not a disease. HSP27 protects against 
apoptosis, decreases oxidative stress, reduces the pro-inflammatory cytokine balance, 
stabilizes actin, and inhibits NFB activation (Garrido et al., 2012) but during labour the 
opposite effect of these events needs to occur. 
Previous publications of HSP27 expression in the placenta are few.  The major point we 
wish to highlight is that controlled sampling and the confounding effects of labour have not 
been considered (Abdulsid et al., 2013a).  These studies can be summarized as follows.  
One study examined the expression of HSP27 in placenta in labour and non-labour 
(Cindrova-Davies et al., 2007b).  No significant differences were found however a 
different approach was taken: since different regions of the placenta were not compared, it 
is impossible to directly compare the present study with that one. 
In another study HSP27 was reported to be unaltered in the placenta in samples from 
labour and non-labour.  However only one biopsy was taken from each placenta and no 
quantification analysis was performed or presented (Li et al., 1996). 
Shah et al showed that HSP27 was detected in intermediate trophoblast and 
syncytotrophoblast cells of the first and the second trimester (Shah et al., 1998).  This 
result also in contrast to our finding that showed high protein expression of HSP27 in the 
term placenta. 
Wataba et al  showed that HSP27 and 70 were increased in syncytial knots, avascular villi 
and the presence of thrombus whereas both were reduced in the presence of infarction 
suggesting different stresses evoke different responses in HSPs in the placenta and the 
response may vary depending on the area of the placenta exposed to the stress (Wataba et 
al., 2004). 
Mineva et al  reported that HSP27 was detected exclusively in the STB layer (Mineva et 
al., 2008).  No systemic sampling was performed and labour was not studied. 
Matalon et al examined HSP27 distribution in the first trimester by using  a human 
trophoblast explant model (Matalon et al., 2008).  This study showed that during the 
culture period trophoblast cells express HSP27 which varied according to their stage of 
differentiation: migratory cells express HSP27 in the cell cytoplasm; non-proliferating 
villous-trophoblast cells express HSP27 in the nucleus and cytoplasm and proliferating 
villous cell did not express HSP27.  This study suggested that HSP27 expression in 
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trophoblast is modulated in concordance with migration dependent parameters. 
Furthermore, 6-mercaptopurine (inhibitor of EVT migration) decreased HSP27 nuclear 
expression and that was associated with decreased MMP2 activity, NO production and 
decreased inducible (iNOS) expression (Matalon et al., 2008). 
Our group has previously examined the expression of HSP70 in the placenta (Abdulsid et 
al., 2013b).  In non-labour HSP70 was reduced in the outer zone of the placenta compared 
with the middle area.  In contrast in the present study HSP27 was reduced in the inner zone 
compared with the middle zone.  With regard to labour our previous study showed that 
HSP70 was increased in the inner and middle areas, the same findings for HSP27.  At this 
stage it is only possible to speculate why such zonal differences exist but may relate to the 
functions of HSP27 and 70, some of which differ and some overlap (Wataba et al., 2004, 
Concannon et al., 2003, Borges et al., 2012).  Placental separation is an important part of 
labour. Herman et al (Herman et al., 2002) showed that the process of placental separation 
from the uterine wall can be divided into three distinct phases i.e. latent, 
contraction/detachment and expulsion.  They showed that placental separation is 
accomplished by means of an orderly multiphasic process with a definite direction and 
sequence.  They found in most cases the placenta separated from the uterine wall in a 
“down-up” separation i.e. initiating from the lower pole.  Interestingly cases with a 
previous Cesarean section had a higher rate of up-down separation.  In contrast in the case 
of “fundal placentae” separation started at the placental poles (bipolar separation) and the 
central area of the placenta was the last to separate.  It would be therefore of interest in a 
future study to investigate whether there was a link between the zonal distribution of 
HSP27 or HSP70 and the method of placental separation. 
Placentas collected at term by caesarean section are not subjected to the stress of labour 
however one possibility is that zonal differences in HSPs might reflect the fact that labour 
is not far off and that the molecular steps to allow labour to precede have started.  Thus it 
would be interesting to compare placentas from the second trimester where labour is not 
close to determine if such zonal differences still exist.  In contrast at labour zonal 
differences in HSPs may be linked to the response to the stress of labour, extent of 
exposure to hypoxia or may contribute to the process that allows the placenta to separate at 
delivery. 
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It has been shown that HSP27 regulates apoptosis through key components of the apoptotic 
signaling pathway, in particular, those involved in caspase activation and apoptosis 
(Concannon et al., 2003).  HSP70 can also inhibit CASP3 and 9 (Borges et al., 2012). 
HSP70, via the TLR-2 receptor, can increase IL-10 production; IL-10 can be pro-
inflammatory at labour which may accelerate parturition (Gibb WL, 2006).  This may also 
explain why HSP70 increases at labour when HSP27 decreases.  Of interest is the 
observation that reduced MMP2 activity has been shown to be linked to reduced HSP27 
(Matalon et al., 2008).  Whether this is linked to the zonal distribution requires further 
investigation.  The expression of HSP27 was also reported to be reduced in placentae from 
SGA neonates although zonal distribution was not investigated (Cañete et al., 2011). 
In summary HSP27 is expressed in a spatial manner in the human placenta and changes in 
expression occur during labour suggest that HSP27 may be part of the signaling process of 
labour and thus warrants further investigation particularly with regard to a role in pre-term 
labour. 
4.3.3 P-HSP27 (ser 15, 78 and 82) in labour and PE 
HSP27 is a stress induced chaperone molecule known to regulate cytoskeletal stability, 
protein folding, cellular stress, and prevention of apoptosis in different cells (Bolhuis and 
Richter‐Landsberg, 2010).  Cellular functions of HSP27 are controlled by phosphorylation 
of HSP27 at three ser sites (Ghayour-Mobarhan et al., 2012). 
When P-HSP27 was assessed in this study the findings showed that there was no spatial 
distribution for P-HSP27 of either ser sites (ser 15, 78 and 82) in both the non-labour and 
the labour groups despite of the clear spatial distribution in protein expression of HSP27, 
which increased especially in the middle zone within individual placentas.  Whether the 
observation that phosphorylation changes were not noted reflects something about the 
function of HSP27 in the placenta remains to be elucidated. 
Similar to the HSP27 protein expression there was increased expression of P-HSP27 at the 
three ser sites (15, 78 and 82) in the non-labour group compared to the labour but in 
contrast to HSP27 findings where the highest expression was in the middle zone, in P-
HSP27 the expression was much higher in the inner and the outer placenta zones.  The 
explanation for less P-HSP27 in labour group but may perhaps allow labour to progress 
and the placenta to detach as repair mechanisms are now reduced.  Again these findings 
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further emphasize that without careful sampling methods differences between study 
samples can be missed. 
For the PE group and due to time constrain, only the labour group was investigated.  The 
P-HSP27 was a significant increased in the labour PE group compared to the labour control 
at the inner for (ser 78 and 82) and the middle for (ser15) zones.  As PE is associated with 
a high level of apoptosis, these results may be explained as increased level of P-HSP27 is a 
defence mechanism to protect cells from oxidative stress and apoptosis that over-rules the 
effects observed in labour alone.  Overall protein expression of HSP27 was increased in 
the labour PE group compared to normotensive women but at the middle and outer zones.  
Again a zonal variation is an important factor and highlighted the urgent need for 
optimization of placental sampling methods. 
Shin et al  showed that P-HSP27 was increase in PE placentas compared to the control 
(Shin et al., 2009).  They obtained 5 tissue pieces from the feto-maternal interface but there 
was no clear systemic sampling was performed and labour was not controlled for. 
We found an increase in phosphorylation at the ser 15 site that matched the increase in 
protein expression in the PE labour group compared with the control labour group at the 
middle zone.  Since phosphorylation favours small oligomers, meaning there are fewer 
larger oligomers that play anti-oxidant roles, and since PE is associated with fewer anti-
oxidants, the reduction in large oligomers may contribute to a more pro-inflammatory state 
in the PE placenta. 
Small HSPs have been studied in myometrium during labour.  The myometrium undergoes 
substantial remodeling at the time of labour including rearrangement of the cellular 
contractile machinery.  Since HSP27 can modulate actin polymerisation one study 
investigated changes in small HSPs in the myometrium at labour (MacIntyre et al., 2008).
 
A 69% decrease in the small HSP αB-crystalline was found in the myometrium at labour 
plus multiple isoforms of HSP27.  In addition, immunoblotting using phosphor-specific 
HSP27 antibodies (P-HSP27 at ser15, 78, and 82) detected marked changes in HSP27 
phosphorylation at labour.  P-HSP27 ser15 was 3.0-fold higher in labouring myometrium. 
In contrast, levels of HSP27 ser 82 were 85% less in labouring myometrium.  There was no 
significant change in HSP27 ser 78.  It was proposed that decreased expression of αB-
crystallin at the time of labour liberates HSP27 enabling it to participate in other cellular 
events such as cytoskeletal remodeling.  Clearly the functions and structure of the 
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myometrium and placenta are different, however since both play a role in labour we 
carried out experiments investigate the expression of αB-crystallin within the placenta 
during labour (chapter V).  Also that particular study highlights how different changes in 
HSP27 can occur depending on the cellular event to be targeted. 
These finding showed a little conflict but although the spatial manner of HSP27 was not 
the same, the high expression was in similar way especially increased expression in non-
labour compared to the labour and also decreased expression in labour control compared to 
the PE.  Future studies will be undertaken to determine whether any other know post-
translational changes occurs in these samples.  Placenta zones distribution also showed a 
little difference this is not clear and further studies include immunohistochemistry will help 
to understand this variation. 
To our knowledge this is the first study to show a decrease in p-HSP27 associated with an 
increase in placental apoptosis during labour.  This study suggests a role for P-HSP27 in 
placental trophoblast apoptosis during labour and PE pregnancies. However, we chose to 
study p-HSP27 for two reasons.  First, because P-HSP27 is involved in the control of 
apoptosis and is expressed in trophoblast cells, second as labour and PE are pro-
inflammatory conditions and is characterized by high level of apoptosis. 
In view of the findings of this study future studies will be directed to understand whether 
any changes in phosphorylation of HSP27 or MAPKAPK-2 or 3 occurs at defined zones 
during labour. 
4.3.4 HSP27 expression in PE and FGR 
This study shows that HSP27 protein expression is increased in placentae from women 
with PE who were in labour when compared to women who were in labour but did not 
have pregnancies complicated by PE.  Furthermore this increase in HSP27 protein was 
only seen at the middle and outer zones (Abdulsid and Lyall, 2014).  It also shows the 
importance of using a systematic method to sample the placenta.  The pathological 
significance of this finding remains to be elucidated but oxidative stress is the common 
link between labour and PE. 
The present study was designed to compare pregnancies complicated by PE with 
uncomplicated pregnancies, but to control for labour.  Controlling for labour is important 
because we have shown that placental HSP27 expression is altered during labour (Abdulsid 
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et al., 2013a). We previously reported, for non-labour, significantly less HSP27 protein in 
the inner placenta region compared with both the middle region within an individual 
placenta. For labour there was also less HSP27 protein in the inner region compared with 
the middle region for an individual placenta.  When non-labour was compared with labour 
there was significantly less HSP27 in the labour group at both the middle zone compared 
with the non-labour group.  Similar to HSP27 protein, there was less HSP27 mRNA in the 
labour group in both the middle and the outer zones compared with the non-labour group. 
This study suggested that placental HSP27 might play a role in labour and is spatially 
controlled.  Thus, we were careful to control for this in the present study 
There were no differences noted at the mRNA level however, it is possible that mRNA 
levels had increased then returned to normal some time before the placentae were 
delivered.  The PE patients used in this study had mostly later-onset disease. Some, but not 
all, changes in PE can be different depending on whether the disorder is early- or late-onset 
(Staff et al., 2013).  However, late-onset disease can also be severe PE. It would be of 
interest in future studies to find if this is the case for HSP27, but this study did not have 
sufficient numbers to allow statistical analysis if PE cases were split into two groups 
according to gestation. 
Apoptosis is a component of normal development and differentiation in most tissues, 
however, in the FGR placenta at term increased apoptosis is a common feature (Gorman et 
al., 2005).  HSP27 has been shown to be involved in the control of apoptotic pathways in 
several cells (Aiko et al., 2002, Paul et al., 2002, Gorman et al., 2005). 
There was no significant difference in the protein expression of HSP27; however, there 
was a significant increase in mRNA expression of FGR group compared to the control 
group at both the inner and outer zone.  The reason for this finding is still unknown. 
Whether the increase in mRNA reflects new protein synthesis about to begin can only be 
speculated. 
Geisler et al performed IHC and showed that HSP27 protein expression was twice that in 
placentas from patients with severe PE and FGR compared to the placentas from 
normotensive women (Geisler et al., 2004).  In this study, no systematic sampling was 
performed and labour was not studied.  
Wataba et al  performed IHC and reported that HSP27 protein expression was increase in 
the CTB and STB layer of the FGR placentas at second and third trimester (Wataba et al., 
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2004).  HSP27 was decreased in CTB and STB around infraction regions.  They suggested 
that although the villous cells around the infarction histologically appeared viable, they 
may have received lethal damage, and as a result the expression of HSPs was decreased.  
Systemic sampling method was not performed. 
Webster et al performed Western blots and showed that HSP27 protein expression was up-
regulated in preterm PE placentas compared to term normotensive placentas (Webster et 
al., 2007).  They concluded that HSP27 is a critical stress-induced protein and it may well 
have been up-regulated due to the stressors specific to PE. However, the drawback in this 
study was labour and systematic sampling method also does not taken in account.  
Jin et al performed Western blotting and reported that HSP27 protein expression was up-
regulated in trophoblast of PE placenta compared to control (Jin et al., 2008).  They 
concluded that HSP27 might take part in the regulation of the phased development of PE 
and pathogenesis of PE.  This study was similar to the present findings of protein 
expression but they did not perform RT-PCR.  However, one central placental sample was 
taken and labour was not studied. 
Shin et al  performed Western blotting and IHC to investigate HSP27 and P-HSP27 protein 
expression (Shin et al., 2009).  It was shown that HSP27 protein expression was increased 
in PE placentas compared to the controls.  Immunoprecipitation analysis showed that the 
interaction between HSP27 and MAPK (p38 and ERK) was significantly increased in PE 
placentas.  They concluded that phosphorylation HSP27 might be induced by p38 and ERK 
in PE placentas.  No clear systemic sampling was performed. 
Bahr et al  performed Western blotting and IHC on human and animal placentas (early, 
mid and late gestation) (Bahr et al., 2014).  In this study they reported that human P-
HSP27 expression was reduced in FGR placentas compared to control placentas. Again the 
site of sampling or labour was not assessed.  In the animal study it has been reported that 
HSP27 expression increased in early gestation in the FGR group and this expression was 
significantly increased by near-term as compared to controls (Bahr et al., 2014).  P-HSP27 
was significantly increased at early gestation but paradoxically decreased near term in the 
FGR group compared to the control. IHC showed that P-HSP27 protein is localized to the 
trophoblast cells of the placenta throughout gestation (Bahr et al., 2014).  They concluded 
that decreased P-HSP27 at term is present when placental apoptosis is increased during 
FGR.  This could be a factor leading to the decreased placental weight observed during 
FGR.  
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Chapter V: Analysis of mRNA expression of small 
HSP family in human placenta of normal 
pregnancies and pregnancies complicated with PE 
 
5 Small HSP family (sHSP) 
5.1 Introduction  
5.1.1 Definition  
Small HSPs (sHSPs) are a family of widespread stress proteins, which are found widely in 
nature. The sHSP vary in size from 12 to 30 kDa (Narberhaus, 2002, Franck et al., 2004, 
Haslbeck et al., 2005), and are present in the cytosol of most cells and tissues even in the 
absence of stress factors.  Most of the sHSP have the α-crystallin domain which is 
characterized by the presence of a conserved sequence of about 80–100 residues 
(Kriehuber et al., 2010).  Some members (HSP27, α-crystallin) form large oligomeric 
assemblies ranging from 150 to 800 kDa (Narberhaus, 2002, Haslbeck et al., 2005), 
whereas other sHSP, which include HSPB2, HSPB6 form small oligomeric assemblies. 
HSPB8 exists as monomer or dimer (Chowdary et al., 2004, Bukach et al., 2009, Prabhu et 
al., 2012).  sHSP family structure include the α-crystallin domain consists of a β-sandwich 
comprising two antiparallel β-sheets, followed by a short C-terminal extension and a long 
loop extending from the β-sandwich (van Montfort et al., 2001).  However, other sequence 
characteristics are the less conserved including the N-terminal domain, the variable central 
region, and the variable region of C-terminal tails (Hu et al., 2008).  
The sHSP family form large oligomeric complexes that are in a dynamic equilibrium with 
smaller structures (Orejuela et al., 2007).  These oligomers can either be homo or hetero 
oligomers involving different members of the sHSP family. For example, HSPB1 can 
interact with HSPB8 in a similar manner as the αA-αB-crystallin pair (HSPB4, HSPB5) 
(Sun et al., 2004).  Differential serine phosphorylation plays an important role in the 
function of mammalian sHSPs (Kato et al., 2002).  Chaperone activity of the sHSPs family 
is modulated by the dynamic structural organization of sHSPs into oligomers by post-
translational modification and by other factors like heat shock.  The sHSPs are responsible 
for the binding of misfolded proteins and their further transfer to the ATP-dependent 
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chaperones or to the protein degradation molecules such as proteasomes or 
autophagosomes (Haslbeck et al., 2005).  Unlike other chaperons sHSPs lack ATPase 
domains (Marini et al., 2005).  However, despite the fact that there are high structural 
similarities of the conserved α-crystallin domain of sHSP, the various members of the 
family do not necessarily possess similar functions in vivo.  For example, HSP27 (HSPB1) 
has an anti-apoptotic action (both upstream and downstream) of the apoptosome while 
HSPB8 shows a pro-apoptotic activity in a cell-specific manner (Gober et al., 2003). 
In humans, 10 α-crystallin–related sHSPs have now been named HSPB1–HSPB10 in 
accordance with the guidelines of the National Centre for Biotechnology Information 
(NCBI) (Kappe et al., 2003) (Table 5-1).  The best-known representatives are HSP27 
(HSPB1) (discussed in Chapter 4), αB-crystallin (HSPB5), and HSP20 (HSPB6).  In 
addition, there are other low molecular weight HSPs, like HSP32 which sometimes also 
included as sHSPs but because they lack the α-crystallin domain, they do not belong to this 
family. 
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Table 5-1: α-Crystallin-related small heat-shock proteins (HSPB1–HSPB10) adapted from 
(Hu et al., 2008, Mymrikov et al., 2011).  
HSPB Molecular 
weight 
(kDa) 
Alternative name Heat 
induction  
Tissue location 
HSPB1 27 HSP27 Yes Uterus, skin, platelets, 
myocardium, breast tumours, 
ovarian and endometrium 
carcinoma  
HSPB2 22 MKBP (myotonic 
dystrophy protein 
kinase-binding 
protein) 
No  Cardiac and skeletal muscle 
HSPB3 17/27  No  Cardiac and skeletal muscle 
HSPB4 20 αA-crystalline No Lens 
HSPB5 20 αB-crystalline Yes  Myocardium, vascular wall, 
lens, lung, kidney and head  
HSPB6 20 HSP20 No  Myocardium, liver, lung, 
kidney, brain, neck tumor and 
platelets 
HSPB7 23/25 CvHSP 
(cardiovascular 
heat shock protein) 
? Heart and skeletal muscle 
HSPB8 22-25 HSP22 Cell type 
dependent  
Heart, liver, lung, kidney, brain 
and skeletal 
HSPB9 17.5  ? Testis  
HSPB10 27/85 ODF1 (outer dense 
fiber protein) 
? Testis 
 
5.1.2 HSPB2 (heat shock 27kDa protein 2) 
HSPB2 is a member of the sHSP family and is highly expressed in heart and skeletal 
muscle (Suzuki et al., 1998, Nakagawa et al., 2001, de Thonel et al., 2012).  HSPB2 
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appears to be essential for skeletal muscle development and the maintenance of its 
structure and function (Nakagawa et al., 2001, de Thonel et al., 2012).  HSPB2 activates 
the myotonic dystrophic kinase (DMPK) and protects its kinase activity after a heat 
inducible stress, thereby acting as a molecular chaperone of DMPK (Suzuki et al., 1998).  
HSPB2 activity like other HSPs is regulated by post-translated phosphorylation of its 
serine site by MAP kinase-activated protein kinase (MAPKAPKs), which are activated by 
phosphorylation of p38 MAP kinase (Rouse et al., 1994).  
HSPB2 is present in the cytosol as granules in association with the outer membrane 
components of the mitochondria and protect the cells from stresses such as oxidative stress, 
heat shock, radiation and anti-cancer drugs (Nakagawa et al., 2001, Yoshida et al., 2004, 
Chang et al., 2011).  In a rat model it has been shown (Shama et al., 1999) that HSPB2 
protein expression increased sharply in heart and skeletal muscle following exposure to 
hypoxia-reoxygenation.  In addition, it has been shown (Pinz et al., 2008) that following IR 
injury, HSPB2 protect cardiac energetic properties while HSPB5 protects the diastolic 
contractile performance.  HSPB2 is involved in tumourigenesis which may be related to 
the ability to protect cells against apoptosis (Laskowska, 2006, Calderwood et al., 2006).  
HSPB2 is associated with pathological conditions such as ectopic endometrium of women 
with endometriosis and in patient with myotonic dystrophy (Ota et al., 1997, Sugiyama et 
al., 2000). 
5.1.3 HSPB3 (HSP17/27) 
HSPB3 is expressed in adult smooth muscle, heart, brain and fetal tissues (Boelens et al., 
1998, Asthana et al., 2012).  HSPB3 exhibits a target protein dependent chaperone like 
activity (Asthana et al., 2012).  HSPB3 induced production of IL8, soluble ICAM-1 and 
monocyte chemo-attractant protein 1 by brain astrocytes and leptomeningeal smooth 
muscle cells (Bruinsma et al., 2011).  Mutation R7S located in the N-terminal part of 
HSPB3 is associated with development of axonal motor neuropathy (Kolb et al., 2010). 
 
5.1.4 HSPB4 (CRYAA, αA-crystallin)  
αA-crystallin can induced by heat shock and belongs to the sHSP family (Horwitz, 2000). 
αA-crystallin, a tissue specific structural protein of the ocular lens maintains the 
transparency and refractive index of the lens (Derham and Harding, 1999, Horwitz, 2000).  
It is synthesised in lens differentiating fibres and it extremely stable proteins so it maintain 
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the lens transparently  (Srinivasan et al., 1992). αA-crystallin has chaperone like activity 
(Banerjee et al., 2014).  The two forms of α-crystallin (αA-crystallin and αB-crystallin) 
share 57% sequence homology and have been reported to form multimeric complexes with 
each other at a ratio of 3:1 (Christopher et al., 2014). αA-crystallin can act as a molecular 
chaperones preventing the aggregation of other lens crystallins and proteins that have 
become unfolded by trapping the protein in a high molecular weight complex (Derham and 
Harding, 1999).  αA and αB gene products are differentially expressed; αA is preferentially 
restricted to the lens and αB is expressed widely in multiple tissues including the retina, 
heart, skeletal muscle, kidney and lung (Derham and Harding, 1999, Horwitz, 2000, 
Christopher et al., 2014).  Defects in this gene cause autosomal dominant congenital 
cataract (Litt et al., 1998). In addition, it was shown (Xu et al., 2015) that knockout of αA-
crystallin inhibited pathologic neovascularization through the VEGF and VEGFR2 
signalling pathways.  αAcrystallin mutations are usually accompanied by development of 
different forms of cataract (Moreau and King, 2012).  Furthermore, it was reported that 
αA-crystallins displayed significant protection to oxidative stress induced cell death 
(Christopher et al., 2014). 
5.1.5 HSPB5 (CRYAB, αB-crystallin)  
αB-crystallin (HSPB5) and HSP27 are members of the sHSP family and are characterized 
by a considerable degree of sequence and functional similarity (Mineva et al., 2008, Reddy 
and Reddy, 2015).  HSPB5 is a heat inducible protein (Dubin et al., 1990), and is produced 
in the presence of several types of cellular stress (Bluhm et al., 1998, Muchowski et al., 
1999, Mineva et al., 2008).  HSPB5 can be phosphorylated at ser19, ser45, and ser59, 
which reduces the complex size  (Peschek et al., 2013).  HSPB5 phosphorylation 
influences chaperone activity (Ecroyd et al., 2007, Reddy and Reddy, 2015).  MAPKAPK2 
kinases are responsible for ser59 phosphorylation, p42/p44 MAPK are responsible for 
ser45 phosphorylation and the signalling pathway responsible for phosphorylation of ser19 
is currently unknown (Reddy and Reddy, 2015). 
5.1.5.1 HSPB5 functions 
HSPB5 exert several cellular functions including chaperone activity (Derham and Harding, 
1999, Arrigo et al., 2007, Srinivas et al., 2008), protects cells from stress and inhibits 
apoptosis (Webster, 2003, Kamradt et al., 2005), inhibits inflammation (Arrigo et al., 2007, 
Arac et al., 2011), stabilizes actin filaments and decreases actin de-polymerization (Wang 
and Spector, 1996, Ghosh et al., 2007).  It has also been suggested to have a role in the 
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ubiquitin/proteasome pathway  (den Engelsman et al., 2003).  In addition, HSPB5 is able to 
protect cytoskeletal elements from ischemic injury and aggregation (Mineva et al., 2008).  
Transgenic mice overexpressing HSPB5showed a protective ability against IR injury in the 
heart (Ray et al., 2001). 
HSPB5 is highly expressed in eye lens and protects lens epithelial cells from apoptosis 
triggered by oxidative stress (Kronschläger et al., 2013).  HSPB5 plays an important role in 
preventing cell death. Increased expression of HSPB5 enhances resistance to thermal 
stress, UV light and other stress conditions (Boelens, 2014). 
HSPB5 is the most abundant of the sHSP family in cardiac cells, with expression levels 
varying between 0.1% and 2% of the soluble protein content (Christians et al., 2012).  
Cardiac tissue overexpressing HSPB5 exhibited less tissue damage and preserved 
contractile function when subjected ex vivo to IR injury (Ray et al., 2001).  In addition, 
HSPB5 can suppress pressure overload cardiac hypertrophy (Kumarapeli et al., 2010) 
In humans, HSPB5 is playing critical roles in angiogenesis and autoimmune diseases, and 
expressed highly in breast cancer and Alzheimer disease (Ousman et al., 2007, Link et al., 
2003).  In addition,  HSPB5 mutation can trigger many diseases such as cataract and 
cardiomyopathy (Sacconi et al., 2012). 
5.1.6 HSPB6 (heat shock protein, alpha-crystallin-related B6, 
HSP20) 
HSPB6 (HSP20) was first isolated from rat and skeletal muscle (Kato et al., 1994a). 
HSPB6 belongs to the group of ubiquitously expressed sHSP and its expression does not 
seem to be heat-inducible (Taylor and Benjamin, 2005).  HSPB6 undergoes post-
translational modifications (phosphorylation), and these modifications are might provide 
little change in HSPB6 activity in the cell (Mymrikov et al., 2011).  HSPB6 can be 
phosphorylated at ser16  by a cAMP-dependent protein kinase A  (Dreiza et al., 2010) and 
cGMP dependent protein kinase G (Beall et al., 1997, Woodrum et al., 1999).  All member 
of sHSP family contain the α-crystallin domain and they interact with each other 
(Mchaourab et al., 2009).  HSPB6 interact with β-crystallin, HSP27 and HSPB8 forming 
hetero-oligomeric complexes (Sugiyama et al., 2000, Bukach et al., 2009, Fontaine et al., 
2005). HSPB2/MKBP and HSP20 were shown to bind partially to actin-associated proteins 
(Golenhofen et al., 2004).  In addition, HSPB2/MKBP co-localization with mitochondria 
suggests that it may function as a molecular chaperone, protecting from apoptosis by 
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inhibiting cytochrome c efflux inhibiting the mitochondrial-dependent death pathways  
(Nakagawa et al., 2001). 
5.1.6.1 HSPB6 functions  
HSPB6 participates in regulation of smooth muscle contraction.  This function is 
controlled by phosphorylation of HSPB6 at ser16, which is facilitated by activation of 
nucleotide-dependent protein kinases (cAMP). Phosphorylated HSPB6 correlated with 
relaxation of carotid artery smooth muscle (Beall et al., 1999, Rembold et al., 2000).  
Phosphorylated HSPB6 is also involve in vascular smooth muscle relaxation, which could 
be beneficial if cellular stress in the heart causes vasoconstriction (Flynn et al., 2003). 
Relaxation induced by HSPB6 phosphorylation was not accompanied by de-
phosphorylation of myosin light chains (Rembold et al., 2000).  The exact mechanism of 
HSPB6 action on smooth muscle relaxation and cell motility remains elusive (Mymrikov et 
al., 2011).  
5.1.6.2 HSPB6 chaperone function 
The α-crystallin domain is shared by all members of the sHSP family and is thought to be 
important for their molecular chaperone activity.  It was believed that HSPB6 is a poor 
chaperone than β-crystallin in preventing insulin aggregation (van de Klundert et al., 
1998b).  However,  it was shown that HSPB6 chaperone activity measured with different 
model protein substrates in vitro, was comparable to that of β-crystallin or HSPB8 
(Mymrikov et al., 2010). 
5.1.6.3 HSPB6 and cardio protective role 
HSPB6 play an important role in cardio protection. Phosphorylation of HSPB6 in 
cardiomyocites is induced by isoproterenol (Chu et al., 2004).  Prolonged isoproterenol 
treatment resulting in apoptosis and overexpression of HSPB6 prevented apoptosis induced 
by the isoproterenol (Fan et al., 2004).  It has been shown (Fan et al., 2005b) that HSPB6 
was effective in protection of cardiomyocytes against IR injury.  This kind of injury leads 
to translocation of HSPB6 to actin filaments resulting in its stabilization (Fan et al., 2004).  
Overexpression of HSPB6 leads to a strong anti-apoptotic effect (Fan et al., 2005a) which 
may be due to an increased protein ratio of Bcl-2/Bax and reduced CASP3 activity (Fan et 
al., 2005b).  In addition, HSPB6 activates Akt and thus reduces doxorubicintriggered 
oxidative stress and cardiotoxicity (Fan et al., 2008).  Phosphorylated HSPB6 might be 
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also be involved in regulation of autophagy thus protecting the cell from apoptosis (Qian et 
al., 2009).  HSPB6 also interacts with and inhibits NF-κβ which is responsible for cytokine 
synthesis during sepsis (Wang et al., 2009).  The cardio protective effect of HSPB6 can be 
at least partly due to its chaperone-like activity (Mymrikov et al., 2011). 
5.1.7 HSPB7 (heat shock 27kDa protein family, member 7 
(cardiovascular, cvHSP) 
The expression of most members of the sHSP family is developmentally regulated and 
many can be induced by various forms of stress (Davidson et al., 2002).  The sHSPs are 
involved in a variety of cellular processes, mostly relating to cytoskeletal rearrangements 
and apoptosis (Quinlan, 2002, Arrigo, 2000, Kappé et al., 2003).  HSPB7 was first 
identified and designated as a cardiovascular HSP due to its high expression in the heart 
(Krief et al., 1999).  HSPB7 is characterized by its small molecular mass, approximately 
20kDa, and a highly conserved α-crystallin domain (Augusteyn, 2004, Chiu et al., 2012).  
HSPB7 is localized within the cytosol or is associated with myofibrils in cardiac or skeletal 
muscle cells (Doran et al., 2007).  HSPB7 was linked to sporadic heart failure on genome-
wide association studies (Cappola et al., 2010, Villard et al., 2011).  HSPB7 is a potential 
early biomarker after myocardial infraction and serves as an independent risk factor of 
acute coronary syndrome (Chiu et al., 2012).  In addition, HSPB7 prevented aggregation of 
disease-associated proteins with an expanded polyQ stretch (Vos et al., 2010). 
5.1.8 HSPB8 (heat shock 22kDa protein 8) 
HSPB8 belongs to the sHSP family and is closely related to other members of the family 
especially to HSP27 (Sun et al., 2004).  HSPB8 is heat-inducible (Chowdary et al., 2004). 
HSPB8 interact with HSPB1mimicking the phosphorylation by MAPKAP2 kinase (Rual et 
al., 2005).  HSPB8 can be phosphorylated at ser24 and ser/thr87  (Villén et al., 2007). 
HSPB8 interacts with other sHSP family members such as HSPB6 and αB-crystallin 
(Fontaine et al., 2005). 
5.1.8.1 HSPB8 chaperone function 
Similar to other sHSP family, HSPB8 has chaperone-like activity, more important HSPB8 
is also able to prevent the accumulation of protein aggregates in the cell (Chowdary et al., 
2004, Mymrikov et al., 2011).  Chaperone activity of HSPB8 also prevents formation of 
the aggresomes formed by the R120G mutant of B-crystallin, which correlates with 
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desmin-related cardiomyopathy (Zobel et al., 2003, Sanbe et al., 2007).  Overexpression of 
HSPB8 was accompanied by reduction in amyloid aggregates leading to improved cardiac 
function and survival (Sanbe et al., 2009).  In addition, it was shown  that HSPB8 was 
more effective than HSPB1 in preventing in vivo aggregation of polyglutamine containing 
proteins (Carra et al., 2005).  Furthermore, HSPB8 interacts with amyloid -peptides and 
inhibits the death of cardiovascular cells (Wilhelmus et al., 2006). 
5.1.8.2 HSPB8 and inflammation 
Several HSPs families are involved in stimulation of APC, chaperoning of antigen proteins 
and induces synthesis of certain interleukins, TNF, and NO (Srivastava, 2002).  HSPB8 
and HSPB4 are involved in the activation of APC through a TLR4 dependent mechanism 
(Roelofs et al., 2006).  In addition, it has been shown (Roelofs et al., 2006) that HSPB8 
plays a role in inflammatory process of autoimmune diseases, for example, HSPB8 was 
abundantly expressed in synovial tissues of rheumatoid arthritis patients. 
5.1.8.3 HSPB8 and cardiac protection  
HSPB8 is involved in cell survival as transit ischemia resulted in increased expression of 
HSPB8 (Depre et al., 2001).  In chronic myocardium dysfunction (hibernating 
myocardium) due to coronary artery disease, HSPB8 was upregulated (Depre et al., 2004).  
The molecular mechanisms of HSPB8 action in cardiomyocytes is still not clear; it is 
believed that HSPB8 produces its anti-apoptotic by activation of protein kinase Ak (Danan 
et al., 2007).  In addition, it was shown that HSPB8 also possesses metabolic and survival 
properties that seem to be due to activation of AMP-dependent protein kinase (Danan et 
al., 2007).  It was postulated (Danan et al., 2007) that HSPB8 is able to produce pre-
conditioning and survival effects by activating the ε-isoform of protein kinase C and the 
inducible NO synthase.  Furthermore, it has been reported that these features are efficient 
in protecting myocardium against irreversible damage and may be explained by the direct 
interaction of HSPB8 with AMP-dependent protein kinase and its translocation to 
perinuclear space (Danan et al., 2007). 
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5.2 Results  
5.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
5.2.2 Undetermined sHSPs 
Presence of HSPB3 (heat shock 27kDa protein 3) and HSPB4 (CRYAA, crystallin, alpha 
A) are undetermined in the human placenta.  
5.2.3 HSPB2 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPB2 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis. There was no 
significant difference in HSPB2 mRNA expression between the three zones of the non-
labour and labour groups (p=0.57 for both) (Figure 5-1). 
 
 
Figure 5-1: RQ values for HSPB2 mRNA measurements in in inner (n=4), middle (n=4) and 
outer zones (n=4) of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone.  Graphs show the median for 
HSPB2 mRNA expressions. Comparison between zones was performed using Friedman 
analysis. 
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Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of HSPB2 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was a significant decrease in HSPB2 mRNA expression in the non-labour 
group when compared to the labour group at the outer zone (p=0.02).  No difference was 
found at the inner and middle zones (p=0.13, p=0.06) (Figure 5-2). 
 
Figure 5-2: RQ values for HSPB2 mRNA measurements in non-labour (n=6) compared to the 
labour group (n=6) at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB2 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test.  There was no significant difference in HSPB2 mRNA at the inner and 
middle zones (p=0.16, p=0.26) (Figure 5-3). 
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Figure 5-3: RQ values for HSPB2 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE groups (n=3) at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB2 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis  There was no significant difference in HSPB2 mRNA in the labour control group 
compared to the labour PE group in the inner or middle placental zones (p=0.6 for both) 
(Figure 5-4). 
 
Figure 5-4: RQ values for HSPB2 mRNA measurements in labour control (n=6) compared to 
the labour PE groups (n=6) at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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5.2.4 HSPB5 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPB5 (CRYAB) within individual placentas obtained from women 
who were not in labour (non-labour group) and from women who were in labour (labour 
group).  Comparison between zones was performed using Friedman test analysis.  There 
was no significant difference in mRNA expression of CRYAB between the three zones of 
the non-labour and labour groups (p=0.74 for both) (Figure 5-5). 
 
 
Figure 5-5: RQ values for CRYAB mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone.  Graphs show median and 
interquartile range for CRYAB mRNA expressions.  Comparison between zones was 
performed using Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of CRYAB between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was no significant difference in CRYAB mRNA expression in the 
labour group when compared to the non-labour group at the inner, middle and outer zones 
(p=0.48, p=0.81, p=0.30) (Figure 5-6).  
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Figure 5-6: RQ values for CRYAB mRNA measurements in non-labour (n=6) compared to the 
labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of CRYAB between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test analysis.  There was no significant difference in the CRYAB mRNA at the 
inner and middle placental zones (p=0.54, p=0.38) (Figure 5-7). 
 
 
Figure 5-7: RQ values for CRYAB mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of CRYAB between labour control and labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using the Mann 
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Whitney test analysis.  There was no significant difference in CRYAB mRNA  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.95, p=0.32) (Figure 5-8). 
 
 
Figure 5-8: RQ values for CRYAB mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
5.2.5 HSPB6 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPB6 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression between the three zones of the non-labour and 
labour groups (p=0.74, p=0.95 respectively) (Figure 5-9). 
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Figure 5-9: RQ values for HSPB6 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show median and 
interquartile range for HSPB6 mRNA expressions.  Comparison between zones was 
performed using Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference mRNA 
expression of HSPB6 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was a significant decrease in mRNA expression of HSPB6 in the labour 
group when compared to the non-labour group at the middle zone (p=0.01).  No difference 
was found at the inner and outer zones (p=0.3 for both) (Figure 5-10). 
 
Figure 5-10: RQ values for HSPB6 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB6 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis. There was a significant decrease in HSPB6 mRNA in the non-labour 
PE group compared to the non-labour control group in the inner zone (p=0.02).  There was 
no significant difference in the HSPB6 mRNA was found at the middle zone (p=0.09) 
(Figure 5-11). 
 
 
Figure 5-11: RQ values for HSPB6 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB6 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in HSPB6 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.52, 
p=1) (Figure 5-12). 
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Figure 5-12: RQ values for HSPB6 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
5.2.6 HSPB7 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPB7 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Mann Whitney test analysis.  There was 
no significant difference in mRNA expression of HSPB7 between the three zones of the 
non-labour and labour groups (p=1, p=0.57) (Figure 5-13). 
 
Figure 5-13: RQ values for HSPB7 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show median and 
interquartile range for mRNA expressions of HSPB7.  Comparison between zones was 
performed using Friedman analysis. 
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Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of HSPB7 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis. There was no significant difference in mRNA expression of HSPB7 in the 
labour group when compared to the non-labour group at the inner, middle and outer zones 
(p=1, p=0.17, p=0.24) (Figure 5-14).  
 
Figure 5-14: RQ values for HSPB7 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB7 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in the HSPB7 mRNA at the 
inner and middle placental zones (p=0.54, p=0.90) (Figure 5-15). 
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Figure 5-15: RQ values for HSPB7 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB7 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis  There was no significant difference in HSPB7 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.32, 
p=0.22) (Figure 5-16). 
 
 
Figure 5-16: RQ values for HSPB7 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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5.2.7 HSPB8 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPB8 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of HSPB8 between the three zones of the non-
labour and labour groups (p=0.57, p=0.14 respectively) (Figure 5-17). 
 
Figure 5-17: RQ values for HSPB8 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions HSPB8.  Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of HSPB8 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of HSPB8 in the labour 
group when compared to the non-labour group at the inner, middle and outer zones 
(p=0.39, p=0.24, p=0.81) (Figure 5-18). 
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Figure 5-18: RQ values for HSPB8 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) groups at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB8 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in HSPB6 mRNA at the inner 
and middle placental zones (p=0.9, p=09) (Figure 5-19). 
 
 
Figure 5-19: RQ values for HSPB8 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPB8 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
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analysis  There was no significant difference in HSPB8 mRNA in the labour control group 
compared to the labour PE group in the inner or middle placental zones (p=0.45, p=0.6) 
(Figure 5-20). 
 
Figure 5-20: RQ values for HSPB8 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
5.2.8 Results summary  
5.2.8.1 HSPB2 
Experiment 1: There was no significant spatial difference in mRNA expression of HSPB2 
expression between the three zones of the non-labour and labour groups. 
Experiment 2: There was a significant decrease in mRNA expression of HSPB2 in the non-
labour group when compared to the labour group at the outer zone (p=0.02).  No difference 
was found at the inner and middle zones. 
Experiment 3: There was no significant difference in mRNA expression of HSPB2 in the 
non-labour control group compared to the non-labour PE group in the inner or middle 
placental zones. 
Experiment 4: There was no significant difference in mRNA expression of HSPB2 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
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5.2.8.2 CRYAB 
Experiment 1: There was no significant spatial difference in mRNA expression of CRYAB 
between the three zones of the non-labour and labour groups. 
Experiment 2: There was no significant difference in CRYAB mRNA expression in the 
non-labour group when compared to the labour group at the inner, middle and outer zones 
Experiment 3:  There was no significant difference in the mRNA expression of CRYAB in 
the non-labour PE group compared to the non-labour control group at the inner and middle 
zones. 
Experiment 4: There was no significant difference in mRNA expression of CRYAB in the 
labour control group compared to the labour PE group at the inner and middle placental 
zones. 
5.2.8.3  HSPB6 
Experiment 1: There was no significant spatial difference in mRNA expression of HSPB6 
expression between the three zones of the non-labour and labour groups. 
Experiment 2: There was a significant decrease in mRNA expression of HSPB6 in the 
labour group when compared to the non-labour group at the middle zone (p=0.01).  No 
difference was found at the inner and outer zones. 
Experiment 3: There was a significant decrease in HSPB6 mRNA in the non-labour PE 
group compared to the non-labour control group in the inner zone (p=0.02).  There was no 
significant difference in the HSPB6 mRNA was found at the middle zone. 
Experiment 4: There was no significant difference in mRNA expression of HSPB6 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
5.2.8.4 HSPB7 
Experiment 1: There was no significant spatial difference in mRNA expression of HSPB7 
between the three zones of the non-labour and labour groups. 
Experiment 2: There was no significant difference in mRNA expression of HSPB7 in the 
non-labour group when compared to the labour group at the inner, middle and outer zones 
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Experiment 3:  There was no significant difference in the mRNA expression of HSPB7 in 
the non-labour PE group compared to the non-labour control group at the inner and middle 
zones. 
Experiment 4: There was no significant difference in mRNA expression of HSPB7 in the 
labour control group compared to the labour PE group at the inner and middle placental 
zones. 
5.2.8.5 HSPB8 
Experiment 1:  Overall there was no significant spatial difference between the three zones 
of the placenta in HSPB8 expression for the non-labour and labour groups. 
Experiment 2:  There was no significant different in HSPB8 expression in the labour group 
compared to the non-labour group at the inner, middle and outer zones of placentas. 
 Experiment 3:  There was no significant increase in HSPB8 expression in the non-labour 
PE group compared to the non-labour control group in the inner and middle zones. 
Experiment 4: There was no significant difference between the labour control and labour 
PE groups at the inner and middle zones. 
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5.3 Discussion  
The mRNA expression of sHSPs of members of the family was investigated using qRT-
PCR.  The inner, middle and outer zones for non-labour and labour groups were analysed 
but due to time constraints only the inner and middle zones for the PE group were studied.  
The aim was to determine whether pilot data from this group of experiments revealed any 
data suggesting that more experiments were warranted and as screen study for mRNA 
expressions of sHSPs in the human placenta.  
HSPB3 and HSPB4 were not detected in the human placenta.  Only HSPBs 1-8 were 
studied as 9 and 10 are testicular HSPs.  There were only a few significant differences in 
mRNA expression of sHSPs between non-labour versus labour groups and normotensive 
versus pregnancies complicated with PE (Table 5-2). 
Table 5-2: Summary of different comparison in mRNA expression of the sHSP family in the 
non-labour group (NLG), labour group (LG), non-labour-PE (NLG-PE) and labour group-PE 
(LG-PE) at the inner (I), middle (M) and outer (O) zones. Comparison was pointed by arrows 
to either increase, decrease or (No) for no change.  
 mRNA                             HSPB2        HSPB5        HSPB6          HSPB7         HSPB8 
 
Spatial distribution                  No              No              No              No                 No 
 
NLG versus LG                          (O)           No                  (M)         No                 No 
 
NLG-PE versus NLG-C            No             No                 (I)           No                 No 
 
LG-PE versus LG-C                 No             No                No             No                 No 
 
5.3.1 HSPB2 (HSP22) and present findings 
HSB2 expression was significantly decreased in the non-labour compared to the labour 
group at the outer zone.  Importantly the present work shows that expression varies on the 
zone of the placenta the piece of tissue is taken from.  Nothing is known about the role of 
HSPB2 in the placenta or whether it plays a role in labour or PE. 
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5.3.2 HSPB2 in labour and PE 
HSPs are induced in response to cell stresses including heat shock, oxidative stress, 
ultraviolet radiation, ischemia-reperfusion injury, viral infections, nutrient deprivation, 
hypoxia and ischemia.  This study shows for this first time that HSPB2 mRNA is 
expressed in the placenta and this expression increased in labour group at outer zone.  The 
physiological and pathological significance of this remains to be elucidated.  Labour is 
associated with inflammation, apoptosis and oxidative stress and HSB2 is an anti-oxidant 
chaperone that protect cells against these conditions. 
5.3.3 HSPB5 and present findings 
HSB5 was shown to be expressed in the placenta in this study.  However, there were no 
significant changes in mRNA expression of HSB5 both in non-labouring, labouring and PE 
placentas. 
5.3.4 HSPB5 and labour and PE 
Normal human labour involves the interaction of hormonal, neurological, mechanical 
stretch and inflammatory pathways and the placenta plays a crucial role. Labour has been 
shown to induce placental oxidative stress, which in turn activates ER stress in vitro (Yung 
et al., 2007, Cindrova-Davies et al., 2007b).  Heat shock proteins are found in several 
tissues involved in human reproduction. Members of all HSP families are found in the 
endometrium of healthy women (Tabibzadeh and Broome, 1999).  It has been shown (Tian 
et al., 2013) that mRNA expression of HSPB5 is detected at the implantation sites in 
mouse uteri.  In addition, mRNA expression of HSPB5 was increased in mouse uterus once 
delayed implantation is activated by estrogen (Su et al., 2010a).  Recently, it has been 
shown that HSPB5 is expressed in mouse decidua and also protects against oxidative and 
inflammatory stress conditions during decidualization (Zuo et al., 2014).  Furthermore, it 
has been shown (Zuo et al., 2014) that HSB5 was significantly induced and phosphorylated 
in stromal cells of mouse decidua when exposed to oxidative stress.  In humans, one study 
showed that HSPB5 is expressed in endometrium during the implantation window (Gruidl 
et al., 1997). 
There is one publication showing HSPB5 expression in the placenta (Mineva et al., 2008).  
This study showed using immunofluorescence that HSPB5 was expressed in the stroma of 
placental villi and there was an inter-individual HSPB5 expression variation. Protein and 
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mRNA expression of HSPB5 also detected in low amounts in term placenta compared to 
HSP27 (Mineva et al., 2008).  However, systematic sampling method was not performed 
and labour was not investigated so it is not possible to compare this finding to our study.  
5.3.5 HSPB6 and present finding 
HSB6 mRNA expression was significantly decreased in the labour group compared to the 
non-labour group at the middle zone.  However, HSPB6 also more less in the non-labour 
PE group compared to non-labour C especially at the inner zone.  Importantly the present 
work shows again that expression varies on the zone of the placenta the piece of tissue is 
taken from.  Nothing is known about the role of HSPB6 in the placenta or whether it plays 
a role in labour or PE. 
5.3.6 HSPB6 expression in labour and PE 
The key finding was the fall in mRNA expression of HSPB6 at the middle zone of the 
placenta during labour.  Many HSPs are increased to protect against oxidative damage and 
lipid peroxidation and regulation of apoptosis (Garrido et al., 2012) however in the present 
finding HSPB6 was reduced.  One reason for this may be that a fall in HSPB6 may be 
necessary to facilitate the inflammatory steps of labour which is, after all, a normal 
physiological process, not a disease.  A reduction in HSPB6 may help to initiate or 
promote labour.  Protein expression of HSPB6 is therefore worth investigating in further 
studies.  There was a significant decrease in mRNA expression of HSPB6 in the non-
labour PE compared to the non-labour control at the inner zone.  The reason for that is not 
clear, but there may be two parallel pathways; one associated with labour and one with PE 
and they may not necessarily work in the same direction. 
5.3.7 HSPB7 and HSPB8  
No changes in mRNA expression of HSPB7 or HSPB8 between non-labour and labour 
groups or normotensive compared to PE pregnancies were found.  There was no zonal 
distribution.  Nothing is known about the role of HSPB7 or HSPB8 in the placenta or 
whether it plays a role in labour or PE. 
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5.3.8 Linking sHSPs expression to oxidative stress and cell death 
Oxidative stress occurs when the production of ROS overwhelms the intrinsic anti-oxidant 
defences.  Contraction of the uterus leads to IR injury that can alter placental sHSP 
expression (Cindrova-Davies et al., 2007b). 
Members of the sHSP family exhibit several properties include chaperone activities, potent 
anti-apoptotic activity, pro-angiogenic properties and anti-inflammatory property involving 
interactions with several clients.  Mitochondria play an important role in cell death via 
production of excess ROS (Ott et al., 2007).  HSPB5 has anti-apoptotic functions that 
protect cells against stress.  This is essential for the protective function of HSPB5 that 
involves P38 and ERK activity (Li and Reiser, 2011).  In addition, it has been shown that 
HSPB5 prevents apoptosis induced upon oxidative stress and upon treating with drugs such 
as doxorubicin and staurosporin (Mehlen et al., 1996, Kamradt et al., 2001, Bakthisaran et 
al., 2014).  HSPB5 has been shown to prevent TNF-α-induced cell death and over-
expression leads to increased levels of glutathione and reduce levels of TNF-α- induced 
increase in ROS (Mehlen et al., 1996).  Under stress conditions, the sHSP family has the 
ability to interact with cytoskeletal elements and protect them against apoptosis and cell 
death.  There seems to be an apoptotic signalling pathway linking cytoskeletal damages to 
mitochondria (Bakthisaran et al., 2014). 
HSPB5 and HSPB6 interact with the pro-apoptotic molecule, Bax and inhibit its 
translocation into mitochondria and the subsequent release of cytochrome c (Mao et al., 
2004, Fan et al., 2005b).  In addition, HSPB5 interacts with cytochrome c and prevents 
interaction of Apaf-1 with pro-caspase 9 to form apoptosome (McGreal et al., 2012). 
HSPB5 also prevents pro-caspase-3 conversion to active CASP3 (Kamradt et al., 2002, 
Jeong et al., 2012).  Furthermore, HSPB5 interacts with the pro-apoptotic molecules 
include Bax and Bcl-Xs and prevents apoptosis by inhibiting their translocation into 
mitochondria (Mao et al., 2004). 
In the heart HSPB6 protects cardiac cells from IR injury induced apoptosis, improves 
recovery of cardiac function (Fan et al., 2005b).  HSPB6 interacts with the Bax (pro-
apoptotic protein) and preventing its translocation to mitochondria, leading to decreased 
CASP3 activation (Fan et al., 2005b).  
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 It has been shown that HSPB2 is a negative regulator of the caspase dependent extrinsic 
apoptotic pathway mediated by the Fas and FADD adaptors (Oshita et al., 2010). HSPB2 
prevents activation of CASP8 and 10  (Oshita et al., 2010). 
In compare to anti-apoptotic properties of the sHSPs, HSPB8 appears to have dual roles 
(Bakthisaran et al., 2014).  It is possible that is a result of anti-apoptotic functions of other 
HSPs or HSPB8 pro-apoptotic property is cell type specific (Bakthisaran et al., 2014). 
HSPB8 protect the heart from IR injury and exhibits an anti-apoptotic property by 
activation of the Akt pathway (Danan et al., 2007, Acunzo et al., 2012). 
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Chapter VI: Analysis of mRNA expression of HO-1 
(HSP32), DNAJ (HSP40) and HSPD1 (HSP60) 
families in human placenta of normal pregnancies 
and pregnancies complicated with PE 
6 HO-1, DNAJ and HSPD1  
6.1 Introduction  
6.1.1 Heme oxygenase (decycling)-1 (HO-1, HSP32) 
Hemoxygenase-1 (HO-1) was discovered by Tenhunen et al (Tenhunen et al., 1968) and is 
an enzyme that facilitates the degradation of heme.  This reaction uses NADPH as cofactor 
and yields the by-products carbon monoxide (CO), ferrous iron and biliverdin, which is 
then subsequently converted into bilirubin by biliverdin reductase (Ponka, 1999, Idriss et 
al., 2008, Barbagallo et al., 2013).  All three products instead display potent cytoprotective 
properties. CO has been demonstrated to display several of the same physiological 
functions as NO (Bainbridge and Smith, 2005).  CO act as a neurotransmitter inhibits 
platelet aggregation and is a vascular smooth muscle relaxant (Lyall et al., 2000).  In 
addition, the second and third catalytic compounds of heme degradation (biliverdin and 
ferrous iron) contribute to HO’s antioxidant effect (Bainbridge and Smith, 2005).  
Biliverdin and its subsequent breakdown product bilirubin demonstrate potent antioxidant 
characteristics (McGeary et al., 2003). 
HO exists in three isoforms; the first isoform is HO-1, a 32 kDa protein induced by several 
stimuli includes heavy metals, ROS, NF-β and hypoxia inducible factor (Idriss et al., 
2008, Syapin, 2008, Wagner et al., 2003).  The second isoform HO-2 is a constitutively 
synthesized 36-kDa protein and is generally non-inducible. Its specific function is thought 
to be maintaining the basic homeostatic balance of heme within body (Bainbridge and 
Smith, 2005).  The third isoform is HO-3, which was originally found in the rat. The 
function of HO-3 is unknown but the enzyme is believed to be inactive (Hayashi et al., 
2004, Idriss et al., 2008, Levytska et al., 2013).  HO-1, which is known as HSP32 is the 
one of greatest interest in relation to this project. 
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6.1.1.1 HO-1 functions  
It is now recognized that HO-1 is involved in the control of vascular tone, anti-
inflammatory, anti-apoptotic, angiogenic, anti-oxidant and cytoprotective functions 
(Christova et al., 1999, Sass et al., 2003, Levytska et al., 2013).  However, although 
physiologically moderate quantities of heme are cytoprotective as they induce the rapid up-
regulation of HO-1; large heme amounts can be toxic by mediating oxidative stress and 
inflammation (Wagener et al., 2003, Idriss et al., 2008, Bainbridge and Smith, 2005).  In 
heart, HO-1 provides cardiac cells protection by several routes include sequestration of 
iron by ferritin,  antioxidant activity of bilirubin and vasodilation effect of CO (Balla et al., 
2007, Kawamura et al., 2005, Wagener et al., 2003, Idriss et al., 2008).  
6.1.1.2 HSP32 and anti-apoptotic and anti-inflammatory functions   
HO-1 exerts anti-apoptotic functions in several ways including  CO production, which has 
been shown to have a cytoprotective effects (Vulapalli et al., 2002), bilirubin has been 
shown to protect cells against oxidative damage.  HO-1 decrease TNF, hyperglycemia and 
iron (Petrache et al., 2000, Idriss et al., 2008).  In addition, various models of tissue culture 
have been shown that HO-1 inhibit apoptosis by suppressing cytotoxic, inflammatory, and 
signalling cytokines (Zhen‐Wei et al., 2007, Rushworth and MacEwan, 2008). 
  It has been shown that HO-1 exerts  cytoprotective and anti-inflammatory functions in the 
innate immunity dominated liver IR injury (Tsuchihashi et al., 2007).  The antioxidant 
activity of bilirubin may feed through to anti-atherogenic properties, possibly by protecting 
LDL from oxidation (Mayer, 2000).  In addition to regulating oxidative stress, increased 
HO-1 activity is anti-inflammatory, attenuating angitenstion II-induced prostaglandin-E2 
and F2α synthesis (Volti et al., 2003).  HO-1 plays an important role in endothelial 
homeostasis and resistance to injury through protein kinase c-ε activity (Mylroie et al., 
2015). 
6.1.1.3 Linking of HSP32 expression to oxidative stress and IR injury 
HO-1 is involved in the oxidative stress response (Petrache et al., 2000, Onda et al., 2015). 
Biliverdin and bilirubin catalytic by-products of heme possess antioxidant properties 
(Petrache et al., 2000).  In addition, iron can stimulate ferritin synthesis which has been 
suggested to decrease the cellular oxidant potential (Choi and Alam, 1996).  Furthermore, 
low CO levels provide protection against oxidant stress (Otterbein et al., 1999).  
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The HO-1– bilirubin pathway can protects cells from IR injury, and restricts vascular 
smooth muscle cell growth by increasing the release of CO (Clark et al., 2000, Onda et al., 
2015).  In a rat model, mono-therapy with either (CO or biliverdin) did not alter the 
survival of heart grafts, however both treatments increased survival with a significant 
decrease of myocardial injury and improved cardiac function (Nakao et al., 2005). 
6.1.1.4 HO-1 expression in the placenta 
There are several studies on HO-1 expression in human pregnancy, mouse and rat 
placentas (Lyall et al., 2000, Zhao et al., 2008, Kreiser et al., 2003, McLean et al., 2000, 
Bilban et al., 2009, Ehsanipoor et al., 2013, Onda et al., 2015).  There are mixed reports on 
the expression of HO-1 and the association with several pregnancy complications such as 
spontaneous abortion, recurrent miscarriage and PE (Bainbridge and Smith, 2005, Kweider 
et al., 2014, Wong et al., 2012).  HO-1 enzyme was identified in STB and CTB cells as 
well as the vascular endothelium (Lyall et al., 2000).  One study showed  mRNA 
expression of HO-1 increases with advancing gestation (Bainbridge and Smith, 2005).  
HO-1 mRNA and protein expression decreased under hypoxic conditions while increased 
in glucose deficient media (Bainbridge and Smith, 2005). 
HO and its catalytic products may play a significant role in the progression of a healthy 
pregnancy to term.  It has been shown that HO-1 antibody had no effect on trophoblast 
invasion whereas the presence of the HO-2 antibodies significantly inhibition trophoblast  
invasion, also presence of  HO inhibitor zinc protoporhyrin-9 led to decrease of trophoblast 
invasion, thus suggest that HO-2 may be important in controlling trophoblast invasion 
(McCaig and Lyall, 2009). 
In normal pregnancy, the physiological placental expression of HO-1 prevents systemic 
vasculopathy by lowering the release of antiangiogenic proteins including sFLT-1 and 
soluble endoglin as well as to promote PlGF activity and inducing the production of CO, a 
potent vasodilator (Levytska et al., 2013, Ahmed and Ramma, 2014, Onda et al., 2015).  In 
addition, it has been suggested (Levytska et al., 2013, Onda et al., 2015) that HO-1 
manipulation may restore the physiology of the trophoblast layer through CO production 
and decrease sFLT-1 levels seen in PE.  HO-1 may play an important role as modulator of 
innate immune responses in pregnancy (Kahlo et al., 2013). 
Several researchers have attempted to profile HO expression, localization, and activity in 
the PE placenta with conflicting results.  It has been reported (Ahmed et al., 2000) that 
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expression HO-1 was decreased in PE, this was in contrast to a positive association 
between placental HO-1 expression and feto-placental vascularization in normal 
pregnancy.  However, other studies (Barber et al., 2001) showed that only endothelial HO-
2 was decreased in PE.  End-tidal breath CO levels, which indicates a decrease in the 
activity of HO were lower in PE patient in compare to the healthy pregnant women, 
supporting the role of CO as a physiologic vasodilator implicated in gestational 
hemodynamic changes (Kreiser et al., 2004, Zhao et al., 2015). 
Recently, it has been shown (Linzke et al., 2014) that CO acts as a key molecule in 
successful pregnancy by modulating the uterine NK cells, which result in the promotion of 
the remodelling of maternal spiral arteries.  Since invasive CTB express HO-2 the CTB 
may a source of CO (Lyall et al., 2000).  Furthermore, it has been shown that sofalcone, a 
gastric antiulcer agent in clinical use, potently increased HO-1 mRNA and protein in both 
primary trophoblasts and human umbilical vein endothelial cells (Onda et al., 2015).  
Sofalcone also decreased the secretion of sFlt-1from primary trophoblasts (Onda et al., 
2015). 
6.1.2 DNAJ (HSP40) heat shock protein 
DNAJ/HSP40s have been found in the nucleus, the cytosol, endosomes, mitochondria, 
ribosomes and ER.  The DNAJ family of co-chaperone proteins play a role in cell stress 
protection, folding of nascent polypeptides, refolding of denatured or aggregated proteins 
and protein degradation (Cyr and Ramos, 2015).  HSP70 binds to unfolded hydrophobic 
regions of proteins, and its activity is controlled by ATP binding, hydrolysis, and 
nucleotide exchange cycle (Qiu et al., 2006, Cyr and Ramos, 2015).  In the ATP bound 
form, HSP70 has a low affinity for substrate proteins.  Upon hydrolysis of the ATP to 
ADP, HSP70 undergoes a conformational change that increases its affinity for substrate 
proteins (Cyr and Ramos, 2015).  The HSP70 proteins are assisted and regulated by several 
different co-chaperones and these include the DNAJ family.  The family can use their 
various domain structures to bind HSP70, help load the substrates on HSP70 and stimulate 
the ATPase activity of HSP70 (Cyr and Ramos, 2015).  In addition, some of the members 
of the family DNAJ also regulate the activity of other chaperones including HSP90 
(Brychzy et al., 2003).  Furthermore, DNAJ can act as chaperones by themselves through 
binding to certain unfolded proteins (Qiu et al., 2006). 
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In mammals, more than 44 DNAJ homologs with diverse activities have been reported, 
however the exact numbers remain unknown (Qiu et al., 2006, Kim et al., 2013, Cyr and 
Ramos, 2015).  They are subdivided into types I, II and III based on the presence of 
conserved regions (Li et al., 2009).  All DNAJ family proteins contain the J domain 
(through which they bind to their partner HSP70), which consist of 70 amino acid residues 
that form four -helices and encompass the conserved tripeptide of histidine, proline and 
aspartic acid (Kostenko et al., 2014).  DNAJ proteins in addition to the J domain contain 
other conserved regions, which are important to their functions (Cajo et al., 2006).  DNAJ 
can be phosphorylated similar to other HSPs (Dephoure et al., 2008, Kostenko et al., 
2014)..  DNAJB1 is mediates repression of transcriptional activity of the HSF1(Kostenko 
et al., 2014). 
DNAJB1 is the homolog; subfamily B member and its mRNA expression was investigated 
in non-labour, labour and PE placentas in this study. 
6.1.3 HSPD1 (HSP60)  
The HSPD family (HSP60, also known as chaperonins) are ubiquitous protein folding 
machines which prevent protein aggregation by binding non-native proteins, and facilitate 
folding and unfolding of proteins (Kampinga et al., 2009).  The HSPD1 family of 
chaperones is one of the most abundant classes of molecular chaperones present in the 
mitochondria (Horváth et al., 2008).  HSPD1 has both the anti and pro-apoptotic roles. 
Cytosolic HSPD1 functions as an anti-apoptotic protein by preventing translocation of Bax 
into mitochondria and promotes cell survival, however, HSPD1 also promotes pro-caspase 
3 maturation, which lead to caspase mediated cell death (Arya et al., 2007).  
HSPD1 is regulated by its co-chaperoning HSP10 when performing its function (Shan et 
al., 2003). HSP10 (known as HSPE) is a 10 kDa highly conserved, mitochondria resident 
protein, which co-chaperones with the mitochondrial HSPD1. HSP10 alone is widely 
involved in protecting cells from stresses caused by infection and inflammation (Jia et al., 
2011). 
6.1.3.1 HSPD1 functions 
HSPD1 responsible for the transportation and refolding of proteins from the cytoplasm to 
the mitochondria, and is also involved in  prevention of denaturation of protein during 
stress (Boshoff, 2015).  HSPD1 is important for the correct folding of many proteins in the 
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cell; under both normal and stress conditions, the folding function of HSPD1 requires a 
cooperation of HSP70 (Boshoff, 2015).  Mitochondrial HSPD1 is heat inducible and also 
plays a role in protein assembly and trafficking (Seo et al., 2010, Xu et al., 2011). 
Furthermore, HSPD1 is involved in the replication and transmission of mitochondrial 
DNA. 
HSPD1 plays a role in the production of pro-inflammatory cytokines and also plays both 
pro-apoptotic and anti-apoptotic roles, depending on their localisation (Knowlton and 
Gupta, 2003, Boshoff, 2015).  The cytoplasmic HSPD1 forms a complex with proteins 
responsible for apoptosis and prevent apoptosis (Itoh et al., 2002).  The cytoplasmic 
HSPD1 is also involved in immune response and cancer (Itoh et al., 2002).  Under stress 
conditions cytoplasmic HSPD1 is imported into the mitochondria by HSP70 (Itoh et al., 
2002). 
6.1.3.2 HSPD1 immunological roles 
It has been suggested (Hansen et al., 2003) that HSPD1 may play a role in the immune 
response and autoimmune disease. Different HSPD1 can bind to several cell surface 
receptors such as TLRs, suggesting there are several subfamilies of HSPD1 (Ranford et al., 
2000).  HSPD1 induces cytokine secretion as well as activation of immune system cells 
such as monocytes, macrophages and dendritic cells (Hansen et al., 2003).  There is a twist 
in the immunological function of HSPD1 because there are two different types (bacteria 
and mammalian) of HSPD1 proteins.  It has been shown (Ranford et al., 2000) that 
bacterial HSPD1 causes the immune system to produce anti-chaperonin antibodies, which 
then recognize and attack human HSPD1 resulting  in autoimmune disease (Ranford et al., 
2000).  HSPD1 has been associated with stress response, diabetes, cancer and certain 
genetic diseases (Imatoh et al., 2009, Olvera-Sanchez et al., 2011).  In addition, the 
association between antibodies against HSPD1 and high serum cholesterol has been shown 
at the beginning of the atherosclerosis in humans (Foteinos and Xu, 2009).  It has been 
suggested (Olvera-Sanchez et al., 2011) that there is a role for HSPD1-like protein in 
cholesterol distribution, as in placental steroidogenesis.  Moreover , HSPD1 are likely to 
suppress the maternal anti-foetal immune response via TGFβ production, thus contributing 
to pregnancy maintenance (Giacomelli et al., 2004). 
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6.2 Results  
6.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
6.2.2 HO-1 expression in normal pregnancies and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSP32 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of HSP32 between the three zones of the non-
labour and labour groups (p=0.74, p=0.95 respectively) (Figure 6-1). 
 
Figure 6-1: RQ values for HSP32 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups). Four quadrants 
were sampled in each zone 6 placentas were studied in each group. Graphs show the 
median for mRNA expressions of HSP32.  Comparison between zones was performed using 
Friedman analysis. 
Experiment 2:  This experiment was designed to test if there was any difference mRNA 
expression of HSP32 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was a significant decrease in mRNA expression of HSP32 in the labour 
group when compared to the non-labour group at the middle and outer zone (p=0.04, 
p=0.008 respectively).  No difference was found at the inner zone (p=0.17) (Figure 6-2). 
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Figure 6-2: RQ values for HSP32 mRNA measurements in non-labour (n=6) compared to the 
labour group (n=6) at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSP32 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test.  There was no significant difference in the HSP32 mRNA was found at the 
inner and middle zones (p=0.71, p=0.54) (Figure 6-3). 
 
Figure 6-3: RQ values for HSP32 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones. 
Comparison between zones was performed using Mann-Whitney analysis. 
Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSP32 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in HSP32 mRNA in the labour control group 
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compared to the labour PE group in the inner or middle placental zones (p=0.17, p=0.58) 
(Figure 6-4). 
 
Figure 6-4: RQ values for HSP32 mRNA measurements in labour control (n=6) compared to 
the labour PE groups (n=6) at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
6.2.3 DNAJAB1 expression in normal pregnancies and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of DNAJB1 within individual placentas obtained from women who 
were not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of DNAJB1 between the three zones of the 
non-labour and labour groups (p=0.18, p=0.14 respectively) (Figure 6-5). 
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Figure 6-5: RQ values for DNAJB1 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of DNAJB1.  Comparison between zones was performed using Friedman 
analysis. 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of DNAJB1 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was a significant decrease in mRNA expression of DNAJB1 in the labour 
group when compared to the non-labour group at the middle zone (p=0.04).  No difference 
was found at the inner and outer zones (p=0.58, p=0.24) (Figure 6-6). 
 
Figure 6-6: RQ values for DNAJB1 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of DNAJB1 between non-labour control and non-labour PE groups at the inner 
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or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test analysis.  There was no significant difference in the DNAJB1 mRNA at the 
inner and middle placental zones (p=0.54 for both) (Figure 6-7). 
 
 
Figure 6-7: RQ values for DNAJB1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of DNAJB1 between labour control and labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test analysis.  There was no significant difference in DNAJB1 mRNA  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.68, p=0.32) (Figure 6-8). 
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Figure 6-8: RQ values for DNAJB1 mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
6.2.4 HSPD1 expression in normal pregnancies and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPD1 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of HSPD1 between the three zones of the non-
labour and labour groups (p=0.25, p=0.05 respectively).  The sub-analysis for the labour 
group showed that there was a significant decrease in RNA expression of HSPD1 at the 
middle zone compared to the inner zone (p=0.02) (Figure 6-9). 
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Figure 6-9: RQ values for HSPD1 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group). Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSPD1.  Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of HSPD1 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of HSPD1 in the labour 
group when compared to the non-labour group at the inner, middle and outer zones (p=0.3, 
p=0.24, p=0.3) (Figure 6-10). 
 
Figure 6-10: RQ values for HSPD1 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSPD1 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in the HSPD1 mRNA at the 
inner and middle placental zones (p=1, p=0.54) (Figure 6-11). 
 
 
Figure 6-11: RQ values for HSPD1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSPD1 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was no significant difference in HSPD1 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.68, 
p=0.32) (Figure 6-12). 
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Figure 6-12: RQ values for HSPD1 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
6.2.5 Results summary  
6.2.5.1 HSP32 
Experiment 1: There was no significant spatial difference in mRNA expression of HSP32 
expression between the three zones of the non-labour and labour groups. 
Experiment 2: There was a significant decrease in mRNA expression of HSP32 in the 
labour group when compared to the non-labour group at the middle and outer zone 
(p=0.04, p=0.008 respectively).  No difference was found at the inner zone. 
Experiment 3: There was no significant difference in the mRNA expression of HSP32 in 
the non-labour control group compared to the non-labour PE group in the inner or middle 
placental zones. 
Experiment 4: There was no significant difference in mRNA expression of HSP32 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
6.2.5.2 DNAJB1 
Experiment 1: There was no significant spatial difference in mRNA expression of 
DNAJB1 between the three zones of the non-labour and labour groups. 
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Experiment 2: There was a significant decrease in mRNA expression of DNAJB1 in the 
labour group when compared to the non-labour group at the middle zone (p=0.04). No 
difference was found at the inner and outer zones. 
Experiment 3:  There was no significant difference in the mRNA expression of DNAJB1 in 
the non-labour PE group compared to the non-labour control group at the inner and middle 
zones. 
Experiment 4: There was no significant difference in DNAJB1 mRNA in the labour 
control group compared to the labour PE group at the inner and middle placental zones. 
6.2.5.3 HSPD1 
Experiment 1: There was no significant spatial difference in mRNA expression of HSPD1 
between the three zones of the non-labour and labour groups.  The sub-analysis for the 
labour group showed that there was a significant decrease in RNA expression of HSPD1 at 
the middle zone compared to the inner zone (p=0.02) 
Experiment 2:  There was no significant difference in mRNA expression of HSPD1 in the 
labour group when compared to the non-labour group at the inner, middle and outer zones. 
Experiment 3:  There was no significant difference in the mRNA expression of HSPD1 in 
the non-labour PE group compared to the non-labour control group at the inner and middle 
zones. 
Experiment 4: There was no significant difference in mRNA expression of HSPD1 in the 
labour control group compared to the labour PE group at the inner and middle placental 
zones. 
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6.3 Discussion 
6.3.1 HO-1 and present findings 
The main finding in this study was that HO-1 mRNA expression was significant decreased 
in labour compared to the non-labour group at the middle and outer placental zones.  One 
possible explanation is as labour is an inflammatory process the fall in HO-1 would allow 
the inflammatory pathways to go further and continue as natural process.  However, 
importantly the present work shows that expression varies on the zone of the placenta the 
piece of tissue is taken from.  There was no spatial distribution or significant difference in 
HO-1 expression between non-labour PE and labour PE groups compare to the non-labour 
and labour control groups.  
HO-1 expression has been studied in both human and mouse placentas.  In human 
placental tissue, the results have been inconsistent, it might due to the intra- and inter-
placental tissue heterogeneity and different gestational ages studied (Zhao et al., 2015).  
Most studies were performed using either term or preterm placentas.  For most studies, the 
tissue collected was only from the placenta without the placental bed, and investigated 
mostly for IHC studies.  In our study we followed a systematic sampling methods by 
dividing placenta into three zones according to distance from cord insertion point (inner, 
middle and outer zones) (Abdulsid et al., 2013b, Abdulsid et al., 2013a, Abdulsid and 
Lyall, 2014).  Because of time constraints it was only possible to perform qRT-PCR 
experiments and future plans would be to investigate HO-1 protein expression and IHC 
protein localization according to the systemic sampling protocol. 
6.3.2 HO-1 in labour and PE 
The mechanism of CO mediated vasodilatation has been investigated, and it is has been 
suggested that the CO/HO system may be involved in the control of placental vascular 
function and may protect the STB and endothelium against oxidative stress injury (Lyall et 
al., 2000).  It has been shown (Appleton et al., 2002) that HO activity was directly 
dependent on O2 concentration.  Thus, although HO protein and mRNA expression 
increased under hypoxic conditions, there is a progressive decrease in HO activity with low 
O2 concentration.  Placentas of PE cases have large and numerous infractions areas 
compared to the normal pregnancies (Benirschke et al., 1998). 
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HO enzyme expression and activity may vary across the placenta.  Consequently, it is 
critical that the sampling site be identified and considered when comparing various studies. 
There are some publications in which HO-1 expression in the placenta and changes during 
adverse pregnancy have been reported.  Again the main point to highlight is that systemic 
sampling and the confounding effects of labour have not been considered.  These studies 
can be summarized as follows. 
Lyall et al (Lyall et al., 2000) presented the most systematic study that investigated the 
HO-1 and HO-2 using ICH and western blotting, by collecting placentas and placental bed 
samples from first and second trimesters as well as term placentas.  This study showed that 
HO-1 protein expression was very low compared to HO-2 and not gestational age 
dependent. Within the placental bed, HO-1 was expressed in EVT but absent from villous  
CTB (Lyall et al., 2000). 
One group  performed RT-PCR, Western blotting and IHC to investigate HO-1 and HO-2 
in human term placenta (McLean et al., 2000).  This study showed that HO-1 was detected 
in placenta tissue at the protein and molecular level. IHC showed wide distribution of HO-
1 including STB, endothelium and smooth muscle of placenta blood vessels however doubt 
has been cast as to how much staining is non-specific with the antibodies used.  However, 
although this group collected the placental samples from non-labouring and labouring 
placentas there was no any comparisons carried out or showed within the study for each.  
No systemic sampling was performed. 
Other research group performed RT-PCR, Western blotting and IHC to investigate HO-1 
and HO-2 in first trimester as well as term human placenta (Yoshiki et al., 2000).  Similar 
to the above study (McLean et al., 2000) HO-1 was detected in placenta tissue at the 
protein and molecular level. IHC showed that distribution of the two HO isoforms had 
distinct topographic patterns:  HO-1 was observed in STB layer with traces in the 
underlying CTB.  In addition, the study also showed that HO-1 expression did not change 
throughout gestation.  It is not appropriate to compare this study to our findings because 
there was no controlled sampling and labour was not investigated. 
Ahmed et al (Ahmed et al., 2000) performed RT-PCR, IHC and western blotting to 
investigate HO-1 in first, second trimesters and term normal pregnancy, term PE placental 
tissue was also investigated.  The level of HO-1 mRNA expression increased with 
increasing gestation in normotensive samples but not PE. HO-1 protein expression was 
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increased 2.6 fold in term compared to first trimester placentas.  There was a significant 
decrease in HO-1 mRNA expression in PE placentas compared to normotensive placenta. 
Barber et al (Barber et al., 2001) performed IHC and Western blotting to investigate HO-1 
and HO-2 in term placenta and placenta bed of normal, PE and FGR pregnancies. HO-1 
protein was undetectable in the placental homogenates collected from both the PE and the 
normotensive placentas.  This follow up study investigated mRNA expression of HO-1 not 
protein, further studies according to controlled sampling would be recommend. 
McLaughlin et al (McLaughlin et al., 2003) performed Western blotting to investigate HO-
1 and HO-2 from four placental regions (chorionic villi, chorionic plate, basal plate and 
fetal membranes) of term human placenta of normotensive and PE pregnancies.  This study 
showed that HO-1 expression was increased in chorionic villi and fetal membranes from 
PE compared with normotensive pregnancy.  However, although samples were taken from 
four placenta regions but there were no controlled sampling methods within placenta. 
Labour was not studied. 
Lash et al (Lash et al., 2003) performed IHC and Western blotting to investigate HO-1 and 
HO-2 in three areas of term non-labour placenta of normotensive and PE pregnancies 
(morphologically normal chorionic villi, peri-infarct chorionic villi, and infarct chorionic 
villi).  This study showed that there were no significant differences in HO-1 protein levels 
in healthy and infarcted tissue for both normotensive and PE placentas.  IHC analysis 
showed decreases in both HO-1 and HO-2 protein expression in all damaged tissue.  In 
addition, they compared HO enzymatic activity in microsomes isolated from normal and 
infarcted chorionic villi and found decreased HO activity in the damaged tissue under 
optimized conditions (Lash et al., 2003).  No systemic sampling method was performed 
and labour was not studied. 
Newby et al (Newby et al., 2005) performed Western blotting to investigate HO-1 and HO-
2 in trophoblast cell cultures.  This study showed that HO-1 expression in STB was 
significantly lower than in CTB in standard conditions. In addition, there was no difference 
in HO-1 expression in CTB transferred to 2% O2 for different times.  However, exposure 
of STB cultures to hypoxia for 12 h resulted in a significant decrease in HO-1 protein 
expression. 
Bilban et al (Bilban et al., 2009) collected first trimester human placental tissues and 
compared the mRNA expression profiles of EVT compared to the less invasive CTB.  This 
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study showed that HO-1 was down-regulated in EVT.  In addition, a high expression of 
HO-1 in the proliferative, Ki67-positive cell column was detected, in contrast to the low 
levels observed in non-cycling, Ki67-negative, invasive EVT (Bilban et al., 2009). 
Yamamoto et al (Yamamoto et al., 2014) performed RT-PCR on placenta and serum 
samples from PE and normal pregnancy patients.  Then JEG-3 cells were cultured with PE 
and normal pregnant sera.  This study showed that HO-1 mRNA expression in placenta 
was decreased significantly in PE patients compared to normal pregnancy patients.  In 
addition, it has been shown that there was no correlation between PlGF and sFlt-1 mRNA 
expression and HO-1mRNA expression. 
Recently, it was shown (Kaitu'u-Lino et al., 2015) that mRNA and protein expression of   
HO-1 is not reduced in PE and does not regulate sFlt-1 or soluble endoglin production in 
human placentas.  In the present study there was no significant difference in mRNA 
expression of HO-1 between PE and normotensive pregnancies.  Although, there was 
similarity in the findings controlled sampling and labour effect were not investigated.   
These contradicting results from different studies add confusion to the potential role of 
HO-1 in the pathogenesis of PE.  However, the disease state, subjects and experimental 
variability may explain some of these differences. 
6.3.3 DNAJB1 and the present findings 
The main finding was that DNAJB1mRNA expression was significantly decreased in the 
labour group when compared to the non-labour group at the middle placental zone.  
Recently, it has been shown that DNAJB1 inhibited p53-mediated apoptosis (Cui et al., 
2015).  The reason for the fall in DNAJB1mRNA expression is unclear but possible 
explanation is this would allow the apoptotic pathways in labour to progress.  
However, importantly the present work shows that expression varies depending on the 
zone of the placenta the piece of tissue is taken from.  There was no spatial distribution or 
any significant difference in DNAJB1 expression between non-labour and labour PE 
compare to the non-labour and labour control. 
There are few publications in which DNAJ expression in the placenta.  These studies can 
be summarized as follows. 
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One study showed  that DNAJ is expressed in the placenta (Ohtsuka, 1993).  DNAJ has 
also been showed that detected in umbilical vein endothelial cells (Chellaiah et al., 1993). 
One group used cDNA oligonucleotide microarray analysis to investigate DNAJAB1 
expression in uncomplicated term placenta of labour and non-labour (Lee et al., 2010).  
They reported that mRNA expression of DNAJAB1was increased (3.83 fold) in the labour 
group compared to the non-labour.  No systemic sampling method was performed. In 
contrast on the present study DNAJAB1 was decreased in labour at the middle zone.  
6.3.4 HSPD1 and present findings 
This study showed that HSPD1 mRNA is expressed in human placenta.  The key finding 
that mRNA expression of HSPD1 is expressed in spatial manner in the placenta with 
highest expression being in the middle zone in labour group.  However, there were no 
significant changes in mRNA expression of HSPD1 in non-labouring, labouring and PE 
placentas. 
6.3.5 HSPD1 expression in labour and PE 
HSPs are essential for cellular survival under stressful conditions.  The heat shock response 
is a mechanism that that protects cell from damage from heat stress by up-regulating the 
expression of genes that code for HSPs including HSPD1 (Vargas-Parada et al., 2001). 
HSPD1, similar to other HSPs, is up-regulated in response to different stresses for example 
it serve as defence mechanisms against neurotoxicity produced by ROS in 
neurodegenerative diseases (Calabrese et al., 2007, Rossi et al., 2002). 
There are some publications in describing HSPD1 expression in the placenta and changes 
during adverse pregnancy.  The major point to highlight is that controlled sampling and the 
confounding effects of labour have not been considered.  These studies can be summarized 
as follows. 
An IHC study of amniochorion and basal plate HSPD1 expression in pre-term labour, term 
labour, term non-labour and pre-term cesarean section for PE or FGR was reported (Divers 
et al., 1995).  This study reported that HSPD1 expression was relatively constant 
throughout the last trimester and was unchanged by labour.  The placenta itself was not 
examined and controlled sampling was not performed. 
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Immunofluorescence was used to investigate HSPD1 and HSPD1 antibody complex 
expression in term, pre-term and FGR placentas (Ziegert et al., 1999).  This study showed 
that HSPD1 protein expressed in placenta, no significant difference between all groups.  
No data or p values were shown to support this statement and no systematic sampling was 
performed. 
Placental HSPD1 protein expression, detected using IHC, was decreased in the CTB and 
STB around infracted regions (Wataba et al., 2004).  The author concluded that although 
the villous cells around the infarction appeared histologically viable, they may have 
received lethal damage, and as a result, the expression of HSPs was decreased.  Systemic 
sampling method was not performed. 
Proteomic  and Western blotting has been used to investigate HSPD1 expression in highly 
purified placental CTB obtained from normal and PE pregnancies, both non-labour and 
labour placentas were collected (Johnstone et al., 2011).  This study showed that HSPD1 
was significant decreased in the cells from PE cases compared to the normotensive 
subjects.  Although placentas were collected from non-labour and labour group the effect 
of labour was not taken in account.  A systemic sampling method was not performed. 
Western blotting, IHC and immunoprecipitation was used by another group to investigate 
HSPD1 protein expression in STB mitochondria of term placentas (Olvera-Sanchez et al., 
2011).  This study concluded that HSPD1 is related to placental steroidogenesis and 
cholesterol transport across mitochondria.  Systemic sampling methods were not 
performed and labour was not studied. 
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Chapter VII: Analysis of mRNA expression of 
HSPA5 (GRP78), HSP90 (HSP90AA and HSP90B1) 
and HSPH1 (HSP105) families in human placenta of 
normal pregnancies and pregnancies complicated 
with PE 
7 HSPA5, HSP90 and HSPH1 expression 
7.1 Introduction  
7.1.1 Glucose regulated protein (GRP78, HSPA5) 
In human  cells the ER forms a vast and dynamic membrane network (English and Voeltz, 
2013).  The ER plays an important function in intracellular calcium homeostasis.  Protein 
translocation into the ER is the first step in the biogenesis of many proteins of mammalian 
cells (Melnyk et al., 2015).  ER stress can be induced by conditions that causing an 
alteration in the intraluminal oxidative status such as Ca
++
 signalling disturbance and 
misfolded protein accumulation, which could lead to induction and progression of 
apoptosis (Grubišic, 2005).  
GRP78 is also known as BiP and recently as heat shock 70 kDa protein 5 (HSPA5) belongs 
to HSP70 family. GRP78 is located in the ER lumen and can be induced by ER stress 
(particularly hypoxia and hypoglycaemia) (Shields et al., 2011, Gonzalez-Gronow et al., 
2012).  Newly synthesized proteins are translocated to the ER where GRP78 binds to them 
to maintain their correct folding and oligomerization.  GRP78 also act as an apoptotic 
regulator by protecting the cell against stress induced death or induced cell death by 
activation CASP3, 7 and 8 of the extrinsic pathways (Grubišic, 2005, Gonzalez-Gronow et 
al., 2007, Gonzalez-Gronow et al., 2012).  Furthermore, GRP78 plays a critical role in the 
quality control of proteins processed in the ER and the regulation of ER signalling in 
response to the UPR or ER stress (Ma and Hendershot, 2004b, Zhang and Zhang, 2010).  
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7.1.1.1 GRP78 immunological roles 
HSPs have three immunological regulatory functions: inside the cell, on the cell membrane 
as signalling receptors, and in the extracellular environment as stress cytokines.  GRP78 
has potent immunological activity when released from the internal cell environment into 
the extracellular compartment (Panayi et al., 2004).  GRP78 has anti-inflammation roles 
such as down regulating the immune system by several mechanisms include cytokine 
production IL-10, IL-1 and TNF) and  down regulating HLA-DR and CD86 (Panayi et al., 
2004, Corrigall et al., 2004). 
7.1.2 Heat shock protein 90 (HSP90) 
HSP90 is most abundant intracellular protein in mammalian cells; it prevents aggregation 
of non-native proteins in an ATP dependent manner (Picard, 2002).  HSP90 is also 
essential for a wide range of protein assembly, trafficking, folding, and degradation 
processes (Clare and Saibil, 2013).  HSP90 plays a role in stabilization of protein at later 
stages of folding (Clare and Saibil, 2013).  HSP90 activation is regulated by ATP-induced 
large conformational changes, co-chaperones and post-translational modifications such as 
phosphorylation, acetylation and nitrosylation (Li et al., 2012a).  HSP90 is dependent on 
ATP hydrolysis and interacts with more than 20 co-chaperones, for chaperone activity 
(Taipale et al., 2010, Prodromou, 2012). 
HSP90 also play a role in kinases signalling and regulation of transcription machinery such 
as steroid receptors and P53 (Khurana and Bhattacharyya, 2015).  It also influences steroid 
receptor function (Pratt et al., 2004, Grad and Picard, 2007, Sanchez, 2012).  HSP90 is a 
major regulator of cancer cell growth and proliferation by assisting oncogenes such as 
several protein kinases and transcription factors (Khurana and Bhattacharyya, 2015).  
HSP90 inhibition results in the simultaneous blockade of multiple signalling pathways and 
can sensitize tumour cells to anticancer drugs, hence HSP90 inhibitors play a major role in 
cancer treatment (Kumalo et al., 2015, Proia and Kaufmann, 2015).  Another function of 
HSP90 is to act as buffer for genetic variation by rescuing mutated proteins with altered 
properties (Taipale et al., 2010). 
7.1.2.1 Intracellular location  
HSP90 is a large dimeric protein found in almost every compartment of eukaryotic cells. 
Cytosolic HSP90 constitutes 1-2% of total protein.  Under stress condition HSP90 
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translocates to other cellular compartments including the nucleus and mitochondria 
(Taipale et al., 2010).  Furthermore, HSP90 exists in the extracellular space where it is 
thought to interact with immune system (Schmitt et al., 2007). 
7.1.2.2 HSP90 isoforms and transcriptional regulation  
HSP90 is generally expressed in the cytoplasm, ER, mitochondria and the nucleus 
(Csermely et al., 1998, Krishna and Gloor, 2001, Chen et al., 2005).  Although HSP90 is 
mainly a cytoplasmic chaperone, a small fraction of HSP90 (about 3%) is present in the 
nucleus  (Khurana and Bhattacharyya, 2015).  There are two major cytosolic isoforms of 
HSP90, which interact with a number of co-chaperones that regulate its ATPase cycle and 
determine its substrate proteins (Chiosis et al., 2013).  Cytosolic HSP90, which is 
presented in two isoforms: α-HSPC2 (HSP90AA, inducible form) and β-HSPC3 
(HSP90AB1, constitutive form) differ in its expression pattern, HSP90AB being abundant 
during normal physiological conditions and HSP90AA expressed during stress (De Maio 
and Vazquez, 2013).  These two isoforms are the result of gene duplication (Krone and 
Sass, 1994).  Other types of molecular chaperones include the ER resident homologue 
GRP94, and a mitochondrial variant TRAP1(Kumalo et al., 2015).  
Despite its high basal abundance HSP90 is transcriptionally induced in response to 
different stress conditions such as heat shock, hypoxia and IR injury (Csermely et al., 
1998).  Mammalian genomes contain genes for both constitutively and inducible HSP90 
isoforms. Inducible HSP90 is controlled by HSF1 (Whitesell and Lindquist, 2009).  Under 
normal conditions HSP90 prevents the activation of HSP gene expression by its interaction 
with HSF1(Zou et al., 1998).  There are other transcription factors which induce HSP90 
expression such as NF-B (Ammirante et al., 2008) and STAT3 (following IL-6 
stimulation) or by STAT1 following interferon-γ stimulation (Stephanou et al., 1997, 
Ripley et al., 1999).  The interface with HSF1 occurs in two ways, STAT1 interacts with 
HSF1 synergistically, and STAT3 antagonizes HSF1 activity (Sekimoto et al., 2010).  In 
addition, HSP90 initiates a potent inflammatory response via transcriptional modulation of 
NF-B and STAT3 (Bohonowych et al., 2014). 
In this study HSP90AA and HSP90AB1 was investigated in normotensive and PE 
pregnancies. HSP90 protein expression was run for optimization but due to time constrain 
we only mRNA experiments were performed. 
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7.1.3 HSPH1 (HSP105/HSP110 family) 
The HSP105/HSP110 family consists of HSP105α and HSP105β, HSP105α is expressed 
constitutively and induced by different forms of stress, while HSP105β, an alternatively 
spliced form of Hsp105α, is expressed specifically during mild heat shock (Hatayama et 
al., 1994, Ishihara et al., 1999).  Both isoforms of HSP105 are composed of an N-terminal 
ATP binding site, a β-sheet, a loop and a C-terminal α-helix domain similar to the HSP70- 
family proteins (Ishihara et al., 2003).  HSP105α is present in the cytoplasm but not the 
nucleoli (Ishihara et al., 1999) whereas HSP105β localized in the nucleus of mammalian 
cells (Saito et al., 2007).  However, it has been shown that HSP105α accumulated in the 
nucleus of cells (Yamagishi et al., 2010).  HSP105α exists as both non-phosphorylated and 
phosphorylated forms and is phosphorylated by protein kinase 2 at ser 509 (Ishihara et al., 
2003). 
HSP105 exist as a complex with HSP70 and HSC70 the constitutive member of the HSP70 
family (Hatayama et al., 1998, Wang et al., 2000, Bracher and Verghese, 2015) and 
suppresses the chaperone activity of HSC70 in cells  (Ishihara et al., 2003, Yamagishi et 
al., 2004).  HSP105α and HSP105β suppress the aggregation of denatured proteins that 
occurs in cell under stress conditions, in which cellular ATP levels decrease markedly 
(Yamagishi et al., 2003, Bracher and Verghese, 2015) and also supresses apoptosis through 
the induction of HSP70 (Yamagishi et al., 2010).  In addition, although both isoforms of 
HSP105 do not shown ATPase activity, their addition to HSP70/HSP40 enhanced ATP 
hydrolysis greater than that of the HSP40-stimulated HSP70 ATPase activity (Yamagishi 
et al., 2000).  HSP105β but not HSP105α up-regulates HSP70 expression through signal 
transducer STAT-3 in cells (Yamagishi et al., 2003, Yamagishi et al., 2009). 
 
 
7.2 Results  
7.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
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7.2.2 HSPA5 expression in normal pregnancies and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPA5 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of HSPA5 between the three zones of the non-
labour and labour groups (p=0.95, p=0.25 respectively) (Figure 7-1). 
 
 
Figure 7-1: RQ values for HSPA5 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone.  Graphs show the median and for 
mRNA expressions HSPA5. Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of HSPA5 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of HSPA5 in the labour 
group when compared to the non-labour group at the inner, middle and outer zones 
(p=0.58, p=0.09, p=0.69) (Figure 7-2). 
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Figure 7-2: RQ values for HSPA5 mRNA measurements in non-labour (n=6) compared to the 
labour (n=6) groups at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSPA5 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in the mRNA expression of 
HSPA5 at the inner and middle placental zones (p=0.9, p=0.26) (Figure 7-3). 
 
 
Figure 7-3: RQ values for HSPA5 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSPA5 between labour control and labour PE groups at the inner or middle 
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zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of HSPA5  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.77, p=0.11) (Figure 7-4). 
 
 
Figure 7-4: RQ values for HSPA5 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
7.2.3 HSP90AA expression in normal pregnancies and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSP90AA within individual placentas obtained from women who 
were not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Mann Whitney test analysis.  There was 
no significant difference in mRNA expression of HSP90AA between the three zones of the 
non-labour and labour groups (p=25, p=0.57) (Figure 7-5) 
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Figure 7-5: RQ values for HSP90 AA mRNA measurements in in inner (n=4), middle (n=4) 
and outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSP90AA.  Comparison between zones was performed using 
Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of HSP90AA between labour and non-labour groups at the inner, middle or 
outer zones of placentas.  Comparison between zones was performed using Mann Whitney 
test analysis.  There was a highly significant decrease in mRNA expression of HSP90AA 
in the non-labour group compared to the labour group at the outer zone (p=0.008).  There 
was no significant difference in mRNA expression of HSP90AA in the non-labour group 
when compared to the labour group at the inner or middle zones (p=0.17, p=0.30) (Figure 
7-6). 
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Figure 7-6: RQ values for HSP90AA mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSP90AA between non-labour control and non-labour PE groups at the 
inner or middle zones of placentas.  Comparison between zones was performed using the 
Mann Whitney test analysis.  There was no significant difference in HSP90AA mRNA at 
the inner and middle placental zones (p=1, p=0.38) (Figure 7-7). 
 
Figure 7-7: RQ values for HSP90AA mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of HSP90AA between labour control and labour PE groups at the inner or 
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middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in HSP90AA mRNA  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.86 for both) (Figure 7-8). 
 
Figure 7-8: RQ values for HSP90AA mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
7.2.4 HSP90B1 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSP90B1  within individual placentas obtained from women who 
were not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Mann Whitney test analysis.  There was 
no significant difference in mRNA expression of HSP90AA between the three zones of the 
non-labour and labour groups (p=0.33, p=0.74) (Figure 7-9). 
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Figure 7-9: RQ values for HSP90B1 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSP90B1.  Comparison between zones was performed using 
Friedman analysis. 
 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of HSP90B1 between labour and non-labour groups at the inner, middle or 
outer zones of placentas.  Comparison between zones was performed using Mann Whitney 
test analysis.  There was a highly significant decrease in HSP90B1 mRNA expression in 
the non-labour group compared to the labour group at the outer zone (p=0.01).  There was 
no significant difference in HSP90B1 mRNA expression in the non-labour group when 
compared to the labour group at the inner and middle zones (p=0.24, p=0.06) (Figure 7-
10).  
 
Figure 7-10: RQ values for HSP90B1 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSP90B1 between non-labour control and non-labour PE groups at the 
inner or middle zones of placentas.  Comparison between zones was performed using 
Mann Whitney test analysis.  There was no significant difference in HSP90B1 mRNA at 
the inner and middle placental zones (p=0.16 for both) (Figure 7-11). 
 
 
Figure 7-11: RQ values for HSP90B1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSP90B1 between labour control and labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test analysis.  There was no significant difference in HSP90B1 mRNA  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.95, p=0.68) (Figure 7-12). 
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Figure 7-12: RQ values for HSP90B1 mRNA measurements in labour control (n=6) compared 
to the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
7.2.5 HSPH1 expression in normal pregnancies and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of HSPH1 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of HSPH1 between the three zones of the non-
labour and the labour groups (p=0.95, p=0.42 respectively) (Figure 7-13). 
 
Figure 7-13: RQ values for HSPH1 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of HSPH1.  Comparison between zones was performed using Friedman 
analysis. 
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Experiment 2:  This experiment was designed to test if there was any difference mRNA 
expression of HSPH1 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of HSPH1 in the labour 
group when compared to the non-labour group at the inner, middle and outer zones 
(p=0.81, p=0.13, p=0.81) (Figure 7-14). 
 
 
Figure 7-14: RQ values for HSPH1 mRNA measurements in non-labour (n=6) compared to 
the labour group (n=6) at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPH1 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney test analysis.  There was no significant difference in the HSPH1 mRNA was 
found at the inner and middle placental zones (p=0.26, p=0.38) (Figure 7-15). 
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Figure 7-15: RQ values for HSPH1 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of HSPH1 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in HSPH1 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.68, 
p=0.32) (Figure 7-16). 
 
Figure 7-16: RQ values for HSPH1 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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7.2.6 Results summary  
7.2.6.1 HSPA5 
Experiment 1:  Overall there was no significant spatial difference in mRNA expression of 
HSPA5 between the three zones of the placenta for both the non-labour and the labour 
groups. 
Experiment 2:  There was no significant difference in mRNA expression of HSPA5 in the 
labour group when compared to the non-labour group at the inner, middle and outer zones. 
 Experiment 3:  There was no significant increase in mRNA expression of HSPA5 in the 
non-labour PE group compared to the non-labour control group in the inner and middle 
zones. 
Experiment 4: There was no significant difference in mRNA expression of HSPA5 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
7.2.6.2 HSP90AA 
Experiment 1: There was no significant spatial difference in mRNA expression of 
HSP90AA between the three zones of the non-labour and labour groups. 
Experiment 2: There was a significant decrease in mRNA expression of HSP90AA in the 
non-labour group compared to the labour group at the outer zone (p=0.008).  There was no 
significant difference at the inner and middle zones. 
Experiment 3:  There was no significant difference in the mRNA expression of HSP90AA 
in the non-labour PE group compared to the non-labour control group at the inner and 
middle zones. 
Experiment 4: There was no significant difference in mRNA expression of HSP90AA in 
the labour control group compared to the labour PE group at the inner and middle placental 
zones. 
7.2.6.3 HSP90B1 
Experiment 1: There was no significant spatial difference in mRNA expression of 
HSP90B1 between the three zones of the non-labour and labour groups. 
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Experiment 2: There was a highly significant decrease in HSP90B1 mRNA expression in 
the non-labour group compared to the labour group at the outer zone (p=0.01).  There was 
no significant difference in HSP90B1 mRNA expression in the non-labour group when 
compared to the labour group at the inner and middle zones. 
Experiment 3:  There was no significant difference in the mRNA expression of HSP90B1 
in the non-labour PE group compared to the non-labour control group at the inner and 
middle zones. 
Experiment 4: There was no significant difference in mRNA expression of HSP90B1 in 
the labour control group compared to the labour PE group at the inner and middle placental 
zones. 
7.2.6.4 HSPH1 
Experiment 1:  Overall there was no significant spatial difference in mRNA expression of 
HSPH1 between the three zones of the non-labour and the labour groups. 
Experiment 2:  There was no significant difference in mRNA expression of HSPH1 in the 
labour group when compared to the non-labour group at the inner, middle and outer zones. 
Experiment 3:  There was no significant difference in the mRNA expression of HSPH1 in 
the non-labour PE group compared to the non-labour control group at the inner and middle 
zones. 
Experiment 4: There was no significant difference in mRNA expression of HSPH1 in the 
labour control group compared to the labour PE group at the inner and middle placental 
zones. 
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7.3 Discussion 
7.3.1 GRP78 expression in the labour and PE  
No changes in mRNA expression of GRP78 were found between non-labour and labour 
groups or between normotensive and PE pregnancies.  There was no zonal distribution.  
There are few publications in which GRP78 expression in the placenta, and changes during 
adverse pregnancy have been reported.  These studies can be summarized as follows. 
Mass spectrometry and two-dimensional (2D) electrophoresis was used to investigate 
expression of several trophoblast genes in non-labour at gestation 28-40 weeks and was 
compared to cases of PE (Jin et al., 2008).  They reported that GRP78 was up-regulated in 
human trophoblast of PE placenta compared to the control.  However, controlled sampling 
was not performed and labour was not studied. 
Western blotting and electronic microscopy was used  to investigate different stress 
pathways including GRP78 in 2
nd
 trimester and term of placentas obtained from non-
labouring PE patient (Yung et al., 2014b).  Controls included 2
nd 
trimester, pre-term and 
normal term, both labour and non-labour placentas.  This study showed that GRP78 was 
increased in early-onset PE compared with both late-onset PE and controls.  They found 
similar findings to our study, that there was no difference in GRP78 expression in late 
onset PE compared with controls however, they investigated protein levels and the present 
study measured mRNA.  In addition, systematic sampling methods and labour were not 
studied by Yung et al (Yung et al., 2014b). 
Some studies have examined GRP78 expression in early pregnancy and its roles in 
trophoblast invasion.  These studies can be summarized as follows. 
ICH and Western blot analysis was used to detect GRP78 in trophoblastic cells of first 
trimester placenta (Arnaudeau et al., 2009).  It was concluded that GRP78 is involved in 
regulation of P53 and trophoblast invasion.  
Western blotting and 2D electrophoresis analyses was used to investigate the effects of the 
cytokine IL11 (regulator of endometrium cell adhesion and trophoblast invasion) on 
GRP78 expression in villous trophoblast cells and EVT of first trimester placentas 
(Sonderegger et al., 2011).  They found that IL11 stimulated secretion of GRP78 in EVT 
and could play a role in trophoblast invasion. 
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In addition, some studies have examined GRP78 expression in early pregnancy and its 
roles in early pregnancy loss.  These studies can be summarized as follows: 
Western blotting, IHC and proteomic analysis was used to investigate GRP78 in decidua 
from early pregnancy loss cases compared to controls (termination of pregnancy for 
psychological cause) (Liu et al., 2010).  GRP78 was significant decreased in early 
pregnancy loss group. 
Immunofluorescence, IHC and Western blotting was used to investigate GRP78 expression 
in decidua from early pregnancy loss compared to controls (Gao et al., 2012).  This study 
showed that GRP78 was up-regulated in decidua cells treated with H2O2 in a dose 
dependent manner.  They concluded that high GRP78 associated with oxidative stress 
induced ER stress and might be involved in development of early pregnancy loss.  
A few studies reported that GRP78 could be uses as predictive marker of PE.  These 
studies can be summarized as follows. 
ELISA analysis was used to investigate GRP78 (C-term fragment, N-term fragment and 
full-length GRP78) and GRP78 autoantibodies in serum of PE women at term, women at 
the 1
st
 trimester who subsequently developed PE and control sera both at 1
st
 trimester and 
term pregnancy (Laverriere et al., 2009).  There was no significant difference in 
autoantibodies-GRP78 complexes or total GRP78 at both first trimester and at term.  
However, the ratio of C-terminal GRP78 over full length GRP78 was significantly 
increased in plasma of PE patients compared with controls both during the first trimester 
and at term.  They concluded that C-terminal GRP78 reflects the invasive properties of 
cells and could be used as PE predictive marker in early pregnancy. 
ELISA and Western blotting was used to investigate GRP78 expression in term placentas 
and anti-GRP78 antibodies were measured in serum of women with PE (mild and severe 
PE) compared with controls (Rezanezhad et al., 2013).  There was no significant difference 
between PE and healthy pregnancies however sub-analysis showed that anti-
GRP78 antibodies were increased in severe PE cases when compared to controls. 
A few studies have used cell culture to induce ER stress and then investigate GRP78 
expression as ER stress marker.  These studies can be summarized as follows 
Western blotting and RT-PCR was used to investigate the role of GRP78 in trophoblast 
fusion using the BeWo choriocarcinoma cell line as a model of CTB fusion (Fradet et al., 
299 
 
2012) as well as purified CTB from 1
st
 trimester and term placenta of PE and control 
subjects (Fradet et al., 2012).  This study showed that chemical inhibitors of GRP78 led to 
a decrease in forskolin-induced fusion capacity of BeWo cells (this highlighted role of 
membrane GRP78 in trophoblast fusion).  In PE placentas they showed that although 
GRP78 mRNA was increased in CTB, the membrane GRP78 was significantly decreased 
compared to control CTB.  They suggested that relocation of GRP78 from the ER to the 
trophoblast cell surface membrane is probably altered in PE. 
In PE there is impaired GRP78 relocation from ER to cell surface. Prostate apoptosis 
response 4 (Par-4) is a protein identified as a partner of GRP78 relocation to the cell 
surface in prostate cancer cells.  Cohen et al performed Western blotting, IHC and qRT-
PCR to investigate GRP78 expression in trophoblast cell surface  and whether (Par-4) is 
present in trophoblast and its role in translocation of GRP78 in term control CTB 
compared to the term PE CTB (Cohen et al., 2013).  This study showed that that 
overexpression of Par-4 led to an increase of cell surface expression of GRP78 and they 
suggested that regulates the invasive property of evCTB (Cohen et al., 2013). 
Western blotting had also been used to investigate GRP78 expression in the BeWo 
choriocarcinoma cell line as a model of placenta trophoblast (Repo et al., 2014).  This 
study found that GRP78 protein expression was increased after exposure to ROS inducer 
agents (ethanol and nicotine). 
7.3.2 HSP90AA and HSP90AB1 and the present findings 
This study shows that there was no spatial distribution in mRNA expression of HSP90AA 
or HSP90B1 between the three zones of the non-labour and labour groups.  The key 
finding was the fall in mRNA expression of HSP90AA and HSP90AB1 in the non-labour 
compared to the labour group at the outer zone.  There was no significant difference in 
mRNA expression of HSP90AA or HSP90AB1 in the normotensive group compared to the 
PE pregnancies.  The study again shows the importance of using a systematic method to 
sample the placenta. 
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7.3.3 HSP90AA and HSP90AB1 expression in the labour and PE 
HSP90 is a highly conserved molecular chaperone, assisting the folding and 
conformational stabilization of several proteins (client) that play a crucial role in growth, 
cell survival, and developmental processes (Zuehlke and Johnson, 2010).  HSP90 
substrates include steroid hormone receptors, receptor tyrosine kinases, signalling kinases 
and NF-ҡβ (Zuehlke and Johnson, 2010).  There are two isoforms of HSP90, HSP90α 
(inducible) and HSP90β (constitutive).  HSP90 has been identified as essential for placenta 
formation in mice.  HSP90 knockout fetuses grow until embryonic day 9.5 and then 
succumb due the non-expansion of the allantoic vasculature to form placental labyrinths 
(Voss et al., 2000). 
There are a few publications in which HSP90 expression in the human placenta and 
changes during adverse pregnancy have been reported.  These studies can be summarized 
as follows. 
One research group  performed an IHC study of HSP90 expression in pre-term labour, 
term labour, term non-labour and pre-term cesarean section for PE or FGR (Divers et al., 
1995).  No changes in HSP90 were reported however different tissues were studied namely 
amniochorion and basal plate.  The placenta itself was not examined and controlled 
sampling was not performed. 
On other research group used IHC to assess HSP90 expression in paraffin sections of 
placentae from normal term pregnancies and reported immunostaining on cell types, 
primarily in the nucleus (Shah et al., 1998).  This study also showed that HSP90 staining 
decreased with advanced gestation. Site of sampling or labour was not assessed. 
Ziegert et al performed immunofluorescence to investigate HSP90 and HSP90 antibody 
complex expression in term, pre-term and FGR placentas (Ziegert et al., 1999).  This study 
showed that HSP90 protein was expressed in placenta and there was no significant 
difference between all groups.  No data or p values were shown to support this statement 
and no systematic sampling was performed. 
Wataba et al  performed IHC to investigate HP90 in second and third trimester of  FGR 
placentas (Wataba et al., 2004).  This study showed that HSP90 protein expression was 
increased in the CTB and STB layer.  In addition, HSP90 were increased in syncytial knots 
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and avascular villi whereas it was reduced in the presence of infarction.  Systemic 
sampling methods were not performed. 
Sotiriou et al  performed IHC to investigate HSP90 in first trimester of missed 
miscarriages and term placentas (Sotiriou et al., 2004).  This study showed that HSP90 was 
increased in chorionic villi of 1
st
 trimester placentas in the STB, CTB, vessel and stroma 
cells compared to term placentas.  In addition, there was a statistically significant increase 
of HSP90A expression in chorionic villi of 1
st
 trimester placentas only in the CTB cells 
compared to full-term placentas (Sotiriou et al., 2004).  
Cindrova-Davies et al   performed Western blotting to compare oxidative stress markers in 
the non-labour, short labour and long labour. (Cindrova-Davies et al., 2007b)  This study 
reported that there was significant increase in HSP90 protein expression in long labour 
group compared to the short labour group.  Since systemic sampling was not performed, it 
is impossible to directly compare the present study with that one. 
Zhang et al  performed Western blotting to investigate HSP90 expression in term placentas 
of PE and controls (Zhang et al., 2011).  This study showed that HSP90 protein expression 
was decreased in PE placentas.  No systemic sampling was performed and labour was not 
studied. 
Padmini and Lavanya  performed Western blotting and immunofluorescence to investigate 
HSP90 (Padmini and Lavanya, 2011a).  This study found that protein expression of HSP90 
was increased in endothelial cells of PE placenta when compared to normotensive subjects.  
Systemic sampling was not performed and labour was not studied. 
The same research group (Padmini and Lavanya, 2011a, Padmini et al., 2012a) using 
ELISA and Western blotting found that expression of HSP90 was increased in PE 
endothelial cells when compared to normotensive subjects. 
Ermini et al performed Western blotting, double affinity chromatography and mass 
spectrometry to investigate HSP90 in trophoblast cells line exposed to different oxygen 
concentration and placenta tissue of 1
st
 and 3
rd
 trimester placentas (Ermini et al., 2013).  
This study reported that HSP90 expression is not affected by varying oxygen tension.  
However, the O-glycosylated isoform of HSP90 is expressed in an O2 dependent manner. 
They concluded that oxygen tension is crucial in modulating glycosylation of proteins 
during placental development. 
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Yung et al performed Western blotting to investigate HSP90 over different time periods 
(10, 20, 30 and 45 min) after delivery of non-labour normotensive placentas (Yung et al., 
2014a).  This study showed that HSP90 did not change over time period.  Systemic 
sampling was not performed. 
7.3.4 HSPH1 (HSP105/HSP110) and present finding  
The study showed that HSPH1 mRNA is expressed in human placenta.  No changes in 
mRNA expression of HSPH1 between non-labour and labour groups or normotensive 
compared to PE pregnancies were found.  There was no zonal distribution. 
7.3.5  HSPH1 expression in the placenta 
One study investigated HSP105 expression in human chorionic villus tissue at 10-17 weeks 
of a normal pregnancy after exposure to heat shock or sodium arsenite or cadmium 
chloride (Honda et al., 1991).  This study showed that HSP105 protein expression was 
increased after exposure to heat shock, sodium arsenite and cadmium chloride through 10-
17 weeks of pregnancy (Honda et al., 1991). 
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Chapter VIII: Analysis of mRNA expression of 
Caspases (CASP3, 7 and 9) apoptotic markers in 
human placenta of normal pregnancies and 
pregnancies complicated with PE 
8 Caspases (CASP3, 7 and 9) expression  
8.1 Introduction  
8.1.1 Apoptosis 
Apoptosis is a form of programmed cell death, which is responsible for the removal of 
unwanted cells during development and adult homeostasis.  Apoptosis is an active form of 
cell death dependent on the internal machinery of the cell; this process is distinguished 
from necrosis which is an unplanned and accidental death caused by external factors 
(Balvan et al., 2015)  During apoptosis cells shrink, detach and end up forming small 
pieces (apoptotic bodies), which are cleared immediately by phagocytes (Muñoz-Pinedo, 
2012).  During apoptosis, cells maintain integrity of their plasma membrane which helps to 
avoid inflammation.  Cell death by necrosis, which occurs due to uncontrolled tissue 
damage, is a passive form of cell death that triggers inflammation pathways.  Apoptosis is 
known to occur in a number of biologic processes, both physiological for example 
involution and atrophy of post-lactational breast and pathological including all neoplastic 
growths, cytotoxic cells and tissues exposed to low dosage of toxic stimuli (Smith et al., 
1997).  Abnormal regulation of cell execution of apoptosis is accomplished by activation 
of caspases, which are regulated by Bcl-2 family members and which are the final effectors 
in apoptosis (Steller, 1995, Cohen, 1997).  Apoptosis in different tissues has been 
implicated in the onset and progression of several diseases include cancer, autoimmune 
disease and neurodegenerative disorders (Leung et al., 2001, Shalini et al., 2014) 
Caspases (CASPs) are a family of cysteine proteases that play critical roles in apoptosis, 
necrosis and inflammation (Muñoz-Pinedo, 2012, Shalini et al., 2014).  Caspases exist as 
inactive proenzymes that are proteolytically activated at conserved aspartic residues to 
produce two subunits, large and small, that dimerize to form the active enzyme (Alnemri et 
al., 1996).  The caspase family consist of 10 members 1-12 (CASP1-10).  Caspases are 
regulated by post translational modification to ensure that they can be rapidly activated 
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leads to an irreversible proteolytic cascade that ends up killing the cell. CASPs are 
classified into two groups based on their sequence homology and their role in cascade: 
initiator (apical) and executioner (effector) caspase. Initiator  (CASPs 2, 8, 9 and 10) have 
a long domain in the N-terminus that are responsible for interactions between initiator 
caspases and the molecules which activate them (Mattson and Chan, 2002, Muñoz-Pinedo, 
2012).  The effector caspases (CASPs 3, 4, 5, 6, 7, 11, 12 and 13) are inactive until they are 
cleaved by initiator caspases (Mattson and Chan, 2002, Muñoz-Pinedo, 2012). 
Apoptosis has been reported to be a common feature observed in trophoblast cells in the 
PE and FGR placenta at term (Leung et al., 2001, Bahr et al., 2014).  Abnormal regulation 
of apoptosis has been implicated in the onset and progression of a broad range of diseases 
(Hetts, 1998, Muñoz-Pinedo, 2012, Shalini et al., 2014). 
Apoptosis is controlled by two mechanisms: the mitochondrial (intrinsic) pathway and 
death receptor (extrinsic) pathway. 
8.1.1.1 Intrinsic pathways 
The outer mitochondrial membrane becomes permeabilized, resulting in release of 
molecules to the cytosol by a reaction controlled by Bcl-2 and Bcl-2 protein (B cell 
lymphocytic-leukaemia proto-oncogene released proteins), which contain pro-apoptotic 
members such as Bax (Zong et al., 2001, Lanneau et al., 2008). Bax (alone or in 
combination with sessile proteins) may play a role in pore formation in outer mitochondrial 
membrane (Zamzami and Kroemer, 2001).  The intrinsic pathway is based on the 
cytochrome c dependent activation of CASPs, special proteases which are involved in 
cleavage and processing of more than 300 different cellular proteins (Fischer et al., 2003).  
Cytochrome c is an intermembrane protein; different signals include oxidative stress 
irradiation and other stress lead to release it from mitochondria, which once in the cytosol, 
it interacts with Apaf1.  Oligomerization of Apaf-1 then binds to cytosolic pro-caspase-9 
and leading to formation of apoptosome (Li et al., 1997), which leads to activation of pro-
caspase-9, which in turn cleaves pro-caspase-3, the main caspase effector during apoptosis 
(Mignotte and Vayssiere, 1998, Mymrikov et al., 2011) (Figure 8-1). 
8.1.1.2 Extrinsic pathway 
The extrinsic pathway apoptosis is dependent on special membrane receptors know as 
plasma membrane death receptors that are members of the TNF receptor gene superfamily, 
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their activation leads to the direct activation of the receptor-proximal CASP8 or CASP10 
in the death-inducing signalling complex (DISC) (Elmore, 2007).  
The Fas receptor plays an important role in induction of apoptosis activating two different 
signal pathways.  First by binding of a special ligand (FasL) to the Fas receptor promotes 
interaction of the Fas receptor with Fas associated-death-domain (FADD) protein which 
activates pro-caspase-8 and downstream CASPs (CASP3, 6, and 7) (Charette et al., 2000) 
(Figure 8-1).  Secondly, binding of Fas-ligand promotes interaction of the Fas receptor 
with Daxx, and induction of apoptosis relies on translocation of Daxx from the nucleus to 
the cytosol, and its interaction with Fas receptor is probably followed by activation of 
Ask1. 
In addition, apoptosis can be activated through ER/Ca
2+
-mediated CASP12 pathways.  
Mitochondria can also release AIF and endonuclease G (EndoG), which lead to apoptosis 
independent of caspase activation (Kwak, 2013). 
 
 
 
Figure 8-1: Apoptotic signaling pathways with overview of two major caspases-dependent 
apoptotic including (1) cytokines/Fas-mediated CASP8 pathways, (2) mitochondrial-
mediated CASP9 pathways.  Modified from (Kwak, 2013).  
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8.1.2 CASPs in inflammation and immunity 
CASPs play an important role in inflammation pathways, for example CASP1 is involved 
in processing and maturation of inflammatory mediators such as IL-1β and IL-18 (Ghayur 
et al., 1997).  There are several caspases, which have been identified as important 
mediators of the innate immune response including CASP1, 4, 5 and 12. Pyroptosis is 
triggered by CASP1 after its activation by various inflammasomes and results in lysis of 
the affected cell (Miao et al., 2011).  Both pyroptosis and apoptosis are programmed cell 
death mechanisms but are dependent on different caspases and results in cellular laysis and 
release of the cytosolic contents to the extracellular space (Miao et al., 2011).  CASP12 can 
inhibit the inflammatory response by inhibiting CASP1.  
8.1.3 Apoptosis and HSPs 
HSPs are a family of proteins that respond to different kinds of environmental and 
physiological stress (Garrido et al., 2006).  HSPs function as molecular chaperones in 
regulating cellular homeostasis and promoting cell survival by blocking caspase-dependent 
apoptosis.  HSPs have been shown to block apoptosis by interfering with caspase 
activation.  
HSP27 functions include acting as a protein chaperone, control of apoptosis, regulation of 
cell glutathione levels, inhibition of actin polymerisation as well as protection against heat 
shock, oxidative stress and mechanical stress (Lanneau et al., 2010).  HSP27 is known to 
be involved in the inhibition of apoptosis in several tissues (Paul et al., 2002). HSP27 
inhibits CASP3 and 9 (GARRIDO et al., 1999), HSP27 increases cell survival by affecting 
both upstream signalling and downstream effector events in the apoptotic pathway (Tezel 
and Wax, 2000, Lanneau et al., 2008).  In the placenta, HSP27 is localized in the 
trophoblast cells and upregulated in the placenta of PE (Shin et al., 2010, Abdulsid and 
Lyall, 2014).  During labour HSP27 is down-regulated suggesting a role for this molecule 
during pregnancy (Abdulsid et al., 2013a).  HSP27 prevent activation of pro-caspase-9 and 
3 like Bcl-2 (GARRIDO et al., 1999).  HSP27 does not prevent cytochrome C and AIF 
release from the mitochondria or translocation of AIF to the nucleus (inhibitory effect is 
specific for cytochrome C, caspase dependent apoptotic pathway).  HSP27 interacts with 
cytosol cytochrome C and prevents apoptosome formation (Parcellier et al., 2006). P-
HSP27 is associated with the Daxx  pathway (caspase-independent pathway) (Charette et 
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al., 2000).  The non-phosphorylated oligomer is the active form of HSP27 in caspase-
dependent pathway (Garrido et al., 2006). 
HSP70 inhibits apoptosis downstream of the release of cytochrom c and upstream of the 
activation of CASP3 by modulation of the apoptosome (Schmitt et al., 2007).  HSP70 has 
anti-apoptotic activity which includes: binding to the Apaf-1 and prevent recruitment of 
pro-caspase-9 to the apoptosome (Saleh et al., 2000, Li et al., 2000).  HSP70 also  binds to 
AIF and inhibits chromatin condensation (Ravagnan et al., 2001),  HSP70 rescues cells 
from late apoptosis (TNF-induced apoptosis), prevents downstream morphological 
changes, acts at an early stage by preventing JNK activation (Meriin et al., 1999, Lanneau 
et al., 2008).  Furthermore, HSP70/Bag-1 regulates Raf-1/ERK kinase and cell growth in 
response to stress (Song et al., 2001).   
HSP90 can inhibit apoptosis by preventing caspase activation as a result of  a negative 
effect on Apaf-1 function (Pandey et al., 2000).  In addition, HSP90 anti-apoptotic 
properties is also reflected by its capacity to interact with phosphorylated serine kinase 
Akt, phosphorylated Akt can phosphorylate the Bcl-2 family protein Bad and CASP9 
(Schmitt et al., 2007) leading to their inactivation and to cell survival.  Furthermore, it has 
been shown that p53 represses HSP90 gene expression in Ultraviolet (UV)-irradiated cells 
(Zhang et al., 2004).  Moreover, the HSP90 family protein GRP94 was shown to inhibit the 
action of the calcium-dependent proteases calpains and protect against IR injury induced 
apoptosis involving calpains (Bando et al., 2003).  
Cytosolic HSPD1 forms a complex with the pro-apoptotic protein Bax (Gupta and 
Knowlton, 2002).  Under stress conditions HSPD1 and Bax dissociate and Bax translocates 
to the mitochondria and induces apoptosis and the interaction with HSPD1 prevents the 
apoptosis. 
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8.2 Results  
8.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
8.2.2 CASP3 mRNA expression in the labour and PE 
Experiment 1:  This experiment was designed to test if there was a spatial difference in 
mRNA expression of CASP3 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression of CASP3 between the three zones of the non-
labour and labour groups (p=0.42, p-0.74) (Figure 8-2). 
 
 
 
Figure 8-2: RQ values for CASP3 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of CASP3.  Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of CASP3 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of CASP3 in the non-
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labour group when compared to the labour group at the inner, middle and outer zones 
(p=0.48, p=0.58, p=0.93 respectively) (Figure 8-3). 
 
 
Figure 8-3: RQ values for CASP3 mRNA measurements in non-labour (n=6) compared to the 
labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3:  This experiment was designed to test if there was any difference in mRNA 
expressions of CASP3 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test.  There was no significant difference in CASP3 mRNA at the inner and 
middle zones (p=0.26, p=1 respectively) (Figure 8-4). 
 
Figure 8-4: RQ values for CASP3 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
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Experiment 4:  This experiment was designed to test if there was any difference in mRNA 
expressions of CASP3 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was a significant decrease in mRNA expression of CASP3 in the 
labour PE group compared to the labour control group at the middle placental zone 
(p=0.04).  No difference was found at the inner zone (p=013) (Figure 8-5). 
 
Figure 8-5: RQ values for CASP3 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
8.2.3 CASP7 mRNA expression in the labour and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of CASP7 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression between the three zones of the non-labour and 
labour groups (p=0.14, p-0.95) (Figure 8.6). 
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Figure 8-6: RQ values for CASP7 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of CASP7.  Comparison between zones was performed using Friedman 
analysis. 
 
Experiment 2:  This experiment was designed to test if there was any difference in mRNA 
expression of CASP7 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was a significant decrease in mRNA expression of CASP7 in the non-
labour group when compared to the labour group at the middle zone (p=0.04). No 
difference was found at the inner and outer zones (p=0.81, p=0.3) (Figure 8-7). 
 
Figure 8-7: RQ values for CASP7 mRNA measurements in non-labour (n=6) compared to the 
labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
312 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of CASP7 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test.  There was a significant decrease in the CASP7 mRNA in the non-labour-PE 
group compared to the non-labour control group at the inner zone (p=0.04). There was no 
significant difference in the CASP7 mRNA was found at the middle zone (p=0.16) (Figure 
8.8). 
 
 
Figure 8-8: RQ values for CASP7 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of CASP7 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in mRNA expression of CASP7  in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones (p=0.95, p=0.08) (Figure 8-9). 
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Figure 8-9: RQ values for HSPB2 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
8.2.4 CASP9 mRNA expression in the labour and PE 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
mRNA expression of CASP9 within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in mRNA expression between the three zones of the non-labour and 
labour groups (p=0.42, p=0.95) (Figure 8-10). 
 
Figure 8-10: RQ values for CASP9 mRNA measurements in in inner (n=4), middle (n=4) and 
outer (n=4) zones of individual placentas (non-labour and labour groups, 6 placentas in 
each group).  Four quadrants were sampled in each zone. Graphs show the median for 
mRNA expressions of CASP9.  Comparison between zones was performed using Friedman 
analysis. 
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Experiment 2: This experiment was designed to test if there was any difference in mRNA 
expression of CASP9 between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was no significant difference in mRNA expression of CASP9 in the 
non-labour group when compared to the labour group at the inner, middle and outer zone 
(p=0.39, p=0.93, p=0.3) (Figure 8-11). 
 
Figure 8-11: RQ values for CASP9 mRNA measurements in non-labour (n=6) compared to 
the labour (n=6) group at the inner, middle and outer placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in mRNA 
expressions of CASP9 between non-labour control and non-labour PE groups at the inner 
or middle zones of placentas.  Comparison between zones was performed using the Mann 
Whitney test analysis.  There was a significant decrease in the mRNA expression of 
CASP9 in the non-labour PE group compared to the non-labour control at middle zone 
(p=0.04). No difference was found at the inner zone (p=0.26) (Figure 8-12). 
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Figure 8-12: RQ values for CASP9 mRNA measurements in non-labour control (n=6) 
compared to the non-labour PE (n=3) groups at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 4: This experiment was designed to test if there was any difference in mRNA 
expressions of CASP9 between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
test analysis.  There was no significant difference in CASP9 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.86, 
p=0.6) (Figure 8-13). 
 
 
Figure 8-13: RQ values for CASP9 mRNA measurements in labour control (n=6) compared to 
the labour PE (n=6) groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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8.2.5 Results summary  
8.2.5.1 CASP3 
Experiment 1: There was no significant spatial difference in mRNA expression of CASP3 
expression between the three zones of the non-labour and labour groups. 
Experiment 2: There was no significant difference in mRNA expression of CASP3 in the 
non-labour group when compared to the labour group at the inner, middle and outer zones 
Experiment 3: There was no significant difference in the mRNA expression of CASP3 in 
the non-labour control group compared to the non-labour PE group at the inner zone and 
middle zones. 
Experiment 4: There was a significant increase in mRNA expression of CASP3 in the 
labour PE group compared to the labour control group at the middle placental zone 
(p=0.04). No difference was found at the inner zone. 
8.2.5.2 CASP7 
Experiment 1: There was no significant spatial difference in mRNA expression of CASP7 
expression between the three zones of the non-labour and labour groups. 
Experiment 2: There was a significant decrease in mRNA expression of CASP7 in the non-
labour group when compared to the labour group at the middle zone (p=0.04).  No 
difference was found at the inner and outer zones. 
Experiment 3: There was a significant decrease in the mRNA expression of CASP7 in the 
non-labour-PE group compared to the non-labour control group at the inner zone (p=0.04). 
There was no significant difference in the CASP7 mRNA was found at the middle zone. 
Experiment 4: There was no significant difference in mRNA expression of CASP7 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones. 
8.2.5.3 CASP9 
Experiment 1: There was no significant spatial difference in mRNA expression of CASP9 
expression between the three zones of the non-labour and labour groups. 
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Experiment 2: There was no significant difference in mRNA expression of CASP9 in the 
non-labour group when compared to the labour group at the inner, middle and outer zones. 
Experiment 3: There was a significant decrease in the mRNA expression of CASP9 in the 
non-labour PE group compared to the non-labour control at middle zone (p=0.04).  No 
difference was found at the inner zone. 
Experiment 4: There was no significant difference in mRNA expression of CASP9 in the 
labour control group compared to the labour PE group in the inner or middle placental 
zones.  
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8.3 Discussion  
8.3.1 CASPs mRNA expression and key findings  
There was no spatial distribution in mRNA expression of CASP3, 7 and 9 across 
individual placentas.  When non-labour was compared to the labour group, there was a 
significant decrease in mRNA expression of CASP7 in the non-labour group at the middle 
zone.  There was no significant difference in mRNA expression of CASP3 and CASP9.  
When the non-labour control was compared to the non-labour PE there was a significant 
decrease in the mRNA expression of CASP7 (inner) and CASP9 (middle) in the non-
labour-PE group.  When the labour control was compared to the labour PE group, there 
was a significant increase in mRNA expression of CASP3 in the labour PE group at the 
middle zone.  No other differences were found. Although the reason for this differential 
expression is unclear, again it highlights the importance for systemic sampling methods. 
8.3.2 CASPs mRNA expression in the human placenta during 
labour and PE 
Apoptosis is a feature of villous trophoblast throughout pregnancy and is an essential 
feature of placental invasion and STB function as well as playing a role in maternal 
immune tolerance.  The amount of apoptosis in placental villi changes throughout normal 
pregnancy.  The incidence of apoptosis in pregnancy increases from the first to the third 
trimester (Smith et al., 2000b), and markedly accelerates beyond 40 wks of gestation 
(Athapathu et al., 2003, Sharp et al., 2010).  Apoptosis within the villus is predominantly 
localized to the STB but not CTB at term and a very low incidence in CTB of 1
st
 trimester 
placenta (Burton et al., 2003).  In addition, STB shows feature consistent with apoptosis 
including CASP8 and 9 activation, cytokeratin-18 cleavage, and DNAse activity (Kadyrov 
et al., 2001, De Falco et al., 2004, Sharp et al., 2010).  
Trophoblast apoptosis is regulated by the interplay of pro and anti-apoptotic events 
(Heazell and Crocker, 2008).  Trophoblast express TNF receptors, Fas and Fas ligand, and 
TNF-related apoptosis-inducing ligand (TRAIL), which may play a role in both apoptosis 
and immune regulation (Abrahams et al., 2004c, Bai et al., 2009).  In addition, other 
factors control trophoblast apoptosis including the transcription factor p53 and members of 
the Bcl-2 family (Sharp et al., 2010). 
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Apoptosis that occurs in the placenta from following vaginal delivery may be of little 
physiological consequence because by this time of delivery the placenta will have 
completed its function.  However, it has been shown (Cindrova-Davies et al., 2007b) that 
intermittent perfusion of the placenta stimulates apoptotic changes, which may explain 
increased apoptosis in PE placentas (Leung et al., 2001).  Apoptotic debris transported into 
the maternal circulation in PE can lead to activation of maternal endothelium.  
One study examined the expression of cleaved CASP3, 9 in placentas of non-labour, short 
and long labour (Cindrova-Davies et al., 2007b).  This study showed that there was no 
difference in CASP3 and 9 expression between labored groups, however, IHC examination 
showed an increased in trophoblast apoptosis as evidenced by the cleavage of cytokeratin 
filaments in the labour group.  In our study there was a significant increase in CASP7 in 
the labour group but not CASP3 and 9, however, it is not possible to compare the two 
studies due to differences in sampling methods. 
Di Santo et al  performed  experiments using human term placentas using both villous 
explant culture and dual perfusion (Di Santo et al., 2003).  They compared trophoblast 
viability during perfusion and in explants cultured under various conditions by monitoring 
several factors include apoptotic cell death.  They performed TUNEL assays and IHC to 
analysis apoptotic cell death by detecting CASP3.  This study showed that prominent cell 
death after 7 h in explant culture compared to dual perfusion experiment in which the 
expression was similar as in native tissue.  
Increased levels of villous trophoblast apoptosis have been identified in placental 
pathologies including PE (Heazell et al., 2008).  In PE increased levels of syncytial derived 
cytokeratin M30 neoepitope can be detected in maternal serum (Hamad et al., 2009).  
Apoptosis has been implicated in both labour and PE.  In the apoptotic pathway, many key 
proteins and cytokines are involved.  For example, HSPs act at several stages to prevent 
cell death initiated by stress-induced damage (Jäättelä, 1999, Kampinga et al., 2009, 
Borges et al., 2012).  
In pregnancy complications there is exaggerated apoptosis due to IR injury and oxidative 
stress (Sharp et al., 2010).  In addition, villous trophoblast from placentas of pregnancies 
complicated by PE show increased susceptibility to apoptosis, these changes rendering 
these cells more vulnerable to oxidative damage (Leung et al., 2001, Ishihara et al., 2002). 
320 
 
In PE apoptosis has been associated with a reduction in STB with excessive syncytial loss 
and alterations in a variety of pro- and anti-apoptotic proteins.  There are some 
publications which show that caspase expression in the placenta changes during adverse 
pregnancy.  These studies can be summarized as follows. 
One research group performed electronic microscopy to investigate apoptosis markers 
(apoptotic nuclei) in villous trophoblast of (>34 wk of gestation) placentas of PE compared 
to control  pregnancies (Leung et al., 2001).  This study showed that there was increased 
apoptosis in PE placentas. 
Another  research group performed IHC and electronic microscopy to investigate apoptosis 
markers in villous trophoblast in term placentas (Ishihara et al., 2002).  This study showed 
that there was an increased TUNEL-positive nuclei in PE in both STB and CTB. BcL-2 
was reduced in severe PE but there was no difference in Fas. 
Hung et al performed Immunofluorescence to investigate CASP3 in villus tissue of term 
non-labour placenta exposed to hypoxia-reoxygenation (Hung et al., 2002).  This study 
reported that there was increased active CASP3 staining in the STB and fetal endothelial 
cells (similar to us). 
Bose et al  performed villous trophoblast culture (mum blood) to investigate CASP7 
expression after  magnesium induced placental apoptosis with or without aspirin (Bose et 
al., 2005).  This study showed that cleaved and activated form of CASP7 was absent in the 
presence of aspirin. 
Chen et al performed  cell based ELISA and electronic microscopy to investigate how anti-
phospholipid antibodies affect trophoblast shedding from the placenta (Chen et al., 2009).  
This study showed decreased CASP3 and 7 in shed trophoblasts.  They concluded that 
anti-phospholipid antibodies are transported into trophoblasts where they affect the 
regulation of the cell cycle leading to excess death and trophoblast shedding (Chen et al., 
2009). 
Shomer et al performed trophoblast culture experiments to examine the effect of 
microvesicles on early-stage or term trophoblast and endothelial cells.  They used flow 
cytometry and fluorescence microscopy to investigate CASP3 and 7 activities. This study 
investigated the effect of microvesicles (membrane vesicles, found in blood circulation of 
pregnant women) of normal and PE pregnancies (Shomer et al., 2013).  The study showed 
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that in endothelial cells, microvesicles of healthy pregnant women reduced CASP3 and 7 
activities.  Microvesicles of women with PE increased term trophoblast apoptosis and 
inhibited early-stage trophoblasts migration compared with cells exposed to microvesicles 
of healthy pregnant women.  They concluded that microvesicle effects on trophoblast cells 
vary according to the physiological/pathological state of a pregnant woman (Shomer et al., 
2013). 
Toro et al used human placenta choriocarcinoma BeWo, first trimester Swan-71 cell lines 
and human placental explants to investigate CASP3 expression in response to addition of 
leptin. (Toro et al., 2014).  This study showed that CASP3 was decreased after addition of 
leptin in does dependent manner.  They suggested that leptin has an anti-apoptotic effect 
in the placenta is in part mediated by the p53 pathway. 
Co et al (Co et al., 2015) performed Western blotting and IHC to investigate inflammatory 
and apoptotic markers in term placenta of PE compared to control subjects.  This study 
showed that CASP9 was up-regulated in PE placenta compared to controls.
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Chapter IX: Analysis of mRNA expression of TLRs, 
MyD88 and NF-κB families in human placenta of 
normal pregnancies and pregnancies complicated 
with PE 
9 TLR expression in the placenta during labour 
and PE 
9.1 Introduction  
9.1.1 Toll-like receptors (TLRs) and innate immunity  
TLRs are a type of pattern recognition receptors (PRRs) that has been shown to play a 
crucial role in the innate immune response and inflammation process.  TLRs are membrane 
spanning receptors that bind to and are activated by, several products include exogenous 
micro-organisms products ligands, such as bacterial, viral, fungi and parasitic and 
endogenous ligands including heat shock protein 60 and 70, fibronectin and surfactant 
protein A (Beutler, 2009). 
9.1.2 Human immune system 
The immune system is a system of biological structures and processes that allow the host 
defence mechanism against pathogens.  The immune system detects a wide range of 
pathogens and distinguishes them from the human’s own tissue.  The immune system is 
divided into two categories which are adaptive (specific) immunity and innate (non-
specific) immunity (Grasso, 2003). 
9.1.2.1 Adaptive immunity  
The adaptive immune response is a subsystem of the immune system that allows the 
human immune system to attack pathogens.  The adaptive immune system is characterized 
by specificity and memory and the responses work through humoral immunity and cell-
mediated immunity.  The cells of the acquired immune system are T and B lymphocytes. 
Major functions of adaptive immunity are recognition of (non-self) antigens by antigen 
presentation, generation of the immune responses and subsequently developing the 
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immunological memory for cells to eliminate pathogen in future infection.  Adaptive 
immunity responses provide long lasting protection and counter effect of stronger attacks 
by the same pathogen on subsequent exposure.  
9.1.2.2 Innate immune system 
The innate immune provides immediate defence against infection through opsonisation, 
phagocytosis and activation of the complement and inflammatory cascades.  Immune 
responses are initiated by PRRs, which recognize microbial components that are essential 
for structures and survival of the microorganism (Beutler, 2009).  Different PRRs react 
with specific ligands and lead to distinct anti-pathogen responses. PRRs can be divided 
into few categories based on their subcellular localization and function (Table 9-1) 
(Hargreaves and Medzhitov, 2005). 
TLRs form the major class of PRRs in drosophila, and mammals including humans 
(Kumar et al., 2009).  TLRs play a major role in pathogen recognition and initiation of 
inflammatory and immune responses.  Recognition of pathogen-associated molecular 
patterns (PAMPs) through TLRs, either alone or in hetrodimerization with other TLR or 
non- TLR receptors, triggers signals responsible for activation of innate immune response 
(Kumar et al., 2009, Beutler, 2009).  Stimulation of TLRs by pathogen products will result 
in induction of anti-pathogen genes and inflammatory cytokines through activation of 
signalling pathways.  TLRs also trigger dendritic cell maturation that lead to increase in the 
antigen-presenting capacity.  In addition, TLRs help to initiate the adaptive immune system 
through the activation of professional antigen-presenting. 
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Table 9-1: Pattern Recognition Receptors (PRRs), location and functions.  
 
9.1.3 TLRs 
TLR family members are expressed differentially in a variety of cells and tissues, including 
innate immune system cells such as T and B lymphocytes and non-immune cells.  TLRs 
are localized both on the cellular membrane and within the cellular compartment.  TLRs 
are highly conserved family of type I trans-membrane glycoprotein receptors with 
molecular weights between 90 and 115 kDa and containing 16-28 extracellular leucine-rich 
repeat domains (Akira, 2004a).  In 1996, insect Toll initially identified as a receptor 
essential for dorso-ventral axis in early development of Drosophila has been shown to be 
essential for immune response against fungal infection (Lemaitre et al., 1996).  These 
findings led to identification of TLRs in mammals; of twelve (TLR1–12) have been 
identified to date (Takeda and Akira, 2001, Akira, 2004b, Beutler, 2009).  TLR11 function 
has not been documented in humans (Yarovinsky et al., 2005).  TLRs are located either on 
the cell membrane (TLR1, TLR2, TLR4, TLR5 and TLR6) or intracellularly (TLR3, 
TLR7, TLR8 and TLR9).  TLRs are characterized by a cytoplasmic signalling domain and 
extracellular domains.  The cytoplasmic domain of TLRs is similar to IL-1 receptor family 
and it is called Toll/IL-1 receptor (TIR) (O'Neill and Dinarello, 2000, Liew et al., 2005).  
However, despite this similarity the extracellular domains are structurally unrelated. TIR 
also exists as intracellular proteins that are named adaptors as they bind through this 
domain to ligand receptors in order to transmit signals inside the cells (Bauer, 2008).  
Myeloid differentiation factor 88 (MyD 88) is one of these adaptors that binds to TLRs and 
Location  PRRs Types  Function  
Soluble PRR c-reactive protein (CRP), 
acute phase proteins and 
mannan-binding lectin 
Opsonins and pathogen elimination by 
activation of  phagocytic and complement 
systems (Gazi and Martinez-Pomares, 2009). 
Intra-
membrane 
PRR  
TLRs (1,2,4,5 and 11) 
scavenger receptors 
(Taylor et al., 2005) 
Enhance the antigen uptake and medicate the 
signalling pathways (Geijtenbeek et al., 
2004). 
Intracellular 
PRR  
TLRs(3,7,8 and 9) Medicate the signalling pathways by 
activation of gene expression and production 
of pro-inflammatory cytokines (Iwasaki and 
Medzhitov, 2004). 
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IL-1RI. TLRs and IL-1RI share similar pathways that activate the NF-κB, MAPKs, p38 
and c-Jun N-terminal kinase (JNK).  Activation of these pathways results in set of genes 
being expression that lead to production of essential molecules for the activation and 
regulation of immune system including chemokines, cytokines and co-stimulatory factors 
(Bauer, 2008).  However, TLRs bind to different adapters which specifically mediate 
certain pathways such as MyD 88-adapter, TRIF-related adapter molecule (TRAM) and 
TIR domain-containing adapter-inducing interferon-B (IFN-B). 
9.1.4 TLRs and their ligands  
TLRs recognise their own unique ligands known as PAMPs. TLR ligands are varied 
including bacterial cell wall or DNA components, viral, fungal and parasites.  TLRs also 
binds with autologous molecules include heat shock proteins,  intracellular products and 
genomic DNA (Ohashi et al., 2000a, Kumar et al., 2009). 
9.1.4.1 TLR1, TLR2 and TLR6 
The TLR1 gene is ubiquitously expressed, and at higher levels than other TLR genes.  
TLR2 recognizes components from a variety of microorganisms including gram negative 
and positive bacteria, spirochetes and mycoplasma (Takeda et al., 2003).  TLR2 is a 
membrane protein which recognises of bacterial lipo-peptides and is up-regulated during 
various disorders.  TLR2 ligand recognition involves cooperation with other TLR family 
members, in particular TLR6 and TLR1 to mediate intracellular signalling (Farhat et al., 
2008).  TLR2 with TLR1 or TLR6 heterodimerization developed to expand the ligand 
spectrum to enable the innate immune system to recognize several different structures of 
lipo-peptides present in various pathogens (Farhat et al., 2008).   
TLR6 functionally cooperates with TLR2 to recognize microbial lipo-peptides (Takeuchi 
et al., 2001).  A TLR6 polymorphism may be associated with an increased risk of several 
diseases for example legionnaire’s disease (Misch et al., 2013).  Furthermore, TLR1, 
TLR2, and TLR6 polymorphisms are associated with increased susceptibility to skin 
structure infections (Stappers et al., 2014). 
9.1.4.2 TLR3  
TLR3 mediates immune responses toward viral dsRNA. TLR3 play a role in response to 
herpes viruses (Gregory and Damania, 2009).  TLR3 is also activated by influenza A and 
Kaposi’s sarcoma-associated herpes viruses (Guillot et al., 2005).  In addition, TLR3 has 
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unique function to recognition of dsRNA as it expressed in mature dendritic cells (Muzio 
et al., 2000).  TLR3 has unique structural features among TLRs, it lacks the proline 
residue.  The activation of TLR3 by viral ligand and TLR4 by bacteria LPS result in 
increased trophoblast secretion of chemokines which lead to monocyte and neutrophil 
chemotaxis. 
9.1.4.3 TLR4  
TLR4 detects lipopolysaccharide from gram negative bacteria and is important in the 
activation of innate immune system (Takeda et al., 2003).  In addition, TLR4 recognizes 
some endogenous ligands such as HSPs (Table 9-2).  HSP60 is the best studied HSP for 
activation of the immune system, this activation is mediated by TLR4 (Vabulas et al., 
2001).  In addition, TLR4 seems to be responsible for the inflammatory responses elicited 
by HSPs and  both TLR2 and TLR4 are required for recognition of HSP70 (Asea et al., 
2002). 
9.1.4.4 TLR5 
TLR5 recognizes bacterial flagellin, which is a principal component of bacteria flagella of 
gram negative bacteria and contributes to its virulence (Hayashi et al., 2001a, Takeda et al., 
2003).  TLR5 activation stimulates TNF production through NF-κB pathways (Sharma et 
al., 2013). 
9.1.4.5 TLR7, TLR8 and TLR9  
TLR7, TLR8 and TLR9 are highly homologous to each other. TLR7 and TLR8 recognise 
single stranded RNA (ssRNA) viruses including Influenza and Coxsackie B viruses 
(Arpaia and Barton, 2011).  In addition, TLR7 has been shown to play a significant role in 
the pathogenesis of autoimmune disorders.  Antiviral response by TLR8 is through 
activation of NF-κB (Arpaia and Barton, 2011).  TLR9 is involved in the recognition of 
unmethylated CpG sequences of bacterial DNA.  TLR9 is expressed intra-cellularly, within 
the endosomal compartments and functions to alert the immune system of viral and 
bacterial infections by binding to DNA CpG motifs (Arpaia and Barton, 2011).  Activation 
of TLR9 leads to the initiation of pro-inflammatory reactions and secretion of cytokines.
327 
 
Table 9-2: TLRs ligands redrawn from (Koga and Mor, 2010, Chang, 2010) 
TLRs                      Ligands   References  
 Exogenous    Endogenous   
TLR1 Bacterial tri-acylated  
lipopeptides with TLR2  
 (Jin et al., 2007). 
TLR2 Gram-positive bacteria 
peptidoglycan,  
Lipopeptides, lipoteichoic 
acids,  zymosan          
 
HSP60,            
HSP70 and  
                                                                             
HMGB1 
(Takeuchi et al., 1999, Gantner 
et al., 2003, Campos et al., 
2001, Asea et al., 2002) 
TLR3 Viral double-strand-RNA  Host dsRNA (Alexopoulou et al., 2001)          
TLR4 Lipopolysaccharides LPS,                                                                              
Fibronectin, fibrinogen  
 
HSP22,
HSP60,HSP70 
                                                                              
HSP96,  
(Poltorak et al., 1998, Monick 
et al., 2003, Asea et al., 2002, 
Ohashi et al., 2000b)
TLR5 Flagellin   (Hayashi et al., 2001b). 
TLR6 Diacyle lipo-peptides with 
TLR2, Zymosan from 
fungal cell wall 
 (Kang et al., 2009) 
TLR7 Single strand viral RNA                                                  Self ssRNA (Heil et al., 2004, Lund et al., 
2003) 
TLR8 Single strand RNA                                               Self ssRNA (Heil et al., 2004) 
TLR9 
 
Non-methylated CpGDNA, 
Herpes-virus, 
Chromatine-IgG 
  self DNA (Lund et al., 2003, Hemmi et 
al., 2000a) 
TLR10 Unknown, Interact with 
TLR2  
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9.1.5 Myeloid differentiation primary response gene (88)  
MyD88 was discovered in mice (Lord et al., 1990).  MyD88 is a pivotal signalling protein 
in the innate immune system which participating in TLR and IL-1 signalling pathways 
during host response to infection (Kawai and Akira, 2011).  These pathways regulate the 
activation of numerous pro-inflammatory genes. MyD88 is composed of an N-terminal 
death domain (DD) (Pettersen et al., 2004) and a highly conserved C-terminal TIR 
(Medzhitov et al., 1998a).  DD is responsible for downstream signalling through kinases of 
the interleukin-1 receptor-associated kinases (IRAKs) (Avbelj et al., 2011).  The MyD88 
TIR domain integrates signals from upstream TLR and IL-1 receptors (Avbelj et al., 2014).  
TLRs trigger the formation of TIR-domain dimers, which results in downstream signalling 
and expression of genes involved in the immune system (Avbelj et al., 2014). 
9.1.6 Nuclear factor kappa light chain enhancer of activated B 
cells (NF-κβ)  
NF-κB transcription factors can both induce and repress gene expression by binding to 
discrete κB elements of DNA sequences, in promoters and enhancers (Hayden and Ghosh, 
2008).  NF-κB also plays an important role in influencing gene expression events that 
impact on cell survival, differentiation and proliferation (Hayden and Ghosh, 2008).  NF-
κB is activated through various posttranslational modifications and translocate to the 
nucleus where it binds to specific DNA sequences and promotes transcription of target 
genes (Hayden and Ghosh, 2008).  NF-κB is a key transcription factor in the TLR-
mediated signalling pathway, and leads to in the regulation of pro-inflammatory cytokine 
and PG production (Allport et al., 2001, Lawrence, 2009, Drexler and Foxwell, 2010).  
TLRs are activated by PAMPs of gram-negative and gram-positive bacteria, this is 
followed by a cascade of cytoplasmic molecular events by activation of the inactive form 
of the NF-κB by phosphorylation of its serine residues and allowing its translocation to a 
nucleus (Jesic et al., 2014).  Activation of the NF-κB pathway is associated with activation 
of apoptosis in placentas from women who underwent labour (Lee et al., 2010).  
9.1.7  TLRs signalling pathways 
Several studies have shown that TLRs are activated by a wide range of ligands.  However, 
the first step in the initiation of signalling by TLRs is their homo or hetero-dimerization.  
This step of pairing provides a special structural form in the cytoplasm where the adapter 
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molecules bind and transmit signalling inside the cell (Kumar et al., 2009).  The 
differences in the TLRs pathways are due to the presence of many adapters that activate 
different biochemical pathways.  This activation leads to expression of pro-inflammatory 
cytokines, chemokines and other immune genes.  However, the adapters not only control 
which pathways that TLRs are going to activate but also these adapter play an essential 
role in regulation of the TLR cascades (Kawai and Akira, 2010).  In addition to these 
adapters there are a several endogenous proteins that interact with TLR signalling at 
adapter level in order to inhibit any over activation that may damage cells (Bauer, 2008, 
Kawai and Akira, 2010).  
9.1.7.1 MyD88 dependent pathway 
MyD 88 is a crucial member for signalling induced by TLRs and IL-1 receptors (Muzio et 
al., 1998, Bonnert et al., 1997, Medzhitov et al., 1998b, Kawai and Akira, 2010).  All 
TLRs that activate MyD88 are similar to the IL-1 RI pathway in its activation of NF-κB 
and MAPKs.  MyD88 binding to ligand TLRs results in the association of the IRAKs to 
the receptor signalling complexes. All TLRs, except TLR3, share common signalling 
pathways that require MyD88 and MyD88 adaptor like Mal.  Activation of this pathway 
leads to TRAK6/IKK complex activation and results in activation of NF-κB and MAPK 
(Tanimura et al., 2008, O'Neill et al., 2009). 
9.1.7.2 The TRIF dependent pathway 
TLR3 and TLR4 can signal through a MyD88-independent manner.  This signalling occurs 
through adaptor Toll/IL-1 receptor domain-containing adaptor inducing interferon-β 
(TRIF).  TRIF can activate the NF-κB pathway and LPS-mediated phosophorylation of 
transcription interferon regulation factors (IRF) resulting in interferon3 production of type 
I interferons and inducible genes (Hemmi et al., 2000b) that are responsible for antiviral 
activity and acquired immunity (Tanimura et al., 2008).  Sterile-alpha and armadillo motif 
containing protein (SARM) is negative protein adaptor for TLRs that blocks TRIF-
dependent signalling (Jiang et al., 2006). 
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9.2 Results:   
9.2.1 Patient clinical data analysis  
Patient data analysis is the same as section (3.4.1.1), results analysis is shown in (Table 3-
2) (Table 3-3). 
9.2.2 Analysis of mRNA TLRs 1-8 expression in normal pregnancy  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
expression of mRNA of TLRs within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis. There was very 
low expression of TLR9 and TLR10 in the human placenta (ct value more than 35 cycles).  
There was no significant difference in mRNA expression between the three zones of the 
non-labour and labour groups for TLR1 (p=0.95, p=0.25 respectively), TLR2 (p=0.14, 
p=0.42 respectively), TLR3 (p=0.95, p=0.57 respectively) and TLR4 (p=0.42 for both) 
(Figure 9-1) 
  331 
 
 
Figure 9-1: RQ values for TLR1-4 mRNA measurements in in inner, middle and outer zones 
of individual placentas of non-labour (n=6) and labour groups (n=6).  Four quadrants were 
sampled in each zone. Graphs show the median for TLR1-4 mRNA expressions.  
Comparison between zones was performed using Friedman analysis. 
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There was also no significant difference in mRNA expression between the three zones of 
the non-labour and labour groups for TLR5 (p=0.25, p=0.57 respectively), TLR6 (p=0.42, 
p=0.57 respectively), TLR7 (p=0.95, p=0.7 4respectively) and TLR8 (p=0.74 for both) 
(Figure 9-2). 
 
 
Figure 9-2: RQ values for TLR5-8 mRNA measurements in in inner, middle and outer zones 
of individual placentas of non-labour (n=6) and labour groups (n=6).  Four quadrants were 
sampled in each zone. Graphs show the median for TLR5-8 mRNA expressions.  
Comparison between zones was performed using Friedman analysis. 
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Experiment 2: This experiment was designed to test if there was any difference TLR1-8 
mRNA expression between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in TLR1 and TLR2 mRNA expression in the 
non-labour group when compared to the labour group at the inner zone (p=0.81, p=0.39 
respectively), middle zone (p=0.13, p=0.81 respectively) and the outer zone (p=0.06, 
p=0.30 respectively) (Figure 9-3). 
 
 
Figure 9-3: RQ values for TLR1 (A) and TLR2 (B) mRNA measurements in non-labour (n=6) 
compared to the labour group (n=6) at the inner, middle and outer placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR3 and TLR4 mRNA expression in the non-
labour group when compared to the labour group at the inner zone (p=0.6, p=0.9 
respectively), middle zone (p=0.1, p=0.9 respectively) and the outer zone (p=0.1, p=0.6 
respectively) (Figure 9-4). 
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Figure 9-4: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was a significant decrease in TLR5 mRNA expression in the labour group when 
compared to the non-labour group at the middle zone (p=0.004).  There was no significant 
difference in TLR6 mRNA expression in the non-labour group when compared to the 
labour group at the middle zone (p=1).  There was no significant difference in TLR5 and 
TLR6 mRNA expression in the non-labour group when compared to the labour group at 
the inner zone (p=0.4, p=0.6 respectively) and the outer zone (p=0.3, p=0.6 respectively) 
(Figure 9-5). 
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Figure 9-5: RQ values for TLR5 (A) and TLR6 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR7 and TLR8 mRNA expression in the non-
labour group when compared to the labour group at the inner zone (p=0.8, p=0.1 
respectively), middle zone (p=0.8, p=0.09 respectively) and the outer zone (p=0.6, p=0.06 
respectively) (Figure 9-6). 
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Figure 9-6: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in non-labour 
compared to the labour group at the inner, middle and outer placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis 
 
9.2.3 Analysis of mRNA TLRs 1-8 expression in pregnancies 
complicated with PE  
Experiment 1: This experiment was designed to test if there was any difference in TLR 1-8 
mRNA expressions between non-labour control and non-labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney.  First the non-labour groups were compared.  There was a significant decrease in 
TLR1 mRNA expression in the non-labour PE group compared to the non-labour control 
group at the middle zones (p=0.02).  There was no significant difference in TLR1 mRNA 
expression in the non-labour PE group compared to the non-labour control group at the 
inner zones (p=1) (Figure 9-7). 
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Figure 9-7: RQ values for TLR1 mRNA measurements in the non-labour PE group compared 
to the non-labour control group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR2 mRNA expression in the non-labour PE 
group compared to the non-labour control group at the inner and middle zones (p=1, p=0.1 
respectively) (Figure 9-8). 
 
 
Figure 9-8: RQ values for TLR2 mRNA measurements in the non-labour PE group compared 
to the non-labour control group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR3 and TLR4 mRNA expression in the non-
labour PE group compared to the non-labour control group at the inner (p=0.7, p=0.1 
respectively) and middle zones (p=0.7 for both) (Figure 9-9). 
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Figure 9-9: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in the non-labour PE 
group compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
There was a significant decrease in TLR5 mRNA expression in the non-labour PE group 
compared to the non-labour control group at the middle zones (p=0.02).  There was no 
significant difference in TLR5 mRNA expression in the non-labour PE group compared to 
the non-labour control group at the inner zones (p=0.09) (Figure 9-10). 
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Figure 9-10: RQ values for TLR5 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR6 mRNA expression in the non-labour PE 
group compared to the non-labour control group at the inner and middle zones (p=0.5, 
p=0.1 respectively) (Figure 9-11). 
 
 
Figure 9-11: RQ values for TLR6 mRNA measurements in the non-labour PE group 
compared to the non-labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR7 and TLR8 mRNA expression in the non-
labour PE group compared to the non-labour control group at the inner (p=0.5, p=0.7 
respectively) and middle zones (p=0.09 for both) (Figure 9-12). 
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Figure 9-12: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in the non-labour 
PE group compared to the non-labour control group at the inner and middle placental 
zones.  Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in TLRs 1-
8 mRNA expressions between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using the Mann Whitney 
analysis test.  There was a significant decrease in mRNA expression of TLR1 in the labour 
PE group compared to the labour control group at the inner and middle zones (p=0.04, 
p=0.002 respectively) (Figure 9-13). 
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Figure 9-13: RQ values for TLR1 mRNA measurements in the labour PE group compared to 
the labour control group at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR2 mRNA expression in the labour PE group 
compared to the labour control group at the inner and middle zones (p=0.09, p=0.4 
respectively) (Figure 9-14).  
 
 
Figure 9-14: RQ values for TLR2 mRNA measurements in the labour PE group compared to 
the labour control group at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis 
 
There was no significant difference in TLR3 and TLR4 mRNA expression in the labour PE 
group compared to the labour control groups at the inner zone (p=0.6, p=0.4 respectively) 
and the middle zones (p=0.3, p=0.06 respectively) (Figure 9-15).  
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Figure 9-15: RQ values for TLR3 (A) and TLR4 (B) mRNA measurements in the labour PE 
group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR5 and TLR6 mRNA expression in the labour PE 
group compared to the labour control groups at the inner zone (p=0.9, p=0.1 respectively) 
and the middle zones (p=0.5, p=0.1 respectively) (Figure 9-16).  
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Figure 9-16: RQ values for TLR5 (A) and TLR6 (B) mRNA measurements in the labour PE 
group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis 
 
There was no significant difference in TLR7 and TLR8 mRNA expression in the labour PE 
group compared to the labour control groups at the inner zone (p=0.09, p=0.2 respectively) 
and the middle zones (p=0.5, p=0.3 respectively) (Figure 9-17).  
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Figure 9-17: RQ values for TLR7 (A) and TLR8 (B) mRNA measurements in the labour PE 
group compared to the labour control group at the inner and middle placental zones.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 5: This experiment was designed to test if there was any difference in TLR 1-8 
mRNA expressions between normotensive pregnancies and pregnancies complicated with 
PE and included non-labour and labour groups combined for both at the inner and middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was a significant decrease in TLR1 mRNA expression in the pregnancies 
complicated with PE group compared to the normotensive pregnancies group in the inner 
and middle placental zones (p=0.04, p=0.0002 respectively) (Figure 9-18). 
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Figure 9-18: RQ values for TLR1 mRNA expression in the PE pregnancy group compared to 
the normotensive pregnancy group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR2 mRNA expression in the pregnancies 
complicated with PE group compared to the normotensive pregnancies group in the inner 
and middle placental zones (p=0.06, p=0.2 respectively) (Figure 9-19). 
 
 
Figure 9-19: RQ values for TLR2 mRNA expression in the PE pregnancy group compared to 
the normotensive pregnancy group at the inner and middle placental zones.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR3 and TLR4 mRNA expression in the 
pregnancies complicated with PE group compared to the normotensive pregnancies group 
in the inner zone (p=0.6, p=0.2 respectively) and middle placental zones (p=0.9, p=0.2 
respectively) (Figure 9-20). 
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Figure 9-20: RQ values for TLR3 (A) and TLR4 (B) mRNA expression in the PE pregnancy 
group compared to the normotensive pregnancy group at the inner and middle placental 
zones.  Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR5 and TLR6 mRNA expression in the 
pregnancies complicated with PE group compared to the normotensive pregnancies group 
in the inner zone (p=0.3, p=0.08 respectively) and middle placental zones (p=0.2, p=0.05 
respectively) (Figure 9-21). 
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Figure 9-21: RQ values for TLR5 (A) and TLR6 (B) mRNA expression in the PE pregnancy 
group compared to the normotensive pregnancy group at the inner and middle placental 
zones.  Comparison between zones was performed using Mann-Whitney analysis. 
 
There was no significant difference in TLR7 and TLR8 mRNA expression in the 
pregnancies complicated with PE group compared to the normotensive pregnancies group 
in the inner zone (p=0.05, p=0.2 respectively) and middle placental zones (p=0.2, p=0.8 
respectively) (Figure 9-22). 
  348 
 
 
Figure 9-22: RQ values for TLR7 (A) and TLR8 (B) mRNA expression in the PE pregnancy 
group compared to the normotensive pregnancy group at the inner and middle placental 
zones.  Comparison between zones was performed using Mann-Whitney analysis. 
 
9.2.4 Analysis of mRNA of MYD88 expression in normal 
pregnancy 
Experiment 1: This experiment was designed to test if there was a spatial difference in 
expression of MYD88 mRNA within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in MYD88 mRNA expression between the three zones of the non-
labour and labour groups (p=0.5, p=0.7 respectively) (Figure 9-23). 
 
  349 
 
 
Figure 9-23: RQ values for MYD88 mRNA measurements in in inner, middle and outer zones 
of individual placentas (non-labour and labour groups).  Four quadrants were sampled in 
each zone. Graphs show the median for MYD88 mRNA expressions.  Comparison between 
zones was performed using Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference MYD88 
mRNA expression between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in MYD88 mRNA expression in the non-
labour group when compared to the labour group at the inner, middle and outer zones (p=1, 
p=0.3, p=0.8 respectively) (Figure 9-24). 
 
 
Figure 9-24: RQ values for MYD88 mRNA measurements in non-labour compared to the 
labour group at the inner, middle and outer placental zones.  Comparison between zones 
was performed using Mann-Whitney analysis. 
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9.2.5 Analysis of mRNA MyD88 expression in pregnancies 
complicated with PE  
Experiment 1: This experiment was designed to test if there was any difference in MYD88 
mRNA expressions between non-labour control and non-labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney.  There was a significant decreased in the MYD88 mRNA expression in the non-
labour PE group compared to the non-labour control group at the inner zone (p=0.02).  
There was no significant difference in the MYD88 mRNA expression in the non-labour 
control group compared to the non-labour PE group at the middle zone (p=0.9) (Figure 9-
25). 
 
 
Figure 9-25: RQ values for MYD88 mRNA measurements in non-labour control compared to 
the non-labour PE groups at the inner and middle placental zones.  Comparison between 
zones was performed using Mann-Whitney analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference in MYD88 
mRNA expressions between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in MYD88 mRNA  in the labour control 
group compared to the labour PE group in the inner or middle placental zones (p=0.5, 
p=0.3 respectively) (Figure 9-26). 
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Figure 9-26: RQ values for MYD88 mRNA measurements in labour control compared to the 
labour PE groups at the inner and middle placental zones.  Comparison between zones was 
performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in MYD88 
mRNA expressions between normotensive pregnancies and pregnancies complicated with 
PE regardless the labour factor at the inner or middle zones of placentas.  Comparison 
between zones was performed using Mann Whitney test analysis.  There was no significant 
difference in MYD88 mRNA expression in the pregnancies complicated with PE group 
compared to the normotensive pregnancies groups in the inner and middle placental zones 
(p=0.1, p=0.2 respectively) (Figure 9-27). 
 
Figure 9-27: RQ values for MYD88 mRNA measurements in normotensive pregnancies 
group compared to the pregnancies complicated with PE group at the inner and middle 
placental zones.  Comparison between zones was performed using Mann-Whitney analysis. 
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9.2.6 Analysis of mRNA NF-κB expression in normal pregnancy  
Experiment 1: This experiment was designed to test if there was a spatial difference in 
expression of NF-κB mRNA within individual placentas obtained from women who were 
not in labour (non-labour group) and from women who were in labour (labour group).  
Comparison between zones was performed using Friedman test analysis.  There was no 
significant difference in NF-κB mRNA expression between the three zones of the non-
labour and labour groups (p=0.7, p=0.5 respectively) (Figure 9-28). 
 
 
Figure 9-28: RQ values for NF-κB mRNA measurements in in inner, middle and outer zones 
of individual placentas (non-labour and labour groups).  Four quadrants were sampled in 
each zone. Graphs show the median for NF-κB mRNA expressions.  Comparison between 
zones was performed using Friedman analysis. 
 
Experiment 2: This experiment was designed to test if there was any difference NF-κB 
mRNA expression between labour and non-labour groups at the inner, middle or outer 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in NF-κB mRNA expression in the non-
labour group when compared to the labour group at the inner, middle and outer zones (p=8, 
p=0.8, p=0.3 respectively) (Figure 9-29). 
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Figure 9-29: RQ values for NF-κB mRNA measurements in non-labour compared to the 
labour group at the inner, middle and outer placental zones.  Comparison between zones 
was performed using Mann-Whitney analysis. 
9.2.7 Analysis of mRNA NF-κB expression in pregnancies 
complicated with PE  
Experiment 1: This experiment was designed to test if there was any difference in NF-κB 
mRNA expressions between non-labour control and non-labour PE groups at the inner or 
middle zones of placentas.  Comparison between zones was performed using Mann 
Whitney.  There was no significant difference in the NF-κB mRNA was found at the inner 
and middle zones (p=0.3, p=0.7) (Figure 9-30). 
 
 
Figure 9-30: RQ values for NF-κB mRNA measurements in labour control compared to the 
labour PE groups at the inner and middle placental zones.  Comparison between zones was 
performed using Mann-Whitney analysis. 
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Experiment 2: This experiment was designed to test if there was any difference in NF-κB 
mRNA expressions between labour control and labour PE groups at the inner or middle 
zones of placentas.  Comparison between zones was performed using Mann Whitney test 
analysis.  There was no significant difference in NF-κB mRNA  in the labour control group 
compared to the labour PE group in the inner or middle placental zones  (p=0.93, p= 1 
respectively) (Figure 9-31). 
 
 
Figure 9-31: RQ values for NF-κB mRNA measurements in labour control compared to the 
labour PE groups at the inner and middle placental zones.  Comparison between zones was 
performed using Mann-Whitney analysis. 
 
Experiment 3: This experiment was designed to test if there was any difference in NF-κB 
mRNA expressions between normotensive pregnancies and pregnancies complicated with 
PE regardless the labour factor at the inner or middle zones of placentas.  Comparison 
between zones was performed using Mann Whitney test analysis.  There was no significant 
difference in NF-κB mRNA expression in the pregnancies complicated with PE group 
compared to the normotensive pregnancies groups in the inner and middle placental zones 
(p=0.6, p=0.7 respectively) (Figure 9-32). 
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Figure 9-32: RQ values for NF-κB mRNA measurements in normotensive pregnancies group 
compared to the pregnancies complicated with PE group at the inner and middle placental 
zones. Comparison between zones was performed using Mann-Whitney analysis. 
 
9.2.8 Results summary  
9.2.8.1 TLRs 
Experiment 1: Within individual placentas no spatial differences in mRNA for TLRs 1-8 
were found either in the labour or non-labour groups.  
Experiment 2: There was a significant decrease in TLR5 mRNA expression in the labour 
group when compared to the non-labour group at the middle zone (p=0.004).  No other 
differences were found when comparing labour with non-labour. 
Experiment 1: When the PE groups (non-labour) were compared with the control groups 
(non-labour) at the middle and inner zones the changes found can be summarized as 
follows: there was a significant decrease in TLR1 mRNA expression in the non-labour PE 
group compared to the non-labour control group at the middle zones (p=0.02).  There was 
a significant decrease in TLR5 mRNA expression in the non-labour PE group compared to 
the non-labour control group at the middle zones (p=0.02). 
Experiment 2: When the PE groups (labour) were compared with the control groups 
(labour) at the middle and inner zones the changes found can be summarized as follows:  
There was a significant decrease in TLR1 mRNA expression in the labour PE group 
compared to the labour control group at the inner and middle zones (p=0.04, p=0.002 
respectively). 
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Experiment 3: When all non-labour and labour was combined.  There was a significant 
decrease in TLR1 mRNA expression in the pregnancies complicated with PE group 
compared to the normotensive pregnancies group in the inner and middle placental zones. 
9.2.8.2 MyD88 
Experiment 1: No spatial differences were found in mRNA expression of MYD88 within 
placentas in labour or non-labour groups. 
Experiment 2: No differences were found in mRNA expression of MYD88 between labour 
and non-labour groups within each zone. 
Experiment 1: There was a significant decreased in the mRNA expression of MYD88 in 
the non-labour PE group compared to the non-labour control group at the inner zone. 
Experiment 2: No difference was found in mRNA expression of MYD88 between labour 
control and labour PE groups at the inner or middle zones of placentas. 
Experiment 3: When all non-labour and labour was combined.  There was no significant 
difference in mRNA expression of MYD88 was found between normotensive pregnancies 
and pregnancies complicated with PE group at the inner and middle placental zones. 
9.2.8.3 NF-ĸβ 
Experiment 1: No spatial differences within placentas were found for labour or non-labour. 
Experiment 2: No differences were found between labour and non-labour at each site. 
Experiment 1: No difference was found between non-labour control and non-labour PE 
when either inner or middle zones were compared. 
Experiment 2: No difference was found between labour control and labour PE when either 
inner or middle zones were compared. 
Experiment 3: When all non-labour and labour was combined.  There was no significant 
difference in mRNA expression of NF-κB was found between normotensive pregnancies 
and pregnancies complicated with PE group at the inner and middle placental zones. 
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9.3 Discussion  
9.3.1 TLRs and present findings  
This study shows that TLR9 and TLR10 mRNA were expressed in very low amounts in 
the human placenta.  There was no spatial distribution of mRNA expression of TLRs 1-8 
within individual placentas either in the labour or non-labour groups.  When the labour 
group was compared to the non-labour group, only TLR5 mRNA expression showed a 
significant difference with a fall in the labour group at the middle zone.  The reason for 
that is unclear. 
Again due to time constrain only inner and middle zones of the PE group placentas were 
compared to the normotensive controls.  When the non-labour PE group was compared to 
the non-labour control group, there was a significant decreased in TLR1 and TLR5 mRNA 
expression in the non-labour PE compared to the non-labour control at the middle zone.  
When the labour PE group was compared to the labour control group, there was a 
significant decrease in TLR1 mRNA expression in the labour PE group compared to the 
labour control group at the inner and middle zones.  Furthermore, when all non-labour and 
labour was combined, there was a significant decrease in TLR1 mRNA expression in the 
pregnancies complicated with PE compared to the normotensive pregnancy group; this 
occurred at the inner and middle placental zones.  The key finding in this study was that 
significant changes seem to be involved only TLR1 and TLR5.  The study also shows the 
importance of using a systematic method to sample the placenta.  Previous reports of TLRs 
expression do not take this into account.  Therefore by taking a single sample or averaging 
protein expression of several samples may well mask possible changes in expression.  
9.3.2 MyD88 and NF-κB and the present findings  
There was no spatial distribution in both MyD88 and NF-κB mRNA expression within 
placentas.  There was a significant decreased in the mRNA expression of MyD88 in the 
non-labour PE group compared to the non-labour control group at the inner zone.  No other 
difference was found.  
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9.3.3 TLRs expression at the maternal-fetal interface 
Innate immune responsive against microorganism at the maternal-fetal interface may have 
a significant impact on the pregnancy outcome.  The maternal-fetal interface is a unique 
immunological site that tolerates the allogeneic fetus and provides the host immunity 
against pathogens.  In addition, TLRs could provide a mechanism of cytokine production 
at the maternal-fetal interface and might have a role in the initiation and maintenance of 
labour (Abrahams et al., 2004a).  
9.3.4 TLR signalling and function at the maternal-fetal interface 
Differential responses to TLR4 and TLR2 ligation in trophoblast cells:  Zymosan and LPS 
stimulation of TLR2 and TLR4 of term placental in vitro cultural experiment induced high 
expression of IL-6 and IL-8 cytokine without effect mRNA or protein expression 
(Holmlund et al., 2002).  These finding suggested that trophoblast have ability to recognize 
pathogen and initiate immune response through activation of immune cells (Koga et al., 
2014).  However, the response pattern for TLR ligation depends on the type of stimuli.  
HSP60 induces apoptosis in first-trimester trophoblast through TLR4 whereas LPS did not.  
This different effect of two different TLR4 ligands may be explained by different use of 
adaptor molecules (Koga and Mor, 2010, Koga et al., 2014).  First trimester trophoblast 
cells are able to recognize and specifically respond to viral products in a highly regulated 
fashion (Abrahams et al., 2006).  This different between first and third trimester 
trophoblast may be explained by presence TLR6 in third trimester.  Koga et al showed that 
TLR4 ligation by LPS inhibit trophoblast migration (Koga et al., 2014). 
9.3.5 TLRs expression in female reproductive tract  
Little is known about TLR expression and distribution in the female reproductive tract in 
humans.  It has been shown that TLR1, 2, 3, 5 and 6 are present in the epithelia of different 
regions of the female reproductive tract (Fazeli et al., 2005).  One study showed that TLR4 
is only present in the endocervix, endometrium and uterine tubes and absent in vagina and 
ectocervix (Fazeli et al., 2005).  Moreover, mRNA expression of TLRs was up-regulated in 
uterine and cervical tissue of pregnant compared to the non-pregnant mice (Gonzalez et al., 
2007).  This study highlighted that there was different expression of TLRs mRNA between 
uterus, cervix and placenta, placenta TLR4 was down-regulated (Gonzalez et al., 2007). 
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9.3.6 TLRs expression in decidua and amnion 
There are few studies regarding TLRs expression in decidua and amnion. The presence of 
all 10 TLR mRNA expression have been shown in the first trimester and the term decidua 
(Krikun et al., 2007a).  In amnion, TLR4 is expressed by amniotic epithelium cells 
indicating that TLR4 is poised to monitor amniotic fluid for the presence of pathogens (Ma 
et al., 2006).  In addition, it has been reported that TLR4 is highly expressed in the amnion 
of preterm infected placentas compared to term placenta (Hayati et al., 2010).  
Furthermore, TLR2 is also highly expressed in amniotic cell and decidua cells of infected 
placentas compared to non-infected placentas in the preterm situation (Hayati et al., 2010).  
These findings suggested TLR2 play an important role in protection of the preterm 
placenta against invading pathogens. 
9.3.7 TLRs expression in placental tissue  
The placenta constitutes a physical barrier against invading pathogens. Several studies 
have shown that all 10 TLRs are expressed by the placenta as well as co-receptors such as 
CD14 (Zarember and Godowski, 2002, Nishimura and Naito, 2005b, Klaffenbach et al., 
2005a, Mitsunari et al., 2006a, Patni et al., 2009).  Cultured cells from term placenta 
showed both STB and CTB cells express TLR2, 3, 4, 5, 6 and 9 (Holmlund et al., 2002, 
Mitsunari et al., 2006a).  TLR2 and TLR4 are highly expressed on intermediate 
trophoblasts in free cell islands, cell column, decidua and trophoblasts covering the 
peripheral chorionic villi, but not the villous core (Holmlund et al., 2002, Kumazaki et al., 
2004b, Beijar et al., 2006). 
It has been reported that  some TLRs  are expressed in temporal manner, for example 
TLR6 (Koga and Mor, 2010).  Abrahams et al  has been shown that the first trimester 
trophoblasts express TLR1, 2, 3 and 4 but not TLR6 (Abrahams et al., 2004b), while TLR6 
is expressed by third trimester trophoblast (Mitsunari et al., 2006a).  In addition, Beijar et 
al compared TLR4 expression in the placenta from the first and the third trimester and 
showed that TLR4 is highly expressed in the term placenta (Beijar et al., 2006).  These 
findings may suggest that the placenta in first trimester is less response to invading 
pathogens when compared to the term placenta. 
TLRs are expressed by other placenta cells such as Hofbauer, macrophage and endothelial 
cells. IHC studies showed that TLR4 is expressed by these cells in the term placenta 
(Kumazaki et al., 2004b).  In addition, Ma et al showed that TLR2 is highly expressed in 
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endothelial cells and macrophage with weaker expression in STB and fibroblast, while 
TLR4 showed stronger expression in STB and fibroblasts (Ma et al., 2006).  These data 
suggested that not only immune system cells response to invading pathogen but also 
trophoblast and other cells within the placenta may be involved in physiological protection 
of the placenta (Koga and Mor, 2010, Koga et al., 2014). 
There are several publications of TLRs, MyD88 and NF-κB expression in the placenta.  
Most of these studies used IHC analysis to detect TLR localization.  Few studies compared 
the labour and non-labour in normal pregnancies.  These studies can be summarized as 
follows. 
Kumazaki et al performed IHC study to investigate TLR4 protein expression in 2
nd
 and 3
rd
 
trimester placentas of normal and complicated pregnancies (Kumazaki et al., 2004a).  This 
study showed that TLR4 was localized to the extra-villous trophoblasts, intermediate 
trophoblasts/X cells in the degenerative villi, and villous Hofbauer cells of all preterm and 
term placentas and also to the inflammatory cells in placentas with chorioamnionitis 
(Kumazaki et al., 2004a).  In addition, TLR4 staining was increased in the villous 
Hofbauer cells of preterm chorioamnionitis placentas.  They suggested that TLR4 plays a 
role in activation of the innate immune system in response to infectious pathogens in 
preterm placentas (Kumazaki et al., 2004a). 
It has been shown, using RT-PCR that in the term placenta choriocarcinoma cell lines 
expressed the TLR1-10 and co-receptors CD14,MyD88,TIRP and TRIF mRNA 
(Klaffenbach et al., 2005a). 
Nishimura and Naito performed RT-PCR to investigate TLR1-10 in several tissues include 
placenta (Nishimura and Naito, 2005a). All TLR1-10 were detected in placenta. 
Klaffenbach et al performed RT-PCR to investigate TLR1-10, fluorescence-activated cell 
sorter analysis to investigate TLR1, 2, 4 and 9 and  activation of NF-κB was determined in 
a reporter assay system in the term human placenta and trophoblast cell lines JAR and 
BeWo (Klaffenbach et al., 2005b).  This study showed that all TLR1-10 were detected in 
term placenta. LPS induced mRNA and protein expression of TLR2 and also activated NF-
κB in the JAR cells.  
Mitsunari et al performed multiplex PCR to investigate mRNA expression for TLR1-6 and 
TLR9 in term non-labour human placental explants (Mitsunari et al., 2006b).  TLR2, 3, 4, 
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5 and 6 was expressed in STB and CTB, while TLR1 and 9 were not detected.  IHC 
analysis showed that TLR2, 4 and 6 protein expression was detected in the STB (Mitsunari 
et al., 2006b).  A difference to the present study was that in the present study mRNA 
expression of TLR1-8 were detected but not TLR9-10; however, labour was not studied. 
Krikun et al performed Western blotting, IHC and RT-PCR to investigate TLRs in 
decidual tissue of 1
st
 trimester and term non-labour pregnancies (Krikun et al., 2007b).  
This study showed that decidua of 1
st
 trimester as well as term trimester expresses mRNA 
for all TLR1-10.  All TLRs apart from TLR2, 7 and 9 were expressed at lower levels in 
term than in 1
st
 trimester decidual cells. 
Ma et al performed IHC, Western blotting and qRT-PCR to localize TLR2 and TLR4 in 
the terminal and stem villi of term placenta (Ma et al., 2007).  TLR2 was localized to 
endothelial cells and macrophages, and to a lesser extent to STB and fibroblasts. TLR4 was 
more prominent in STB and endothelial cells.  In addition, Western blot and mRNA results 
showed that TLR2 and TLR4 were expressed mostly in STB whereas myofibroblasts 
expressed only TLR4.  They concluded that there exists cell type-specific patterns of TLR 
function in placenta which likely regulate innate immune response at the maternal-fetal 
interface (Ma et al., 2007) 
Patni et al performed qRT-PCR to investigate TLR1-10 expression in human term 
placentas of non-labour and labour groups  (Patni et al., 2009).  This study showed that all 
TLR1-10 were expressed in human placentas.  In addition, TLR2 and TLR5 were 
significantly increased in labour group.  In our study TLR5 was decreased in the labour 
group and no significant changes were found in TLR2 expression.  A systematic sampling 
method was not performed in the other study. 
Lee et al  compared non-labour and labour placentas and reported that mRNA expression 
of TLR8 and NF-κB were increased in the labour group (Lee et al., 2010).  However, no 
systemic sampling method was performed. 
A recent study performed IHC, Western blotting and qRT-PCR to investigate TLR3 and 
TLR4 expression in 1
st
 and 3
rd
 trimester placental explants after exposure to either bacteria 
or viral antigens (Lye et al., 2015).  TLR3 and TLR4 mRNA expression increased from the 
1
st
 to 3
rd
 trimester, and the receptors localized to CTB in the 1
st
 trimester and to STB in the 
3
rd
 trimester (Lye et al., 2015).  In addition, TLR3 and TLR4 expression decreased in the 
3
rd
 trimester after exposure to viral antigen.  They concluded that bacterial infections likely 
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alter exposure of the fetus to toxins during early pregnancy whereas viral exposure may 
disrupt fetal protection in later stages of pregnancy (Lye et al., 2015). 
9.3.8 TLRs in complicated pregnancies 
Recent studies have linked TLRs to many pregnancy disorders such as PE, preterm labour 
and early pregnancy loss.  
PE effect at least 2-3 % of all pregnancies and it is a major cause of maternal morbidity 
and mortality.  Despite progress in understanding the cause of PE, the aetiology remains 
unclear.  The placenta has been shown to play an important role in the development of this 
serious syndrome (Roberts and Escudero, 2012).  Recent investigations have suggested 
that immune response and inflammation activated by infectious or non-infectious pathogen 
or host derived molecules may be important factor in pathogenesis of PE (Koga et al., 
2014).  The activation of host derived molecules by TLRs may be a link between PE and 
activation of the maternal immune system (Holmlund et al., 2007).  TLR4 expression was 
reported to be increased in trophoblast in women with preterm delivery PE  compared to 
the term PE (Kim et al., 2005).  In addition, Rahman et al (Rahman et al., 2006) described 
the relationship between high levels of TLR4 expression in endothelial cells and placenta 
vascular disease.  
It has been shown that injection of poly (I:C) (TLR3 agonist) into wild type mice induces a 
strong pro-inflammation response by trophoblast cells resulting in a change in the 
distribution and activation of immune cells at the feto-maternal interface (Koga et al., 
2009).  It was concluded that poly (I:C) induces preterm delivery via a TLR3-dependent 
manner (Koga et al., 2009). 
A few studies have examined TLRs expression in complicated pregnancies such as pre-
term and PE.  These studies can be summarized as follows. 
Kim et al performed double IHC to investigate TLR2 and TLR4 expression in trophoblasts 
at the placental bed of labour and non-labour normal term pregnancies and labour and non-
labour of pre-term and term  pregnancies complicated with PE or chorioamnionitis (Kim et 
al., 2005).  This study showed that there was no significant difference in TLR4 protein 
expression in the interstitial trophoblast between the labour and the non-labour 
normotensive groups.  TLR4 was increased in the interstitial trophoblasts of PE (both 
  363 
 
combined term and pre-term) compared to the pre-term labour with or without 
chorioamnionitis.  There were no significant changes of TLR2 between all groups. 
Rindsjo et al performed IHC to investigate the expression of TLR2 in 2
nd
 and 3
rd
 trimester 
placentas with chorioamnionitis compared to normal term controls (Rindsjo et al., 2007).  
TLR2 was localized to the CTB and STB cell layer and decidual stromal cells.  TLR2 
expression was decreased in placentas with chorioamnionitis compared to normal controls.  
In addition, TLR2 expression was high in 2
nd
 compared to 3
rd
 trimester placentas.  There 
was  a significantly higher TLR2 expression  in placentas from live-born babies than still-
birth babies (Rindsjo et al., 2007).  It was concluded that TLR2 expression in the 
trophoblast could be involved in the response to infectious pathogens in the placenta. 
Hayati et al performed IHC to detect TLR2 and TLR4 in amniotic cells and decidual cells 
in infected placentas and normal controls (Hayati et al., 2010).  TLR2 expression was 
increased in the amniotic cells and decidua cells in infected pre-term placentas.  They 
concluded that TLR2 plays a role in the innate immunity in bacterial and viral infection in 
the placenta. 
Pineda et al  performed immunofluorescence and confocal microscopy to detect TLR2, 3, 
4 and 9 in term human placentas of PE and normal subjects (Pineda et al., 2011).  All 4 
TLRs were expressed in the trophoblast, villous stroma and vascular endothelium.  TLR2, 
3, 4 and 9 expression were increased in PE placentas (Pineda et al., 2011). 
Bernardi et al performed Western blotting to investigate TLR4, MyD88 and NF-κB 
expression in term normotensive and PE placentas (Bernardi et al., 2012).  This study 
showed that TLR4 and NF-κB was increased in PE placentas compared to the controls.  
They concluded that the TLR4- NF-κB pathway is upregulated in PE, and this probably 
generated local inflammatory response that is followed by local oxidative damage.  
Chaparro et al performed RT-PCR and ELISA to investigate TLR2 and TLR4 mRNA 
expression in hypertensive disorders and PE placentas compared to the placentas of 
normotensive subjects (Chaparro et al., 2013).  This study showed that TLR2 was 
significantly increased in hypertensive disorders placentas. 
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9.3.9 Immune mechanisms and PE 
9.3.9.1 Infectious microorganisms in PE 
Several studies have shown that maternal infection and PE are connected, and this link 
may be through TLRs activation (Abrahams et al., 2005, Kim et al., 2005).  It has been 
suggested that infectious pathogens such as cytomegalovirus (CMV) and chlamydia 
pneumonia (C. pneumonia) may contribute to cardiovascular disease and atherosclerosis 
(Martin-Ventura et al., 2004).  Since PE has many pathological feature similar to 
atherosclerosis this link may exist in PE. Several investigators have examined CMV and C. 
pneumonia in PE (von Dadelszen et al., 2003, Teran et al., 2003).  It has been reported, 
using  ELISA, that there was an increase in C. pneumonia antibodies in PE (Teran et al., 
2003).  Other researchers detected elevated anti-CMV antibodies levels in women with 
early onset PE compared to late onset PE (von Dadelszen et al., 2003).  LPS activates an 
inflammatory response and even a low dose of LPS injected into pregnant rats produced 
pathological changes similar to PE (Faas et al., 1994). 
9.3.9.2 TLR polymorphisms and susceptibility to PE 
TLR polymorphisms can affect the susceptibility to PE.  It has been reported that maternal 
TLR4 polymorphisms alter the susceptibility to early onset PE and HELLP syndrome (van 
Rijn et al., 2008).  In addition, the presence of two TLR4 SNPs (Asp299Gly and 
Thr399Ile) and TLR2 Arg753Gln was associated with a normal pregnancy outcome 
(Hirschfeld et al., 2007). 
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Chapter X: Investigation of several HSPs and 
CASPs (tissue culture experiment) 
10 Hypoxia-reperfusion tissue culture experiment  
10.1 Introduction  
The placenta performs key transport, metabolic and secretory functions to support fetal 
development.  The human placenta is made up of a tree of villi; some villi are free-floating 
while anchoring villi are attached to the basal plate.  The floating villi are covered by the 
STB, which is bathed in maternal blood and regulates maternal-fetal exchange.  In early 
pregnancy trophoblast differentiation is controlled by the oxygen concentration (Genbacev 
et al., 1997).  At change to the end of first trimester the blood flow starts in the inter-
villous space and oxygen tension increases from 2% to 8% (Burton et al., 1999).  Changes 
in oxygen tension are thought to be linked to trophoblast invasion of the placental spiral 
arteries.  PE and FGR are linked with exposing the placenta villi to hypoxia (Kingdom and 
Kaufmann, 1997, Newby et al., 2005). 
10.1.1 Response of ischemic placenta to reperfusion during peri-
partum period 
Different events are associated with changes in function of the placenta during the peri-
partum period.  The placenta is subject to several changes in homeostasis of metabolism 
due to change in blood supply.  During uterine contractions of labour, there are cycles of 
normal blood flow alternating with episodes of ischemia followed by reperfusion.  Placenta 
detachment from the uterine wall during third stage of delivery leads to severe impairment 
of blood flow and will result in complete ischemia in the placenta.  Uterine contractions 
develop in late pregnancy long before start of proper labour,  these early contractions may 
have a pre-conditioning effect providing increased tolerance of severe hypoxia in the fetus 
and placenta in preparation for labour (Schneider, 2009).  However, this mechanism of pre-
conditioning may not be sufficient to protect against oxidative stress generated during 
vaginal delivery as is clear when comparing placentas of non-labour patients to patients 
who underwent labour (Cindrova-Davies et al., 2007b). 
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10.1.2 Free radicals and oxidative stress in normal pregnancy  
Free radicals are reactive molecules that have one or more unpaired electrons. ROS like 
hydrogen peroxide, super oxide and hydroxyl radicals form as a product of oxygen 
metabolism and have important roles in cell signalling (Valko et al., 2006); however in 
high quantities they are associated with cell damage.  Polyunsaturated fatty acids in the 
plasma membrane as well as lipoproteins are susceptible to the oxidation (lipid 
peroxidation process).  ROS are generated from different sources for example 
mitochondria via cytochrome P450 and the electron transport chain (Bobba et al., 2008).  
Oxygen radicals are generated by oxidation of catecholamine and metabolism of 
arachidonic acid by both the lipoxygenase and cyclooxygenase pathways (Halliwell and 
Gutteridge, 1990).  Lipid and hydrogen peroxides initiate the lipid peroxidation reaction 
that continues until it is interrupted by antioxidants (Sies, 1997).  Antioxidants are either 
endogenous such as catalase, superoxide dismutase and glutathione peroxidase or are 
obtained from the diet such as vitamin A, C and E (Gutteridge, 1995). 
PE is a syndrome characterized by a generalized systemic maternal inflammatory response, 
associated with diffuse endothelial cell dysfunction.  The placenta is the organ which is 
thought to where the disorder originates.  Many theories have been suggested including 
that deportation of placental debris into the maternal circulation is a key element in 
development of the syndrome (Redman and Sargent, 2000).  One potential source of the 
debris is turnover of the placental epithelial STB layer through apoptosis which is 
increased in PE as a result of oxidative stress (Hung et al., 2002). 
10.1.3 Endoplasmic reticulum (ER) stress 
 ER stress has recently been identified as a major regulator of cell homeostasis through its 
involvement in post-translational protein modifications and folding, and its capacity to 
activate the UPR.  
The ER is where synthesis of growth factors, polypeptide hormones and plasma membrane 
proteins and their post-translational protein modification takes place, and its capacity to 
activate the UPR.  ER stress is a pathophysiological phenomenon closely linked with 
oxidative stress (Wang and Kaufman, 2012).  Because of the ER role in protein folding and 
transport, the ER is also rich in Ca
2+
 dependent molecular chaperones for example GRP78, 
GRP94 and BiP which stabilize protein folding (Schröder and Kaufman, 2005, Orrenius et 
al., 2003, Ma and Hendershot, 2004a).  The ER lumen contains a high concentration of 
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Ca
2+
 ions and it is also present in an oxidative environment which is critical for the 
formation of disulphide bonds. Any disturbances of these conditions cause accumulation of 
unfolded proteins in the ER, triggering the evolutionarily conserved UPR.  The UPR 
functions to restore the homeostatic balance within the ER, but if this cannot be achieved it 
activates the apoptotic pathways (Burton et al., 2009b).  However, as ER, the UPR require 
high energy, this would be disturbed by minor metabolic changes.  The initial role for the 
UPR is to re-establish normal ER function by a mechanism involving transcriptional 
programs that induce an expression of genes that enhance the protein folding capacity and 
promote misfolded proteins degradation.  Accumulation of unfolded and misfolded 
proteins activates the ER stress-response pathways and the UPR pathway.  The UPR 
comprises three signalling pathways: the protein kinase (PKR)-like endoplasmic reticulum 
kinase (PERK)–eIF2α pathway, which attenuates non-essential protein synthesis; and the 
ATF6 and IRE1–XBP1 pathways, which increase the folding capacity by up-regulation of 
the ER chaperones GRP78 and GRP94 and phospholipid biosynthesis.  However, if this 
mechanism fails, the ER-associated protein degradation (ERAD) pathway facilitates 
protein degradation (Schröder and Kaufman, 2005).  Excessive and prolonged ER stress 
triggers cellular apoptosis (Xu et al., 2005).  IR induces oxidative stress and activates the 
ER stress (Yung et al., 2007). 
10.1.4 IR experiments  
For many years, there has been interest in understanding the role that placental oxidative 
stress plays in the pathophysiology of complications of human pregnancy (Hubel, 1999, 
Myatt and Cui, 2004, Burton and Jauniaux, 2004, Lyall et al., 2013b).  The cause of the 
oxidative stress is not certain, but several pregnancy complications such as PE and FGR 
have been associated with abnormal uterine spiral arteries conversion, suggesting that 
impaired perfusion of the placenta is the initiating insult (Brosens et al., 1972, Brosens, 
1977, Kim et al., 2003).  During a healthy pregnancy maternal spiral arteries are 
dramatically remodelled.  They become widely dilated and lose their responsiveness to 
vasoconstrictive stimuli.  Thus blood enters the intervillous space in a non-pulsatile 
manner and under low pressure (Lyall, 2006).  Abnormal conversion of spiral arteries is 
associated with retention of smooth muscle cells in the spiral artery leading  to poor or 
intermittent perfusion of the placenta (Hung et al., 2001).  Hypoxia-reoxygenation 
experiments have demonstrated that placental oxidative stress can be induced rapidly by an 
  368 
 
IR type insult that can alter placental gene and protein expression (Cindrova-Davies et al., 
2007b). 
Tissue damage caused by IR injury represents a serious event, which leads to deterioration 
of organ function.  IR injury is associated with transient oxygen deprivation due to 
vascular occlusion and subsequent reperfusion following blood flow restoration.  Tissue 
damage during an ischemic period is aggravated more through ROS generation and 
inflammation responses.  IR injury occurs during organ transplantation, surgical 
intervention, and diseases such as circulatory shock, myocardial infraction and toxic 
injuries (Lorenzen et al., 2013, Karatzas et al., 2014). 
 
10.2 Results  
As time was limited one set of experiments was performed for all the data shown below, 
with a view to zooming in on particular time points should any obvious trends be spotted.  
As will be evident there appeared to a trend for differences to be apparent around 6 h and 
this would require future experiments. 
10.2.1 Protein and mRNA expression of HSP70 analysis using 
hypoxia-reperfusion tissue culture experiment.  
Experiment 1A: This experiment undertaken involved exposing placenta samples to 2% 
O2 (hypoxia) for one hour and then 8% O2 (normoxia) compared to the control samples 
which were exposed to only 8% O2 (normoxia) at four time points 3, 6, 12 and 22 h. Ref 1 
is the sample collected in the labour suite and -1 time point which reflected time before 
experiment carried out in laboratory. Ref 2 is the sample collected after arriving in the 
laboratory and 0 time point reflected time when the experiment started.  These two time 
point (-1 and 0) were advised by department statistician.  HSP70 protein expression was 
investigated using Western blot analysis. HSP70 mRNA was investigated using RT-qPCR.  
The interaction plot was used to demonstrate the findings.  Examples of Western blots 
showing HSP70 expression for the set of experiments performed on placental tissue 
obtained from the inner zone are shown in (Figure 10-1).  The interaction plot showed that 
expression of HSP70 in the treated group increased slightly from 3 h then gradual fall after 
6 h.  The control group showed that HSP70 expression increased from Ref1 to Ref2 points 
after that the expression increased sharply until 3 h when it decreased dramatically.  
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Overall both groups show that there was an increase in HSP70 expression, the control 
group from Ref2 point and treated group from 6 h before both showed a gradual fell with 
time. 
 
Figure 10-1: Representative image of Western blot showing HSP70 expression (upper panel) 
in the inner placental zone. Ref1 is the sample collected in the labour suite. Ref2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP70 protein expression at the inner zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 1B: This experiment was the same as the above but now the middle zone of the 
placenta was assessed in its response to hypoxia-reperfusion.  Example of Western blots 
showing HSP70 expression for the middle zone of the placenta sample is shown in (Figure 
10-2).  The interaction plot showed that expression of HSP70 in the treated group fell 
gradually over time.  The control group showed that HSP70 expression increased slightly 
until 3 h when the expression decreased gradually.  Overall both groups show that HSP70 
expression was reduced over time in both groups, perhaps due to protein turnover. 
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Figure 10-2: Representative image of Western blot showing HSP70 expression (upper panel) 
in the middle placental site. Ref1 is the sample collected in the labour suite. Ref2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP70 protein expression at the middle site. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 1C: This experiment was the same as the above but now the outer zone of the 
placenta was assessed in its response to hypoxia-reperfusion.  Examples of Western blots 
showing HSP70 expression are shown in (Figure 10-3).  The interaction plot showed that 
expression of HSP70 in treated group fell sharply over time with a slight increase after 6 h 
until 12 h when expression fell gradually.  The control group showed that HSP70 
expression decreased slightly until Ref2 point when the expression increased sharply, after 
3 h the expression fall with slight increase after 12 h.  Overall both groups show that 
HSP70 expression was reduced over time, the HSP70 expression in control group showed 
a peak at 3 h. 
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Figure 10-3: Representative image of Western blot showing HSP70 expression (upper panel) 
in the outer placental zone. Ref1 is the sample collected in the labour suite. Ref2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP70 protein expression at the outer zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 2A: This experiment was designed to test if there was any difference in mRNA 
expression of HSP70 between tissues were exposing to hypoxia-reperfusion and control at 
the inner zone of placentas at four different time points (3, 6, 12 and 22 h).  HSP70 mRNA 
was investigated using RT-qPCR.  The interaction plot was used to demonstrate the 
findings (Figure 10-4).  The interaction plot showed that mRNA expression of HSP70 in 
the treated group increased sharply from 3-6 h; the peak was at the 6 h and then decreased 
after that until 12 h when it increased again.  The control group showed that mRNA 
expression of HSP70 continued without changes over the time until 6h when it increased 
slightly.  Overall the treated group showed that there was a sharp peak of HSP70 
expression at 6 h compared to the control group that showed small peak at 6-12 h.  
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Figure 10-4: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
Experiment 2B: This experiment was the same as the above but now the middle zone of the 
placenta was assessed in its response to hypoxia-reperfusion.  The interaction plot showed 
that mRNA expression of HSP70 in the treated group increased sharply after 3 h.  The 
control group showed that there was a slight increase in HSP70 expression after 6 h then 
before decreased after 12 h (Figure 10-5). However at 6 hours the experimental group 
showed a clear increase.   
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Figure 10-5: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 2C: This experiment was the same as the above but now the outer zone of the 
placenta was assessed in its response to hypoxia-reperfusion.  The interaction plot showed 
that mRNA expression of HSP70 in the treated group increased sharply after 3 h until 12 h 
before it falling.  The control group showed a slight increase in HSP70 expression after 6 h 
then decreased after 12 h.  However at 6 hours the experimental group showed a clear 
increase (Figure 10-6).    
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Figure 10-6: The graph shows the interaction plot analysis of the data for HSP70 mRNA at 
the outer zone.  The graph shows data of the samples exposing to hypoxia reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
10.2.2 Analysis of protein and mRNA expression of HSP27 in the 
hypoxia-reperfusion tissue culture experiment.  
The experiments below are the same as those above for HSP70 and therefore less text 
detail are included. 
Experiment 1A: Examples of Western blots showing HSP27 expression for the set of 
experiments performed on placental tissue obtained from the inner zone are shown in 
(Figure 10-7).  The interaction plot showed that expression of HSP27 in the treated group 
decreased gradually over time.  The control group showed that HSP27 expression also 
decreased slowly over time (Figure 10-7).  Overall both groups showed that HSP27 
expression was reduced over time, perhaps due to protein turnover. 
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Figure 10-7: Representative image of Western blot showing HSP27 expression (upper panel) 
in the inner placental zone. Ref1 is the sample collected in the labour suite. Ref2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP27 protein expression at the inner zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 1B: This experiment was the same as the above but now the middle zone of the 
placenta was assessed in its response to hypoxia-reperfusion.  Examples of Western blots 
showing HSP27 expression for the middle zone of the placenta sample are shown in 
(Figure 10-8).  The interaction plot showed that expression of HSP27 in the treated group 
decreased gradually over time.  The control group showed that HSP27 expression 
increased slightly from Ref1 to Ref2 point before it decreased gradually over time (Figure 
10-8).  Overall both groups showed that HSP27 expression was reduced over time in, 
perhaps due to protein turnover. 
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Figure 10-8: Representative image of Western blot showing HSP27 expression (upper panel) 
in the middle placental zone. Ref 1 is the sample collected in the labour suite. Ref 2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP27 protein expression at the middle zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 1C: This experiment was designed to test if there was any difference in HSP27 
protein expression between tissues following exposing placental samples from the outer 
zone to hypoxia-reperfusion.  Examples of Western blots showing HSP27 expression are 
shown in (Figure 10-9).  The interaction plot showed that expression of HSP27 in the 
treated group decreased gradually over time.  The control group showed that HSP27 
expression also decreased over time (Figure 10-9).  Overall both groups showed that 
HSP27 expression was reduced over time, perhaps due to protein turnover. 
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Figure 10-9: Representative image of Western blot showing HSP27 expression (upper panel) 
in the outer placental zone. Ref 1 is the sample collected in the labour suite. Ref 2 is the 
sample collected after arriving in the laboratory.  Different time points (3, 6, 12 and 22 h) of 
reperfusion were performed.  The graph shows the interaction plot analysis of the data for 
HSP27 protein expression at the outer zone. Samples exposed to hypoxia-reperfusion are 
shown as a (red dotted line, YES) and compared to the control samples (Blue continuous 
line, NO) at different time points. 
 
Experiment 2A: This experiment was designed to test if there was any difference in HSP27 
mRNA expression between tissues were exposing to hypoxia reperfusion at the inner zone  
of placentas according to four different time points.  The interaction plot showed that 
expression of HSP27 in the treated group did not change with time.  The control group 
showed that HSP27 expression decreased sharply from Ref1 to Ref2 point then did not 
change over time (Figure 10-10).  
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Figure 10-10: The graph shows the interaction plot analysis of the data for HSP27 mRNA at 
the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
Experiment 2B: This experiment was designed to test if there was any difference in HSP27 
mRNA expression between tissues were exposing to hypoxia-reperfusion at the middle 
zone  of placentas at four different time points.  The interaction plot showed that mRNA 
expression of HSP27 in the treated group increased sharply after 3 h until 6 h then fell.  
The control group showed that there was a slight increase in HSP27 expression between 3-
12 h then decreased after 12 h.  However at 6 hours the experimental group showed a clear 
increase (Figure 10-11). 
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Figure 10-11: The graph shows the interaction plot analysis of the data for HSP27 mRNA at 
the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 2C: This experiment was designed to test if there was any difference in mRNA 
expression of HSP27 between tissues exposed to hypoxia-reperfusion at the outer zone of 
placentas at four different time points.  The interaction plot showed that mRNA expression 
of HSP27 in the treated group increased sharply after 3 h until 12 h then fell.  The control 
group showed that there was a slight increase in HSP27 expression between –Ref1 and 
Ref2 points and 6-12 then decreased until 12 h where there was a slight increased.  
However at 3 hours the experimental group showed again a clear increase (Figure 10-12).  
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Figure 10-12: The graph shows the interaction plot analysis of the data for HSP27 mRNA at 
the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
10.2.3 Analysis of mRNA expression of HSF1 in the hypoxia-
reperfusion tissue culture experiment.  
Experiment 1A: This experiment was designed to test if there was any difference in HSF1 
mRNA expression between tissues exposed to hypoxia-reperfusion at the inner zone of 
placentas at four different time points.  The interaction plot showed that mRNA expression 
of HSF1 in the treated group increased gradually after 3 h until 12 h then increased further.  
The control group showed that there was a sharp decrease in HSF1 expression between 
Ref1 and Ref2 points then there was a slight increase after 6 h before falling after 12 h. 
(Figure 10-13).  
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Figure 10-13: The graph shows the interaction plot analysis of the data for HSF1 mRNA at 
the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
Experiment 1B: This experiment was designed to test if there was any difference in HSF1 
mRNA expression between tissues exposed to hypoxia-reperfusion at the middle zone of 
placentas at four different time points.  The interaction plot showed that mRNA expression 
of HSF1 in the treated group increased gradually after 3 h until 12 h then declined.  The 
control group showed that there was a gradual increase in HSF1 expression from 3-12 h 
then decreased after 12 h (Figure 10-14). 
  
  382 
 
 
Figure 10-14: The graph shows the interaction plot analysis of the data for HSF1 mRNA at 
the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 1C: This experiment was designed to test if there was any difference in mRNA 
expression of HSF1 between tissues exposed to hypoxia-reperfusion at the outer zone of 
placentas at four different time points.  The interaction plot showed that mRNA expression 
of HSF1 in the treated group increased sharply after 3 h then fell after 6 h.  The control 
group showed that there was a slight increase in HSF1 expression from Ref1 to Ref2 time 
point and 6-12 h then declined again (Figure 10-15). 
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Figure 10-15: The graphs show the interaction plot analysis of the data for HSF1 mRNA at 
the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion (Red 
dotted line, YES) compared to the control samples (Blue continuous line, NO) at different 
time points. 
 
10.2.4 Analysis of mRNA expression of HSP90AA in the hypoxia-
reperfusion tissue culture experiment.  
Experiment 1A: This experiment was designed to test if there was any difference in 
HSP90AA mRNA expression between tissues exposed to hypoxia-reperfusion at the inner 
zone of placentas at four different time points.  The interaction plot showed that expression 
of HSP90AA in the treated group remained unaltered.  The control group showed that 
HSP90AA expression decreased sharply from Ref1 to Ref2 time point then remained 
unchanged over time (Figure 10-16).  
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Figure 10-16: The graph shows the interaction plot analysis of the data for HSP90AA mRNA 
at the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 1B: This experiment was designed to test if there was any difference in 
HSP90AA mRNA expression between tissues exposed to hypoxia-reperfusion at the 
middle zone of placentas at four different time points.  The interaction plot showed that 
mRNA expression of HSP90AA in the treated group increased sharply after 3 h until 6 h 
before falling.  The control group showed that there was a slight increase in HSP90AA 
expression between 6-12 h before falling (Figure 10-17). 
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Figure 10-17: The graph shows the interaction plot analysis of the data for HSP90AA mRNA 
at the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 1C: This experiment was designed to test if there was any difference in mRNA 
expression of HSP90AA between tissues exposed to hypoxia-reperfusion at the outer zone 
of placentas at four different time points.  The interaction plot showed that mRNA 
expression of HSP90AA in the treated group was increased sharply after 3 h until 12 h 
before falling.  The control group showed that there was a slight increase in HSP90AA 
expression between Ref1 and Ref2 time point and 6-12 h then it decreased (Figure 10-18). 
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Figure 10-18: The graph shows the interaction plot analysis of the data for HSP90AA mRNA 
at the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
10.2.5 Analysis of mRNA expression of HSP90B1 in the hypoxia-
reperfusion tissue culture experiment.  
Experiment 1A: This experiment was designed to test if there was any difference in 
HSP90B1 mRNA expression between tissues exposed to hypoxia-reperfusion at the inner 
zone of placentas at four different time points.  The interaction plot showed that expression 
of HSP90B1 in the treated group remained the same over time.  The control group showed 
that HSP90B1 expression decreased sharply from Ref1 to Ref2 time point then remained 
the same (Figure 10-19). 
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Figure 10-19: The graph shows the interaction plot analysis of the data for HSP90B1 mRNA 
at the inner zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 2B: This experiment was designed to test if there was any difference in 
HSP90B1 mRNA expression between tissues exposed to hypoxia reperfusion at the middle 
zone of placentas at four different time points.  The interaction plot showed that mRNA 
expression of HSP90B1 in the treated group increased slightly after 3 h until 6 h before it 
fell.  The control group showed that there was a slight increase in HSP90B1 expression 
from Ref1 to Ref2 time point and then there was a sharp increase from 6-12 h before 
falling (Figure 10-20). 
  
  388 
 
 
Figure 10-20: The graph shows the interaction plot analysis of the data for HSP90B1 mRNA 
at the middle zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
Experiment 1C: This experiment was designed to test if there was any difference in mRNA 
expression of HSP90B1 between tissues exposed to hypoxia-reperfusion at the outer zone 
of placentas at four different time points.  The interaction plot showed that mRNA 
expression of HSP90B1 in the treated group showed a sharp increase after 3 h until 6 h 
before falling.  The control group showed that there was a slight increase in HSP90B1 
expression from Ref1 to Ref2 time point and 6-12 h then decreased (Figure 10-21).  
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Figure 10-21: The graph shows the interaction plot analysis of the data for HSP90B1 mRNA 
at the outer zone.  The graph shows data of the samples exposing to hypoxia-reperfusion 
(Red dotted line, YES) compared to the control samples (Blue continuous line, NO) at 
different time points. 
 
 
10.3 Discussion 
10.3.1 IR experiment and present findings 
HSP70: There was no significant difference in mRNA and protein expression of HSP70 in 
the IR experiment over the time periods studied. HSF1:  There was also no significant 
difference in mRNA expression of HSF1. 
HSP27: There was a significant decrease in HSP27 protein expression (all zones) and 
mRNA (inner zone) over time, the letter perhaps due to protein turnover.  There was no 
significant difference in protein expression of HSP27 due to hypoxia-reperfusion. 
HSP90AA: There was a significant decrease in mRNA expression of HSP90AA over time 
only in the inner zone.  There was no significant difference in mRNA expression of 
HSP90AA due to hypoxia-reperfusion. HSP90B1: there was a significant increase in 
mRNA expression of HSP90B1 due to hypoxia-reperfusion over time in the inner zone. 
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10.3.2 IR experiment and key findings 
IR injury is a transient ischemia which when followed by reperfusion induces tissue 
damage.  Several HSPs protect cells during IR injury and allow greater capacity for 
increased work during acute inotropic challenge; for example in the heart, HSP20 protects 
cardiac cells (Pinz et al., 2008) whereas HSPB5 protects diastolic contractile performance 
during IR (Hu et al., 2008). 
There are several studies which have examined the effect of hypoxia on cultured 
trophoblasts (Hung et al., 2002, Hardy and Yang, 2002, Newby et al., 2005).  Trophoblast 
cells remain viable for up to 72h in hypoxic conditions and CTB differentiation into 
syncytium is inhibited by exposure to hypoxia (Nelson et al., 1999, Newby et al., 2005).  
In the present study, there were no significant changes in both protein and mRNA 
expression of (HSP27 and HSP70) and mRNA expression of (HSP90AA and HSF1) 
expression due to hypoxia-reperfusion. HSP90B1 expression showed significant increased 
due to the IR insult.  However, there was significant decrease in HSP27 and HSP90AA 
expression over time but at different placenta zones. 
Although these data are very preliminary there was an obvious increase in HSP70, HSP27 
and HSP90AA mRNA expression when exposed to IR at the 6 h point.  Future experiments 
should follow this up to determine if this is a real statistical effect. 
The important point to highlight here is placental zonal variation in responding to IR insult. 
Our previous study (Abdulsid et al., 2013b) was to investigate protein and mRNA 
expression HSP70 in the labour and PE groups.  In the labour HSP70 protein expression 
was higher in the labour group compared to the non-labour at the middle zone and there 
were no significant changes in HSP70 mRNA expression.  In the PE group HSP70 protein 
was increased in non-labour PE group compared to the control group at the inner zone and 
no changes were noted at the mRNA level.  In the IR experiment, protein expression of 
HSP70 a little higher in the treated group compared to the control at the 6 h time at the 
middle zone.  There was a high mRNA expression of HSP70 in the treated group at all 
zones at time 6 h.  These findings highlighted that IR insult had an effect on HSP70 
expression at the 6 h time but in different placental zones.  
Another study from our group (Abdulsid et al., 2013a, Abdulsid and Lyall, 2014) involved 
investigating protein and mRNA expression HSP27 in the labour and PE groups.  In the 
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non-labour group HSP27 protein and mRNA expression was increased compared to the 
labour group at the inner (only mRNA) and middle zone (both).  In the PE group, HSP27 
protein expression was increased in the labour PE compared to the control at the middle 
and outer zones. No changes were found at the mRNA level.  In the IR experiment protein 
expression of HSP27 was a slightly increased in the treated group compared to the control 
group on the 6 h time at the inner zone but there was a high mRNA expression of HSP27 
in the treated group at the middle and outer zones at time 6 h.  Again, these finding showed 
that IR had an effect on HSP27 expression especially at 6 h at middle and outer placental 
zones. 
Other study from our group (chapter VII) involved investigating mRNA expression 
HSP90AA and HSP90B1 in the labour and PE groups.  In the labour both HSP90AA and 
HSP90B1 mRNA expression was increased in the labour group compared to the non-
labour group at the outer zone.  In the PE group, there was no difference in HSP90AA and 
HSP90B1 mRNA expression.  In the IR experiment, there was an increased in HSP90B1 
mRNA expression due to IR effect at the inner zone. HSP90AA mRNA expression 
significantly decreased over time.  This study showed a clear link between IR and 
increased HSP90B1 expression at the inner zone.  It also showed a decreased HSP90AA 
expression over time again at the inner zone. 
Another study (chapter III) involved investigating protein and mRNA expression of HSF1 
in the labour and PE groups.  At the molecular level, in the labour group, there was a 
significant increase in mRNA expression of HSF1 compared to the non-labour at the inner 
zone.  In the PE group, there was high HSF1 mRNA expression in the non-labour PE 
group compared to the controls.  In the IR experiment there was no changes over period of 
time due to the IR insult in any placental zones. 
10.3.3 Placental oxidative stress in labour and PE 
Oxidative stress is associated with activation of several pathways such as p38, MAPK, and 
the NF-κB signalling pathways.  Oxidative stress also increase production of TNF-α, IL-1β 
and apoptotic changes localized principally in the STB (Hung et al., 2002, Hung et al., 
2004, Bainbridge et al., 2006, Cindrova-Davies et al., 2007a).  Antioxidant can block these 
changes and this suggesting role for ROS (Cindrova-Davies et al., 2007a) 
Pregnancy is associated with an increase rate of lipid peroxidation and oxidative stress 
compared with non-pregnant women (Kaur et al., 2008).  The placenta initially developed 
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in a hypoxic environment but toward end of first trimester, its vascularization develops and 
the circulation starts, with this comes an increase in the oxygen concentration.  When 
mitochondria are exposed to high maternal oxygen levels the result will be increased 
production of ROS and the start of the oxidative stress process (Siddiqui et al., 2010). 
There are many evidences for placental oxidative stress in labour and PE.  Uterine 
contractions during labour are associated with intermittent utero-placental blood perfusion 
providing the basis for IR type injury to the placenta.  Doppler ultrasound studies have 
demonstrated a linear inverse relationship between uterine artery resistance and the 
intensity of the uterine contractions during labour (Brar et al., 1988).  In addition, labour is 
also associated with placental alterations in several pathways linked to oxidative stress 
(Cindrova-Davies et al., 2007b).  In PE spiral artery remodelling is partial or incomplete 
(Lyall, 2006) and perfusion by intermittent pulses of fully oxygenated arterial blood is 
thought to lead to fluctuations in oxygen delivery resulting in oxidative stress (Burton and 
Jauniaux, 2011).  In PE, there are several evidences for oxidative stress including increased 
concentrations of protein carbonyls, lipid peroxides, nitrotryosine residues and DNA 
oxidation.  Our group has shown that HSP27 and HSP70 are selectively up-regulated in 
labour and PE suggesting a link to placental oxidative stress (Abdulsid et al., 2013b, 
Abdulsid and Lyall, 2014). 
 
10.3.4 Placenta ER and the inflammatory response  
The ER is where synthesis of polypeptide hormones, growth factors and plasma membrane 
proteins and their post-translational modification takes place. IR and hypoxia induces 
oxidative stress and activates ER stress (Yung et al., 2007), through three ways: the first 
one by disturbance of calcium homeostasis as well as increased generation of ROS through 
mitochondrial pathways or by proteolytic cleavage of xanthine dehydrogenase to the 
xanthine oxidase form, which is higher in PE (Halliwell, 2005, Burton et al., 2009b).  
Secondly, the UPR can activate same intracellular inflammatory signalling pathways (Xu 
et al., 2005, Zhang and Kaufman, 2008).  Thirdly,  protein folding is an oxidative event 
that also generates ROS (Tu and Weissman, 2004).  Ire1 activates the NF-kB pathway 
through phosphorylation of IKK, and the p38 MAPK pathway through ASK1 (Burton et 
al., 2009b). 
In vitro, exposing placenta explants to IR generates oxidative stress and increased cytokine 
release such as TNFα, sFLT-1 and IL-1β (Hung et al., 2001, Hung et al., 2004, Cindrova-
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Davies et al., 2007a).  These changes can blocked by inhibition of the p38 and    NF-
κB  pathways or addition of anti-oxidant vitamins C and E (Cindrova-Davies et al., 2007a, 
Cindrova-Davies, 2009). 
Apoptosis and necrosis are common outcomes of IR injury.  Apoptosis increased in villous 
trophoblast on exposure to oxygen concentrations less than 2% (Kilani et al., 2003).  
During the reperfusion phase, ROS are generated within mitochondria and also through the 
actions of enzymes such as xanthine oxidase (Collard and Gelman, 2001).  Imbalances of 
ROS lead to loss of Ca
+2  
homeostasis, and promote opening of the mitochondrial pore lead 
to release of cytochrome c and activation of caspase pathways (Kowaltowski et al., 2001, 
Hung et al., 2002). 
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Chapter XI: Heat shock tissue culture experiment 
and investigation of HSPs and caspases at the 
inner, middle and outer placental zones. 
11 Heat shock tissue culture experiment  
11.1 Introduction  
Heat shock is effect of exposing a tissue to a higher temperature than the physiological 
temperature. Hyperthermia induces complex cellular responses including protein 
aggregation, misfolding or unfolding due to the interactions of the exposed hydrophobic 
groups (Roti Roti, 2008).  In addition, hyperthermia effects also include organelle 
fragmentation, changes in protein associations, and ROS generation (Roti Roti, 2008, 
Bruskov et al., 2002).  Furthermore, hyperthermia may cause stalling of the DNA 
replication fork and double strand breaks, micronucleus formation, chromosome 
aberrations and inhibition of DNA repair processes (Roti Roti, 2007, Hintzsche et al., 
2012, Eppink et al., 2012). 
Heat shock induces the expression of the highly conserved HSPs, which belong to a 
superfamily sharing a protection function against cellular stress.  In cells, there are basal 
levels of HSPs (constitutive HSPs).  HSPs can also be induced by several pathological or 
stressful situations (inducible HSPs) to protect cells from stress (Lanneau et al., 2010).  
HSPs assist in protein refolding and salvage, as well as disaggregation of inappropriate 
protein collectives, and will promote the degradation of unrecoverable proteins (Saibil, 
2013).  Sub-lethal hyperthermia increases expression of several HSPs, which are consistent 
with the cellular need for protein repair and stabilization (Dong and Dong, 2008). 
Hyperthermia is used in combination with anticancer drugs to increase their cytotoxicity 
(Sottile et al., 2015).  One of the important results of hyperthermia is the producing of 
HSPs, which are able to associate with DNA repair pathways (Sottile et al., 2015).  When 
tumour cells were exposed to sub-lethal heat shock prior to the chemotherapy, the latter 
was less effective (Kiang et al., 1998). 
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11.2 Results  
As time was limited one set of experiments was performed for all the data shown below, 
with a view to zooming in on particular time points should any obvious trends be spotted.  
As will be evident there appeared to a trend for differences to be apparent around 6 h and 
this would require future experiments. 
11.2.1 Analysis of protein and mRNA expression of HSP70 in the 
heat shock tissue culture experiment.  
Experiment 1A, protein analysis: This experiment involved exposing placenta samples to 
43 C for 30 min and then 37 C for different time periods.  The control samples were 
exposed to 37 C only. Five time points (1, 3, 6, 12 and 24 h) were used for recovery. 
HSP70 protein expression was investigated using Western blot analysis. HSP70 mRNA 
was investigated using RT-qPCR.  Interaction plots were prepared to demonstrate the 
findings.  Examples of Western blots showing HSP70 expression for the set of experiments 
performed on placental tissue obtained from the inner zone are shown in (Figure 11-1). 
The interaction plot showed that expression of HSP70 in the heat shocked group decreased 
from 1-3 h then there was a sharp increase until 6 h when it falls down and then increased 
slightly.  The control group showed that HSP70 expression increased slowly from 0-1 h 
after that it decreased gradually until 6 h when there was a slow increase from 6-12 h 
before it falls down after 12 h (Figure 11-1).  Overall because this is based on one placenta 
it appears that the only clear change appeared to be the increase in HSP70 at the 6 h in the 
treatment group. 
  396 
 
 
Figure 11-1: Representative image of Western blot showing HSP70 expression (upper panel) 
in the inner placental zone. Ref is the sample collected in the labour suite.  Different time 
points (1, 3, 6, 12 and 24 h) of recovery at 37 C were studied. Graphs show the interaction 
plots analysis of the data for HSP70 protein expression at the inner zone.  Samples exposed 
to heat shock are shown as a (red dotted line, YES) and compared to the control samples 
(Blue continuous line, NO) at different time points. 
 
Experiment 1 B: This experiment involved exposing placenta samples to 43C for 30 min 
and then recovery at 37 C for different time periods.  The control samples were exposed 
to 37 C only.  Examples of Western blots showing HSP70 expression for the set of 
experiments performed on placental tissue obtained from the middle zone are shown in 
(Figure 11-2).  The interaction plot showed that protein expression of HSP70 in heat 
shocked group was decreased until 3 h then was increased sharply, after 6 h and there was 
a steady decrease until 24 h.  The control group showed that HSP70 expression was 
increased until 1 h then decreased gradually until 6 h where there was a slight increase 
before it falls down again.  Both group showed sudden decrease after 1h with sharp 
increase after 3 h for the heat shocked group and slight increase after 6 h for the control 
group before both groups showed fall down in HSP70 expression after 12 h (Figure 11-2). 
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Overall because this is based on one placenta and again it appears that the only clear 
change appeared to be the increase in HSP70 at 6 h in the treatment group.  
 
Figure 11-2: Representative image of Western blot showing HSP70 expression (upper panel) 
in the middle placental zone. Ref is the sample collected in the labour suite.  Different time 
points (1, 3, 6, 12 and 24 h) of recovery at 37 C were performed.  Graphs show the 
interaction plots analysis of the data for HSP70 protein expression at the middle zone.  
Samples exposed to heat shock are shown as a (red dotted line, YES) and compared to the 
control samples (Blue continuous line, NO) at different time points.  
 
Experiment 1 C: This experiment involved exposing placenta samples to 43 C for 30 min 
and then 37 C for different time periods. The control samples were exposed to 37 C only.  
Examples of Western blots showing HSP70 expression for the set of experiments 
performed on placental tissue obtained from the outer zone are shown in (Figure 11-3).  
Interaction plot showed that expression of HSP70 in the heat shocked group slightly 
increased from 1-6 h then decreased gradually over time.  In the control group HSP70 
expression was decreased suddenly from 0-1 h then increased slightly between 1-3 h and 6-
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12 h before it decreased again (Figure 11-3).  Overall both groups show that expression of 
HSP70 was reduced, perhaps due to protein turnover.  
 
 
Figure 11-3: Representative image of Western blot showing HSP70 expression (upper panel) 
in the outer placental zone. Ref is the sample collected in the labour suite.  Different time 
points (1, 3, 6, 12 and 24 h) of recovery at 37 C were studied.  Graphs show the interaction 
plots analysis of the data for HSP70 protein expression at the outer zone.  Samples exposed 
to heat shock are shown as a (red dotted line, YES) and compared to the control samples 
(Blue continuous line, NO) at different time points. 
 
Experiment 2 A mRNA analysis: This experiment involved exposing placenta samples to 
43 C for 30 min and then 37 C for different time periods.  The control samples were 
exposed to 37 C only.  Five time points (1, 3, 6, 12 and 24 h) were used for recovery. 
HSP70 mRNA was investigated using RT-qPCR.  Interaction plots were used to 
demonstrate the findings. (Figure 11-4) shows mRNA expression of HSP70 for the set of 
experiments performed on placental tissue obtained from the inner zone.  The interaction 
plot showed that mRNA expression of HSP70 in heat the shocked group increased sharply 
from 3-6 h then decreased gradually over time.  The control group showed that mRNA 
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expression of HSP70 continued without changes over the time (Figure 11-4).  Overall 
because this is based on one placenta and again it appears that the only clear change 
appeared to be the increase in HSP70 at 6 h in the treatment group.  
 
 
Figure 11-4: The graphs show the interaction plots analysis of the data for HSP70 mRNA at 
the inner zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
Experiment 2 B: This experiment involved exposing placenta samples to 43 C for 30 min 
and then 37 C for different time periods.  The control samples were exposed to 37  C 
only. (Figure 11-5) shows HSP70 mRNA expression for the set of experiments performed 
on placental tissue obtained from the middle zone.  The interaction plot showed that 
mRNA expression of HSP70 in heat shock group was increased sharply after 3 h then it 
decreased sharply after 6 h.  The control group showed that there was a slight increase in 
HSP70 expression after 3 h then before decreased after 6 h (Figure 11-5).  Overall both 
groups show that there was increase of HSP70 expression after 3 h until 6 h sharply for 
heat shocked group and slightly for the control group.  Overall because this is based on one 
placenta and again it appears that the only clear change appeared to be the increase in 
HSP70 at 6 h in the treatment group.  
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Figure 11-5: The graphs show the interaction plots analysis of the data for HSP70 mRNA at 
the outer zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
Experiment 2 C: This experiment involved exposing placenta samples to 43 C for 30 min 
and then 37 C for different time periods.  The control samples were exposed to 37 C 
only. (Figure 11-6) shows HSP70 mRNA expression for the set of experiments performed 
on placental tissue obtained from the outer zone.  The interaction plot showed that mRNA 
expression of HSP70 in heat shocked group decreased at 1 h then increased slightly at the 3 
h before it decreased again at 6 h, at the 12 h mRNA expression of HSP70 showed that 
there was a sharp increase.  The control group showed slight changes in mRNA expression 
of HSP70 with slight increase at the 3 h before it decreased again at the 6 h (Figure 11-6).  
Overall both groups showed that there was a small increase of HSP70 expression between 
3-6 h then at the 12 h there was a large increase in the heat shocked group compared to the 
control group that showed a small increase. 
 
  401 
 
 
Figure 11-6: The graphs show the interaction plots analysis of the data for HSP70 mRNA at 
the outer zone. The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
11.2.2 Analysis of protein and mRNA expression of HSP27 in the 
heat shock tissue culture experiment.  
The experiments below are the same as those above for HSP70 and therefore less text 
detail are included. 
Experiment 1 A, protein analysis: Examples of Western blots showing HSP27 expression 
for the set of experiments performed on placental tissue obtained from the inner zone are 
shown in (Figure 11-7).  The interaction plot showed that expression of HSP27 in the heat 
shocked group was reduced from 1-3 h then increased after 3 h; the peak was at the 6 h and 
then decreased over time.  The control group showed that HSP27 expression was decreased 
gradually from time period 0-6 h then slight increased after 6 h.  Overall both groups show 
that there was a decrease in HSP27 expression over the time, perhaps due to protein 
turnover.  There was a sharp increase in HSP27 expression in heat shocked group at the 6 h 
time point (Figure 11-7). 
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Figure 11-7: Representative image of Western blot showing HSP27 expression (upper panel) 
in the inner placental zone. Ref is the sample collected in the labour suite.  Different time 
point (1, 3, 6, 12 and 24 h) of recovery at 37 ᵒC was performed.  Graphs show the interaction 
plots analysis of the data for HSP27 protein expression at the inner zone.  Samples exposed 
to heat shock are shown as a (red dotted line, YES) and compared to the control samples 
(Blue continuous line, NO) at different time points. 
 
Experiment 2 B: The interaction plot showed that expression of HSP27 in the heat shocked 
group was increased from 1-3 h then reduced sharply until 6 h after that there was a 
gradual decrease.  The control group showed that HSP27 expression was decreased sharply 
from time period 0-3 h then gradually over time.  Overall both groups show that there was 
a decrease in HSP27 expression over the time perhaps due to protein turnover, with slight 
increase in HSP27 expression of heat shocked group between 1-3 h of recovery period 
(Figure 11-8). 
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Figure 11-8: Representative image of Western blot showing HSP27 expression (upper panel) 
in the middle placental zone. Ref is the sample collected in the labour suite.  Different time 
points (1, 3, 6, 12 and 24 h) of recovery at 37  C were performed.  Graphs show the 
interaction plots analysis of the data for HSP27 protein expression at the middle zone.  
Samples exposed to heat shock are shown as a (red dotted line, YES) and compared to the 
control samples (Blue continuous line, NO) at different time points. 
 
Experiment 2 C: Interaction plot showed that expression of HSP27 in heat shocked group 
was reduced over the recovery period with a slight increase from 3-6 h.  In the control 
group HSP27 expression was decreased from 0-1 h then slight reduced over the time 
(Figure 11-9).  Overall no major findings were observed with heat shock.  
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Figure 11-9: Representative image of Western blot showing HSP27 expression (upper panel) 
in the outer placental zone. Ref is the sample collected in the labour suite.  Different time 
points (1, 3, 6, 12 and 22 hours) of recovery at 37 ᵒC were performed.  Graphs show the 
interaction plots of the data for HSP27 protein expression at the outer zone.  Samples 
exposed to heat shock are shown as a (red dotted line, YES) and compared to the control 
samples (Blue continuous line, NO) at different time points. 
 
Experiment 2 A: (Figure 11-10) shows mRNA expression of HSP27 for the set of 
experiments performed on placental tissue obtained from the inner zone.  Interaction plot 
showed that mRNA expression of HSP27 in the heat shocked group was very high at 6 h 
then there was a sharp reduction.  The control group showed that mRNA expression of 
HSP27 was reduced sharply from 0-1 h.  
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Figure 11-10: The graphs show the interaction plots analysis of the data for HSP27 mRNA at 
the inner zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
Experiment 2 B: The interaction plot showed that mRNA expression of HSP27 in the heat 
shocked group increased markedly at 6 h then there was a sharp reduction.  The control 
group showed that mRNA expression of HSP27 was reduced from 0-3 h then increased 
slightly until 6 h before dropping down again (Figure 11-11). 
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Figure 11-11: The graphs show the interaction plots analysis of the data for HSP27 mRNA at 
the middle zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
Experiment 2 C: The interaction plot showed that mRNA expression of HSP27 in the heat 
shocked group decreased sharply from 1-3 h then slightly increased until 6 h then 
decreased at 12 h there was a sharp increased.  The control group showed that mRNA 
expression of HSP27 was reduced from 0-3 h then increased slightly until 6 h before drop 
down again.at the 12 h there was a slight increase (Figure 11-12). 
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Figure 11-12: The graphs show the interaction plots analysis of the data for HSP27 mRNA at 
the outer zone.  The graph shows data of the samples exposing to heat shock (Red dotted 
line, YES) compared to the control samples (Blue continuous line, NO) at different time 
points. 
 
11.2.3 Several HSPs and caspases mRNA expression after 
exposure to the heat shock  
Because there was a large volume of data, main finding will summarized in next section 
11.2.3.1 HSP32:  
It appears that the only clear change appeared to be the increase in HSP32 at 6 hour (h) in 
the treatment group.  
11.2.3.2 HSP90AA:  
There was an obvious increase in HSP90AA mRNA in inner, middle and outer placental 
zones when exposed to heat shock at the 6 h point.    
11.2.3.3 HSP90B1:  
It was clear that there was an increase in 3-6 h in the treated group at the inner and outer 
zones, however, at the middle zone the expression in the control group was slightly 
increased. 
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11.2.3.4 HSF1:  
It appears that the only clear change appeared to be the increase in HSF1 at 6 h in the 
treatment group.  
11.2.3.5 HSF2:  
It appears that the only clear change appeared to be the decrease in HSF2 over time at the 
inner zone.   
11.2.3.6 DNAJAB1:  
It appears that the only clear change appeared to be the increase in DNAJAB1 mRNA in 
inner, middle and outer placental zones when exposed to heat shock at the 6 h point.   
11.2.3.7 HSPB2:  
It appears that the only clear change appeared to be the increase in HSB2 due to heat shock 
effect at the inner zone when exposed to heat shock at the 6h point.   
11.2.3.8 HSPB6:  
It appears that the only clear change appeared to be the increase in HSB6 at 6 h in the 
treatment group. 
11.2.3.9 HSPD1:  
Although these data are very preliminary there was an obvious increase in HSPD1 mRNA 
in inner, middle and outer placental zones when exposed to heat at the 6 h point.   
11.2.3.10 CASP3: 
 It appears that there was an increase in mRNA expression of CASP3 due to heat shock 
effect at the inner zone and decrease in mRNA expression of CASP3 over time at the inner 
and middle zones, no changes at the outer zone. 
11.2.3.11 CASP7:  
There was a decrease in mRNA expression of CASP7 over time at the middle zone. 
11.2.3.12 CASP9:  
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There were no changes in mRNA expression of CASP9 due to heat shock effect over time. 
 
 
11.3 Discussion  
11.3.1 HSP70 and HSP27 protein and mRNA expression and 
present findings 
There was no significant difference in protein or mRNA expression of HSP27 and HSP70 
due to heat shock.  There was a significant decrease in HSP70 and HSP27 protein 
expression over time but at different zones. 
11.3.2 Different HSPs mRNA expression and present findings 
There was no significant difference in mRNA expression of HSP32, HSP90AA, HSP90B1, 
HSF1, DNAJAB1, HSPB6 and HSPD1 due to heat shock or time.  There was a fall in 
HSF2 expression over time and there was a significant increase in HSPB2 due to heat 
shock, both at the inner zone. 
11.3.3 CASPs mRNA expression and present findings 
There was a fall in CASP3 and CASP7 mRNA expression over time at the middle zone. 
There was a significant increase in CASP3 due to heat shock at the inner zone. No changes 
in CASP9 were found. 
There was a clear trend for increases in most HSPs and caspases mRNA expression at the 6 
h time and this seems to be the key finding.  As this set of work was performed close to the 
end of the thesis future experiments should follow this up to determine if this is a real 
statistical effect however, the preliminary results suggest there are. 
11.3.4 Heat shock experiment  
There is nothing in the literature to compare to this study; however sampling from different 
placental zones is a key point. Overall there was only significant increase in HSPB2 and 
CASP3 expression after exposure to heat shock, both at the inner zone.  There was a 
significant decrease in HSF2, CASP3 and CASP7 over time, also at the inner zone. It 
seems that the inner zone is the most sensitive area to hyperthermia.  Another important 
point was the time (6 h) for the highest expression of majority of genes that were studied. 
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Several studies have been carried out to investigate the effect of heat shock on HSP 
expression most of them on cell culture.  Examples include: 
Wiegant et al performed heat shock experiments on hepatoma cells of Reuber H35 rat 
(Wiegant et al., 1994).  This study examined the effect of different stressors including heat 
shock, arsenite, cadmium, dinitrophenol and ethanol on cell survival and induction of 
HSPs. Heat shock was applied between 30 min to 60 min at 41 C, 41.5  C, 42  C, 42.5  
C or 43  C by immersing the culture flasks in a water bath.  They found that there was 
increased inhibition of protein synthesis as the temperature of the heat shock increased, 
with 10% fall at 43  C for 60 min.  They concluded that the pattern of induced HSPs 
might be used as biomarker of chemical or stress exposure, however; they added that HSPs 
cannot be used as a general risk-assessment tool (Wiegant et al., 1994). 
Ovelgonne et al performed heat shock experiment on Reuber H35 hepatoma cells to 
investigate HSF and HSP 60, HSP68 and HSP84 expression and to compare different 
stressful factors (Ovelgonne et al., 1995).  This study showed that the rate of HSP synthesis 
correlated well with HSP mRNA levels and the stress response is regulated mainly at the 
transcriptional level (Ovelgonne et al., 1995).  HSF was activated and they concluded that 
more processes than just HSF activations are involved in the induction of HSPs. 
Kiang et al performed a heat shock experiment on T47-D cells, a human breast cancer cell 
line that expresses estrogen receptors, to investigate HSP expression by Western blotting 
analysis (Kiang et al., 1998).  Heat shock was applied at 44 C. This study showed that 
there was an increased in HSP70, GRP78 and GRP94 expression in a time dependent 
manner and the maximal expression rate was between 2 and 4 h after heat shock.  In 
addition, cells over expressing HSP70, GRP78 and GRP94 displayed resistance against a 
lethal temperature (47 C for 50 min) (Kiang et al., 1998).  
Dong and Dong performed a heat shock experiment on sea cucumbers using sub-lethal and 
lethal temperatures between 30-40  C (Dong and Dong, 2008).  This study found that 
there was an increased in survival rates of the sea cucumbers when they were exposed to 
34 C, HSP70 expression level also increased and induced a thermotolerance (Dong and 
Dong, 2008).  They concluded that there a close relationship existed between the induction 
of thermotolerance and the levels of HSP70. 
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Tazawa et al used heat shock to investigate HSP70 expression in microfluidic tissue 
culture and its relation to endothelial damage (Tazawa et al., 2015).  This study reported 
that live cell imaging showed only minor changes in the appearance of heat-treated cells; 
however, increased HSP70 mRNA expression showed that the endothelial cells responded 
well to heat treatment (Tazawa et al., 2015).  They concluded that heat-induced endothelial 
changes under stress and this introduces a potent tool for analysing endothelial secretions 
in tissue culture.  
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Chapter XII: Analysis of stress and apoptic 
pathways in placentas from four different BMI 
groups 
12 BMI study  
12.1 Introduction  
The worldwide prevalence of obesity has increased markedly over the past few decades, 
with the World Health Organization  (WHO) describing this trend as a ‘global epidemic’ 
posing a serious threat to public health (WHO, 2000).  Obesity is asscoiated with 
hyperinsulinemia, dyslipidemia, higher blood pressure, impaired endothelial function and 
inflammatory up-regulation.  The increasing prevalence of obesity among women during 
childbearing age is concern as obesity carries additional risk for both mother and fetus  
(Heslehurst et al., 2007). 
12.1.1 Obesity and inflammation  
Obesity is characterized by a chronic, low-grade inflammation and an impaired 
intracellular stress defence system (Fernández-Sánchez et al., 2011).  Obesity-induced 
inflammation depends on a set of classical inflammatory mediators.  In obese individuals 
the stress response is more complex and includes an impairment of the heat shock response 
(HSR), ER stress and down-regulation of the cellular antioxidant system (Bruce et al., 
2003, Hotamisligil, 2010, Sies, 2007).  In addition, there are high levels of inflammatory 
mediators, adipocytes and C-reactive protein (CRP) in the circulation of obese women 
(Bodnar et al., 2005a).  Adipose tissues produce inflammatory mediators including TNF-α 
which leads to vasodilation, vascular permeability, endothelial damage, insulin resistance, 
and oxidative stress, and its levels related to adiposity degree and insulin resistance 
(Tzanavari et al., 2009, Fernández-Sánchez et al., 2011).  Obesity is involved in 
development of type2 diabetes mellitus (Fernández-Sánchez et al., 2011).  Inflammation is 
a result of increased oxidative stress in obese people and is related to endothelial 
dysfunction and insulin resistance, these changes lead to metabolic and vascular alterations 
(Fonseca-Alaniz et al., 2007).  Adipose tissue produces 25% of systemic IL-6 which 
contributes to systemic inflammation related to obesity (Fernández-Sánchez et al., 2011). 
In addition, adipose tissue in obese people activates CD8 (+) T-cells, which activate 
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macrophages and the start of adipose inflammation (Nishimura et al., 2009).  Furthermore, 
hypoxia is a result of adipose tissue overgrowth that leads to production of acute phase 
proteins and adipokines (Fernández-Sánchez et al., 2011). 
12.1.2 Obesity and endothelial dysfunction  
Endothelial dysfunction is characterized by a pro inflammtory, pre-coagulant and 
proliferative state that all lead to atherogenesis (Hadi et al., 2005).  Obesity is associated 
with higher levels of superoxide radicals and nitrotyrosine in endothelial cells.  In obesity 
there is increased oxidative stress and endothelial dysfunction associated with high levels 
of leptin (Galili et al., 2007).  Inflammation, LDL oxidation, cytokines and ROS can 
stimulate endothelial dysfunction by secretion of adhesion molecules, which results in 
monocyte infiltration into the sub-endothelial space (Couillard et al., 2005).  Obesity is 
associated with oxidative stress, which increases vascular endothelial permeability and 
promotes leukocyte adhesion (Hadi et al., 2005).  Weight loss improves endothelial 
activation markers and vasodilation and also decreases cytokines (Hadi et al., 2005). 
12.1.3 Obesity and insulin resistance  
Metabolic syndrome features include obesity, insulin resistance, impaired glucose 
tolerance, hypertension and dyslipidemia. Insulin resistance is estimated to be present in 
two thirds of individuals with excess weight, this in turn strongly, predisposes to type2 
diabetes and cardiovascular disease (Murdolo et al., 2013, Jeyabalan, 2013).  Dyslipidemia 
and the increase in free fatty acid production from adipocytes has been suggested to 
contribute to oxidative stress and insulin resistance, which are obesity features (Jeyabalan, 
2013).  Oxidative stress markers are increased in obese individuals.  For example, 8-iso 
prostaglandin F2α is an oxidative stress marker (8-isoPGF α), and the urine concentration 
is positively correlated with obesity and insulin resistance (Keaney et al., 2003).  Oxidative 
stress is associated with the pathogenesis of insulin resistance via the inhibition of insulin 
signals and the dysregulation of adipokines (Houstis et al., 2006, Matsuda and Shimomura, 
2013).  In pregnancies complicated by PE with obesity, insulin resistance is common and 
can persist for several years, thus also increasing cardiovascular diseases risk (Laivuori et 
al., 2000). 
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12.1.4 Obesity and oxidative stress 
Oxidative stress and production of ROS occur under several physiological and pathological 
conditions, which lead to tissue damage (Fernández-Sánchez et al., 2011, Matsuda and 
Shimomura, 2013).  Oxidative stress is involved in many diseases such as obesity, 
cardiovascular disease, diabetes and cancer (Fernández-Sánchez et al., 2011, Matsuda and 
Shimomura, 2013).  Obesity could induce systemic oxidative stress and in turn oxidative 
stress is associated with abnormal adipokine production (Esposito et al., 2006).  C-reactive 
protein (CRP) is a marker of oxidative stress and is higher in obese people, in addition, 
antioxidant markers are lower in obese individuals (Chrysohoou et al., 2007).  
Furthermore, a diet high in fat and carbohydrates diet increase oxidative stress and 
inflammation in obese individuals (Patel et al., 2007).  Oxidative stress and endothelial 
dysfunction may predispose obese women to develop PE (Jeyabalan, 2013). 
12.1.5 The association of obesity with PE 
Obesity has increased globally over last few decades. This increasing trend has substantial 
implications for pregnancy, as obesity is associated with infertility, spontaneous 
miscarriage, thromboembolic complications, gestational diabetes, stillbirth, caesarean 
section, large babies and hypertensive complications (Yogev and Catalano, 2009).  Obesity 
is associated with a two to three fold increased risk of PE (Bodnar et al., 2005b).  Obesity 
is associated with a risk for late onset PE as well as early onset PE, which is associated 
with perinatal morbidity and mortality (Catov et al., 2007).  The association between PE 
risk and obesity has been reported in several countries and this supporting the evidence that 
weight loss reduces this risk (Hauger et al., 2008, Magdaleno Jr et al., 2012).  Obesity is a 
potentially modifiable risk factor for PE and weight loss prior to pregnancy is encouraged 
in obese women (Yogev and Catalano, 2009). 
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12.2 Results  
12.2.1 Patient clinical data analysis  
12.2.1.1 BMI groups: 
The patient details for the four BMI groups (Table 2-2) were compared by using one way 
ANOVA and are shown in (Table 12-1). 
Table 12-1: Patient’s clinical details; the descriptive analysis showed the mean and standard 
deviation.  Analyses between the four groups were performed using one way ANOVA, P 
value < 0.05 was considered statistically significant. 
 
12.2.2 Analysis of protein and mRNA expression of HSP70 
between 4 BMI groups. 
 Group 1 (BMI <30), group 2 (BMI 30-35), group 3 (BMI 35-40) and group 4 (BMI>40)  
Experiment 1: This experiment was designed to test if there was any difference in protein 
expression of HSP70 between 4 BMI groups. Group 1 (BMI <30), group 2 (BMI 30-35), 
Category BMI<30 (n=6) BMI 30-35 
(n=6) 
BMI 35-40 
(n=6) 
BMI>40  
(n=6) 
p-value 
Maternal 
age 
28.83±5.3 35.00±4.69 31.33±6.74 35.50±7.97 p=0.2 
Placenta 
weight 
679.8±170.7 630.0±103.1 708.7±166.8 684.0±169.3 P=0.8 
 
 
Birth 
weight 
3858±894 3381±183 3827±676 3444±459 p=0.4 
No. PG 1 1 1 0  
Gestation 
age at 
delivery 
39.21±0.39 38.60±1.54 39.03±0.70 38.86±0.54 P=0.6 
 
 
No. 
smokers 
2 1 1/3 NA 0  
BMI 24.58±2.7 32.38±0.95 36.91±0.69 45.92±4.34  
  416 
 
group 3 (BMI 35-40) and group 4 (BMI>40) at the inner, middle and outer zones of 
placentas.  Western blots showing placental protein expression of HSP70 in the 4 BMI 
groups at the inner zone are shown in (Figure 12-1).  The graphs and statistical analysis are 
shown below the blots.  There was no significant difference in HSP70 expression when 4 
BMI groups compared (p=0.82) at the inner placental zone (Figure 12-1).  Dunn's Multiple 
Comparison Test showed that there was no significant changes between different BMI 
groups. 
 
 
Figure 12-1: Graph shows the median HSP70 expressions in the inner placental zone in 4 BMI groups 
(n=6 in each group). Comparison between zones was performed using Kruskal Wallis analysis. 
Western blots images were not shown because of missing one set of the original gel image. 
 
Western blots showing placental protein expression of HSP70 in the 4 BMI groups at the 
middle zone are shown in Figure 2.  The graphs and statistical analysis are shown below 
the blots.  There was no significant difference in HSP70 expression when the 4 BMI 
groups were compared (p=0.7) at the middle placental zone (Figure 12-2).  Dunn's 
Multiple Comparison Test showed that there was no significant changes between different 
BMI groups. 
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Figure 12-2: Representative images of Western blots showing HSP70 expressions in the 
middle placental zone in 4 BMI groups (n=6 in each group).  Graphs show the median for 
HSP27 protein expressions. Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Western blots showing placental protein expression of HSP70 in the 4 BMI groups at the 
outer zone are shown in Figure 3.  The graphs and statistical analysis are shown below the 
blots.  There was no significant difference in HSP70 expression when 4 BMI groups 
compared (p=0.15) at the outer placental zone (Figure 12-3).  Dunn's Multiple Comparison 
Test showed that there was no significant changes between different BMI groups. 
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Figure 12-3: Representative images of Western blots showing HSP70 expressions in the 
outer placental zone in 4 BMI groups (n=6 in each group).  Graphs show the median for 
HSP27 protein expressions.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 2: This experiment was designed to test if there were any differences in mRNA 
expression of HSP70 between the 4 BMI groups at the inner, middle and outer zones.  
(Figure 12-4) shows the HSP70 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was no significant difference in HSP70 
expression when 4 BMI groups were compared at the inner, middle and outer placental 
zones (p=0.95, p=0.4, p=0.89 respectively) (Figure 12-4).  Dunn's Multiple Comparison 
Test showed that there was no significant changes between different BMI groups. No 
changes were found in subanalysis. 
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Figure 12-4: Graph showing mRNA expressions of HSP70 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP27.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
12.2.3 Analysis of protein and mRNA expression of HSP27 
between 4 BMI groups. 
Experiment 1: This experiment was designed to test if there was any difference in protein 
expression of HSP27 between 4 BMI groups. Group 1 (BMI <30), group 2 (BMI 30-35), 
group 3 (BMI 35-40) and group 4 (BMI>40) at the inner, middle and outer zones of 
placentas.  Western blots showing placental protein expression of HSP27 in the 4 BMI 
groups at the inner zone are shown in (Figure 12-5).  The graphs and statistical analysis are 
shown below the blots.  There was a significant decrease in protein expression of HSP27 
between the 4 BMI groups (p=0.006) at the inner placental zones.  Dunn's Multiple 
Comparison Test showed that there was a significant diffences between different <30, 30-
35 and 35-40 groups compared to the >40 BMI group.  The subanalysis of all groups was 
as follows: HSP27 was signifiacnt decreased in >40 BMI group compared to the <30 BMI 
group (p=0.002), 30-35 BMI group (p=0.01) and 35-40 BMI group (p=0.002) (Figure 12-
6). 
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Figure 12-5: Representative images of Western blots showing HSP27 expressions in the 
inner placental zone in 4 BMI groups (n=6 in each group).  Graphs show the median for 
HSP27 protein expressions.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
 
Figure 12-6: Graph showing the sub-analysis of 4 BMI groups HSP27 expression at the inner 
zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 in each 
group). The graphs show the box and whiskers analysis of the blots.  Comparison between 
zones was performed using Mann-Whitney analysis. 
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Western blots showing placental protein expression of HSP27 in the 4 BMI groups at the 
middle zone are shown in (Figure 12-7).  The graphs and statistical analysis are shown 
below the blots.  There was no significant difference in HSP27 expression when all 4 BMI 
groups were compared (p=0.06) at the middle placental zones (Figure 12-7).  Dunn's 
Multiple Comparison Test showed that there was no diffences between the 4 groups.  The 
subanalysis of all groups was as follows: HSP27 was significantly decreased in >40 BMI 
group compared to the <30 BMI group (p=0.02) and 35-40 BMI group (p=0.01).  No other 
difference were found (Figure 12-8).  
 
 
Figure 12-7: Representative images of Western blots showing HSP27 expressions in the 
middle placental zone in 4 BMI groups (n=6 in each group).  Graphs show the median for 
HSP27 protein expressions. Comparison between zones was performed using Kruskal-
Wallis analysis. 
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Figure 12-8: Graph showing the sub-analysis of 4 BMI groups for HSP27 expression at the 
middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 in 
each group). The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Protein expression of HSP27 in the 4 BMI groups at the outer zone is shown in (Figure 12-
9).  The graphs and statistical analysis are shown below the blots.  There was no significant 
difference in HSP27 expression when all 4 BMI groups compared (p=0.05) at the outer 
placental zones (Figure 12-9).  Dunn's Multiple Comparison Test showed that there was a 
significant decrease in > 40 BMI group compared to the 30-35 BMI group.  The sub-
analysis of all groups was as follows: HSP27 was decreased significantly in >40 BMI 
group compared to the 35-40 BMI group (p=0.01) (Figure 12-10).  No other significant 
differences were found. 
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Figure 12-9: Representative images of Western blots showing HSP27 expressions in the 
middle placental zone in 4 BMI groups (n=6 in each group).  Graphs show the median for 
HSP27 protein expressions.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
 
 
Figure 12-10: Graph showing the sub-analysis of 4 BMI groups HSP27 expression at the 
middle zone.  Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 in 
each group). The graphs show the box and whiskers analysis of the blots. Comparison 
between zones was performed using Mann-Whitney analysis. 
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Experiment 2: This experiment was designed to test if there were any differences in mRNA 
expression of HSP27 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-11) shows the HSP27 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was no significant difference in mRNA 
expression of HSP27 when 4 BMI groups were compared at the inner, middle and outer 
placental zones (p=0.09, p=0.6, p=0.6 respectively) (Figure 12-11).  Dunn's Multiple 
Comparison Test showed that there was no significant changes between different BMI 
groups.  Sub-analysis showed that there was a significant decrease in HSP27 expression in 
the >40 BMI compared to the <30 BMI group at the inner zone (p=0.03). 
 
Figure 12-11: Graph showing mRNA expressions of HSP27 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP27.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
12.2.4 Analysis of mRNA expression of other HSPs families 
between 4 BMI groups. 
Experiment 1: This experiment was designed to test if there were any differences in mRNA 
expression of HSPB6 (heat shock protein, alpha-crystallin-related, B6) between the 4 BMI 
groups at the inner, middle and outer zones. (Figure 12-12) shows the HSPB6 RQ values 
when the 4 BMI groups were compared at the inner (A), middle (B) and outer zones (C).  
There was no significant difference in HSPB6 expression when all 4 BMI groups were 
compared at the inner, middle and outer placental zones (p=0.13, p=0.34, p=0.23 
respectively) .  Dunn's Multiple Comparison Test showed that there was no significant 
changes between different BMI groups.  No changes were found in sub-analysis (p=0.08 
for all) (Figure 12-13). 
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Figure 12-12: Graph showing mRNA expressions of HSPB6 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSPB6.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Figure 12-13: Graph showing the sub-analysis of 4 BMI groups HSPB6 expression at the 
middle zone.  Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 in 
each group).The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Experiment 2: This experiment was designed to test if there were any differences in mRNA 
expression of HSPB2 (HSP27, protein 2) between the 4 BMI groups at the inner, middle 
and outer zones. (Figure 12-14) shows the HSPB2 RQ values when the 4 BMI groups were 
compared at the inner (A), middle (B) and outer zones (C).  There was a significant 
difference in mRNA expression of HSPB2 when 4 BMI were compared at the inner zone 
(p=0.04).  There was no significant difference in HSPB2 expression when all 4 BMI 
groups were compared at the middle and outer placental zones (p=0.65, p=0.18 
respectively).  Dunn's Multiple Comparison Test showed that there was no significant 
changes between different BMI groups.  Sun-analysis of significant results showed that 
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there was a significant decrese in HSPB2 in the BMI>40 group compared to the BMI<30 
group at the inner zone (p=0.01).  No other changes were found in sub-analysis. 
 
Figure 12-14: Graph showing mRNA expressions of HSPB2 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSPB2. Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of HMOX1 (HSP32) between the 4 BMI groups at the inner, middle and outer 
zones. (Figure 12-15) shows the HSP32 RQ values when the 4 BMI groups were compared 
at the inner (A), middle (B) and outer zones (C).  There was a significant difference in 
mRNA expression of HSP32 when all 4 BMI groups were compared at the outer placental 
zone (p=0.04).  Dunn's Multiple Comparison Test showed that there was no significant 
changes between different BMI groups.  Sub-analysis of significant results showed that 
there was a significant decrease in HSP32 in BMI>40 group compared to BMI<30 group at 
inner, middle and outer zones (p=0.01,p=0.03, p=0.004 respectively). 
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Figure 12-15: Graph showing mRNA expressions of HSP32 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP32.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 4: This experiment was designed to test if there were any differences in mRNA 
expression of DNAJB1 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-16) shows the DNAJB1 RQ values when the 4 BMI groups were compared at 
the inner (A), middle (B) and outer zones (C).  There was no significant difference in 
mRNA expression of DNAJB1 when all 4 BMI groups were compared at the inner, middle 
and outer placental zones (p=0.8 for all).  Dunn's Multiple Comparison Test showed that 
there was no significant difference in mRNA expression of DNAJB1 in BMI>40 compared 
to the any other BMI group.  Sub-analysis showed that there was no significant difference 
in DNAJB1 when all 4 BMI groups were compared.  Sub-analysis showed no difference 
was found between all 4 BMI groups. 
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Figure 12-16: Graph showing mRNA expressions of DNAJB1 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of DNAJB1.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 5: This experiment was designed to test if there were any differences in mRNA 
expression of HSPD1 (HSP60) between the 4 BMI groups at the inner, middle and outer 
zones. (Figure 12-17) shows the HSPD1 RQ values when the 4 BMI groups were 
compared at the inner (A), middle (B) and outer zones (C).  There was no significant 
difference in mRNA expression of HSPD1 when all 4 BMI groups were compared at the 
inner, middle and outer placental zones (p=0.6, p=0.3, p-0.6 respectivelyl).  Dunn's 
Multiple Comparison Test showed that there was no significant difference in mRNA 
expression of HSPD1 in BMI>40 compared to the any other BMI group.  Sub-analysis 
showed no difference in HSPD1 was found between all 4 BMI groups. 
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Figure 12-17: Graph showing the sub-analysis of 4 BMI groups mRNA expression of HSPD1 
at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group 
(n=6 in each group). The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 6: This experiment was designed to test if there were any differences in mRNA 
expression of HSPA5 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-18) shows the HSPA5 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was no significant difference in mRNA 
expression of HSPA5 when all 4 BMI groups were compared at the inner, middle and outer 
placental zones (p=0.3, p=0.6, p-0.1 respectivelyl).  Dunn's Multiple Comparison Test 
showed that there was no significant difference in mRNA expression of HSPA5 in 
BMI>40 compared to the any other BMI group.  Sub-analysis showed a significant 
decrease in HSPA5 in BMI>40 group compared to BMI 30-35 group (p=0.04).  No other 
differences were found. 
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Figure 12-18: Graph showing the sub-analysis of 4 BMI groups mRNA expression of HSPA5 
at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group 
(n=6 in each group).The graphs show the box and whiskers analysis of the blots. 
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 7: This experiment was designed to test if there were any differences in mRNA 
expression of HSP90AA between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-19) shows the HSP90AA RQ values when the 4 BMI groups were compared at 
the inner (A), middle (B) and outer zones (C).  There was no significant difference in 
mRNA expression of HSP90AA when all 4 BMI groups were compared at the inner, 
middle and outer placental zones (p=0.79, p=0.31, p=0.28 respectively) .  Dunn's Multiple 
Comparison Test showed that there was no significant changes between different BMI 
groups.  No changes were found in sub-analysis. 
 
Figure 12-19: Graph showing mRNA expressions of HSP90AA in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP90AA.  Comparison between zones was performed using 
Kruskal-Wallis analysis. 
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Experiment 8: This experiment was designed to test if there were any differences in mRNA 
expression of HSP90B1 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-20) shows the HSP90B1 RQ values when the 4 BMI groups were compared at 
the inner (A), middle (B) and outer zones (C).  There was no significant difference in 
HSP90B1 expression when all 4 BMI groups were compared at the inner, middle and outer 
placental zones (p=0.7, p=0.2, p=0.5 respectively) .  Dunn's Multiple Comparison Test 
showed that there was no significant changes between different BMI groups.  No changes 
were found in sub-analysis. 
 
Figure 12-20: Graph showing mRNA expressions of HSP90B1 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of HSP90B1.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 9: This experiment was designed to test if there were any differences in mRNA 
expression of HSPH1 (heat shock 105kDa/110kDa protein 1) between the 4 BMI groups at 
the inner, middle and outer zones. (Figure 12-21) shows the HSPH1 RQ values when the 4 
BMI groups were compared at the inner (A), middle (B) and outer zones (C).  There was 
no significant difference in mRNA expression of HSPH1 when all 4 BMI groups were 
compared at the inner, middle and outer placental zones (p=0.2, p=0.2, p=0.6 
respectivelyl).  Dunn's Multiple Comparison Test showed that there was no significant 
difference in mRNA expression of HSPH1 in BMI>40 compared to the any other BMI 
group.  Sub-analysis showed no difference in HSPH1 was found between all 4 BMI 
groups. 
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Figure 12-21: Graph showing the sub-analysis of 4 BMI groups mRNA expression of HSPH1 
at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group 
(n=6 in each group). The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
12.2.5 Analysis of mRNA expression of CASP3, 7 and 9 between 4 
BMI groups. 
Experiment 1: This experiment was designed to test if there were any differences in mRNA 
expression of CASP3 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-22) shows the CASP3 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was a significant difference in mRNA 
expression of CASP3 when all 4 BMI groups were compared at the inner and middle 
placental zones (p=0.04, p=0.03 respectively).  There was no siginifacnt difference at the 
outer zone (p=0.5).  Dunn's Multiple Comparison Test showed that there was a significant 
decrese in mRNA expression of CASP3 in BMI>40 compared to the BMI 30-35 group at 
the inner zone.  Sub-analysis of significant difference at the inner showed that there was a 
significant increase in CASP3 in BMI >40 group compared to the BMI<30 and BMI 30-35 
groups (p=0.03, p=0.01 respectively).  No difference was found between BMI 35-40 and 
BMI>40 groups at the inner zone (Figure 12-23). 
  433 
 
 
Figure 12-22: Graph showing mRNA expressions of CASP3 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of CASP3.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
 
Figure 12-23: Graph showing the sub-analysis of 4 BMI groups mRNA expression of CASP3 
at the inner zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group (n=6 
in each group). The graphs show the box and whiskers analysis of the blots.  Comparison 
between zones was performed using Mann-Whitney analysis. 
 
Sub-analysis of significant difference at the middle zone showed that there was a 
significant increase in CASP3 in BMI >40 group compared to the BMI 30-35 groups at the 
middle zone (p=0.01).  No difference was found between BMI<30 and BMI 35-40 
compared to the BMI>40 groups at the middle zone (Figure 12-24).  No sub-analysis was 
performed for the outer zone as there was no significant change. 
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Figure 12-24: Graph showing the sub-analysis of 4 BMI groups mRNA expression of CASP3 
at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group 
(n=6 in each group).  The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
Experiment 2: This experiment was designed to test if there were any differences in mRNA 
expression of CASP7 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-25) shows the CASP7 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was no significant difference in mRNA 
expression of CASP7 when all 4 BMI groups were compared at the inner, middle and outer 
placental zones (p=0.9, p=0.1, p=0.6 respectively).  Dunn's Multiple Comparison Test 
showed that there was no significant difference in mRNA expression of CASP7 in 
BMI>40 compared to other BMI groups. Sub-analysis showed that there was no significant 
difference in CASP7 when all 4 BMI groups were compared.  Sub-analysis showed no 
difference was found between all 4 BMI groups.  
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Figure 12-25: Graph showing mRNA expressions of CASP7 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of CASP7.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Experiment 3: This experiment was designed to test if there were any differences in mRNA 
expression of CASP9 between the 4 BMI groups at the inner, middle and outer zones. 
(Figure 12-26) shows the CASP9 RQ values when the 4 BMI groups were compared at the 
inner (A), middle (B) and outer zones (C).  There was a significant difference in mRNA 
expression of CASP9 between the 4 BMI groups at the middle zone (p=0.01).  There was 
no significant difference was found at the inner and outer placental zones (p=0.7, p=0.8 
respectively).  Dunn's Multiple Comparison Test showed that there was a significant 
increase in mRNA expression of CASP9 in BMI >40 group compared to the BMI 30-35 
and 35-40 groups at the middle zone. Sub-analysis for significant results showed that there 
was a significant increase   in mRNA expression of CASP9 in BMI >40 group compared to 
the BMI 30-35 and 35-40 groups at the middle zone (p=0.008, p=0.004 respectively).  No 
difference was found between BMI<30 and BMI>40 groups (p=0.32) (Figure 12-27). 
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Figure 12-26: Graph showing mRNA expressions of CASP9 in the in 4 BMI groups (n=6 in 
each group) at the inner, middle and outer placental zones.  Graphs show the median for 
mRNA expressions of CASP9.  Comparison between zones was performed using Kruskal-
Wallis analysis. 
 
Figure 12-27: Graph showing the sub-analysis of 4 BMI groups mRNA expression of CASP3 
at the middle zone. Groups <30, 30-35 and 35-40 groups compared to the >40 BMI group 
(n=6 in each group). The graphs show the box and whiskers analysis of the blots.  
Comparison between zones was performed using Mann-Whitney analysis. 
 
12.2.6 Results summary 
12.2.6.1 HSP70 expression in the 4 BMI groups 
Experiment 1: There was no significant difference in protein expression of HSP70 when 
the 4 BMI groups were compared at the inner, middle and outer placental zones.  
Experiment 2: There was no significant difference in mRNA expression of HSP70 when 
the 4 BMI groups compared at the inner, middle and outer placental zones.  
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12.2.6.2 HSP27 expression in the 4 BMI groups 
Experiment 1: There was a significant decrease in protein expression of HSP27 between 
the 4 BMI groups (p=0.006) at the inner placental zones.  The sub-analysis of all groups 
was as follows: HSP27 was significantly decreased in >40 BMI group compared to the <30 
BMI group (p=0.002), 30-35 BMI group (p=0.01) and 35-40 BMI group (p=0.002).  There 
was no significant difference in HSP27 expression when all 4 BMI groups were compared 
(p=0.06) at the middle placental zones.  The sub-analysis of all groups was as follows: 
HSP27 was significantly decreased in >40 BMI group compared to the <30 BMI group 
(p=0.02) and 35-40 BMI group (p=0.01).  There was no significant difference in HSP27 
expression when all 4 BMI groups compared (p=0.05) at the outer placental zones.  The 
sub-analysis of all groups was as follows: HSP27 was decreased significantly in >40 BMI 
group compared to the 35-40 BMI group (p=0.01).  
Experiment 2: There was no significant difference in mRNA expression of HSP27 when 4 
BMI groups were compared at the inner, middle and outer placental zones.  However, sub-
analysis showed that there was a significant decrease in HSP27 expression in the >40 BMI 
compared to the <30 BMI group at the inner zone (p=0.03). 
12.2.6.3 Summary results for mRNA expression of other HSPs families 
between 4 BMI groups. 
Experiment 1: There was no significant difference in HSPB6 expression when all 4 BMI 
groups were compared at the inner, middle and outer placental zones  
Experiment 2: There was a significant difference in mRNA expression of HSPB2 when 4 
BMI groups were compared at the inner zone (p=0.04).  There was no significant 
difference in HSPB2 expression when all 4 BMI groups were compared at the middle and 
outer placental zones.  Sub-analysis showed that there was a significant decrese in HSPB2 
in the BMI>40 group compared to the BMI<30 group at the inner zone (p=0.01). 
Experiment 3: There was a significant difference in mRNA expression of HSP32 when all 
4 BMI groups were compared at the outer placental zone (p=0.04).  Sub-analysis showed 
that there was a significant decrease in HSP32 in BMI>40 group compared to BMI<30 
group at inner, middle and outer zones (p=0.01,p=0.03, p=0.004 respectively). 
Experiment 4: There was no significant difference in mRNA expression of DNAJB1 when 
all 4 BMI groups were compared at the inner, middle and outer placental zones. 
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Experiment 5: There was no significant difference in mRNA expression of HSPD1 when 
all 4 BMI groups were compared at the inner, middle and outer placental zones. 
Experiment 6: There was no significant difference in mRNA expression of HSPA5 when 
all 4 BMI groups were compared at the inner, middle and outer placental zones.  However, 
sub-analysis showed a significant decrease in HSPA5 in BMI>40 group compared to BMI 
30-35 group (p=0.04).  
Experiment 7: There was no significant difference in mRNA expression of HSP90AA 
when all 4 BMI groups were compared at the inner, middle and outer placental zones. 
Experiment 8: There was no significant difference in HSP90B1 expression when all 4 BMI 
groups were compared at the inner, middle and outer placental zones 
Experiment 9: There was no significant difference in mRNA expression of HSPH1 when 
all 4 BMI groups were compared at the inner, middle and outer placental zones. 
12.2.6.4 CASP3, 7 and 9 expression in the 4 BMI groups 
Experiment 1: There was a significant difference in mRNA expression of CASP3 when all 
4 BMI groups were compared at the inner and middle placental zones (p=0.04, p=0.03 
respectively).  There was no significant difference at the outer zone.  Sub-analysis of 
significant difference at the inner zone showed that there was a significant increase in 
CASP3 in BMI >40 group compared to the BMI<30 and BMI 30-35 groups (p=0.03, 
p=0.01 respectively).  Sub-analysis showed that there was a significant increase in CASP3 
in BMI >40 group compared to the BMI 30-35 groups at the middle zone (p=0.01). 
Experiment 2: There was no significant difference in mRNA expression of CASP7 when 
all 4 BMI groups were compared at the inner, middle and outer placental zones. 
Experiment 3: There was a significant difference in mRNA expression of CASP9 between 
the 4 BMI groups at the middle zone (p=0.01).  There was no significant difference was 
found at the inner and outer placental zones.  Sub-analysis showed that there was a 
significant increase in mRNA expression of CASP9 in the BMI >40 group compared to the 
BMI 30-35 and BMI 35-40 groups at the middle zone (p=0.008, p=0.004 respectively).  
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12.3 Discussion  
12.3.1 HSPs family expression in obese pregnant women and the 
present findings 
This study describes, for the first time, expression of HSPs and CASPs families in different 
BMI groups.  The most interesting results were the reduction in expresstion of some HSPs 
in the morbid obesity group (BMI>40) compared to the normal BMI group and obese 
grade 1 or 2.  In contrast, CASP 3 and CASP9 was increased in the same group (BMI>40) 
compared to the normal BMI group and obese grade1 or 2.  Reduced HSPs and increased 
CASPs indicate reduced cellular protection and increased cellular damage respectively. 
12.3.2 Key findings of HSP70 and HSP27 protein and mRNA 
expression  
HSP70: There was no significant difference in protein and mRNA expression of HSP70 
when the 4 BMI groups were compared at the inner, middle and outer placental zones.  
HSP27:  There was a significant decrease in protein expression of HSP27 in the BMI >40 
group at the inner, middle and outer placental zones.  There was a significant decrease in 
mRNA expression of HSP27 in the BMI >40 group compared to the BMI<30 group at the 
inner zone, no other differences were found. 
12.3.3 Key findings of other HSPs families mRNA expression  
HSPB2: There was a significant decrese in HSPB2 in the BMI>40 group compared to the 
BMI<30 group at the inner zone.  No other differences were found. HSP32: There was a 
significant decrease in HSP32 in the BMI>40 group compared to BMI<30 group at the 
inner, middle and outer zones. HSPA5:  There was a significant decrease in HSPA5 in the 
BMI>40 group compared to the BMI 30-35 group.  There was no significant difference in 
mRNA expression of other HSPs families when all 4 BMI groups were compared at the 
inner, middle and outer placental zones. 
12.3.4 Key findings in mRNA expression of CASPs  
CASP3: There was a significant increase in CASP3 in the BMI >40 group compared to the 
BMI<30 and BMI 30-35 groups at the inner and middle zones. CASP9:  There was a 
significant increase in mRNA expression of CASP9 in the BMI >40 group compared to 
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both BMI 30-35 and BMI 35-40 groups at the middle zone.  No difference was found in 
CASP7 expression. 
12.3.5 Obesity and HSPs 
HSPs act as molecular chaperones and demonstrate important protective functions in 
stressed cells. In the obese state, adipose tissue is characterized by an impaired intracellular 
stress defense system and unbalanced HSR.  Several members of the HSP family have 
been identified as adipokines released upon cellular stress (Habich and Sell, 2015).  The 
inducible isoform of HSP70, HSP72 is attracting most attention (Henstridge et al., 2014b).  
Several studies showed that HSP72 protects against disturbed metabolic homeostasis via 
multiple modes of action including improving skeletal muscle oxidation and decreasing 
inflammation (Chung et al., 2008, Gupte et al., 2009, Henstridge et al., 2014a).  In 
addition, HSP60 has also been implicated in the cause of mitochondrial homeostasis and 
maintenance of insulin sensitivity, for instance HSP60 was decreased in insulin resistance 
and mitochondrial dysfunction (Kleinridders et al., 2013).  HSP60 reduction in obese, 
diabetic mice was due to a disruption of leptin signalling and was restored by leptin 
treatment (Henstridge et al., 2014b).  Furthermore, HSP40 was decreased in obese patients 
and positively correlated with maximum oxygen consumption. Of interest was that 
exercise restored the expression of HSP40 (Abubaker et al., 2013).  HSP27 may also play a 
role in the aetiology of metabolic disease and expression is reduced in the skeletal muscle 
of  insulin resistance rats (Gupte et al., 2008). 
There are several studies on different interventions that stimulate the HSR against obesity, 
and showing a concomitant improvement of clinical outcomes.  These interventions 
include heat therapy (Gupte et al., 2009), electrical therapy, physical exercise (Morino et 
al., 2008) and HSR pharmacological stimulation (Literati-Nagy et al., 2009). 
However, while our knowledge of the mechanisms and the contribution of HSP are well 
documented for other conditions, little is known about their dysregulation during the 
course of obesity.  
Apoptosis is a form of programmed cell death and has been observed in the placenta of 
normal pregnancies (Smith et al., 1997).  Apoptosis was the subject of study in relation to 
the pathophysiology of PE (Levy et al., 2000).  Placentas from PE and FGR patients 
showed enhanced apoptosis as compared to placentas of normal prenancy (Ishihara et al., 
2002).  However, the molecular mechansims leading to apopotosis are complex, and 
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several pathways are involved including bcl-2, CASP3 and NF-κB (Adams and Cory, 
1998). 
One research group  performed spectrophotometer and enzymatic measurements to 
investigate oxidative stress markers and lipid profiles in placentas as well as maternal and 
fetal blood of obese women compared to control (Malti et al., 2014).  In this study they 
used same systematic sampling methods to our study.  This study showed that maternal, 
fetal and placenta triglyceride levels were increased in the obese group.  In addition, 
oxidative stress markers were increased in the obese group (Malti et al., 2014).  
Furthermore, there was a variation in redox balance indicating high oxidative stress in the 
placenta and in the new born of the obese group.  They concluded that maternal obesity is 
associated with metabolic alterations and dysregulation of redox balance in the mother and 
fetal-placenta unit (Malti et al., 2014). 
Another study performed Western blotting, IHC and RNA sequencing on term placenta of 
obese and non-obese pregnant women (Saben et al., 2014). RNA-seq revealed 288 genes to 
be significantly different in placentas from obese women by1.4 fold (Saben et al., 2014). 
They showed that genes involved in angiogenesis and lipid metabolism were significantly 
decreased in placentas of obese women.  They also showed that pro-inflammatory ILs (IL-
6, IL-23A, IL21R and IL-12RB2) and certain chemokines were increased in obese women.  
In contrast, a significant decrease in pro-inflammatory IL1R1 and receptor protein was 
reported in placenta of obese women.  In addition, there were a significant decrease in 
adiponectin receptors and number of hormones (CRH, Lep and CCK) in placentas of obese 
women compared to normal weight women.  Furthermore, indicative of a lipotoxic 
environment, increased placental lipid was associated with decreased AMPK and increased 
activation of NF-κB in placenta from obese women.  There was a 25% decrease in total 
antioxidant capacity.  They concluded that maternal obesity leads to a lipotoxic placental 
environment that is associated with decreased regulators of angiogenesis and increased 
markers of inflammation and oxidative stress (Saben et al., 2014). 
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Chapter XIII: Difficulties and limitation  
13 Difficulties  
I was presented with some difficulties with placenta sample collection.  When the project 
was started the medical genetics lab was located at Yorkhill hospital as was next the 
Queens mothers maternity hospital and so placenta collection was relatively 
straightforward.  However during the project the maternity hospital and the vast majority 
of medical genetics staff relocated some distance away to the Southern General Hospital 
site.  It was a monumental task to follow these women, identify suitable women and get the 
placentas fresh as I had to travel continually between the two sites by taxi.  
The second limitation was when the medical genetics department was evacuated there was 
a long delay in my work as cell culture stopped for 18 months.  The gas supply set up used 
for running the incubators in our laboratory was cancelled as this was on an NHS contract.  
The reason for this was at the start of my project it was a joint NHS University department.  
Two things happened; the University underwent restructure with removal of departments 
and no longer did the joint NHS University department exist.  This situation has prevented 
me from performing the HSP induction and tissue culture experiments which were planned 
as an important component of my work. By the time the culture system was reinstated my 
time in the laboratory had finished. 
One of main limitation in the tissue culture experiment was the sample size in both heat 
shock and hypoxic-reperfusion experiments as only one experiment in each group was 
performed.  The second limitation was how to create in vitro condition similar to the real in 
vivo condition.  For example as going from 2% to 8% in real life ischemia it is probably 
not as black and white as that.  The third limitation was the transport time between two 
hospitals and it is effect on tissue culture experiments. 
  
  443 
 
Chapter XIV: Summary and conclusions 
14 Summary  
Human parturition involves interaction of hormonal, neurological, mechanical stretch and 
inflammatory pathways and the placenta plays a crucial role.  HSPs are induced in cells as 
a protective mechanism to cope with cellular stress.  HSPs also play an important role in 
regulating signal transduction, inhibition of apoptosis and cellular proliferation and 
differentiation.  The activation of HSPs is mediated by HSF1, which binds to the promoter 
regions of HSPs.  Apoptosis has been implicated in both PE and labour.  In the apoptotic 
pathway, HSPs act at several stages to prevent cell death initiated by stress-induced 
damage. For example HSP70 inhibits CASP 3 and 9.  Thus it is possible HSP70 acts to 
keep the rate of apoptosis in check. TLR family members are expressed differentially in a 
variety of cells and tissues.  TLR are the principal signalling molecules through which 
mammal’s sense infection, so called innate immunity.  This project investigated the stress, 
apoptotic and inflammatory pathways. 
First aim: This study showed for the first time that (within placentas) HSP70 and HSP27 
protein is expressed in a spatial manner in the labour and the non-labour groups with the 
highest expression being in the middle zone for both.  HSF1 protein expression (both 
forms) was spatially distributed in the labour group placentas while HSF1 mRNA 
expression was spatially distributed in the non-labour group.  No other changes were 
found. 
At this stage it is only possible to speculate why such zonal differences exist but may relate 
to the functions of HSP70, HSP27 and HSF1, some of which differ and some overlap.  
Placental separation is an important part of labour and one study showed that the process 
of placental separation from the uterine wall can be divided into three distinct phases i.e. 
latent, contraction/detachment and expulsion.  They showed that placental separation is 
accomplished by means of an orderly multiphasic process with a definite direction and 
sequence.  They found in most cases the placenta separated from the uterine wall in a 
“down-up” separation i.e. initiating from the lower pole.  Interestingly cases with a 
previous Cesarean section had a higher rate of up-down separation. In contrast in the case 
of “fundal placentae” separation started at the placental poles (bipolar separation) and the 
central area of the placenta was the last to separate.  It would be therefore of interest in a 
future study to investigate whether there was a link between the zonal distribution of 
HSP27 or HSP70 and the method of placental separation.  In addition, different genes 
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expression would vary in different placental zones perhaps due to the variation in blood 
supply to each zone or link to IR injury and are some zones of placenta more susceptible to 
IR injury.  It may also be within zones there are subtle differences in signal pathways that 
mean each zone behaves differently. 
Second aim: This study also showed for the first time that there was a zonal difference in 
expression of several proteins when comparing the non-labour group to the labour group.  
HSP70 protein expression was increased in the labour group compared to the non-labour 
group at the middle zone.  In contrast, HSP27 protein expression was increased in the non-
labour group when compared to the labour group.  HSP27 mRNA expression was 
significantly increased in the non-labour group compared to the labour group at the inner 
and middle zones.  No difference was found in HSP70 mRNA expression. 
This study also shows that P-HSP27 expression was significantly increased in the non-
labour group when compared to the labour group at the inner zone for all P-HSP27 (ser 15, 
78 and 82).  There was a significant increase in P-HSP27 expression in the non-labour 
group when compared to the labour group at the outer zone for P-HSP27 (ser 15 and ser 
78).  No difference was found at the middle zone. 
HSF1 protein expression was increased in the non-labour group when compared to the 
labour group for both isoforms at the inner and middle zones.  There was, paradoxically, an 
increase in HSF1 mRNA expression in the labour group at the inner zone. 
In this study the mRNA expression of several stress genes was compared between labour 
and non-labour groups at the all placental zones. HSPB6, HSP32 and DNAJB1 were 
increased in non-labour group compared to the labour group at the middle zone. HSPB2, 
HSP90AA and HSP90B1 were increased in the labour group compared to the non-labour 
at the outer zone. 
This study compared caspases (3, 7 and 9) mRNA expression in the non-labour group and 
labour group.  CASP7 was increased in labour group at the middle zone. 
This study also shows that mRNA expression of TLR9-10 was negligible in the placenta 
and the only difference of the inflammatory mediators (TLRs, MyD88 and NF-κB) was in 
mRNA expression of TLR5 when comparing the labour group to the non-labour group 
which was increased in the labour group and again at the middle zone. 
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Third aim: There was a significant decrease in protein expression of HSP70 in the non-
labour control group compared to the non-labour PE group at the inner zone.  No other 
difference in HSP70 was found when comparing the labour control with the labour PE.  No 
difference in mRNA HSP70 expression was found between groups. 
NP-HSF1 protein expression was increased in the non-labour and labour PE compared to 
the non-labour and labour control at the inner and middle zones.  No changes in P-HSF1 
expression were found.  At the mRNA level there was increased in HSF1 expression in the 
non-labour PE compared to the non-labour control at the inner zone. 
This study showed that protein expression of HSP27 was increased in the labour PE group 
compared to the labour controls at the middle and outer zones.  There was no difference in 
non-labour PE compared to the non-labour controls.  No changes at the mRNA level were 
found. 
Due to time constraints only the labour group was compared for P-HSP27. P-HSP27 (ser 
15, ser 78 and ser 82) was significantly increased in the labour PE group compared to 
labour control group at the inner zone (ser 78 and ser 82) and middle (ser 15) zones. 
This study showed that mRNA expression of CASP3 was reduced in the labour PE group 
compared to the labour control group at the middle zone.  There was a significant decrease 
in the non-labour PE group compared to the non-labour control group in mRNA expression 
of CASP7 (inner) and CASP9 (middle) zones. 
TLR1, TLR5 and HSPB6 mRNA expression was significantly decreased in the non-labour 
PE group compared to the non-labour control group at the middle zone.  TLR1 mRNA 
expression was also decreased in the labour PE group compared to the labour control group 
again at the inner and middle zone.  
This project also included a small study to investigate protein and mRNA expression of 
HSP70 and HSP27 in the labour FGR compared to the labour control group at the inner 
and outer zones.  HSP70 protein expression was significantly decreased in FGR group 
compared the control group at the outer zone, no changes in mRNA expression were 
found. HSP27 mRNA expression was increased in FGR group compared to the control 
group in both the inner and outer zone.  No changes in protein expression were found. 
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The increase or decrease in expression of several proteins and genes in labour, PE and 
FGR at precise zones suggests that there is a controlled spatial change in their expression 
or a susceptibility to changes in expression.  The physiological and pathological 
significance of these remains to be elucidated but oxidative stress is the common link.  
Oxidative stress occurs when the production of ROS (such as the superoxide anion) 
overwhelms the intrinsic anti-oxidant defenses (such as superoxide dismutase, glutathione 
peroxidase, ascorbate (vitamin C) and α-tocopherol (vitamin E).  Excessive generation of 
superoxide can also lead to interactions with nitric oxide to form peroxynitrite (ONOO
−
). 
Peroxynitrite is a powerful pro-oxidant. Under conditions of stress activation of redox-
sensitive transcription factors, such as AP-1, p53 and NF-κB occurs to increase expression 
of pro-inflammatory and other cytokines, cell differentiation and apoptosis. 
During a healthy pregnancy maternal spiral arteries are dramatically remodeled.  They 
become widely dilated and lose their responsiveness to vasoconstrictive stimuli.  Thus 
blood enters the intervillous space in a non-pulsatile manner and under low pressure 
Uterine contractions during labour are associated with intermittent utero-placental 
perfusion. Doppler ultrasound studies have demonstrated a linear inverse relationship 
between uterine artery resistance and the intensity of the uterine contractions during labour 
In PE spiral artery remodeling is partial or incomplete.  The resulting high-pressure flow 
results in hydrostatic damage to the placental villi. In addition perfusion by intermittent 
pulses of fully oxygenated arterial blood is thought to lead to fluctuations in oxygen 
delivery resulting in oxidative stress. 
The intermittent perfusion might explain the placental zonal variation in both labour and 
PE by different response to IR injury in each placental zone. 
Placentas collected at term by caesarean section are not subjected to the stress of labour 
however one possibility is that zonal differences might reflect the fact that labour is not far 
off and that the molecular steps to allow labour to precede have started.  Thus it would be 
interesting to compare placentas from the second trimester where labour is not close to 
determine if such zonal differences still exist.  In contrast at labour zonal differences in 
some gene expression may be linked to the response to the stress of labour, extent of 
exposure to hypoxia or may contribute to the process that allows the placenta to separate at 
delivery. 
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in vitro studies: In this procedure placenta tissue was exposed to low oxygen levels, then 
exposed to normal oxygen levels (8%).  These samples were then compared to the control 
samples that were only exposed to the normal oxygen level.  This particular experiment 
focused on the expression of stress proteins. 
With regards to reperfusion injury of ischemic placenta exposure to 8% oxygen following 
exposure to low oxygen for different periods of time significantly induced mRNA 
expression of HSP90B1 at the inner zone.  There was a decrease in HSP27 protein 
expression (all zones) and of HSP27 mRNA in inner zone.  HSP90AA was also decreased 
at the inner zone over time periods with less expression after 22 h recovery period, the 
letter perhaps due to protein turnover.  No changes were found in HSP70 and HSF1 
expression following exposure to I-R injury.  
This in vitro data supports the idea the cellular stress markers are altered due to reperfusion 
of placenta tissue during labour and/or PE.  In addition, although these data are very 
preliminary there was an obvious increase in HSP70, HSP27 and HSP90AA mRNA 
expression when exposed to IR at the 6 h point.  Future experiments should follow this up 
to determine if this is a real statistical effect.  
This project also included in vitro experiments in order to investigate expression of several 
stress genes and caspases in placenta tissues after exposure to heat shock and also to 
examine the effect on zonal distribution.  In this study placenta tissue from all zones were 
exposed to heat shock for 30 min, then a recovery period for different time periods in 
compare to control which were kept all time at 37 C.  A limitation of such studies is that 
by cutting the placenta into its 3 zones the structure of the placenta is no longer maintained 
in the way it would be exposed to blood flow in vivo. 
In this study there was a decrease in HSP70 and HSP27 protein expression over time.  No 
changes were noted at the mRNA level.  There was a fall in HSF2 expression over time 
and there was an increase in HSPB2 due to heat shock, both at the inner zone.  No other 
changes were found in stress genes. 
There was a fall in CASP3 and CASP7 mRNA expression over time at the middle zone. 
There was an increase in CASP3 due to heat shock at the inner zone.  No changes in 
CASP9 were found. 
  448 
 
Again there was a clear trend for increases in mRNAs expression of most HSPs and 
caspases at the 6 h time and this seems to be the key finding.  As this set of work was 
performed close to the end of the thesis future experiments should follow this up to 
determine if this is a real statistical effect however, the preliminary results suggest there 
are. 
For the first time we showed that there was a clear zonal variation in response in both 
hypoxia-reperfusion and heat shock experiments.  
There was a significant increase in HSP70 in the labour group compared to the non-labour 
but at the middle zone.  There was a significant increase in HSP70 in the non-labour PE 
group compared to the non-labour control at the inner zone.  In the heat shock experiment 
HSP70 protein expression was decreased over time at the inner and middle zones.  No 
change in HSP70 expression was found in the hypoxia-reperfusion experiment.  The in 
vitro heat shock experiment totally reflects the changes in HSP70 expression in labour and 
PE groups at the inner and middle zones.  
There was a significant increase in HSP27 in the non-labour group compared to the labour 
at the inner and middle zones.  HSP27 expression was increased in labour PE group 
compared to the labour control group at the middle zone.  In the heat shock experiment 
HSP27 protein expression was decreased over time at the inner and middle zones.  HSP27 
expression was decreased over time at the inner zone in the hypoxia-reperfusion 
experiment.  The in vitro heat shock and hypoxia-reperfusion experiments reflecst the 
changes in HSP27 expression in labour and PE groups the inner and middle zones. 
There was a significant increase in HSP90AA, HSP90B1 and HSPB2 in the labour group 
compared to the non-labour at the outer zone.  HSPB2 expression was increased in the 
non-labour control compared to the non-labour PE group at the middle zone.  In the heat 
shock experiment HSP90AA, HSP90B1 and HSPB2 expression was increased at the 6h of 
recovery time at the inner zone.  HSP90AA expression was decreased and HSP90B1 
expression was increased over time at the inner zone in the hypoxia-reperfusion 
experiment.  The in vitro heat shock and hypoxia-reperfusion experiments do not at all 
reflect the changes in HSP90AA, HSP90B1 and HSPB2 expression in labour and PE 
groups at the middle and outer zones. 
There was a significant increase in CASP7 in the labour group compared to the non-labour 
at the middle zone.  CASP7 and CASP9 expression was increased in the non-labour and 
labour control compared to the non-labour and labour PE at the inner (CASP9) and middle 
(CASP7) zones.  In the heat shock experiment CASP7 expression was decreased over time 
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at the middle zone.  CASP3 expression was increased due to heat shock at the inner zone.  
The in vitro heat shock and hypoxia-reperfusion experiments reflect the changes in CASPs 
expression in labour and PE groups at at the inner and middle zones. 
It was a clear that in vitro heat shock and hypoxia-reperfusion experiments reflect, for the 
majority of changes, the genes in labour and PE groups in their placental zones. 
Final aim: BMI study 
This study describes, for the first time, placental expression of HSPs and CASPs families 
in different BMI groups. The most interesting observations were that some HSPs (HSPB2, 
HSP27, HSP32 and GRP78) were reduced in the morbid obesity group (BMI>40) 
compared to the normal BMI group and obese grade 1 or 2.  In contrast, CASP 3 and 
CASP9 was increased in the same group (BMI>40) compared to the normal BMI group 
and obese grade1 or 2. Reduced HSPs and increased CASPs indicate reduced cellular 
protection and increased cellular damage respectively. 
The experiments, within this thesis examined placenta gene and protein expression only.  
Whether factors within the systemic circulation are altered requires further investigation.  
 This project is novel because it looked at the expression of stress, apoptotic and 
inflammatory pathways within the human placenta of labour, PE and FGR groups using 
precise sampling methods and how these genes were influenced by zonal difference, BMI 
classification,  ischemic-reperfusion and heat shock insults.  It also examined how such 
expression was affected by pregnancy complication such as PE and FGR.  This project for 
the first time shows the important of systemic sampling methods.  This project allowed a 
better understanding about how these different genes are expressed in the placenta alone 
and how labour, PE and FGR can affect them.  It has also highlighted the best ways in 
which such investigations could be extended.  This project has contributed important data 
to the area of placenta research and could potentially help lead to an improvement in 
placenta protection during labour and PE.  However it is clearly a complex process as the 
findings that zonal expression can differ so differently between different molecules and 
proteins makes interpretation of the studies very difficult.  If researchers all use similar 
sampling methods it would make it much easier to compare studies and to move this field 
of research forward. 
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16 Appendices 
Maternity Department 
Southern General Hospital 
1345 Govan Road 
G51 4TF 
 
 
Patient information sheets for collecting placentas and blood samples  
Dr Akrem Abdulsid (Researcher) 
Dr Kevin Hanretty (Consultant Obstetrician) 
Prof Fiona Lyall (Professor) 
Title: Understanding the cause of small birth weight babies and high blood pressure in pregnancy. 
(Title of the project: An investigation of the regulation and functions of the stress pathways in pregnant 
women and in the human placenta. 
Full title: An investigation of the regulation and functions of the inflammation, stress and apoptotic path-
ways in pregnant women and in the human placenta focused on the impact of pre-eclampsia and fetal growth 
restriction on these pathways.) 
 
Invitation: you are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. Ask us if there is anything that is not clear or if 
you would like more information. Take time to decide whether or not you wish to take part. 
What is the purpose of the study? Some mums have high blood pressure when pregnant. In some cases the 
mums can be quite sick and the babies can be small for dates. The reasons for that are not known. We are 
studying the blood and afterbirth (placenta) as it may give us important clues to understanding the above 
conditions. We are interested in inflammatory and oxidative stress proteins which are involved in immunity 
response against microorganisms at maternal-fetal interface.  We are trying to understand why this protein 
does  not always work properly in pregnancies where the baby was small for dates or when the mum had 
very high blood pressure. Our study will last for 5 years to give us enough time to perform all the 
experiments and collect sufficient numbers of samples. 
Why have I been chosen? To perform our research we therefore need to collect blood and placentas after the 
baby has been born. We will collect placentas from mums with high blood pressure, mums whose babies 
were small for dates and mums who had uncomplicated pregnancies. 
Do I have to take part? It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you decide to take part 
you are still free to withdraw at any time and without giving a reason. A decision to withdraw at any time, or 
a decision not to take part, will not affect the standard of care you receive. 
What will happen if I take part? If you do take part we will collect blood samples, <1 teaspoon before and 
after delivery from a line that is already in place. Few placenta samples will be taken and transport to the 
laboratory. Then we will study different proteins to try and find out how they differ between the different 
pregnancies. 
What are the possible benefits of taking part? This study will not be of any use to you if you had a small 
baby or high blood pressure. However by studying the placenta and blood markers we may understand these 
conditions better with a hope of one day finding a treatment. 
 If you wish to complain or have any concerns about any aspect of the way you have been approached or 
treated during the course of this study, the normal National Health Service complaints mechanism may be 
available to you.  
Normally placentas are incinerated. We will take a few samples from the placenta for research and these 
samples will be stored until the end of the study and then will be discarded.  
Incidental finding: as the implications of these results are as yet clinically uncertain, no action can be 
justified in direct response. 
Will taking part in this study be kept confidential? All information which is collected about you (blood 
pressure, baby’s weight, and your age, etc) will be kept strictly confidential. Any information about you 
which leaves the hospital will have your name and address removed so that you cannot be recognised from it 
i.e. it is will be strictly anonymous. 
What will happen to the results of the study? 
 When our studies are complete we will publish them in scientific journals. If you are interested then a copy 
of the results can be obtained from us and our contact details are given. 
Who is funding the research? Fund for this project covers by a PhD scholarship from Libyan Ministry of 
Higher Education and Scientific Research 
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The patient will be given a copy of the information sheet and a signed consent form to keep. 
 
Thank you again for your time. 
 
1. Dr Akrem Abdulsid (Researcher)  
PhD student  
University of Glasgow 
Medical Genetics Department  
Dalnair Street  
Glasgow  
G3 8SJ 
 
2. Dr Kevin Hanretty (Consultant Obstetrician) 
Maternity Department 
1345 Goven Road  
Glasgow  
G51 4TF 
 
3. Prof Fiona Lyall (Professor) 
Professor of Maternal and Fetal Health 
University of Glasgow  
Medical Genetics Department  
Dalnair Street  
Glasgow  
G3 8SJ 
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Maternity Department 
Southern General Hospital 
1345 Govan Road 
G51 4TF 
 
 
 
CONSENT FORM 
 
 
Title of the project: Understanding the cause of small birth weight babies and high blood pressure in 
pregnancy. 
 
(Full title: An investigation of the regulation and functions of the inflammation, stress and apoptotic 
pathways in pregnant women and in the human placenta focused on the impact of pre-eclampsia and fetal 
growth restriction on these pathways.) 
 
Researcher’s names: Dr. K. Hanretty (CI), Dr. A. Abdulsid (PI) and Prof. F. Lyall (AS) 
                                                                                                                                                                                                                                                                                        
 
                                                                                                                                      Please initial Box 
 
I confirm that I have read and understood the information sheet dated                       
            16/05/2013 of the above study and I have had the opportunity to consider  
             the information, ask questions and have had these answered satisfactorily. 
 
 
I understand that my participation is voluntary and that I am free to 
              Withdraw at any time without giving any reason, without my medical  
             care or legal rights being affected. 
 
 
I understand that sections of any of my medical notes may be looked   
             at by responsible individuals from regulatory authorities where it is  
              relevant to my taking part in research. I give permission for these 
              individuals to have access to my records.   
 
I agree to blood samples being taken and to placental examination to be  
Undertaken. 
 
I agree to these samples being stored for the study time duration.  
 
 
I agree to take part in the above study 
 
 
 
---------------------------------------                   -------------------------                         ------------------------------ -
Name of patient                                           Date                                                  Signature  
 
---------------------------------------                   -------------------------                         ------------------------------  
Name of person taking consent                   Date                                                   Signature 
(If different from researcher) 
 
---------------------------------------                  ----------------------------                          -------------------------------
-. 
Doctor                                                          Date                                                   Signature 
 
 
1 copy for the patient; 1 for researcher site file; 1 (original) to be kept in medical notes 
 
 
 
 
 
 
 
 
 
